data_2mni_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mni _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.048 0.451 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.64 118.75 37.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 HG22 ' A' ' 39' ' ' VAL . 38.2 t -111.83 119.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 30.0 mt-10 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.272 0.558 . . . . 0.0 110.687 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.753 HG23 ' SD ' ' A' ' 36' ' ' MET . 4.8 mt -98.08 152.48 4.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.378 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -122.33 126.07 47.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.922 0.391 . . . . 0.0 110.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' HE1' ' SD ' ' A' ' 36' ' ' MET . 8.0 m-30 -116.89 125.8 28.01 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.249 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 38.9 Cg_exo -59.4 108.5 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.036 1.824 . . . . 0.0 110.788 171.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.8 -36.07 35.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.743 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -38.55 75.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.637 0.256 . . . . 0.0 111.588 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.7 mpt_? -86.59 -35.56 19.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.379 -173.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.405 HG22 HD21 ' A' ' 62' ' ' LEU . 9.6 tp -66.12 -22.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 109.626 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.17 24.52 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.216 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.27 170.65 15.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.74 136.9 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.92 26.31 19.8 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -63.34 -29.17 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.579 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.88 -4.3 23.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.487 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.23 -8.41 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.898 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -80.43 115.69 20.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.345 0.593 . . . . 0.0 109.897 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.29 -33.46 75.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.325 -168.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -43.31 75.8 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.841 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -64.45 -40.07 95.03 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.719 0.771 . . . . 0.0 109.02 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.77 -44.76 66.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -74.19 -26.8 60.49 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.559 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.9 50.49 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.388 0.613 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.753 ' SD ' HG23 ' A' ' 14' ' ' ILE . 94.8 mmm -72.69 -29.37 63.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.445 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.47 -27.84 70.64 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.88 -41.57 91.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 110.17 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 12' ' ' VAL . 3.6 p -108.65 77.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.161 0.981 . . . . 0.0 110.202 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -150.6 -25.47 0.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.401 -174.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.18 -32.56 16.57 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.103 -174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 t -143.45 63.77 12.91 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.407 0.622 . . . . 0.0 110.695 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 17.5 Cg_endo -93.58 14.86 1.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.96 2.44 . . . . 0.0 113.332 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.518 ' HG3' HD22 ' A' ' 80' ' ' ASN . 21.2 tp10 75.36 -39.32 0.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.444 0.698 . . . . 0.0 112.117 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.42 -104.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.937 -0.477 . . . . 0.0 110.632 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -102.05 -90.5 0.35 Allowed 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.028 0.442 . . . . 0.0 110.735 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.665 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 162.97 -111.71 0.48 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.436 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.5 tmt? -57.95 -44.86 99.7 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 51.8 Cg_exo -58.2 -41.85 62.78 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.971 1.78 . . . . 0.0 111.976 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.891 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.83 -40.59 93.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.317 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.493 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.1 ttp85 -54.95 -46.21 74.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.602 0.239 . . . . 0.0 110.583 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -58.76 -48.53 80.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.675 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.891 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.0 p-90 -72.73 -40.05 66.42 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.235 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 t -61.2 -51.04 77.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.576 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.75 -43.25 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.249 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 52' ' ' ALA . 62.4 mttp -63.23 -50.23 71.03 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.26 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.8 m -61.39 -45.85 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.21 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.31 . . . . 0.0 110.859 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -57.97 -52.49 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.934 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 46.8 mt-10 -69.09 -39.73 78.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.28 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.83 88.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.405 HD21 HG22 ' A' ' 21' ' ' ILE . 6.4 tp -70.71 -45.55 64.74 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.95 -32.87 74.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 28.4 mmmt -80.03 -22.71 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.349 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -140.94 69.56 29.16 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.475 0.655 . . . . 0.0 109.707 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.47 50.34 3.35 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.406 2.737 . . . . 0.0 113.182 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' HB2' ' HZ1' ' A' ' 67' ' ' LYS . 9.8 mtmp? -142.18 28.33 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.374 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.07 -172.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.35 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -131.57 -39.86 1.12 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.143 -173.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -164.3 156.75 16.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.797 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.11 122.55 48.17 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.414 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 7.9 mt -106.56 136.71 45.87 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.125 -173.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.99 117.62 61.06 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.448 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HG2' HG13 ' A' ' 83' ' ' VAL . 43.1 Cg_exo -40.05 135.5 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.58 2.853 . . . . 0.0 113.347 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -62.65 -25.67 68.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.355 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.87 68.3 9.3 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 t -57.35 -23.19 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.363 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 3.5 mptp? -61.56 -24.05 66.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.518 HD22 ' HG3' ' A' ' 44' ' ' GLU . 51.5 t30 -65.9 -17.94 65.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.34 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.495 ' HG ' ' C ' ' A' ' 80' ' ' ASN . 79.1 p 62.17 -96.57 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -78.11 53.69 1.24 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.33 0.586 . . . . 0.0 112.555 -167.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.474 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.1 p -142.11 134.53 27.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.928 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -139.37 145.4 38.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.693 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.0 117.29 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.713 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.404 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 13.2 t-160 -98.01 102.64 14.44 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.7 t -91.77 112.92 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.101 0.477 . . . . 0.0 109.985 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.2 mt -104.3 139.03 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.051 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -102.71 106.91 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.49 135.91 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.77 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 9.3 p-10 -101.43 119.2 38.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.578 0.704 . . . . 0.0 109.771 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -95.3 139.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.791 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -92.25 130.95 37.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.381 0.61 . . . . 0.0 110.337 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.541 HD11 ' SD ' ' A' ' 36' ' ' MET . 25.5 mt -128.59 133.19 67.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.553 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 61.1 m80 -120.26 126.29 50.23 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 110.795 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.2 m-85 -127.57 115.01 21.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 37.3 Cg_exo -61.27 121.95 10.4 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.292 1.994 . . . . 0.0 111.861 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -43.35 -44.01 5.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 113.851 -1.522 . . . . 0.0 113.901 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -77.41 -38.31 49.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HD2' ' HG2' ' A' ' 17' ' ' PRO . 17.7 ptp180 -89.34 -25.14 21.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.741 -172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -71.65 -22.57 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.08 -11.89 58.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 142.3 44.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.198 0.523 . . . . 0.0 110.845 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.44 -19.43 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.75 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.54 55.36 0.83 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -67.85 -40.46 83.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.489 0.185 . . . . 0.0 111.211 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 61.92 1.51 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.696 0.76 . . . . 0.0 110.032 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.21 -34.9 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.247 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 29.2 t70 -75.1 119.97 19.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.813 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.483 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 29.5 tt0 -64.57 -35.24 80.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.36 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.36 -43.06 92.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.252 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -65.59 -41.9 92.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.73 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -70.3 -45.09 66.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.092 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 90.4 m-20 -61.8 -37.6 84.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.379 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -73.76 -41.93 61.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 70.8 mmm -86.84 12.24 11.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.9 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.19 -27.14 6.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 164.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.77 -62.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.076 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.09 71.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 122.07 0.938 . . . . 0.0 109.771 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.7 t-20 -147.5 -44.65 0.17 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -165.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.27 -39.56 54.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.838 0.352 . . . . 0.0 111.034 -171.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -128.55 69.77 79.48 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.694 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -98.96 25.52 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.312 2.674 . . . . 0.0 112.816 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 80' ' ' ASN . 5.1 tp10 73.38 -39.39 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.552 0.741 . . . . 0.0 112.114 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' CB ' HD23 ' A' ' 50' ' ' LEU . 32.5 mt-10 -85.56 -88.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.266 0.555 . . . . 0.0 111.441 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.01 -86.61 0.44 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.054 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 158.49 -78.45 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.972 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.459 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -63.0 -47.62 86.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 17.3 Cg_exo -69.02 -24.32 33.19 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.857 1.705 . . . . 0.0 110.326 175.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.661 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -59.77 -48.2 82.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.649 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 36.3 ptt180 -75.11 -38.86 60.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.584 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.29 81.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.209 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.0 p-90 -72.45 -43.83 63.21 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.91 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -40.99 78.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.383 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.47 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 83.1 mt -66.54 -45.59 88.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.522 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 38.6 ttmt -63.96 -47.7 79.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.5 m -65.26 -42.61 93.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.193 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.73 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.395 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.21 -52.63 64.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.575 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 19.2 mm-40 -61.53 -42.47 98.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.863 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.03 93.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.415 HD23 HG22 ' A' ' 21' ' ' ILE . 8.4 tp -63.65 -46.97 83.21 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.511 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.1 -26.89 63.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.18 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.77 -40.03 91.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 110.082 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -135.86 73.78 59.25 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.322 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 55.84 4.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.037 2.492 . . . . 0.0 112.322 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -132.16 -6.58 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.631 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 pt -93.52 -175.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.177 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.82 -9.51 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.418 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -166.37 152.72 8.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.973 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.89 156.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.353 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -111.17 115.66 29.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.325 0.583 . . . . 0.0 109.898 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.123 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -118.93 131.84 24.17 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.43 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -26.9 137.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 1 C-N-CA 125.709 4.272 . . . . 0.0 115.905 173.317 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -55.47 -45.1 76.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.578 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.68 83.25 2.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.59 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.38 -21.37 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.394 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -65.07 -24.09 67.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.478 ' ND2' HG11 ' A' ' 83' ' ' VAL . 48.4 t30 -64.75 -22.76 67.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m 68.54 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 m -79.24 49.45 0.97 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -167.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.478 HG11 ' ND2' ' A' ' 80' ' ' ASN . 6.7 p -142.85 136.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -146.79 154.59 41.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.539 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.07 135.06 54.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.126 0.489 . . . . 0.0 110.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -106.11 103.47 12.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.608 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.0 111.95 24.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.71 137.76 35.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.172 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 71.4 m-85 -102.46 108.53 19.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.391 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.553 ' OD1' ' HB3' ' A' ' 15' ' ' HIS . 10.5 m-20 -76.38 120.39 21.56 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 121.573 0.701 . . . . 0.0 110.914 -174.135 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 HG21 ' A' ' 83' ' ' VAL . 3.3 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.42 118.62 37.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.233 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.72 117.78 43.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 31.7 mt-10 -103.93 112.04 24.85 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.202 0.525 . . . . 0.0 110.449 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 2.3 mt -108.5 124.42 64.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.49 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 79.6 m80 -101.83 112.37 24.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -99.94 128.93 29.64 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.526 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 40.5 Cg_endo -68.13 111.43 2.46 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.048 1.832 . . . . 0.0 111.133 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 tt -51.09 -37.87 48.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.223 -171.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -70.34 -34.95 73.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -93.49 -30.79 14.85 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.304 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.08 -24.85 34.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 121.076 0.465 . . . . 0.0 109.901 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.03 68.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.26 148.53 41.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.521 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.86 -22.01 29.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.327 0.584 . . . . 0.0 109.77 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.57 3.24 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 173.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -71.87 -13.93 61.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.807 0.337 . . . . 0.0 111.627 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.13 -12.08 61.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.304 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.14 -5.42 56.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.48 107.05 18.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.253 0.549 . . . . 0.0 110.876 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.58 -32.15 72.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.4 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.5 mt -58.5 -45.78 88.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.001 0.429 . . . . 0.0 110.507 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.17 -40.8 67.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.46 0.648 . . . . 0.0 110.001 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.76 -44.08 67.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.621 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 2.5 p30 -71.94 -34.24 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.792 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -69.87 -38.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.807 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.24 5.68 29.25 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.762 175.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.88 -28.68 8.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 32.3 mmtp -77.02 -70.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.38 34.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.975 0.893 . . . . 0.0 110.596 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 36' ' ' MET . 26.8 t-20 -138.63 -8.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.812 -173.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.14 -32.27 63.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.453 0.644 . . . . 0.0 109.866 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -138.45 67.75 45.47 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.462 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -88.9 7.96 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 112.636 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 72.64 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.711 0.804 . . . . 0.0 111.873 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG3' ' HB1' ' A' ' 77' ' ' ALA . 10.2 tt0 -64.1 -70.05 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.828 0.346 . . . . 0.0 111.05 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.63 -129.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.568 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -154.61 -94.88 0.11 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 167.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 11.1 ttp -53.16 -42.89 93.3 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 14.4 Cg_exo -70.5 -28.36 21.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.912 1.742 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.8 tm? -57.69 -45.69 85.32 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -60.19 -49.22 78.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.46 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.72 76.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 -175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.5 p-90 -73.41 -37.38 65.93 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.523 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.96 -51.34 67.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.61 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.707 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 4.8 tppp? -64.1 -50.37 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.863 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 73' ' ' LEU . 50.0 t -61.7 -46.46 89.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.342 . . . . 0.0 110.724 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.43 89.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.461 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -62.37 -45.35 93.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.114 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 56' ' ' LYS . 58.6 mt-10 -62.45 -47.21 85.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.2 96.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.199 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 62' ' ' LEU . 3.2 tm? -74.37 -37.88 63.33 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.436 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.27 -26.07 36.05 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.449 -0.782 . . . . 0.0 112.024 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.7 tmtp? -82.72 -37.12 25.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.636 ' ND2' HG22 ' A' ' 68' ' ' ILE . 4.0 t30 -131.4 90.43 37.88 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.864 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -88.14 31.68 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.611 2.207 . . . . 0.0 111.365 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -118.34 11.29 13.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.636 HG22 ' ND2' ' A' ' 65' ' ' ASN . 7.3 pt -95.49 166.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.243 173.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -129.4 -3.58 4.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.92 157.35 9.82 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.984 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.38 156.94 39.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.981 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -110.39 117.45 33.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.384 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.5 mt -111.1 140.76 45.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.627 0.727 . . . . 0.0 112.383 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 23.6 tptm -117.58 123.93 29.38 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.425 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD2' ' HD2' ' A' ' 74' ' ' LYS . 68.7 Cg_exo -38.97 144.44 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.247 3.298 . . . . 0.0 113.799 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -65.79 -30.96 71.68 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HB1' ' HG3' ' A' ' 45' ' ' GLU . . . -79.11 76.62 5.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.844 169.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.73 -25.14 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -57.09 -24.0 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.683 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -62.93 -36.57 83.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.107 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m 65.67 -76.38 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -86.68 36.33 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.442 HG12 ' HG2' ' A' ' 75' ' ' PRO . 7.4 p -140.79 130.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -127.9 151.15 49.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.208 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' CE2' HD23 ' A' ' 50' ' ' LEU . 74.4 m-85 -112.19 123.65 50.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.239 0.542 . . . . 0.0 110.2 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 12.1 t-160 -112.14 102.25 10.46 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 90.1 t -95.52 113.68 30.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.135 0.493 . . . . 0.0 110.206 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.483 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 88.0 mt -101.82 140.78 19.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -103.13 107.62 18.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 33.8 m-20 -94.72 116.69 29.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 121.574 0.702 . . . . 0.0 111.083 -176.139 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.08 121.53 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.549 0.69 . . . . 0.0 110.27 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 39' ' ' VAL . 87.3 t -92.28 139.58 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.719 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.62 112.8 26.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.0 110.519 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.0 mt -103.07 152.21 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 56.3 m80 -130.43 142.84 50.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.488 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -141.96 132.53 12.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.075 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' O ' HG21 ' A' ' 21' ' ' ILE . 19.4 Cg_endo -58.3 115.26 2.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.503 2.135 . . . . 0.0 111.706 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 62' ' ' LEU . 1.5 tm? -43.07 -50.82 6.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.584 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' H ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.55 -18.82 58.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 9.5 ttt180 -100.77 -35.3 9.5 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.881 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -69.4 -25.72 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.223 0.535 . . . . 0.0 109.81 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.85 -12.13 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.92 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.6 171.31 12.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.002 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.24 -52.3 17.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 109.783 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.06 71.32 3.03 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.103 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' HD22 ' A' ' 32' ' ' LEU . 16.7 p90 -65.24 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.909 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.04 4.97 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.0 111.251 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.485 ' OD1' ' HD3' ' A' ' 20' ' ' ARG . 36.3 t70 -75.39 113.96 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.51 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -63.03 -34.8 78.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.466 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.537 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 32.1 tp -61.5 -40.33 94.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.522 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -55.84 -42.73 76.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 109.58 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.444 HD13 ' NH2' ' A' ' 51' ' ' ARG . 3.5 mm? -65.08 -47.7 76.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.407 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.53 -41.83 88.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.83 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 14.5 mt-30 -66.42 -44.09 83.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.343 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.5 mmm -87.68 -1.09 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.3 -26.68 15.12 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 165.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 35' ' ' GLN . 60.6 tttp -64.81 -66.58 0.52 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.274 -0.963 . . . . 0.0 110.829 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 ' CG1' ' A' ' 12' ' ' VAL . 7.5 p -108.61 97.59 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.748 0.785 . . . . 0.0 110.229 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -176.59 -26.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.55 -44.56 96.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.043 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -145.1 73.98 14.44 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.745 0.783 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -91.44 21.03 0.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.838 2.359 . . . . 0.0 112.45 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 71.59 -37.76 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 112.366 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.682 ' CD ' ' HB3' ' A' ' 75' ' ' PRO . 23.6 tp10 -82.4 -94.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.332 -0.23 . . . . 0.0 111.169 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 32.7 mt-10 -114.82 -109.16 0.36 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.737 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 167.67 -106.27 0.25 Allowed Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.658 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.667 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 10.8 tpt -49.77 -48.39 77.34 Favored Pre-proline 0 C--O 1.247 0.954 0 CA-C-O 120.958 0.409 . . . . 0.0 111.317 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.597 ' HG2' ' HB3' ' A' ' 46' ' ' GLU . 31.4 Cg_endo -60.58 -34.15 92.81 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.043 1.162 . . . . 0.0 110.366 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.71 ' O ' ' HE3' ' A' ' 53' ' ' TRP . 4.0 mt -60.28 -44.41 95.38 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.2 ptm180 -62.83 -39.21 93.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.211 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.36 94.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.722 0.772 . . . . 0.0 110.047 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.71 ' HE3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -51.15 69.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.95 1.3 . . . . 0.0 112.881 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.61 ' HB ' ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -73.35 -43.71 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -58.52 -38.98 73.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.628 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 12.5 mmmm -69.62 -49.1 57.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.698 174.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.666 ' SG ' HD11 ' A' ' 73' ' ' LEU . 49.7 t -59.18 -44.45 92.17 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.777 0.322 . . . . 0.0 110.942 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.18 92.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.301 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -61.35 -48.14 82.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.424 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 33.3 mm-40 -64.54 -44.0 92.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.514 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.45 95.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.439 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.42 HD11 HD22 ' A' ' 18' ' ' LEU . 10.1 tt -68.63 -48.19 64.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.149 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -63.64 -25.51 68.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.702 0.287 . . . . 0.0 111.337 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -71.76 -33.58 68.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.219 0.533 . . . . 0.0 110.279 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -149.36 73.4 9.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.717 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.29 33.73 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.323 2.682 . . . . 0.0 113.026 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.04 18.87 10.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.525 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.0 pt -96.1 -173.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.923 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.72 -27.38 2.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.529 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -165.06 168.86 16.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 176.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.17 153.51 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -110.96 132.55 54.11 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.644 0.735 . . . . 0.0 111.303 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.666 HD11 ' SG ' ' A' ' 57' ' ' CYS . 1.8 mm? -107.87 143.9 35.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.492 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -130.83 122.62 19.6 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.682 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -32.74 140.46 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 125.273 3.982 . . . . 0.0 115.906 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.518 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 42.4 mtp180 -57.75 -37.59 73.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.989 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.96 84.6 7.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.511 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.68 -12.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.379 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -59.07 -32.14 69.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.608 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 45' ' ' GLU . 4.9 t-20 -63.13 -37.72 88.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.503 -172.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m 69.24 -59.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -77.63 -34.2 53.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -167.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.514 HG12 ' HG2' ' A' ' 75' ' ' PRO . 8.8 p -89.88 132.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 112.255 -171.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -130.6 161.66 31.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.721 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.93 136.23 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.442 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -111.92 111.12 21.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.8 t -92.04 110.36 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 15' ' ' HIS . 82.3 mt -101.2 136.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.162 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.31 111.51 23.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.239 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -77.19 113.92 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 N--CA 1.439 -1.008 0 CA-C-O 121.725 0.774 . . . . 0.0 110.341 179.726 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.675 0.274 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.58 118.42 31.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.24 119.98 56.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 23.6 mt-10 -100.27 118.98 37.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.085 0.469 . . . . 0.0 111.173 -168.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.525 HD11 ' SD ' ' A' ' 36' ' ' MET . 24.4 mt -101.32 132.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.084 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.578 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.5 m80 -112.39 112.09 23.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 110.896 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -106.21 153.51 40.28 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.0 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' HG23 ' A' ' 21' ' ' ILE . 87.5 Cg_endo -81.69 113.89 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.281 1.988 . . . . 0.0 111.673 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -43.3 -49.1 6.86 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.95 -32.07 61.64 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' HD2' ' OD1' ' A' ' 29' ' ' ASP . 2.6 ttm180 -96.86 -21.46 17.49 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.85 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 17' ' ' PRO . 6.7 tp -72.28 -27.34 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.02 -9.11 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.13 155.27 19.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.125 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -84.01 -14.35 50.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.833 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.08 43.71 1.65 Allowed Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -60.03 -27.76 67.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 111.624 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -14.34 62.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.639 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.99 -18.47 43.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.557 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 25.5 t70 -84.7 109.0 17.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 111.57 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -29.61 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.25 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . 2.9 tm? -63.86 -40.2 95.98 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.3 -43.84 98.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.297 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.97 -44.57 92.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -58.4 -43.32 88.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.257 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 2.4 mp0 -68.44 -45.21 73.16 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.525 ' SD ' HD11 ' A' ' 14' ' ' ILE . 66.2 mmm -90.15 13.43 15.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.172 0.51 . . . . 0.0 110.825 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.88 -38.29 3.67 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -63.4 -66.11 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.121 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 p -91.36 68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 122.338 1.066 . . . . 0.0 110.267 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.11 9.8 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.145 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.34 -36.95 3.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.987 0.423 . . . . 0.0 110.055 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.417 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.1 p -141.94 59.3 9.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.989 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 42' ' ' THR . 67.1 Cg_endo -94.68 30.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.047 2.498 . . . . 0.0 113.098 -174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 73.79 -47.9 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.31 0.644 . . . . 0.0 111.048 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.558 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -77.81 -92.64 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.95 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -130.06 -91.3 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.605 0.241 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 165.96 -102.6 0.19 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.597 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 9.1 ttp -53.55 -45.97 98.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 48' ' ' MET . 19.2 Cg_endo -60.9 -30.2 89.56 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.879 1.719 . . . . 0.0 111.05 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.795 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -59.06 -45.96 89.47 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.292 176.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 18.0 ttm180 -59.98 -48.94 79.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.2 78.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.376 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.795 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.3 p-90 -72.38 -41.93 65.8 Favored 'General case' 0 CA--C 1.522 -0.096 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.852 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -43.18 80.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.689 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.78 -46.23 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.316 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.53 -41.81 88.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.586 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.42 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 71.7 m -66.28 -44.85 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.819 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.33 83.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.833 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -59.35 -49.35 78.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.967 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -64.56 -41.83 96.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.043 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.9 96.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.283 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD22 HG22 ' A' ' 21' ' ' ILE . 15.6 tp -69.48 -47.36 64.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.135 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.66 -26.44 67.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -42.17 98.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.494 0.664 . . . . 0.0 109.961 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.4 75.09 33.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.75 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.15 47.77 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.073 2.515 . . . . 0.0 112.709 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -139.26 2.83 2.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.69 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -85.64 -179.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.574 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.19 -19.75 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.878 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -165.51 155.47 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.0 t -127.28 152.36 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.681 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -110.1 116.22 31.16 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.429 HD23 ' CZ3' ' A' ' 53' ' ' TRP . 29.8 tp -127.7 141.89 51.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.338 -167.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -126.38 126.86 24.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.448 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 18.1 Cg_endo -63.16 171.22 6.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.107 2.538 . . . . 0.0 114.733 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -66.41 -61.01 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.66 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.99 118.01 4.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.49 -9.75 13.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.156 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -58.81 -39.57 81.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' OD1' HG13 ' A' ' 83' ' ' VAL . 1.6 p30 -73.46 -27.06 61.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.495 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m 74.49 -66.51 0.29 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 m -125.85 27.07 6.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.422 HG13 ' OD1' ' A' ' 80' ' ' ASN . 9.9 p -90.16 134.98 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -134.86 152.25 51.59 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.996 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -108.51 118.86 37.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.632 0.73 . . . . 0.0 109.623 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.4 t-160 -94.05 102.04 14.09 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.32 112.22 25.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -113.54 139.11 40.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.528 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.57 106.65 17.12 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.201 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -86.9 127.32 35.05 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.248 179.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.21 118.39 28.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.014 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.05 119.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -98.77 112.22 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 0.0 110.26 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.412 HD13 ' SD ' ' A' ' 36' ' ' MET . 10.2 mt -111.95 123.34 67.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -99.66 112.82 25.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.237 0.542 . . . . 0.0 110.914 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-30 -111.42 116.04 51.23 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.589 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 33.6 Cg_exo -61.79 119.74 7.01 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.008 . . . . 0.0 111.789 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.7 tm? -42.38 -45.2 4.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.765 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -71.98 -43.54 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.785 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 11.5 ptp180 -83.13 -28.66 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.277 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 17' ' ' PRO . 7.8 tp -75.24 -17.69 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.0 109.891 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.88 -13.72 55.6 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.25 0.548 . . . . 0.0 110.395 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.35 156.94 20.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.369 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.9 -14.37 51.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.351 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.16 60.61 1.1 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -82.16 -41.53 20.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 111.158 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.37 -4.75 43.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.2 9.38 30.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.501 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 18.0 t70 -95.57 119.5 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.882 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.62 -31.56 71.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.607 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 6.4 mt -69.03 -43.21 75.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.26 0.552 . . . . 0.0 110.465 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.0 -36.56 75.24 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.394 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -47.9 58.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.28 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.3 p30 -71.45 -35.16 70.81 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.864 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -66.47 -45.21 80.47 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.999 0.428 . . . . 0.0 110.64 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 7.3 tpt -93.34 16.81 12.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.133 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.09 -32.98 3.85 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 163.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.53 -62.98 1.43 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.63 -0.785 . . . . 0.0 110.576 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 39' ' ' VAL . 11.4 p -94.6 52.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.705 1.24 . . . . 0.0 110.165 -176.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 36' ' ' MET . 4.2 t-20 -133.16 -29.37 1.43 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.583 -171.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -79.48 -31.38 42.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.67 -169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 p -126.1 62.38 44.92 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.906 0.384 . . . . 0.0 111.225 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.479 ' O ' HG22 ' A' ' 83' ' ' VAL . 11.3 Cg_endo -97.21 6.6 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.936 2.424 . . . . 0.0 113.456 -174.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 71.19 -42.03 0.52 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.698 0.799 . . . . 0.0 112.205 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HB3' HD22 ' A' ' 50' ' ' LEU . 3.9 tp10 -66.72 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.345 0.117 . . . . 0.0 110.983 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 31.5 mt-10 -136.28 -86.44 0.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.328 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 160.9 -110.26 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.099 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.547 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.6 tpt -52.72 -49.53 85.91 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.9 Cg_endo -67.82 -35.73 20.47 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.208 1.272 . . . . 0.0 111.566 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.725 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.38 -43.2 96.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.415 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 48' ' ' MET . 35.6 ptt180 -69.51 -29.87 67.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.997 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -49.31 77.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.668 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.725 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 12.2 p-90 -73.09 -36.84 66.87 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.148 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -49.1 82.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.43 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 79.6 mt -65.55 -38.64 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.427 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.2 tptt -63.65 -48.86 75.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.727 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 73' ' ' LEU . 47.7 t -62.68 -46.95 85.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.69 83.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.667 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -62.4 -52.23 64.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.547 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 56.7 mm-40 -65.04 -38.35 90.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.661 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.71 -44.12 90.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 62' ' ' LEU . 8.2 tt -72.94 -47.23 47.39 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.782 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.55 -26.08 63.18 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.805 -0.559 . . . . 0.0 112.09 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -84.05 -44.96 13.57 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.57 ' ND2' HG22 ' A' ' 68' ' ' ILE . 3.2 t30 -139.45 100.14 7.69 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.866 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -96.79 25.66 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.695 2.263 . . . . 0.0 112.012 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.04 8.22 32.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' ND2' ' A' ' 65' ' ' ASN . 4.7 pt -77.51 166.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.733 0.777 . . . . 0.0 111.474 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HE ' ' HB2' ' A' ' 69' ' ' ARG . 2.0 mtm180 -106.89 -51.39 2.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.325 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.9 150.37 27.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.139 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.55 156.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.772 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -111.16 115.1 28.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 57' ' ' CYS . 11.2 mt -111.69 136.68 50.6 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.636 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -113.93 119.16 41.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HG2' HG12 ' A' ' 83' ' ' VAL . 88.2 Cg_exo -37.23 147.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 125.034 3.823 . . . . 0.0 114.301 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -61.32 -40.33 93.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.957 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.76 85.8 3.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.984 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.51 -22.67 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.075 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -57.58 -29.27 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.216 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.23 -38.56 91.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.724 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m 65.6 -56.64 0.33 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 123.945 0.778 . . . . 0.0 113.02 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 m -76.87 -37.37 55.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.492 HG12 ' HG2' ' A' ' 75' ' ' PRO . 7.8 p -87.68 140.23 16.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -146.47 153.3 40.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.69 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.15 126.43 52.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.447 0.641 . . . . 0.0 111.053 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -109.31 102.84 11.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.87 114.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.615 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 77.2 mt -104.17 133.15 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.85 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 87.6 m-85 -102.65 109.91 21.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.659 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 17.5 t70 -99.58 131.91 45.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 C--N 1.32 -0.698 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.892 -179.004 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.16 119.61 26.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.688 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 89.1 t -118.54 130.3 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.4 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.14 127.07 53.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 110.552 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mt -116.16 129.45 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -102.22 140.12 36.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -132.46 126.87 20.42 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 22.4 Cg_endo -63.59 111.25 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.941 1.76 . . . . 0.0 110.242 172.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.31 -35.44 18.2 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.894 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 3.5 mptp? -68.23 -40.58 82.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.682 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -83.19 -36.69 24.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.832 0.348 . . . . 0.0 110.508 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.461 HG22 HD21 ' A' ' 62' ' ' LEU . 10.8 tp -74.69 -3.49 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.248 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.59 -6.36 22.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.13 168.81 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.066 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.41 -44.48 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.13 49.97 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.178 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.01 -34.9 77.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.39 32.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -95.62 2.1 53.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.19 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -89.56 123.06 33.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.094 0.473 . . . . 0.0 109.996 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.68 -32.59 74.12 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.809 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 22.4 tp -70.71 -42.36 70.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -43.04 86.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.308 0.575 . . . . 0.0 109.831 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.4 tp -70.6 -49.87 43.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.935 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 4.5 p30 -74.8 -27.58 60.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.728 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.745 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.2 tt0 -66.63 -45.45 79.03 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 7.03 44.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.059 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.04 -27.15 8.42 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.74 -66.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.449 . . . . 0.0 111.171 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.49 41.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.924 1.345 . . . . 0.0 109.719 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -145.84 -3.94 0.67 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.119 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.88 -30.83 65.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.506 0.669 . . . . 0.0 109.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.8 67.89 79.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 89.4 Cg_endo -95.37 25.48 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.257 2.638 . . . . 0.0 113.263 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.49 -55.58 0.62 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.456 0.702 . . . . 0.0 111.773 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.13 -108.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -93.88 -124.79 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.565 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -153.1 -89.17 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.568 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -58.38 -39.6 76.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 32.8 Cg_endo -77.63 -23.97 9.28 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 120.82 1.329 . . . . 0.0 110.591 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.562 HD21 ' NE1' ' A' ' 53' ' ' TRP . 3.1 tm? -58.87 -46.01 88.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.725 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 48' ' ' MET . 13.0 ptt180 -67.36 -38.6 85.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.42 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.69 80.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.891 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.562 ' NE1' HD21 ' A' ' 50' ' ' LEU . 7.6 p-90 -72.93 -37.28 67.24 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.885 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.47 -51.11 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.43 -41.15 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.734 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -62.45 -49.5 75.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.768 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.44 -45.24 94.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.99 92.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -57.79 -58.23 9.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.299 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -64.08 -41.95 97.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.72 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 21' ' ' ILE . 7.8 tp -76.84 -47.79 20.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.035 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.68 -27.35 65.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 2.7 mmmp? -69.36 -29.15 66.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -149.01 73.62 10.19 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.12 41.39 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.076 2.517 . . . . 0.0 113.171 -170.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -133.44 26.22 4.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.38 -172.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.3 0.571 . . . . 0.0 111.67 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -127.04 -44.01 1.64 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.555 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.46 152.87 12.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -122.73 156.96 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.985 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.47 116.88 32.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.71 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -106.08 144.28 33.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.3 0.571 . . . . 0.0 111.198 -174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 13.4 tmtt? -123.83 115.38 27.96 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.887 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 90.0 Cg_exo -46.32 138.51 13.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.867 3.045 . . . . 0.0 113.521 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -56.91 -29.51 63.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.031 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.67 96.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.054 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' HZ1' ' A' ' 74' ' ' LYS . 58.1 t -62.4 -29.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.269 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -61.69 -28.54 69.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.829 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -73.54 -39.77 64.49 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.076 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 m 64.4 -71.97 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.436 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 m -91.92 59.6 3.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.95 136.22 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.978 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.38 160.16 40.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.229 0.538 . . . . 0.0 111.399 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 62.0 m-85 -120.79 123.62 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.709 171.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -91.9 101.65 14.22 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.77 112.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.2 138.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.661 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -103.61 110.35 22.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 7.5 m-20 -99.34 132.36 44.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.721 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.44 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 1.1 pm0 . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 0.0 110.811 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.7 t . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 120.583 0.23 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.39 117.78 35.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -106.06 140.24 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -103.09 112.26 25.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.421 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' SD ' ' A' ' 36' ' ' MET . 40.2 mt -111.63 142.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 64.7 m80 -125.61 119.52 28.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 21.8 m-85 -118.11 106.96 44.43 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.157 174.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_exo -59.07 123.33 13.25 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.931 1.754 . . . . 0.0 111.586 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -48.86 19.74 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -68.74 -29.11 67.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 12.4 ptp180 -94.58 -28.66 15.28 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.605 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.91 -25.06 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.184 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -82.17 -11.22 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 110.686 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.57 177.11 6.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.438 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.58 151.93 24.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 21.61 51.15 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -170.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -61.84 -30.51 70.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.544 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.24 59.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.214 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -76.64 -27.29 55.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.425 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 102.55 0.79 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.039 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 35.8 tt0 -62.46 -31.13 71.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.008 -171.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 36.8 tp -60.65 -42.51 97.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.46 -42.14 83.51 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.618 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD13 ' NH2' ' A' ' 51' ' ' ARG . 7.3 tp -67.16 -46.3 74.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.779 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.488 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 93.5 m-20 -59.74 -42.95 94.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 43.3 mt-30 -64.86 -43.49 92.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.438 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 72.2 mmm -87.69 9.02 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.78 -29.26 5.04 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 166.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -73.19 -61.62 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.587 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -92.77 30.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.428 1.109 . . . . 0.0 110.188 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.544 HD22 ' HB2' ' A' ' 50' ' ' LEU . 26.0 t-20 -141.6 0.78 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.778 -170.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.77 -47.07 76.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.294 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.37 72.04 82.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 75.6 Cg_endo -92.69 23.09 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.095 2.53 . . . . 0.0 113.577 -172.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 71.3 -57.33 0.61 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.257 0.623 . . . . 0.0 112.004 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.563 ' HB3' HD11 ' A' ' 50' ' ' LEU . 5.5 tp10 -67.0 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.895 0.478 . . . . 0.0 111.231 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -127.93 -91.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 170.63 -114.42 0.54 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.897 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -56.91 -40.14 82.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.58 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.21 -37.38 69.98 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.921 1.747 . . . . 0.0 112.11 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.743 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.9 mt -60.08 -45.56 92.5 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 36' ' ' MET . 1.8 ttt180 -56.55 -41.83 77.5 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.106 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.743 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.1 -40.32 68.27 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.767 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -43.08 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 71.2 mt -64.06 -44.89 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 176.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.63 -48.4 77.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.603 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.0 m -67.59 -39.38 84.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.089 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.64 89.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.44 -54.56 39.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.578 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.02 -36.74 82.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.3 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.37 75.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.191 0.52 . . . . 0.0 110.932 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.9 tm? -83.62 -41.43 17.82 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.717 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -79.64 -29.13 40.87 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.107 -0.37 . . . . 0.0 111.321 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -89.64 -14.78 34.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.822 0.82 . . . . 0.0 109.315 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -144.45 68.9 15.34 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.373 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 46.4 Cg_endo -83.24 37.93 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.767 2.312 . . . . 0.0 112.766 -170.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -17.97 13.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.498 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 pp -80.77 -173.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.426 0.632 . . . . 0.0 112.184 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -140.94 -16.42 0.87 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.643 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.25 163.06 20.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.199 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p -134.59 153.25 34.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.075 0.464 . . . . 0.0 110.422 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -109.52 113.58 26.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -121.8 143.82 49.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.544 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -116.89 131.78 23.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.33 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HD2' HG12 ' A' ' 83' ' ' VAL . 86.8 Cg_exo -51.41 151.62 13.22 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.382 2.721 . . . . 0.0 112.848 172.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -63.12 -33.19 74.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.733 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HB2' ' ND2' ' A' ' 80' ' ' ASN . . . -65.87 112.81 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.751 0.786 . . . . 0.0 111.131 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.4 -33.54 59.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.771 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -65.02 -26.13 68.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.743 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.551 ' ND2' ' HB2' ' A' ' 77' ' ' ALA . 87.7 m-20 -64.55 -29.36 70.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.783 0.325 . . . . 0.0 110.909 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.9 t 66.67 -82.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.666 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 t -108.8 37.99 2.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 80' ' ' ASN . 13.1 p -101.03 130.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -130.36 136.31 48.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.421 ' HA ' HG13 ' A' ' 12' ' ' VAL . 10.9 m-30 -105.61 124.2 49.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.742 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.27 102.47 12.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 40.4 t -94.43 111.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.92 140.43 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.425 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 78.9 m-85 -101.33 108.22 19.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 6.5 t70 -83.94 135.78 34.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.265 -169.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--N 1.321 -0.661 0 CA-C-O 121.351 0.596 . . . . 0.0 109.981 176.631 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.81 119.01 33.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.23 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.28 130.19 55.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.271 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -108.41 117.17 33.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.507 0.67 . . . . 0.0 110.406 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 HD11 ' SD ' ' A' ' 36' ' ' MET . 33.4 mt -115.75 133.06 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.06 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -120.84 107.72 13.07 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.589 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.3 132.23 24.75 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.847 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 10.2 Cg_exo -66.56 120.73 7.88 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.672 1.581 . . . . 0.0 109.547 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -53.92 -42.23 68.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.814 -167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -79.56 -24.11 42.34 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.492 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 17' ' ' PRO . 7.8 mpt_? -81.28 -38.03 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.53 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tp -70.75 -26.31 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.287 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.23 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.99 157.85 34.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.55 -21.72 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.335 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.52 38.94 3.14 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.465 ' O ' HD22 ' A' ' 32' ' ' LEU . 32.1 p90 -66.36 -35.94 81.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.503 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.0 -9.68 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.224 0.535 . . . . 0.0 111.29 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.38 -3.2 50.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.2 124.78 30.21 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.738 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.29 -28.98 70.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -170.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.524 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 3.1 tm? -76.51 -36.82 57.53 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.633 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -66.23 -40.33 90.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.829 177.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.31 -49.6 63.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.966 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.9 p30 -73.45 -34.06 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.91 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.633 HE21 ' HA ' ' A' ' 32' ' ' LEU . 3.5 pt20 -67.99 -41.48 82.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.926 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.437 ' SD ' HD11 ' A' ' 14' ' ' ILE . 86.7 mmm -90.32 5.82 45.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.11 -28.19 11.19 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 164.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 68.1 mttm -77.11 -73.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.344 -0.428 . . . . 0.0 111.986 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.59 50.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.722 0.772 . . . . 0.0 110.564 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -142.49 -23.9 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.404 -170.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -87.18 -18.23 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.173 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 p -133.27 57.43 27.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.25 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 42' ' ' THR . 26.5 Cg_endo -101.52 24.01 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.321 2.681 . . . . 0.0 113.814 -174.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 70.54 -58.04 0.56 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.053 0.541 . . . . 0.0 112.239 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.495 ' HB3' HD12 ' A' ' 50' ' ' LEU . 37.8 tt0 -73.09 -86.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.601 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.32 -95.7 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.171 -0.331 . . . . 0.0 110.569 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 162.18 -83.05 0.12 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.84 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 12.6 tpt -54.36 -49.89 88.08 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 48' ' ' MET . 47.9 Cg_endo -68.56 -27.78 32.46 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.402 1.401 . . . . 0.0 110.02 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 2.3 mt -57.83 -46.31 84.92 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HE1' ' A' ' 36' ' ' MET . 27.8 ttt180 -64.28 -47.0 81.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.61 -49.87 75.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.841 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.58 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 6.2 p-90 -74.06 -41.29 61.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.888 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.7 t -61.45 -51.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.419 HD13 ' HG3' ' A' ' 36' ' ' MET . 80.1 mt -60.28 -41.37 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.7 tmtt? -63.2 -50.43 70.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.578 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -64.14 -41.45 97.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.832 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.72 97.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.369 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.99 -49.58 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.29 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 10.4 mm-40 -61.77 -45.8 92.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.51 93.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -60.95 -46.03 92.35 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.452 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.4 -27.46 52.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -63.72 -50.3 69.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.995 0.426 . . . . 0.0 109.854 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -130.58 76.04 78.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 121.44 0.638 . . . . 0.0 109.936 177.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 42.02 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.483 2.789 . . . . 0.0 113.237 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 65' ' ' ASN . 54.0 mtmt -124.89 -1.21 7.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.407 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.0 pt -83.0 -174.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -143.04 -18.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.697 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -165.63 157.73 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.108 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.24 155.49 37.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -111.56 116.83 31.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.217 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.473 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 15.5 mt -108.44 140.22 42.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.77 0.795 . . . . 0.0 112.611 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 24.3 tptm -120.97 116.68 31.24 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.689 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.483 ' HG2' ' HB ' ' A' ' 83' ' ' VAL . 96.0 Cg_exo -33.29 143.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.766 3.644 . . . . 0.0 114.605 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -62.87 -32.24 73.44 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.305 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.11 69.9 7.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.037 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.5 -22.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.945 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -57.74 -23.77 53.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.97 -36.1 80.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m 71.51 -57.1 0.62 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.299 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -96.63 54.57 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.483 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -140.68 134.4 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.208 173.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.74 143.98 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -117.17 123.98 48.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.176 0.513 . . . . 0.0 109.957 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -101.68 103.61 14.4 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.017 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.7 t -95.85 112.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.1 mt -113.26 142.36 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -101.81 110.49 22.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.303 0.573 . . . . 0.0 110.131 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.49 133.03 38.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.238 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 1.4 pm0 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.516 0.674 . . . . 0.0 110.026 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.0 118.69 23.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.17 139.12 49.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -107.43 128.35 54.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.266 0.555 . . . . 0.0 110.235 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.53 HD12 ' SD ' ' A' ' 36' ' ' MET . 44.2 mt -117.13 149.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -125.96 123.14 37.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.977 0.418 . . . . 0.0 111.099 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 22.1 m-85 -126.09 108.29 24.69 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.814 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 36.7 Cg_exo -57.55 124.16 15.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.02 1.813 . . . . 0.0 111.546 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -49.83 9.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -170.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -77.04 -29.17 55.1 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.232 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -79.92 -34.33 39.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.82 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 5.4 tp -73.63 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.975 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.4 -7.78 54.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.19 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 26' ' ' TYR . . . -83.58 149.13 26.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.941 0.401 . . . . 0.0 110.689 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.66 -40.07 29.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.278 0.561 . . . . 0.0 109.826 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.21 44.8 2.63 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.639 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.531 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 26.2 p90 -70.1 -10.6 59.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.381 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.75 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.539 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -80.53 -16.96 52.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.894 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.531 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 31.1 m-20 -81.72 94.55 7.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.636 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -60.4 -31.29 70.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.74 -173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.607 HD11 ' NE2' ' A' ' 35' ' ' GLN . 1.3 tm? -57.08 -42.94 81.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.2 -43.65 94.38 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.015 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.617 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.31 -46.14 79.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.748 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' HD11 ' A' ' 31' ' ' LEU . 6.3 mt-30 -64.74 -44.56 89.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.53 ' SD ' HD12 ' A' ' 14' ' ' ILE . 82.3 mmm -91.78 18.0 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.735 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.73 -31.5 3.16 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 163.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -70.54 -63.78 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -0.634 . . . . 0.0 111.086 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 35' ' ' GLN . 26.8 m -90.84 41.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.846 0.831 . . . . 0.0 110.088 -175.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 51' ' ' ARG . 28.3 t-20 -137.25 -21.99 1.17 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.584 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.57 -43.72 96.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.5 t -135.26 79.2 50.12 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.856 0.836 . . . . 0.0 110.192 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.33 14.44 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.077 2.518 . . . . 0.0 112.609 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 72.74 -47.45 0.67 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.684 0.794 . . . . 0.0 111.297 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 54.9 mm-40 -56.32 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.204 0.525 . . . . 0.0 111.066 174.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -146.04 -98.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.582 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.517 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . 174.1 -83.23 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 168.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.23 -45.73 99.1 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 11.7 Cg_exo -72.84 -28.24 13.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.081 1.854 . . . . 0.0 110.715 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.7 tm? -57.34 -44.77 84.55 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 36' ' ' MET . 34.4 ttp180 -67.06 -49.32 65.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.159 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.49 80.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.75 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.559 ' HE1' HD22 ' A' ' 50' ' ' LEU . 5.6 p-90 -72.75 -39.07 67.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.022 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.17 -43.1 79.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.743 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.73 -41.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 110.518 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -65.33 -44.99 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.113 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 t -63.76 -44.87 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.458 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.412 . . . . 0.0 110.394 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -60.05 -50.95 71.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.299 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.23 -34.89 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.211 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.02 -42.44 76.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.97 0.414 . . . . 0.0 111.185 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.402 ' C ' HD11 ' A' ' 62' ' ' LEU . 2.9 tm? -72.14 -47.32 51.89 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.486 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.99 -28.8 63.64 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 111.841 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HZ3' ' HB3' ' A' ' 64' ' ' LYS . 7.4 ttpm? -86.26 -12.64 49.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.91 0.862 . . . . 0.0 109.173 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' O ' HG12 ' A' ' 68' ' ' ILE . 8.7 t30 -154.64 73.43 5.95 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.041 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -85.86 34.34 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.605 2.203 . . . . 0.0 112.629 -170.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.41 -2.78 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.75 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 65' ' ' ASN . 6.1 pt -84.96 166.9 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.371 0.605 . . . . 0.0 111.388 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HA ' ' HB2' ' A' ' 89' ' ' PHE . 35.4 ptt180 -138.46 -4.16 1.66 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.509 176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -167.75 149.47 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.479 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.2 m -136.83 156.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 122.706 0.402 . . . . 0.0 110.015 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.84 117.74 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.879 0.371 . . . . 0.0 110.052 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.33 141.09 45.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 112.361 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -108.78 122.18 40.87 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.483 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 59.3 Cg_endo -70.3 -179.97 3.55 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.878 2.385 . . . . 0.0 114.542 -171.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -65.12 -54.74 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.73 -167.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -58.96 107.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 0.0 111.828 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.82 -37.93 79.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.672 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -70.68 -25.05 62.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.151 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.467 ' ND2' HG11 ' A' ' 83' ' ' VAL . 59.8 t30 -65.14 -36.48 84.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t 67.24 -89.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 163.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.7 m -80.46 63.91 5.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.604 0.716 . . . . 0.0 111.592 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.467 HG11 ' ND2' ' A' ' 80' ' ' ASN . 4.9 p -139.92 129.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.511 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -128.39 137.12 51.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.229 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -115.3 122.49 46.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.314 0.578 . . . . 0.0 110.28 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -95.81 108.64 20.99 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.226 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -92.12 108.88 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.597 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 72.2 m-85 -100.77 111.61 23.87 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 13.4 t70 -74.94 142.88 43.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.2 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.488 0.661 . . . . 0.0 109.33 -167.51 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.5 t . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -120.16 132.95 55.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.175 0.512 . . . . 0.0 110.028 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.01 119.71 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.4 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 7.1 pt-20 -102.21 113.77 27.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.341 0.591 . . . . 0.0 110.846 -174.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.472 HD11 ' SD ' ' A' ' 36' ' ' MET . 5.9 mt -105.66 142.73 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.104 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.522 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 73.1 m80 -113.07 112.67 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.076 0.465 . . . . 0.0 110.579 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 14.7 m-30 -104.08 120.62 50.43 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.533 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' HE ' ' A' ' 20' ' ' ARG . 32.3 Cg_exo -58.96 116.37 3.21 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.048 1.832 . . . . 0.0 111.081 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 18' ' ' LEU . 2.2 tm? -46.68 -43.28 17.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.55 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.136 -172.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.577 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -88.63 -29.47 19.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.253 -173.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 6.1 tp -74.47 -25.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.29 11.95 9.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.642 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.95 173.94 7.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.813 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -116.13 144.35 44.27 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.1 22.83 16.25 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -168.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -59.84 -18.66 45.81 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.909 -0.646 . . . . 0.0 111.688 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.9 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.74 1.36 57.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.967 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 35.6 t70 -85.6 104.02 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.21 -28.12 69.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.732 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.2 mt -62.07 -42.94 99.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.123 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.562 HD23 ' NH1' ' A' ' 20' ' ' ARG . 51.9 tp -70.94 -41.58 70.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.23 -46.52 73.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.086 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.3 p30 -72.58 -32.39 65.97 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.039 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.732 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.97 -45.33 82.06 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.373 0.606 . . . . 0.0 110.085 177.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.472 ' SD ' HD11 ' A' ' 14' ' ' ILE . 83.0 mmm -91.24 12.3 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.363 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.7 -33.24 6.5 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 162.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 43.8 mmtm -72.28 -75.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.263 -0.469 . . . . 0.0 111.557 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -84.84 60.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 122.138 0.97 . . . . 0.0 110.178 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -161.82 -23.42 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.396 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.63 -39.41 67.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 0.0 110.592 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -134.81 63.98 60.79 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.976 0.893 . . . . 0.0 110.528 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 46.3 Cg_endo -97.3 23.54 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.364 2.709 . . . . 0.0 113.466 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 71.97 -56.13 0.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.768 0.668 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 50' ' ' LEU . 3.7 tp10 -65.86 -77.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.405 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 41.8 mt-10 -143.7 -91.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.682 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 160.59 -90.72 0.11 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.837 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.499 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 6.8 ttp -57.24 -47.35 99.2 Favored Pre-proline 0 C--N 1.314 -0.969 0 O-C-N 122.172 -0.605 . . . . 0.0 112.156 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 48' ' ' MET . 54.4 Cg_endo -69.69 -24.02 30.44 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.34 1.36 . . . . 0.0 110.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 3.0 mt -59.1 -47.63 84.54 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.204 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' MET . 32.0 ptt180 -73.73 -33.62 64.43 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.68 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.7 73.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.254 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.516 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 7.0 p-90 -73.75 -42.06 61.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.247 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.1 t -60.0 -51.03 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.611 0.243 . . . . 0.0 111.132 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -41.49 92.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.971 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 46.5 tttm -69.91 -41.47 74.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.927 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.1 m -67.46 -41.46 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.465 0.174 . . . . 0.0 110.803 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.09 85.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 109.914 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.46 -53.69 53.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.84 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 17.0 mm-40 -59.0 -47.19 86.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.155 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.8 99.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.333 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.88 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.483 -175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.3 -32.15 73.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -78.96 -20.1 50.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.172 -176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.68 70.13 13.72 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.371 0.605 . . . . 0.0 109.697 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.09 45.78 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.18 2.587 . . . . 0.0 112.787 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -127.01 -1.19 6.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.522 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 pt -86.66 -172.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.739 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -153.19 -0.55 0.24 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.17 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -166.43 157.18 12.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.524 0.202 . . . . 0.0 110.593 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.44 156.73 42.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.989 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -110.35 113.39 26.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.088 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 12.1 mt -112.27 134.65 53.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -115.03 127.93 26.39 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.252 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 56.0 Cg_endo -69.03 -173.0 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.316 2.011 . . . . 0.0 112.649 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' H ' ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -80.64 -38.87 28.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.684 -174.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.454 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . . . -76.28 78.6 3.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.562 0.696 . . . . 0.0 110.365 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.68 -17.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.421 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -57.35 -24.94 58.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -63.14 -27.95 69.73 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 109.898 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.3 m 67.22 -77.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.834 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 m -103.38 29.86 5.34 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -101.23 136.68 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.38 160.16 38.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.9 120.13 29.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.7 t-160 -110.05 102.64 11.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.051 -176.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.88 113.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.846 0.355 . . . . 0.0 110.33 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.5 141.69 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 66.0 m-85 -103.23 114.53 28.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 15.7 m-20 -76.08 115.34 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.319 -176.459 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 83' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.251 0.548 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.35 138.81 50.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.799 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.46 140.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.78 117.98 35.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.171 0.51 . . . . 0.0 110.499 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.665 HD11 ' SD ' ' A' ' 36' ' ' MET . 22.1 mt -115.24 123.3 70.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.557 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 48.4 m80 -110.74 112.0 23.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.518 0.675 . . . . 0.0 111.11 -177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.502 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 17.1 m-85 -106.52 116.97 58.17 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.461 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 35.9 Cg_exo -58.75 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.214 1.942 . . . . 0.0 110.543 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.5 tp -52.61 -39.28 61.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.897 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -79.19 -28.57 42.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.605 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 9.1 mmm180 -81.5 -38.79 25.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.406 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.11 -28.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.859 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.91 59.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 110.83 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.26 -179.97 6.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.709 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -115.79 18.5 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.939 0.876 . . . . 0.0 109.844 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.5 25.36 10.45 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' HB2' HD22 ' A' ' 32' ' ' LEU . 45.0 p90 -71.14 -35.31 71.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.67 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -17.32 60.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 0.0 110.414 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -91.53 -2.06 57.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.608 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 22.3 t70 -90.71 116.08 28.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.032 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.61 -28.89 64.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.448 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.524 ' HG ' HE22 ' A' ' 35' ' ' GLN . 9.6 tp -70.23 -43.79 69.89 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.7 tp -63.9 -39.5 94.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.623 0.725 . . . . 0.0 109.423 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -41.72 92.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.397 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.633 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 m-20 -60.22 -49.24 78.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.612 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 1.4 mp0 -64.99 -45.1 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.665 ' SD ' HD11 ' A' ' 14' ' ' ILE . 88.7 mmm -97.53 21.26 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.511 . . . . 0.0 111.038 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.98 -34.07 4.13 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 31.9 mmtp -67.95 -68.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.03 76.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.54 -41.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.842 -171.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -40.4 75.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 p -142.14 67.2 21.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.199 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 80.8 Cg_endo -89.69 28.21 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.831 2.354 . . . . 0.0 112.352 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 72.58 -50.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.641 0.776 . . . . 0.0 111.414 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.56 -82.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -176.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.22 -86.63 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.477 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.678 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 161.98 -101.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.122 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.426 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 12.5 tpt -56.22 -44.82 99.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 39.5 Cg_exo -60.77 -33.78 92.51 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.374 2.049 . . . . 0.0 111.414 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.691 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.93 -45.4 86.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.515 176.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HE1' ' A' ' 36' ' ' MET . 22.7 ttt180 -63.38 -47.72 80.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.004 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.53 -47.72 84.42 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.456 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.691 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.34 -44.57 62.42 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.886 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -40.88 78.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.206 -174.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.502 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 69.5 mt -64.45 -45.82 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.834 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 61.0 tttp -64.76 -47.87 76.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.14 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 88.9 m -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.491 0.186 . . . . 0.0 111.163 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.14 92.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.652 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -61.08 -50.85 71.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.158 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 34.7 mm-40 -61.34 -44.34 97.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.136 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 tp -71.06 -45.34 63.99 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.77 -25.56 67.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.47 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -97.84 -2.2 41.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.517 0.675 . . . . 0.0 109.725 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.74 55.0 1.88 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.91 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.83 48.52 2.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.485 2.124 . . . . 0.0 112.438 -168.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -125.83 -11.64 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.807 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 69' ' ' ARG . 2.8 pp -92.73 -172.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.432 ' H ' ' HB ' ' A' ' 68' ' ' ILE . 49.4 mtp180 -143.61 -11.91 0.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.986 -169.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -165.95 150.35 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.143 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.54 155.66 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.948 0.404 . . . . 0.0 110.298 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -111.48 117.28 32.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.335 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -121.59 144.19 48.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.28 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -118.05 120.83 32.07 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.95 174.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 26.5 Cg_endo -61.41 160.41 27.58 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.978 2.452 . . . . 0.0 112.964 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 76' ' ' ARG . 11.7 mtp180 -58.26 -28.62 65.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.151 -172.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.92 86.63 0.71 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.5 0.667 . . . . 0.0 110.708 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 12.0 p -64.77 -28.09 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.815 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -63.58 -24.69 67.91 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.883 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -64.33 -31.74 73.06 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m 65.98 -74.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -98.15 54.05 1.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.136 0.493 . . . . 0.0 112.113 -170.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 10' ' ' VAL . 14.3 p -134.58 130.53 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -132.87 137.76 46.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.36 124.33 47.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.264 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -104.1 103.43 13.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.97 110.38 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -109.72 139.34 33.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.217 -173.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 83.3 m-85 -102.65 108.95 20.39 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.924 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.557 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 7.0 m-20 -75.76 116.89 16.93 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.406 0.622 . . . . 0.0 109.843 -176.508 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -104.82 118.37 36.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.909 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.17 121.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.191 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 2.6 pt-20 -98.38 118.41 34.97 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.005 0.431 . . . . 0.0 109.862 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 HD11 ' SD ' ' A' ' 36' ' ' MET . 29.1 mt -114.47 142.94 25.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 67.2 m80 -124.12 125.36 44.35 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.2 m-30 -122.46 131.26 24.41 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 18.4 Cg_endo -60.13 121.52 9.93 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.813 2.342 . . . . 0.0 111.279 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.8 tp -51.42 -36.91 45.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.724 -173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -75.88 -38.86 57.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . 22.2 mtt180 -80.93 -29.86 35.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.2 -15.84 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.553 0.692 . . . . 0.0 109.528 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.77 24.02 7.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.087 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 144.18 44.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.4 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.27 -11.49 46.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.424 . . . . 0.0 110.542 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -99.93 32.6 7.08 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.456 ' HB2' HD21 ' A' ' 32' ' ' LEU . 52.6 p90 -63.56 -21.83 66.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.009 -0.595 . . . . 0.0 112.003 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.33 -17.59 64.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.017 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -97.67 -9.44 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.934 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 45.4 m-20 -81.36 103.32 11.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.705 0.764 . . . . 0.0 110.606 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.08 -38.94 71.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.031 -171.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 17.7 tp -61.75 -39.4 91.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.06 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 26' ' ' TYR . 1.2 tp -68.81 -44.66 73.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.32 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.14 -48.22 68.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.959 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 p30 -70.21 -32.02 69.72 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.363 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -65.23 -43.33 91.78 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.223 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 14' ' ' ILE . 81.7 mmm -83.87 4.11 30.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.656 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.34 -29.29 9.65 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 60.5 mtpt -68.2 -69.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.233 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.9 p -100.37 82.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.428 1.108 . . . . 0.0 110.424 -175.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -172.08 -26.82 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.842 -170.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -74.84 -36.04 62.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.894 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 p -135.87 67.96 64.33 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.366 0.603 . . . . 0.0 110.781 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -98.62 2.19 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.836 3.024 . . . . 0.0 113.168 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 73.61 -44.23 0.57 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.73 0.812 . . . . 0.0 111.922 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 42.7 tp10 -60.25 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.263 0.225 . . . . 0.0 111.241 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' OE2' ' HD3' ' A' ' 76' ' ' ARG . 47.2 mt-10 -145.38 -102.01 0.1 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.614 0.245 . . . . 0.0 110.797 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 168.66 -106.74 0.26 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.375 176.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.585 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 tpt -49.71 -45.94 79.51 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 48' ' ' MET . 18.6 Cg_endo -58.44 -33.19 97.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.977 1.784 . . . . 0.0 111.914 174.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 82.1 mt -57.13 -48.1 79.49 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.184 0.516 . . . . 0.0 109.652 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -61.4 -46.4 90.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.608 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.17 70.62 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.6 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.612 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 7.4 p-90 -73.87 -37.82 64.62 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.46 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -69.64 -44.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.99 -39.79 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.626 0.251 . . . . 0.0 110.744 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -62.72 -48.85 77.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 48.4 t -65.04 -46.98 79.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.872 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.65 84.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -60.77 -46.73 89.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.858 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -63.18 -47.44 82.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.64 97.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.501 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD11 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -66.34 -46.0 78.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 -178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.54 -27.71 62.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 0.0 111.555 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -66.06 -34.32 77.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.573 . . . . 0.0 110.607 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.73 74.55 12.32 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.661 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.92 33.51 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.244 2.629 . . . . 0.0 113.721 -169.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.29 18.42 9.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -97.53 -179.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -145.23 -8.35 0.6 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -167.88 156.04 8.93 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 111.213 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 87' ' ' VAL . 34.2 m -141.43 159.47 22.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.056 0.455 . . . . 0.0 110.648 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -108.28 120.09 41.38 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.8 0.809 . . . . 0.0 108.983 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.425 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 28.9 tp -123.0 141.1 52.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.565 -168.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 125.64 28.31 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.476 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 52.9 Cg_endo -74.33 173.61 13.92 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.819 1.679 . . . . 0.0 112.77 -175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 57.1 mtp180 -65.72 -36.62 84.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.678 -162.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -68.93 93.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.658 0.742 . . . . 0.0 111.037 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.2 t -61.92 -32.17 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.783 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.24 -23.98 67.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 70.1 m-20 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.065 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p 57.06 -70.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.705 1.253 . . . . 0.0 112.864 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 m -90.89 57.84 3.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.259 0.552 . . . . 0.0 111.655 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.21 130.46 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.53 138.39 36.26 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.133 0.492 . . . . 0.0 111.108 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -102.95 120.97 41.57 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.583 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -108.49 102.81 11.86 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.416 ' CG1' HG21 ' A' ' 71' ' ' VAL . 8.7 p -97.81 124.05 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.568 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.435 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 77.8 mt -112.8 135.71 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.354 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.52 113.07 26.29 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.251 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.09 120.92 22.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 110.492 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 4.5 p-10 -122.65 121.65 36.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.424 0.63 . . . . 0.0 110.066 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.2 121.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.477 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 50.0 mt-10 -93.95 111.97 23.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 110.855 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.494 HD12 ' SD ' ' A' ' 36' ' ' MET . 13.4 mt -102.33 142.81 15.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.529 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 33.6 m80 -119.64 111.88 18.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.998 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-85 -110.46 117.29 51.4 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.154 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.437 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -58.51 127.49 24.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.241 1.961 . . . . 0.0 110.954 174.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.44 -44.98 45.93 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.36 -173.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -77.9 -19.78 54.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 20.4 mmm180 -91.24 -36.88 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -73.44 -14.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.304 0.574 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.65 -0.56 57.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.486 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.37 153.59 17.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.316 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.21 -23.34 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.161 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.87 18.73 52.32 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.661 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -22.88 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.959 0.504 . . . . 0.0 112.018 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.15 -13.61 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.118 0.485 . . . . 0.0 110.794 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -116.8 10.17 14.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.067 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.9 119.55 25.01 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.805 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.12 -33.37 73.27 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.931 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.63 -46.65 84.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.328 0.585 . . . . 0.0 109.977 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.42 -38.99 91.57 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.855 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.19 -41.82 80.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.012 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 96.0 m-20 -65.94 -49.37 68.19 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.054 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.55 -46.64 72.17 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.309 0.576 . . . . 0.0 110.265 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.777 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 11.1 tpt -67.45 -44.71 78.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.185 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.98 -34.13 57.68 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.634 0.584 . . . . 0.0 112.581 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 71.3 mmtt -60.92 -48.26 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.79 42.79 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.236 0.541 . . . . 0.0 111.611 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.777 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -117.64 -35.61 3.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.015 -171.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -81.9 -29.07 32.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.211 0.529 . . . . 0.0 110.537 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 p -127.82 65.45 68.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.226 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 82.3 Cg_endo -90.75 7.29 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.432 2.088 . . . . 0.0 111.533 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.12 -49.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.393 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.17 -80.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.13 -69.93 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 0.0 111.493 -172.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . 134.96 -95.01 0.25 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.762 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.463 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 6.8 ttp -64.91 -43.56 68.82 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' A' ' 50' ' ' LEU . 5.3 Cg_exo -79.37 -26.79 4.72 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.526 2.151 . . . . 0.0 108.915 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.606 HD21 ' HE1' ' A' ' 53' ' ' TRP . 2.3 tm? -58.0 -45.53 86.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 112.524 -2.126 . . . . 0.0 109.235 172.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 12.5 ttm180 -62.97 -49.79 73.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.069 173.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.22 81.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.576 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.606 ' HE1' HD21 ' A' ' 50' ' ' LEU . 2.5 p-90 -72.16 -39.69 68.55 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.704 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -69.22 -42.63 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.377 -174.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.501 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 65.2 mt -67.53 -41.95 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.058 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -61.31 -50.6 72.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.8 t -63.87 -40.85 97.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.67 87.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.793 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -57.51 -58.09 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.556 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.3 -32.84 72.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.698 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.74 94.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -67.39 -48.0 68.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.05 -27.49 66.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -64.15 -43.59 94.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' C ' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -135.8 75.28 56.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.428 0.632 . . . . 0.0 110.113 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 38.51 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.104 2.536 . . . . 0.0 112.444 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 65' ' ' ASN . 34.7 mmtp -131.58 22.39 4.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.11 -174.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.358 0.599 . . . . 0.0 111.337 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -118.11 -49.78 2.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.235 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.2 pt-20 -163.56 163.19 24.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.425 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.71 149.93 32.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.855 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -110.37 118.58 36.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.513 0.673 . . . . 0.0 109.645 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.9 mt -108.02 144.4 35.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.655 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.495 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 12.8 tmtt? -121.45 120.04 29.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 28.8 Cg_endo -61.15 162.2 20.49 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.479 2.786 . . . . 0.0 113.634 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -66.3 -17.63 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.844 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.79 89.21 1.35 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.326 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.495 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.3 t -63.22 -21.92 29.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.846 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -56.93 -32.17 65.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.462 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -73.83 -38.66 64.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t 70.87 -63.74 0.4 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.761 0.663 . . . . 0.0 111.838 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.5 m -109.0 47.98 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.35 138.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.971 -0.456 . . . . 0.0 109.884 170.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 46.2 mt-30 -138.9 150.79 46.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.29 0.567 . . . . 0.0 110.714 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.69 117.82 35.11 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.4 t-160 -95.29 102.09 13.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.899 -173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 63.1 t -97.94 113.27 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.26 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.47 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.9 mp -101.9 139.8 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 70.9 m-85 -102.4 109.78 21.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.926 0.393 . . . . 0.0 110.172 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 16.7 m-20 -77.39 115.4 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.385 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.56 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -105.38 118.74 37.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.191 0.52 . . . . 0.0 111.1 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 28.0 t -119.38 138.79 48.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -121.96 131.23 53.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.279 0.561 . . . . 0.0 111.941 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.548 HD13 ' SD ' ' A' ' 36' ' ' MET . 8.2 mt -106.98 136.09 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.693 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -109.01 127.84 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 22.7 m-85 -127.8 125.29 23.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.382 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 19.1 Cg_exo -66.8 120.79 7.91 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 121.934 1.756 . . . . 0.0 111.046 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 tp -42.18 -44.6 3.79 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.578 1.151 . . . . 0.0 113.645 -167.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -75.7 -40.59 55.48 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 14.3 ptp180 -90.75 -19.06 23.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 6.5 tp -72.26 -21.04 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.17 -14.44 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.552 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.61 151.76 34.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.575 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -78.46 -28.54 46.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.379 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.24 3.02 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -66.15 -38.64 88.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.641 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -1.37 21.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.92 -7.95 18.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.533 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 t70 -81.17 121.32 25.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.216 0.531 . . . . 0.0 110.966 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.18 -35.33 78.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.206 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 4.4 mt -65.44 -42.44 92.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.034 0.445 . . . . 0.0 110.005 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.3 -41.89 76.16 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.336 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.7 mt -66.37 -49.04 68.22 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.407 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 2.7 p30 -74.88 -28.66 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.811 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.711 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -69.65 -47.03 64.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.776 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 15.5 tpt -72.25 -42.6 65.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.67 -32.31 46.74 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.377 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.03 -53.38 39.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 39' ' ' VAL . 48.3 t -85.17 39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.132 0.968 . . . . 0.0 110.535 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.776 ' HB2' ' O ' ' A' ' 36' ' ' MET . 2.5 t-20 -133.44 -30.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.103 -0.998 . . . . 0.0 112.918 -170.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 26.2 t70 -80.04 -27.35 39.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -172.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.1 p -122.67 60.78 14.88 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 26.8 Cg_endo -98.86 1.74 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.846 2.364 . . . . 0.0 113.711 -173.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 74.04 -46.83 0.63 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.554 0.742 . . . . 0.0 111.92 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' CB ' HD22 ' A' ' 50' ' ' LEU . 37.5 mt-10 -65.6 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 111.739 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -126.09 -77.95 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.266 0.555 . . . . 0.0 110.464 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.74 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 148.96 -96.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.834 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.715 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 1.5 tmt? -59.8 -40.68 80.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 O-C-N 122.121 -0.635 . . . . 0.0 112.34 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 48' ' ' MET . 38.2 Cg_exo -64.54 -29.78 61.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.706 1.604 . . . . 0.0 110.742 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.74 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -59.88 -47.77 84.39 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.581 178.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -67.46 -40.72 85.35 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.993 178.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.32 78.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.385 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.649 ' CH2' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -71.67 -46.13 59.83 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.984 -176.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.68 -41.78 77.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.462 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 90.4 mt -64.64 -42.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.713 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.9 tttp -65.22 -46.6 79.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.141 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.6 -43.53 89.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.608 0.242 . . . . 0.0 110.904 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.7 95.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -60.09 -52.24 66.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.565 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 32.5 mm-40 -58.78 -44.18 90.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.254 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.83 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.747 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD23 HG22 ' A' ' 21' ' ' ILE . 6.6 tp -67.31 -46.34 73.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.605 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.44 -25.92 65.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.342 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -63.96 -48.55 76.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -131.47 75.58 76.8 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.208 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.83 43.61 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.078 2.519 . . . . 0.0 112.675 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -128.46 10.38 6.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.846 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 pt -98.34 179.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.173 0.511 . . . . 0.0 110.989 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -128.36 -18.4 4.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.839 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.95 158.41 17.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.304 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.0 p -129.09 151.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -109.61 112.74 25.01 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 122.17 0.986 . . . . 0.0 109.36 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD23 ' CH2' ' A' ' 53' ' ' TRP . 8.8 tt -125.95 144.7 50.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.558 -163.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HZ1' ' HA ' ' A' ' 81' ' ' SER . 72.8 tttt -126.95 132.32 24.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.236 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.558 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -33.82 140.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.141 3.894 . . . . 0.0 115.764 175.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -58.78 -38.93 79.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.007 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 74.31 4.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.409 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.18 -19.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.129 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.78 -23.77 65.27 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.63 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -63.24 -33.75 76.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.074 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.456 ' HA ' ' HZ1' ' A' ' 74' ' ' LYS . 16.2 m 69.84 -68.05 0.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.121 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 m -73.95 -19.5 60.65 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HG2' ' A' ' 75' ' ' PRO . 5.6 p -86.47 129.4 38.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.304 0.573 . . . . 0.0 110.669 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -130.69 137.53 49.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.041 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.558 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 19.9 m-85 -106.67 125.94 51.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.579 0.704 . . . . 0.0 110.652 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -105.14 104.92 14.74 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.401 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 48.1 t -92.4 112.09 25.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.66 137.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.33 109.67 21.37 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.676 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 115.52 16.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 0.0 110.231 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.074 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 120.806 0.336 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -123.47 119.45 30.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.403 0.62 . . . . 0.0 109.595 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 96.3 t -120.95 125.48 74.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.065 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -105.54 112.92 26.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.459 0.647 . . . . 0.0 111.265 -174.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 4.1 mt -101.6 128.01 54.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 79.8 m80 -104.13 109.6 21.46 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.288 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 18.6 m-30 -107.14 117.58 55.99 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.151 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' HG23 ' A' ' 21' ' ' ILE . 31.6 Cg_exo -59.7 120.56 8.44 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.07 1.847 . . . . 0.0 110.982 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HG ' HD11 ' A' ' 62' ' ' LEU . 2.9 tt -50.57 -36.24 33.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.91 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 18.6 ptpt -72.2 -32.76 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.169 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.566 ' HD3' ' OD2' ' A' ' 29' ' ' ASP . 3.0 mmp_? -92.76 -39.03 11.47 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -72.43 -21.99 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.278 0.561 . . . . 0.0 109.638 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.69 -26.96 64.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.846 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.07 155.59 25.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.855 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.18 -31.35 30.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.592 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.47 49.27 2.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.942 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -73.48 -18.34 61.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.614 0.245 . . . . 0.0 111.598 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.61 -13.39 62.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 -24.32 52.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.166 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.566 ' OD2' ' HD3' ' A' ' 20' ' ' ARG . 7.7 m-20 -83.72 110.81 18.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.87 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.3 -25.11 67.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.797 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.2 pp -54.41 -41.63 69.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.196 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 31' ' ' LEU . 15.5 tp -73.18 -27.92 61.92 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.499 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.28 -45.82 65.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.901 172.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -61.07 -38.17 85.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.45 -46.68 82.06 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.994 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.487 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 83.9 mmm -94.46 17.6 12.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.702 0.763 . . . . 0.0 110.11 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.31 -24.44 7.15 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 164.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -82.81 -65.65 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.256 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 12' ' ' VAL . 30.1 m -100.83 45.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.639 0.733 . . . . 0.0 111.072 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -139.79 -17.71 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.896 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.4 -38.2 68.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.866 0.365 . . . . 0.0 110.512 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 p -127.59 70.84 77.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.443 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.2 Cg_endo -92.65 13.28 1.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.949 2.433 . . . . 0.0 112.393 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 73.44 -40.45 0.47 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.203 1.001 . . . . 0.0 112.343 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HB2' HD13 ' A' ' 50' ' ' LEU . 37.7 mt-10 -74.53 -78.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 111.414 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.63 -80.06 0.33 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 111.103 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.778 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 154.31 -92.79 0.13 Allowed Glycine 0 C--O 1.222 -0.624 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.697 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.452 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.5 tmt? -62.79 -43.93 84.51 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.931 -0.747 . . . . 0.0 112.692 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 48' ' ' MET . 41.4 Cg_endo -70.63 -24.44 25.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 120.913 1.075 . . . . 0.0 109.765 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.778 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -58.37 -45.86 87.43 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.115 172.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 33.4 ttt180 -61.51 -48.74 79.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.191 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.57 77.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.72 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 8.2 p-90 -73.52 -37.76 65.55 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.272 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -69.3 -41.4 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.0 110.165 -174.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.58 -41.7 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.673 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.94 -50.11 73.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.207 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.6 t -62.36 -46.19 89.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.995 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 0.0 110.501 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -62.59 -50.5 71.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.129 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.02 -34.86 79.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.837 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.99 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.417 HD11 ' HG ' ' A' ' 18' ' ' LEU . 4.7 tt -71.23 -48.41 51.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.403 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.15 -25.7 67.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.693 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.81 -33.27 75.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 110.25 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -151.36 72.38 8.37 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.078 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.27 39.29 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.965 2.443 . . . . 0.0 113.924 -168.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 34.0 4.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.425 0.631 . . . . 0.0 109.532 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.8 pt -106.47 -175.45 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.577 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 16.9 mtm180 -117.52 -51.21 2.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.235 -177.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' OE2' ' HB2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -156.22 161.47 40.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.18 -177.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -132.46 158.4 43.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.435 0.636 . . . . 0.0 111.401 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.35 113.37 26.12 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.03 0.919 . . . . 0.0 109.428 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.613 HD23 ' CH2' ' A' ' 53' ' ' TRP . 6.1 tt -110.02 139.26 45.34 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.858 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.55 129.38 25.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.157 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HG2' HG13 ' A' ' 83' ' ' VAL . 75.3 Cg_exo -46.11 151.03 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.809 3.006 . . . . 0.0 113.292 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -66.98 -37.69 84.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.565 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.6 75.78 2.61 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.737 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.15 -10.72 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.338 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' CB ' HG11 ' A' ' 83' ' ' VAL . 83.1 m-20 -64.74 -37.1 86.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.184 0.516 . . . . 0.0 110.436 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.3 t 71.46 -67.15 0.27 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.744 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -82.27 6.35 17.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.8 p -108.39 131.83 57.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.034 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -139.21 144.36 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.186 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 81.0 m-85 -107.62 124.63 50.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.145 0.498 . . . . 0.0 109.789 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.1 t60 -103.0 106.0 16.43 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 91.8 t -93.22 116.83 35.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.393 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.428 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.4 mp -100.05 136.41 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 40.7 m-85 -103.08 106.68 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.94 0.4 . . . . 0.0 110.381 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 22.1 m-20 -79.69 114.86 18.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.013 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 39.8 t . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -136.11 134.93 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.37 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.23 138.66 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.243 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -106.82 121.22 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.472 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.3 mt -115.91 122.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.599 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 79.6 m80 -99.73 132.01 45.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.182 0.515 . . . . 0.0 110.288 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CD1' HG12 ' A' ' 87' ' ' VAL . 3.3 m-85 -119.76 129.07 25.55 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.233 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 21.4 Cg_exo -65.25 110.92 1.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.005 1.804 . . . . 0.0 110.389 171.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.88 -42.51 12.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.953 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HG3' ' HD2' ' A' ' 20' ' ' ARG . 17.1 ptpt -78.1 -28.53 48.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 3.7 mpt_? -89.68 -35.27 15.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 112.049 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.58 -25.74 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.463 . . . . 0.0 110.129 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.36 12.66 15.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.16 173.02 7.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.975 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.98 -26.86 20.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.229 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.79 46.72 3.48 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.604 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -79.09 -34.6 43.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.735 0.303 . . . . 0.0 111.277 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.04 59.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.303 0.573 . . . . 0.0 110.415 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -83.71 -9.41 58.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.3 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -85.15 110.54 19.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.244 0.545 . . . . 0.0 110.708 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.84 -34.81 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.764 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.77 -46.69 89.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.87 -40.29 65.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.567 0.698 . . . . 0.0 109.794 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.15 -46.06 78.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.343 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -73.34 -30.78 63.57 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.395 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.599 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 45.3 mt-30 -73.52 -44.84 56.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.346 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.531 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -75.09 -15.64 60.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.633 177.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 -21.2 41.29 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -76.2 -54.83 6.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 35' ' ' GLN . 14.7 m -85.71 59.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.739 0.78 . . . . 0.0 109.782 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.1 t-20 -137.66 -39.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.398 -170.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -70.23 -41.14 73.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.849 -170.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 p -140.98 66.0 24.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.723 0.297 . . . . 0.0 111.51 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.2 Cg_endo -67.46 -62.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.252 1.968 . . . . 0.0 112.011 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 13.4 tp10 152.53 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -76.79 -85.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.587 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -135.7 -79.04 0.43 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.09 0.471 . . . . 0.0 109.988 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 151.17 -109.71 0.43 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.992 176.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.453 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -51.35 -48.21 86.59 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 36.2 Cg_exo -61.41 -40.43 48.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.032 1.821 . . . . 0.0 112.013 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.774 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -61.07 -43.68 98.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.958 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -67.63 -34.34 76.77 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.506 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.86 79.98 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.774 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.2 p-90 -72.44 -38.2 68.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.332 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.95 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.047 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.0 mt -57.86 -44.06 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.347 0.117 . . . . 0.0 110.752 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 53.3 tptt -63.85 -49.54 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.85 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.0 t -64.07 -43.86 94.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.051 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.85 92.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.0 109.977 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 6.4 t-160 -58.22 -58.93 6.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.544 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 11.8 pt-20 -66.98 -34.51 77.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.78 98.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 110.552 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tp -66.84 -45.96 76.59 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.135 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 51.6 mt-10 -63.31 -27.85 69.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.404 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.46 -39.54 85.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.458 . . . . 0.0 110.168 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -141.28 71.74 26.96 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.279 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.95 42.31 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.04 2.493 . . . . 0.0 113.065 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -128.79 11.6 6.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.008 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt -89.34 178.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.632 0.729 . . . . 0.0 112.268 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -110.37 -43.74 3.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.545 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.9 pt-20 -163.64 151.27 12.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.832 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.6 150.08 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.63 111.46 22.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD12 ' CH2' ' A' ' 53' ' ' TRP . 3.7 pp -109.85 133.23 53.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.464 0.65 . . . . 0.0 110.833 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -103.24 124.28 38.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 81.1 Cg_endo -80.03 175.97 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.201 1.934 . . . . 0.0 114.178 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.98 -13.88 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.551 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.49 74.99 3.23 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.52 -24.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.042 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -63.74 -27.47 69.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.563 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.42 -34.43 47.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.966 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.2 p 58.84 -72.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.709 1.256 . . . . 0.0 112.382 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m -84.07 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 8.5 p -134.32 130.65 54.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -136.92 139.0 41.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.154 0.502 . . . . 0.0 111.437 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.498 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 79.7 m-85 -101.92 128.1 48.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.688 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -96.74 107.95 20.51 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 16' ' ' PHE . 54.0 t -91.81 109.63 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 66.4 mt -102.42 135.04 41.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.76 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -102.62 110.25 22.13 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -99.36 122.95 43.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.804 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 . . . . . 0 C--N 1.328 -0.344 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.843 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -127.35 133.58 50.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.967 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 p -117.31 138.56 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.68 111.49 23.73 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.309 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.464 HD13 ' SD ' ' A' ' 36' ' ' MET . 17.1 mt -102.79 123.69 56.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.184 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.87 127.11 46.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -120.84 126.96 26.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.17 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -59.97 117.03 3.73 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.147 1.898 . . . . 0.0 110.945 171.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.07 -36.89 66.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.931 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.49 -29.16 56.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.651 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HD3' ' HB2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -91.82 -31.38 15.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.862 -177.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.32 -19.1 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 109.983 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.12 -7.21 56.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.04 149.64 21.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.781 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.73 -21.03 41.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.63 34.92 4.57 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.402 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.54 -5.72 38.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 111.173 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.23 -2.94 35.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.855 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.49 117.16 28.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -63.91 -31.59 72.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.076 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.708 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.5 mm? -61.67 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.336 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -72.12 -37.59 69.47 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.595 0.712 . . . . 0.0 109.577 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.97 -45.64 63.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.349 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -73.44 -33.6 64.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.675 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.708 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.23 -46.72 32.0 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -176.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.464 ' SD ' HD13 ' A' ' 14' ' ' ILE . 9.7 tpt -95.06 3.62 54.63 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.22 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.27 -24.01 23.03 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 165.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.37 -68.75 0.42 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.879 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 m -87.73 65.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.87 0.843 . . . . 0.0 110.396 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.41 HD21 HD13 ' A' ' 50' ' ' LEU . 4.5 t-20 -149.56 -27.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.78 -169.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.18 -44.97 71.1 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.665 0.745 . . . . 0.0 110.196 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -124.74 71.2 59.37 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.249 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 45' ' ' GLU . 73.5 Cg_endo -91.86 -2.12 4.27 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.774 2.316 . . . . 0.0 112.37 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 71.39 -42.58 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.56 0.744 . . . . 0.0 110.428 -173.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.523 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -50.67 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.026 175.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' OE1' ' HB2' ' A' ' 49' ' ' PRO . 44.4 mt-10 -144.07 -73.77 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.595 0.712 . . . . 0.0 109.879 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 146.27 -105.81 0.35 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.528 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.414 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.7 tpt -57.3 -46.29 99.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 12.1 Cg_exo -68.7 -32.29 24.02 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.185 1.924 . . . . 0.0 110.742 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.62 HD23 ' CE2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -57.76 -45.24 86.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.853 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -65.6 -45.91 81.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.013 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -48.32 81.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.716 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.586 ' CZ2' ' HA ' ' A' ' 75' ' ' PRO . 3.8 p-90 -72.29 -39.18 68.5 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.019 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -41.15 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.716 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.8 -40.9 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.586 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -58.86 -50.44 74.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 111.009 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.491 ' SG ' HD21 ' A' ' 73' ' ' LEU . 44.6 t -61.97 -44.47 96.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.739 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.09 94.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.52 -51.11 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.83 -45.73 81.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.343 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.34 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -47.26 73.63 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.669 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.7 -36.76 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 110.324 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.74 75.07 12.2 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.828 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.21 39.99 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.214 2.609 . . . . 0.0 113.206 -170.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -136.3 26.15 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.5 -172.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.401 0.62 . . . . 0.0 111.835 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -123.99 -45.92 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.37 159.51 17.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.27 155.99 42.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.841 0.353 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.87 114.86 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.026 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.491 HD21 ' SG ' ' A' ' 57' ' ' CYS . 7.3 mt -108.12 140.14 41.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -101.86 122.5 47.15 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 91.1 Cg_endo -76.84 -171.19 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.121 1.881 . . . . 0.0 113.626 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -73.81 -47.03 41.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.24 76.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 111.063 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.96 -16.97 21.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.158 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -68.19 -25.31 65.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 110.293 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.469 ' ND2' ' HB ' ' A' ' 83' ' ' VAL . 66.2 t30 -64.46 -25.1 67.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 68.13 -81.49 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.6 173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -83.48 61.48 6.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.223 0.535 . . . . 0.0 111.53 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.469 ' HB ' ' ND2' ' A' ' 80' ' ' ASN . 10.0 p -140.13 135.32 37.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -140.22 137.68 34.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.887 0.375 . . . . 0.0 110.498 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.62 ' CE2' HD23 ' A' ' 50' ' ' LEU . 20.9 m-85 -105.48 119.09 38.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.465 0.65 . . . . 0.0 109.407 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.71 102.87 13.08 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.698 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.1 t -92.8 113.44 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.47 135.61 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.03 106.86 17.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.171 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -79.4 142.43 35.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.777 -177.369 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -108.53 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.045 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 43.1 t -108.93 135.79 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -104.29 112.25 25.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.454 -175.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.406 HD12 ' SD ' ' A' ' 36' ' ' MET . 26.9 mt -108.3 129.14 63.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.418 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 68.8 m80 -113.91 127.76 56.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.13 0.49 . . . . 0.0 110.776 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 25.0 m-85 -125.51 121.87 24.83 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.223 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.538 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 27.9 Cg_exo -61.11 129.96 30.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.746 1.631 . . . . 0.0 110.84 175.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CD2' HD22 ' A' ' 62' ' ' LEU . 2.5 tm? -50.54 -38.66 46.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.043 -175.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.05 -29.68 60.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.34 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 21.3 mmm180 -90.35 -37.19 14.19 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.452 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 tp -73.17 -16.9 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 109.659 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.94 18.84 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.305 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.95 169.79 8.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.613 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.79 -38.47 18.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.03 42.38 2.28 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.314 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 27.1 p90 -73.77 -26.76 60.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.14 -4.02 36.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -114.69 4.7 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.752 0.787 . . . . 0.0 109.394 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 31' ' ' LEU . 19.2 t70 -87.18 119.6 27.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.511 -175.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.65 -36.71 67.35 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.71 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 3.9 mm? -63.9 -46.0 86.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.557 0.694 . . . . 0.0 110.665 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -35.84 75.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.358 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.1 -48.01 59.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.241 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.85 -35.67 64.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.728 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -71.66 -46.6 58.46 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.974 0.416 . . . . 0.0 110.723 -177.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.609 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -93.14 3.75 55.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.21 0.528 . . . . 0.0 110.467 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.62 -26.95 12.18 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 167.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -74.52 -58.86 3.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 35' ' ' GLN . 20.2 m -86.45 53.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.744 0.783 . . . . 0.0 110.338 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.5 t-20 -134.34 -35.25 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.85 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.6 -35.6 67.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 p -128.69 70.17 80.3 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -92.63 5.54 3.31 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.878 2.385 . . . . 0.0 112.52 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 72.27 -43.14 0.55 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.786 0.834 . . . . 0.0 111.564 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' A' ' 75' ' ' PRO . 10.8 tp10 -67.46 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.841 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -139.85 -88.97 0.19 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.51 0.195 . . . . 0.0 111.064 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 161.42 -92.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.725 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.618 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 1.7 tmt? -64.65 -45.22 75.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 31.9 Cg_exo -65.35 -31.1 53.13 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 121.526 1.484 . . . . 0.0 110.345 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.563 HD23 ' HE1' ' A' ' 53' ' ' TRP . 2.5 tm? -58.61 -47.1 85.47 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.045 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.4 ptm180 -69.72 -40.98 75.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.806 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.13 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.563 ' HE1' HD23 ' A' ' 50' ' ' LEU . 11.2 p-90 -73.63 -37.32 65.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.854 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.0 -42.27 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.422 0.153 . . . . 0.0 110.931 -175.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.497 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 93.0 mt -67.2 -39.53 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.6 mmmm -62.66 -50.18 72.2 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.707 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.29 -43.42 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.733 0.301 . . . . 0.0 110.747 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.22 98.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.541 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -63.44 -45.19 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.366 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 43.9 mm-40 -62.07 -47.18 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.38 83.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.155 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 18' ' ' LEU . 3.1 tm? -65.17 -47.18 77.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.135 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.66 -27.05 62.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.789 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 3.0 ttmp? -71.5 -38.84 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.173 0.511 . . . . 0.0 110.125 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -135.81 74.98 56.76 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.25 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.45 29.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.455 2.77 . . . . 0.0 113.506 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -125.86 25.72 6.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.222 0.534 . . . . 0.0 110.232 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.71 179.39 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.809 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -118.97 -36.75 3.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.863 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -164.32 168.34 18.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.914 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 13.9 p -135.86 148.97 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.96 117.21 33.18 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.449 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 49.8 tp -130.71 132.29 45.28 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.54 -164.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -109.77 134.05 20.74 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.488 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 29.0 Cg_endo -61.23 158.78 33.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.639 2.226 . . . . 0.0 113.2 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -61.88 -42.86 99.57 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.399 -165.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.84 116.83 8.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.843 0.83 . . . . 0.0 110.946 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.86 -16.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.543 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -58.04 -40.59 81.29 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.149 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -75.09 -36.53 61.7 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.915 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.4 m 70.68 -63.55 0.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.425 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 p -111.18 58.85 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.37 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -135.43 142.13 45.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.952 0.406 . . . . 0.0 111.13 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.442 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 99.9 m-85 -105.16 124.29 49.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -97.31 103.89 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 75.2 t -91.42 110.76 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.433 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 89.8 mt -105.48 134.61 46.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.177 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 57.4 m-85 -103.02 106.26 16.75 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.181 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -86.07 126.47 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.694 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.25 118.55 36.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.285 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 21.4 t -121.07 121.78 65.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -112.04 132.59 54.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.919 -166.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.18 152.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.568 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.406 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 64.7 m80 -120.71 128.15 52.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.827 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 8.4 m-85 -127.75 105.63 20.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.835 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.745 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 26.3 Cg_exo -60.67 120.55 8.35 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 121.588 1.525 . . . . 0.0 110.888 172.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -54.6 -42.33 70.98 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.804 -169.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -61.25 -32.0 71.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.251 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 5.0 mtt180 -95.55 -35.65 11.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 17' ' ' PRO . 4.8 tp -69.7 -27.13 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.069 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.46 59.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 110.967 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.63 -169.45 1.66 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -125.91 138.36 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.87 17.37 18.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -170.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.585 ' CD1' ' HB3' ' A' ' 20' ' ' ARG . 7.9 t80 -67.03 -23.87 65.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.957 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.1 -9.36 38.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.661 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -103.41 1.66 32.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.708 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.57 112.66 6.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.57 -42.47 88.06 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.793 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.26 -42.21 90.64 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.517 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.522 HD22 ' HH ' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -64.52 -39.83 94.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.047 0.451 . . . . 0.0 110.046 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.24 -40.99 87.69 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.996 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -73.49 -41.63 62.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.137 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -70.13 -50.39 41.03 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.307 0.575 . . . . 0.0 111.899 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.636 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -80.68 -22.35 40.48 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.8 95.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.245 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -62.87 -56.72 14.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 39' ' ' VAL . 85.8 t -85.19 69.67 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.643 0.735 . . . . 0.0 110.242 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.636 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -154.08 -34.96 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.748 -175.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.57 -36.8 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.205 -169.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -134.27 66.66 71.53 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.813 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -98.11 4.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.585 2.19 . . . . 0.0 112.948 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.85 -39.56 0.45 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.931 . . . . 0.0 112.417 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.6 OUTLIER -64.9 -79.25 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.363 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -143.95 -81.56 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.005 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 156.0 -110.93 0.46 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.194 177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.451 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 5.6 ttp -60.07 -41.35 84.29 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 48' ' ' MET . 43.3 Cg_exo -59.67 -44.47 31.37 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.84 1.693 . . . . 0.0 111.531 174.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.786 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -60.01 -37.68 80.43 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.503 ' HB2' HD22 ' A' ' 40' ' ' ASN . 22.1 ttt180 -55.51 -49.73 71.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.186 173.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.46 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.747 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.786 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.7 p-90 -72.1 -39.27 69.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.62 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -62.42 -51.04 77.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.639 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 96.0 mt -59.63 -36.91 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -48.52 67.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.987 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.1 m -70.58 -41.06 72.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.589 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.63 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.506 0.669 . . . . 0.0 109.626 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.639 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.3 t-160 -56.62 -54.03 50.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.954 175.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.41 -39.08 93.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.325 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.39 98.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 21' ' ' ILE . 13.2 tp -68.31 -46.65 69.69 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 39.4 mt-10 -65.31 -27.62 68.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.799 0.333 . . . . 0.0 110.986 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 12.3 tmtt? -65.33 -34.45 78.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 109.817 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.409 ' ND2' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -149.86 75.25 9.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.681 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 46.67 2.12 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.323 2.682 . . . . 0.0 113.285 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -143.38 34.87 1.32 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.304 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.409 HD13 ' ND2' ' A' ' 65' ' ' ASN . 23.3 pt -110.7 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.512 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -144.39 -19.85 0.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.467 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -166.34 149.91 7.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -139.05 157.84 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.379 . . . . 0.0 110.677 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -116.46 113.27 22.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.579 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.5 pp -109.28 136.31 48.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.566 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -109.87 129.16 24.24 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 90.5 Cg_endo -77.56 162.75 30.13 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.779 1.653 . . . . 0.0 114.097 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -65.31 -13.67 59.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.499 -172.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.4 88.08 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.224 0.535 . . . . 0.0 110.035 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.59 -33.06 57.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.607 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.8 -27.44 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.663 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . 5.0 m-20 -65.78 -38.9 90.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.627 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m 61.25 -77.43 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.344 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -83.53 33.74 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.663 ' CG2' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -112.01 130.45 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.85 139.57 51.17 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.763 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.526 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 69.8 m-85 -97.59 120.38 37.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.544 0.687 . . . . 0.0 109.252 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.76 100.61 13.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.547 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.7 t -98.37 112.2 29.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.195 0.521 . . . . 0.0 110.129 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.0 mp -99.24 141.1 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.259 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 58.7 m-85 -101.32 106.46 17.64 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.745 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 m-20 -83.81 136.52 34.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.724 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 176.217 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -83.98 50.31 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.143 0.497 . . . . 0.0 111.392 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.0 76.06 1.36 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.831 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.3 mtp -83.06 60.27 5.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.091 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.51 -85.29 0.41 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.179 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -147.96 137.88 22.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 55.7 ttp -103.31 104.8 43.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.59 -9.09 23.57 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.938 2.425 . . . . 0.0 113.438 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.75 108.86 17.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.13 0.49 . . . . 0.0 110.015 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -103.16 119.27 51.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.877 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.64 118.75 37.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 HG22 ' A' ' 39' ' ' VAL . 38.2 t -111.83 119.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 30.0 mt-10 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.272 0.558 . . . . 0.0 110.687 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.753 HG23 ' SD ' ' A' ' 36' ' ' MET . 4.8 mt -98.08 152.48 4.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.378 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -122.33 126.07 47.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.922 0.391 . . . . 0.0 110.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' HE1' ' SD ' ' A' ' 36' ' ' MET . 8.0 m-30 -116.89 125.8 28.01 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.249 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 38.9 Cg_exo -59.4 108.5 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.036 1.824 . . . . 0.0 110.788 171.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.8 -36.07 35.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.743 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -38.55 75.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.637 0.256 . . . . 0.0 111.588 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.7 mpt_? -86.59 -35.56 19.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.379 -173.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.405 HG22 HD21 ' A' ' 62' ' ' LEU . 9.6 tp -66.12 -22.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 109.626 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.17 24.52 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.216 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.27 170.65 15.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.74 136.9 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.92 26.31 19.8 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -63.34 -29.17 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.579 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.88 -4.3 23.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.487 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.23 -8.41 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.898 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -80.43 115.69 20.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.345 0.593 . . . . 0.0 109.897 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.29 -33.46 75.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.325 -168.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -43.31 75.8 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.841 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -64.45 -40.07 95.03 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.719 0.771 . . . . 0.0 109.02 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.77 -44.76 66.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -74.19 -26.8 60.49 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.559 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.9 50.49 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.388 0.613 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.753 ' SD ' HG23 ' A' ' 14' ' ' ILE . 94.8 mmm -72.69 -29.37 63.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.445 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.47 -27.84 70.64 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.88 -41.57 91.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 110.17 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 12' ' ' VAL . 3.6 p -108.65 77.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.161 0.981 . . . . 0.0 110.202 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -150.6 -25.47 0.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.401 -174.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.18 -32.56 16.57 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.103 -174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 t -143.45 63.77 12.91 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.407 0.622 . . . . 0.0 110.695 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 17.5 Cg_endo -93.58 14.86 1.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.96 2.44 . . . . 0.0 113.332 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' HG3' HD22 ' A' ' 80' ' ' ASN . 21.2 tp10 75.36 -39.32 0.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.444 0.698 . . . . 0.0 112.117 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.42 -104.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.937 -0.477 . . . . 0.0 110.632 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -102.05 -90.5 0.35 Allowed 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.028 0.442 . . . . 0.0 110.735 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.665 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 162.97 -111.71 0.48 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.436 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.5 tmt? -57.95 -44.86 99.7 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 51.8 Cg_exo -58.2 -41.85 62.78 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.971 1.78 . . . . 0.0 111.976 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.891 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.83 -40.59 93.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.317 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.493 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.1 ttp85 -54.95 -46.21 74.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.602 0.239 . . . . 0.0 110.583 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -58.76 -48.53 80.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.675 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.891 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.0 p-90 -72.73 -40.05 66.42 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.235 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 t -61.2 -51.04 77.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.576 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.75 -43.25 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.249 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 52' ' ' ALA . 62.4 mttp -63.23 -50.23 71.03 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.26 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.8 m -61.39 -45.85 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.21 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.31 . . . . 0.0 110.859 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -57.97 -52.49 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.934 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 46.8 mt-10 -69.09 -39.73 78.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.28 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.83 88.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.405 HD21 HG22 ' A' ' 21' ' ' ILE . 6.4 tp -70.71 -45.55 64.74 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.95 -32.87 74.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 28.4 mmmt -80.03 -22.71 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.349 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -140.94 69.56 29.16 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.475 0.655 . . . . 0.0 109.707 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.47 50.34 3.35 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.406 2.737 . . . . 0.0 113.182 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' HB2' ' HZ1' ' A' ' 67' ' ' LYS . 9.8 mtmp? -142.18 28.33 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.374 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.07 -172.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.35 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -131.57 -39.86 1.12 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.143 -173.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -164.3 156.75 16.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.797 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.11 122.55 48.17 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.414 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 7.9 mt -106.56 136.71 45.87 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.125 -173.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.99 117.62 61.06 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.448 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HG2' HG13 ' A' ' 83' ' ' VAL . 43.1 Cg_exo -40.05 135.5 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.58 2.853 . . . . 0.0 113.347 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -62.65 -25.67 68.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.355 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.87 68.3 9.3 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 t -57.35 -23.19 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.363 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 3.5 mptp? -61.56 -24.05 66.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.518 HD22 ' HG3' ' A' ' 44' ' ' GLU . 51.5 t30 -65.9 -17.94 65.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.34 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.495 ' HG ' ' C ' ' A' ' 80' ' ' ASN . 79.1 p 62.17 -96.57 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -78.11 53.69 1.24 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.33 0.586 . . . . 0.0 112.555 -167.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.474 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.1 p -142.11 134.53 27.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.928 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -139.37 145.4 38.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.693 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.0 117.29 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.713 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.404 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 13.2 t-160 -98.01 102.64 14.44 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.7 t -91.77 112.92 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.101 0.477 . . . . 0.0 109.985 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.2 mt -104.3 139.03 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.051 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -102.71 106.91 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.49 135.91 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.77 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -90.13 112.99 24.66 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.697 -175.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 73.55 -51.52 0.7 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.2 55.63 7.35 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.405 0.621 . . . . 0.0 110.631 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -127.18 146.83 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.803 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.16 124.37 8.98 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.409 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.461 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 m170 -77.93 62.77 2.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.231 0.539 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.68 90.56 9.11 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.417 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 36.7 Cg_exo -60.05 132.97 47.4 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.241 2.627 . . . . 0.0 112.615 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.17 108.77 17.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.55 119.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.1 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 9.3 p-10 -101.43 119.2 38.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.578 0.704 . . . . 0.0 109.771 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -95.3 139.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.791 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -92.25 130.95 37.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.381 0.61 . . . . 0.0 110.337 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.541 HD11 ' SD ' ' A' ' 36' ' ' MET . 25.5 mt -128.59 133.19 67.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.553 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 61.1 m80 -120.26 126.29 50.23 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 110.795 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.2 m-85 -127.57 115.01 21.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 37.3 Cg_exo -61.27 121.95 10.4 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.292 1.994 . . . . 0.0 111.861 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -43.35 -44.01 5.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 113.851 -1.522 . . . . 0.0 113.901 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -77.41 -38.31 49.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HD2' ' HG2' ' A' ' 17' ' ' PRO . 17.7 ptp180 -89.34 -25.14 21.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.741 -172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -71.65 -22.57 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.08 -11.89 58.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 142.3 44.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.198 0.523 . . . . 0.0 110.845 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.44 -19.43 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.75 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.54 55.36 0.83 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -67.85 -40.46 83.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.489 0.185 . . . . 0.0 111.211 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 61.92 1.51 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.696 0.76 . . . . 0.0 110.032 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.21 -34.9 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.247 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 29.2 t70 -75.1 119.97 19.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.813 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.483 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 29.5 tt0 -64.57 -35.24 80.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.36 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.36 -43.06 92.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.252 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -65.59 -41.9 92.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.73 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -70.3 -45.09 66.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.092 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 90.4 m-20 -61.8 -37.6 84.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.379 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -73.76 -41.93 61.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.598 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 70.8 mmm -86.84 12.24 11.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.9 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.19 -27.14 6.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 164.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.77 -62.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.076 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.09 71.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 122.07 0.938 . . . . 0.0 109.771 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.7 t-20 -147.5 -44.65 0.17 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -165.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.27 -39.56 54.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.838 0.352 . . . . 0.0 111.034 -171.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -128.55 69.77 79.48 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.694 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -98.96 25.52 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.312 2.674 . . . . 0.0 112.816 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 80' ' ' ASN . 5.1 tp10 73.38 -39.39 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.552 0.741 . . . . 0.0 112.114 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' CB ' HD23 ' A' ' 50' ' ' LEU . 32.5 mt-10 -85.56 -88.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.266 0.555 . . . . 0.0 111.441 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.01 -86.61 0.44 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.054 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 158.49 -78.45 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.972 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.459 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -63.0 -47.62 86.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 17.3 Cg_exo -69.02 -24.32 33.19 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.857 1.705 . . . . 0.0 110.326 175.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.661 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -59.77 -48.2 82.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.649 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 36.3 ptt180 -75.11 -38.86 60.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.584 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.29 81.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.209 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.0 p-90 -72.45 -43.83 63.21 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.91 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -40.99 78.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.383 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.47 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 83.1 mt -66.54 -45.59 88.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.522 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 38.6 ttmt -63.96 -47.7 79.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.5 m -65.26 -42.61 93.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.193 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.73 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.395 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.21 -52.63 64.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.575 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 19.2 mm-40 -61.53 -42.47 98.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.863 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.03 93.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.415 HD23 HG22 ' A' ' 21' ' ' ILE . 8.4 tp -63.65 -46.97 83.21 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.511 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.1 -26.89 63.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.18 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.77 -40.03 91.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 110.082 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -135.86 73.78 59.25 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.322 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 55.84 4.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.037 2.492 . . . . 0.0 112.322 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -132.16 -6.58 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.631 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 pt -93.52 -175.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.177 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.82 -9.51 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.418 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -166.37 152.72 8.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.973 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.89 156.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.353 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -111.17 115.66 29.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.325 0.583 . . . . 0.0 109.898 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.123 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -118.93 131.84 24.17 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.43 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -26.9 137.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 1 C-N-CA 125.709 4.272 . . . . 0.0 115.905 173.317 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -55.47 -45.1 76.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.578 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.68 83.25 2.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.59 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.38 -21.37 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.394 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -65.07 -24.09 67.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.478 ' ND2' HG11 ' A' ' 83' ' ' VAL . 48.4 t30 -64.75 -22.76 67.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m 68.54 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 m -79.24 49.45 0.97 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -167.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.478 HG11 ' ND2' ' A' ' 80' ' ' ASN . 6.7 p -142.85 136.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -146.79 154.59 41.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.539 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.07 135.06 54.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.126 0.489 . . . . 0.0 110.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -106.11 103.47 12.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.608 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.0 111.95 24.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.71 137.76 35.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.172 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 71.4 m-85 -102.46 108.53 19.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.391 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.553 ' OD1' ' HB3' ' A' ' 15' ' ' HIS . 10.5 m-20 -76.38 120.39 21.56 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.39 115.55 21.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.573 0.701 . . . . 0.0 110.914 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 C--O 1.244 0.769 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.421 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m 71.27 -55.16 0.66 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.405 0.682 . . . . 0.0 112.332 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.21 59.68 2.63 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.451 0.643 . . . . 0.0 110.451 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -89.59 -22.3 22.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.38 -119.68 3.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.402 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 56.05 52.3 10.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 110.53 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.3 mtp -71.25 120.91 82.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.145 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.37 152.57 59.9 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.462 2.108 . . . . 0.0 111.479 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 82' ' ' SER . . . -83.76 114.33 21.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 HG21 ' A' ' 83' ' ' VAL . 3.3 m -94.29 140.44 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.466 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.42 118.62 37.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.233 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.72 117.78 43.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 31.7 mt-10 -103.93 112.04 24.85 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.202 0.525 . . . . 0.0 110.449 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 2.3 mt -108.5 124.42 64.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.49 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 79.6 m80 -101.83 112.37 24.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -99.94 128.93 29.64 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.526 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 40.5 Cg_endo -68.13 111.43 2.46 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.048 1.832 . . . . 0.0 111.133 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.4 tt -51.09 -37.87 48.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.223 -171.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -70.34 -34.95 73.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -93.49 -30.79 14.85 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.304 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.08 -24.85 34.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 121.076 0.465 . . . . 0.0 109.901 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.03 68.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.26 148.53 41.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.521 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.86 -22.01 29.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.327 0.584 . . . . 0.0 109.77 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.57 3.24 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 173.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -71.87 -13.93 61.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.807 0.337 . . . . 0.0 111.627 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.13 -12.08 61.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.304 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.14 -5.42 56.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.48 107.05 18.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.253 0.549 . . . . 0.0 110.876 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.58 -32.15 72.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.5 mt -58.5 -45.78 88.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.001 0.429 . . . . 0.0 110.507 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.17 -40.8 67.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.46 0.648 . . . . 0.0 110.001 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.4 tp -70.76 -44.08 67.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.621 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 2.5 p30 -71.94 -34.24 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.792 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -69.87 -38.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.807 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.24 5.68 29.25 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.762 175.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.88 -28.68 8.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 32.3 mmtp -77.02 -70.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.38 34.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.975 0.893 . . . . 0.0 110.596 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 36' ' ' MET . 26.8 t-20 -138.63 -8.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.812 -173.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.14 -32.27 63.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.453 0.644 . . . . 0.0 109.866 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -138.45 67.75 45.47 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.462 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -88.9 7.96 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 112.636 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 72.64 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.711 0.804 . . . . 0.0 111.873 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG3' ' HB1' ' A' ' 77' ' ' ALA . 10.2 tt0 -64.1 -70.05 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.828 0.346 . . . . 0.0 111.05 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.63 -129.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.568 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -154.61 -94.88 0.11 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 167.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 11.1 ttp -53.16 -42.89 93.3 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 14.4 Cg_exo -70.5 -28.36 21.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.912 1.742 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.8 tm? -57.69 -45.69 85.32 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -60.19 -49.22 78.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.46 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.72 76.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 -175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.5 p-90 -73.41 -37.38 65.93 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.523 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.96 -51.34 67.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.61 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.707 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 4.8 tppp? -64.1 -50.37 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.863 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 73' ' ' LEU . 50.0 t -61.7 -46.46 89.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.342 . . . . 0.0 110.724 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.43 89.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.461 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -62.37 -45.35 93.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.114 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 56' ' ' LYS . 58.6 mt-10 -62.45 -47.21 85.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.2 96.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.199 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 62' ' ' LEU . 3.2 tm? -74.37 -37.88 63.33 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.436 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.27 -26.07 36.05 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.449 -0.782 . . . . 0.0 112.024 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.7 tmtp? -82.72 -37.12 25.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.636 ' ND2' HG22 ' A' ' 68' ' ' ILE . 4.0 t30 -131.4 90.43 37.88 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.864 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -88.14 31.68 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.611 2.207 . . . . 0.0 111.365 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -118.34 11.29 13.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.636 HG22 ' ND2' ' A' ' 65' ' ' ASN . 7.3 pt -95.49 166.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.243 173.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -129.4 -3.58 4.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.92 157.35 9.82 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.984 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.38 156.94 39.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.981 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -110.39 117.45 33.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.384 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.5 mt -111.1 140.76 45.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.627 0.727 . . . . 0.0 112.383 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 23.6 tptm -117.58 123.93 29.38 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.425 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD2' ' HD2' ' A' ' 74' ' ' LYS . 68.7 Cg_exo -38.97 144.44 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.247 3.298 . . . . 0.0 113.799 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -65.79 -30.96 71.68 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HB1' ' HG3' ' A' ' 45' ' ' GLU . . . -79.11 76.62 5.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.844 169.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.73 -25.14 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -57.09 -24.0 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.683 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -62.93 -36.57 83.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.107 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m 65.67 -76.38 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 16.0 m -86.68 36.33 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -167.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.442 HG12 ' HG2' ' A' ' 75' ' ' PRO . 7.4 p -140.79 130.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -127.9 151.15 49.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.208 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' CE2' HD23 ' A' ' 50' ' ' LEU . 74.4 m-85 -112.19 123.65 50.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.239 0.542 . . . . 0.0 110.2 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 12.1 t-160 -112.14 102.25 10.46 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 90.1 t -95.52 113.68 30.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.135 0.493 . . . . 0.0 110.206 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.483 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 88.0 mt -101.82 140.78 19.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -103.13 107.62 18.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 33.8 m-20 -94.72 116.69 29.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.96 114.21 25.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.574 0.702 . . . . 0.0 111.083 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 C--O 1.246 0.908 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.224 178.443 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.924 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 m -82.15 69.12 8.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 111.199 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.31 -49.56 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.485 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.0 mtt -105.81 6.25 31.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 171.29 40.27 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.155 -174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -145.83 -31.67 0.38 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.1 mmm -130.91 71.1 82.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.735 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.64 78.03 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.044 2.496 . . . . 0.0 111.787 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.59 109.53 18.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.101 0.477 . . . . 0.0 110.448 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.66 119.06 48.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.879 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.08 121.53 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.549 0.69 . . . . 0.0 110.27 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 39' ' ' VAL . 87.3 t -92.28 139.58 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.719 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.62 112.8 26.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.0 110.519 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.0 mt -103.07 152.21 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 56.3 m80 -130.43 142.84 50.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.488 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -141.96 132.53 12.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.075 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' O ' HG21 ' A' ' 21' ' ' ILE . 19.4 Cg_endo -58.3 115.26 2.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.503 2.135 . . . . 0.0 111.706 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 62' ' ' LEU . 1.5 tm? -43.07 -50.82 6.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.584 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' H ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.55 -18.82 58.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 9.5 ttt180 -100.77 -35.3 9.5 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.881 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -69.4 -25.72 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.223 0.535 . . . . 0.0 109.81 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.85 -12.13 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.92 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.6 171.31 12.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.002 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.24 -52.3 17.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 109.783 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.06 71.32 3.03 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.103 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' HD22 ' A' ' 32' ' ' LEU . 16.7 p90 -65.24 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.909 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.04 4.97 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.0 111.251 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.485 ' OD1' ' HD3' ' A' ' 20' ' ' ARG . 36.3 t70 -75.39 113.96 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.51 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -63.03 -34.8 78.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.466 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.537 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 32.1 tp -61.5 -40.33 94.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.522 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -55.84 -42.73 76.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 109.58 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.444 HD13 ' NH2' ' A' ' 51' ' ' ARG . 3.5 mm? -65.08 -47.7 76.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.407 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.53 -41.83 88.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.83 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 14.5 mt-30 -66.42 -44.09 83.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.343 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.5 mmm -87.68 -1.09 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.3 -26.68 15.12 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 165.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 35' ' ' GLN . 60.6 tttp -64.81 -66.58 0.52 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.274 -0.963 . . . . 0.0 110.829 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG22 ' CG1' ' A' ' 12' ' ' VAL . 7.5 p -108.61 97.59 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.748 0.785 . . . . 0.0 110.229 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -176.59 -26.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.55 -44.56 96.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.043 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -145.1 73.98 14.44 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.745 0.783 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -91.44 21.03 0.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.838 2.359 . . . . 0.0 112.45 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 71.59 -37.76 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 112.366 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.682 ' CD ' ' HB3' ' A' ' 75' ' ' PRO . 23.6 tp10 -82.4 -94.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.332 -0.23 . . . . 0.0 111.169 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . 32.7 mt-10 -114.82 -109.16 0.36 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.737 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 167.67 -106.27 0.25 Allowed Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.658 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.667 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 10.8 tpt -49.77 -48.39 77.34 Favored Pre-proline 0 C--O 1.247 0.954 0 CA-C-O 120.958 0.409 . . . . 0.0 111.317 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.597 ' HG2' ' HB3' ' A' ' 46' ' ' GLU . 31.4 Cg_endo -60.58 -34.15 92.81 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.043 1.162 . . . . 0.0 110.366 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.71 ' O ' ' HE3' ' A' ' 53' ' ' TRP . 4.0 mt -60.28 -44.41 95.38 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.2 ptm180 -62.83 -39.21 93.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.211 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.36 94.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.722 0.772 . . . . 0.0 110.047 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.71 ' HE3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -51.15 69.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.95 1.3 . . . . 0.0 112.881 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.61 ' HB ' ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -73.35 -43.71 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -58.52 -38.98 73.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.628 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 12.5 mmmm -69.62 -49.1 57.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.698 174.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.666 ' SG ' HD11 ' A' ' 73' ' ' LEU . 49.7 t -59.18 -44.45 92.17 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.777 0.322 . . . . 0.0 110.942 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.18 92.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.301 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -61.35 -48.14 82.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.424 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 33.3 mm-40 -64.54 -44.0 92.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.514 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.45 95.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.439 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.42 HD11 HD22 ' A' ' 18' ' ' LEU . 10.1 tt -68.63 -48.19 64.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.149 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -63.64 -25.51 68.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.702 0.287 . . . . 0.0 111.337 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -71.76 -33.58 68.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.219 0.533 . . . . 0.0 110.279 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -149.36 73.4 9.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.717 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.29 33.73 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.323 2.682 . . . . 0.0 113.026 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.04 18.87 10.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.525 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.0 pt -96.1 -173.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.923 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.72 -27.38 2.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.529 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -165.06 168.86 16.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 176.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.17 153.51 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -110.96 132.55 54.11 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.644 0.735 . . . . 0.0 111.303 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.666 HD11 ' SG ' ' A' ' 57' ' ' CYS . 1.8 mm? -107.87 143.9 35.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.492 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -130.83 122.62 19.6 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.682 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -32.74 140.46 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 125.273 3.982 . . . . 0.0 115.906 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.518 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 42.4 mtp180 -57.75 -37.59 73.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.989 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.96 84.6 7.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.511 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.68 -12.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.379 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -59.07 -32.14 69.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.608 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 45' ' ' GLU . 4.9 t-20 -63.13 -37.72 88.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.503 -172.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m 69.24 -59.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -77.63 -34.2 53.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -167.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.514 HG12 ' HG2' ' A' ' 75' ' ' PRO . 8.8 p -89.88 132.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 112.255 -171.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -130.6 161.66 31.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.721 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.93 136.23 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.442 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -111.92 111.12 21.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.8 t -92.04 110.36 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 15' ' ' HIS . 82.3 mt -101.2 136.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.162 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.31 111.51 23.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.239 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -77.19 113.92 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -89.66 110.64 21.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.725 0.774 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.301 170.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.633 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -80.53 -67.29 0.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.701 0.286 . . . . 0.0 111.425 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.86 -74.18 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.4 mmt 58.37 67.54 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.679 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 37.03 51.0 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.285 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -141.93 114.14 8.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.931 0.396 . . . . 0.0 110.605 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.5 ptm -154.44 156.26 31.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.616 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.25 43.08 0.95 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.769 2.312 . . . . 0.0 113.077 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 82' ' ' SER . . . -108.86 115.93 31.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.719 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.1 t -114.52 119.35 61.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.923 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.58 118.42 31.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.24 119.98 56.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 23.6 mt-10 -100.27 118.98 37.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.085 0.469 . . . . 0.0 111.173 -168.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.525 HD11 ' SD ' ' A' ' 36' ' ' MET . 24.4 mt -101.32 132.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.084 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.578 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.5 m80 -112.39 112.09 23.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 110.896 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -106.21 153.51 40.28 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.0 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' HG23 ' A' ' 21' ' ' ILE . 87.5 Cg_endo -81.69 113.89 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.281 1.988 . . . . 0.0 111.673 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -43.3 -49.1 6.86 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -74.95 -32.07 61.64 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' HD2' ' OD1' ' A' ' 29' ' ' ASP . 2.6 ttm180 -96.86 -21.46 17.49 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.85 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 17' ' ' PRO . 6.7 tp -72.28 -27.34 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.02 -9.11 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.13 155.27 19.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.125 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -84.01 -14.35 50.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.833 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.08 43.71 1.65 Allowed Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -60.03 -27.76 67.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 111.624 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -14.34 62.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.639 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.99 -18.47 43.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.557 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 25.5 t70 -84.7 109.0 17.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 111.57 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -29.61 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.25 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . 2.9 tm? -63.86 -40.2 95.98 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.3 -43.84 98.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.297 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.97 -44.57 92.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -58.4 -43.32 88.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.257 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 2.4 mp0 -68.44 -45.21 73.16 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.525 ' SD ' HD11 ' A' ' 14' ' ' ILE . 66.2 mmm -90.15 13.43 15.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.172 0.51 . . . . 0.0 110.825 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.88 -38.29 3.67 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -63.4 -66.11 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.121 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 p -91.36 68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 122.338 1.066 . . . . 0.0 110.267 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.11 9.8 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.145 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.34 -36.95 3.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.987 0.423 . . . . 0.0 110.055 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.417 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.1 p -141.94 59.3 9.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.989 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 42' ' ' THR . 67.1 Cg_endo -94.68 30.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.047 2.498 . . . . 0.0 113.098 -174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 73.79 -47.9 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.31 0.644 . . . . 0.0 111.048 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.558 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -77.81 -92.64 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.95 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -130.06 -91.3 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.605 0.241 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 165.96 -102.6 0.19 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.597 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 9.1 ttp -53.55 -45.97 98.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 48' ' ' MET . 19.2 Cg_endo -60.9 -30.2 89.56 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.879 1.719 . . . . 0.0 111.05 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.795 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -59.06 -45.96 89.47 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.292 176.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 18.0 ttm180 -59.98 -48.94 79.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.2 78.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.376 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.795 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.3 p-90 -72.38 -41.93 65.8 Favored 'General case' 0 CA--C 1.522 -0.096 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.852 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -43.18 80.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.689 -174.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.78 -46.23 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.316 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.53 -41.81 88.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.586 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.42 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 71.7 m -66.28 -44.85 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.819 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.33 83.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.833 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -59.35 -49.35 78.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.967 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -64.56 -41.83 96.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.043 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.9 96.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.283 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD22 HG22 ' A' ' 21' ' ' ILE . 15.6 tp -69.48 -47.36 64.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.135 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.66 -26.44 67.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -42.17 98.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.494 0.664 . . . . 0.0 109.961 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.4 75.09 33.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.75 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.15 47.77 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.073 2.515 . . . . 0.0 112.709 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -139.26 2.83 2.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.69 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -85.64 -179.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.574 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.19 -19.75 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.878 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -165.51 155.47 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.0 t -127.28 152.36 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.681 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -110.1 116.22 31.16 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.429 HD23 ' CZ3' ' A' ' 53' ' ' TRP . 29.8 tp -127.7 141.89 51.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.338 -167.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -126.38 126.86 24.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 18.1 Cg_endo -63.16 171.22 6.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.107 2.538 . . . . 0.0 114.733 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -66.41 -61.01 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.66 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.99 118.01 4.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.49 -9.75 13.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.156 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -58.81 -39.57 81.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' OD1' HG13 ' A' ' 83' ' ' VAL . 1.6 p30 -73.46 -27.06 61.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.495 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m 74.49 -66.51 0.29 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 26.8 m -125.85 27.07 6.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.422 HG13 ' OD1' ' A' ' 80' ' ' ASN . 9.9 p -90.16 134.98 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -134.86 152.25 51.59 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.996 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -108.51 118.86 37.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.632 0.73 . . . . 0.0 109.623 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.4 t-160 -94.05 102.04 14.09 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.32 112.22 25.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -113.54 139.11 40.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.528 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.57 106.65 17.12 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.201 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -86.9 127.32 35.05 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.29 114.85 21.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE2' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.664 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -78.47 124.96 28.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.911 0.386 . . . . 0.0 111.089 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.13 -42.48 2.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.555 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttp 54.94 71.49 0.53 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.89 -175.21 46.67 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.448 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -139.85 149.22 43.17 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.8 mtm -64.25 117.65 38.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 82' ' ' SER . 36.1 Cg_endo -64.94 95.94 0.25 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.89 2.393 . . . . 0.0 113.072 -172.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.22 113.55 21.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.489 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -98.99 119.71 47.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.21 118.39 28.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.014 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.05 119.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -98.77 112.22 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 0.0 110.26 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 HD13 ' SD ' ' A' ' 36' ' ' MET . 10.2 mt -111.95 123.34 67.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -99.66 112.82 25.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.237 0.542 . . . . 0.0 110.914 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-30 -111.42 116.04 51.23 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.589 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 33.6 Cg_exo -61.79 119.74 7.01 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.008 . . . . 0.0 111.789 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.7 tm? -42.38 -45.2 4.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.765 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -71.98 -43.54 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.785 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 11.5 ptp180 -83.13 -28.66 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.277 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 17' ' ' PRO . 7.8 tp -75.24 -17.69 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.0 109.891 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.88 -13.72 55.6 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.25 0.548 . . . . 0.0 110.395 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.35 156.94 20.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.369 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.9 -14.37 51.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.351 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.16 60.61 1.1 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -82.16 -41.53 20.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 111.158 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.37 -4.75 43.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.2 9.38 30.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.501 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 18.0 t70 -95.57 119.5 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.882 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.62 -31.56 71.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.607 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 6.4 mt -69.03 -43.21 75.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.26 0.552 . . . . 0.0 110.465 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.0 -36.56 75.24 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.394 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -47.9 58.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.28 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.3 p30 -71.45 -35.16 70.81 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.864 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -66.47 -45.21 80.47 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.999 0.428 . . . . 0.0 110.64 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 7.3 tpt -93.34 16.81 12.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.133 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.09 -32.98 3.85 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 163.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.53 -62.98 1.43 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.63 -0.785 . . . . 0.0 110.576 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 39' ' ' VAL . 11.4 p -94.6 52.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.705 1.24 . . . . 0.0 110.165 -176.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 36' ' ' MET . 4.2 t-20 -133.16 -29.37 1.43 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.583 -171.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -79.48 -31.38 42.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.67 -169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 p -126.1 62.38 44.92 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.906 0.384 . . . . 0.0 111.225 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.479 ' O ' HG22 ' A' ' 83' ' ' VAL . 11.3 Cg_endo -97.21 6.6 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.936 2.424 . . . . 0.0 113.456 -174.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 71.19 -42.03 0.52 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.698 0.799 . . . . 0.0 112.205 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HB3' HD22 ' A' ' 50' ' ' LEU . 3.9 tp10 -66.72 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.345 0.117 . . . . 0.0 110.983 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 31.5 mt-10 -136.28 -86.44 0.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.328 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 160.9 -110.26 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.099 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.547 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.6 tpt -52.72 -49.53 85.91 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.9 Cg_endo -67.82 -35.73 20.47 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.208 1.272 . . . . 0.0 111.566 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.725 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.38 -43.2 96.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.415 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 48' ' ' MET . 35.6 ptt180 -69.51 -29.87 67.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.997 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -49.31 77.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.668 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.725 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 12.2 p-90 -73.09 -36.84 66.87 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.148 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -49.1 82.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.43 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 79.6 mt -65.55 -38.64 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.427 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.2 tptt -63.65 -48.86 75.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.727 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 73' ' ' LEU . 47.7 t -62.68 -46.95 85.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.69 83.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.667 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -62.4 -52.23 64.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.547 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 56.7 mm-40 -65.04 -38.35 90.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.661 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.71 -44.12 90.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 62' ' ' LEU . 8.2 tt -72.94 -47.23 47.39 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.782 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.55 -26.08 63.18 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.805 -0.559 . . . . 0.0 112.09 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -84.05 -44.96 13.57 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.57 ' ND2' HG22 ' A' ' 68' ' ' ILE . 3.2 t30 -139.45 100.14 7.69 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.866 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -96.79 25.66 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.695 2.263 . . . . 0.0 112.012 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.04 8.22 32.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' ND2' ' A' ' 65' ' ' ASN . 4.7 pt -77.51 166.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.733 0.777 . . . . 0.0 111.474 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HE ' ' HB2' ' A' ' 69' ' ' ARG . 2.0 mtm180 -106.89 -51.39 2.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.325 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.9 150.37 27.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.139 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.55 156.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.772 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -111.16 115.1 28.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 57' ' ' CYS . 11.2 mt -111.69 136.68 50.6 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.636 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -113.93 119.16 41.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HG2' HG12 ' A' ' 83' ' ' VAL . 88.2 Cg_exo -37.23 147.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 125.034 3.823 . . . . 0.0 114.301 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -61.32 -40.33 93.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.957 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.76 85.8 3.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.984 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.51 -22.67 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.075 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -57.58 -29.27 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.216 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.23 -38.56 91.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.724 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m 65.6 -56.64 0.33 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 123.945 0.778 . . . . 0.0 113.02 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 8' ' ' PRO . 5.7 m -76.87 -37.37 55.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.492 HG12 ' HG2' ' A' ' 75' ' ' PRO . 7.8 p -87.68 140.23 16.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -146.47 153.3 40.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.69 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.15 126.43 52.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.447 0.641 . . . . 0.0 111.053 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -109.31 102.84 11.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.87 114.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.615 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 77.2 mt -104.17 133.15 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.85 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 87.6 m-85 -102.65 109.91 21.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.659 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 17.5 t70 -99.58 131.91 45.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.68 108.32 18.6 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.892 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.245 0.847 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.885 172.324 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -138.44 143.83 39.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.689 0.244 . . . . 0.0 110.467 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.89 39.02 20.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.476 0.655 . . . . 0.0 110.596 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.75 116.02 26.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.115 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.83 70.18 2.93 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.197 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 26.3 p80 -83.22 26.54 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 0.0 111.272 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.527 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 26.4 ttt -108.88 -54.48 0.06 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.737 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HD2' ' H ' ' A' ' 7' ' ' MET . 29.9 Cg_endo -64.85 -34.18 50.15 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.355 1.37 . . . . 0.0 111.177 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . -124.81 108.54 12.05 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.49 119.39 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.16 119.61 26.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.688 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 89.1 t -118.54 130.3 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.4 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.14 127.07 53.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 110.552 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mt -116.16 129.45 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -102.22 140.12 36.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -132.46 126.87 20.42 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 22.4 Cg_endo -63.59 111.25 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.941 1.76 . . . . 0.0 110.242 172.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.31 -35.44 18.2 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.894 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 3.5 mptp? -68.23 -40.58 82.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.682 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -83.19 -36.69 24.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.832 0.348 . . . . 0.0 110.508 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.461 HG22 HD21 ' A' ' 62' ' ' LEU . 10.8 tp -74.69 -3.49 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.248 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.59 -6.36 22.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.13 168.81 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.066 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.41 -44.48 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.13 49.97 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.178 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.01 -34.9 77.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.39 32.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -95.62 2.1 53.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.19 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -89.56 123.06 33.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.094 0.473 . . . . 0.0 109.996 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.68 -32.59 74.12 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.809 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 22.4 tp -70.71 -42.36 70.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -43.04 86.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.308 0.575 . . . . 0.0 109.831 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.4 tp -70.6 -49.87 43.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.935 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 4.5 p30 -74.8 -27.58 60.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.728 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.745 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.2 tt0 -66.63 -45.45 79.03 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 7.03 44.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.059 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.04 -27.15 8.42 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.74 -66.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.449 . . . . 0.0 111.171 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.49 41.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.924 1.345 . . . . 0.0 109.719 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -145.84 -3.94 0.67 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.119 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.88 -30.83 65.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.506 0.669 . . . . 0.0 109.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.8 67.89 79.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 89.4 Cg_endo -95.37 25.48 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.257 2.638 . . . . 0.0 113.263 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.49 -55.58 0.62 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.456 0.702 . . . . 0.0 111.773 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.13 -108.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -93.88 -124.79 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.565 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -153.1 -89.17 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.568 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -58.38 -39.6 76.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 32.8 Cg_endo -77.63 -23.97 9.28 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 120.82 1.329 . . . . 0.0 110.591 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.562 HD21 ' NE1' ' A' ' 53' ' ' TRP . 3.1 tm? -58.87 -46.01 88.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.725 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 48' ' ' MET . 13.0 ptt180 -67.36 -38.6 85.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.42 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.69 80.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.891 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.562 ' NE1' HD21 ' A' ' 50' ' ' LEU . 7.6 p-90 -72.93 -37.28 67.24 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.885 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.47 -51.11 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.43 -41.15 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.734 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -62.45 -49.5 75.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.768 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.44 -45.24 94.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.99 92.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -57.79 -58.23 9.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.299 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -64.08 -41.95 97.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.72 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 21' ' ' ILE . 7.8 tp -76.84 -47.79 20.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.035 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.68 -27.35 65.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 2.7 mmmp? -69.36 -29.15 66.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -149.01 73.62 10.19 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.12 41.39 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.076 2.517 . . . . 0.0 113.171 -170.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -133.44 26.22 4.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.38 -172.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.3 0.571 . . . . 0.0 111.67 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -127.04 -44.01 1.64 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.555 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.46 152.87 12.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -122.73 156.96 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.985 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.47 116.88 32.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.71 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -106.08 144.28 33.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.3 0.571 . . . . 0.0 111.198 -174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 13.4 tmtt? -123.83 115.38 27.96 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.887 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 90.0 Cg_exo -46.32 138.51 13.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.867 3.045 . . . . 0.0 113.521 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -56.91 -29.51 63.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.031 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.67 96.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.054 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' HZ1' ' A' ' 74' ' ' LYS . 58.1 t -62.4 -29.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.269 176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -61.69 -28.54 69.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.829 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -73.54 -39.77 64.49 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.076 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 m 64.4 -71.97 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.436 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 m -91.92 59.6 3.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.95 136.22 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.978 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.38 160.16 40.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.229 0.538 . . . . 0.0 111.399 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.594 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 62.0 m-85 -120.79 123.62 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.709 171.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -91.9 101.65 14.22 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.77 112.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.2 138.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.661 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -103.61 110.35 22.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 7.5 m-20 -99.34 132.36 44.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.721 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 1.1 pm0 -94.59 120.9 35.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 0.0 110.811 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.139 175.476 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 m -70.94 -33.29 70.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.92 83.0 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.417 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -58.56 -46.15 87.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.279 0.561 . . . . 0.0 109.708 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.81 179.27 41.24 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.253 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -78.95 91.32 4.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.521 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 21.8 mmt -64.22 -53.73 44.78 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.9 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 64.0 Cg_endo -92.63 37.3 0.23 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.009 1.806 . . . . 0.0 112.452 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.52 135.99 48.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.98 118.6 44.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.503 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.39 117.78 35.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -106.06 140.24 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -103.09 112.26 25.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.421 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' SD ' ' A' ' 36' ' ' MET . 40.2 mt -111.63 142.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 64.7 m80 -125.61 119.52 28.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 21.8 m-85 -118.11 106.96 44.43 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.157 174.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_exo -59.07 123.33 13.25 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.931 1.754 . . . . 0.0 111.586 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -48.86 19.74 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -68.74 -29.11 67.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 12.4 ptp180 -94.58 -28.66 15.28 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.605 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.1 tp -72.91 -25.06 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.184 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -82.17 -11.22 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 110.686 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.57 177.11 6.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.438 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.58 151.93 24.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 21.61 51.15 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -170.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -61.84 -30.51 70.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.544 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.24 59.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.214 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -76.64 -27.29 55.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.425 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 102.55 0.79 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.039 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 35.8 tt0 -62.46 -31.13 71.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.008 -171.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 36.8 tp -60.65 -42.51 97.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.46 -42.14 83.51 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.618 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD13 ' NH2' ' A' ' 51' ' ' ARG . 7.3 tp -67.16 -46.3 74.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.779 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.488 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 93.5 m-20 -59.74 -42.95 94.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 43.3 mt-30 -64.86 -43.49 92.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.438 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 72.2 mmm -87.69 9.02 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.78 -29.26 5.04 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 166.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -73.19 -61.62 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.587 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -92.77 30.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.428 1.109 . . . . 0.0 110.188 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.544 HD22 ' HB2' ' A' ' 50' ' ' LEU . 26.0 t-20 -141.6 0.78 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.778 -170.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.77 -47.07 76.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.294 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.37 72.04 82.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 75.6 Cg_endo -92.69 23.09 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.095 2.53 . . . . 0.0 113.577 -172.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 71.3 -57.33 0.61 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.257 0.623 . . . . 0.0 112.004 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.563 ' HB3' HD11 ' A' ' 50' ' ' LEU . 5.5 tp10 -67.0 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.895 0.478 . . . . 0.0 111.231 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -127.93 -91.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 170.63 -114.42 0.54 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.897 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -56.91 -40.14 82.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.58 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.21 -37.38 69.98 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.921 1.747 . . . . 0.0 112.11 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.743 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.9 mt -60.08 -45.56 92.5 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 36' ' ' MET . 1.8 ttt180 -56.55 -41.83 77.5 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.106 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.743 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.1 -40.32 68.27 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.767 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -43.08 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 71.2 mt -64.06 -44.89 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 176.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.63 -48.4 77.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.603 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.0 m -67.59 -39.38 84.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.089 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.64 89.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.44 -54.56 39.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.578 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.02 -36.74 82.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.3 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.37 75.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.191 0.52 . . . . 0.0 110.932 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.9 tm? -83.62 -41.43 17.82 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.717 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -79.64 -29.13 40.87 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.107 -0.37 . . . . 0.0 111.321 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -89.64 -14.78 34.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.822 0.82 . . . . 0.0 109.315 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -144.45 68.9 15.34 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.373 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 46.4 Cg_endo -83.24 37.93 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.767 2.312 . . . . 0.0 112.766 -170.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -17.97 13.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.498 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 pp -80.77 -173.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.426 0.632 . . . . 0.0 112.184 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -140.94 -16.42 0.87 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.643 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.25 163.06 20.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.199 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p -134.59 153.25 34.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.075 0.464 . . . . 0.0 110.422 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -109.52 113.58 26.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -121.8 143.82 49.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.544 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -116.89 131.78 23.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.33 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HD2' HG12 ' A' ' 83' ' ' VAL . 86.8 Cg_exo -51.41 151.62 13.22 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.382 2.721 . . . . 0.0 112.848 172.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -63.12 -33.19 74.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.733 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HB2' ' ND2' ' A' ' 80' ' ' ASN . . . -65.87 112.81 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.751 0.786 . . . . 0.0 111.131 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.4 -33.54 59.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.771 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -65.02 -26.13 68.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.743 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.551 ' ND2' ' HB2' ' A' ' 77' ' ' ALA . 87.7 m-20 -64.55 -29.36 70.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.783 0.325 . . . . 0.0 110.909 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.9 t 66.67 -82.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.666 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 t -108.8 37.99 2.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 80' ' ' ASN . 13.1 p -101.03 130.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -130.36 136.31 48.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.421 ' HA ' HG13 ' A' ' 12' ' ' VAL . 10.9 m-30 -105.61 124.2 49.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.742 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.27 102.47 12.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 40.4 t -94.43 111.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.92 140.43 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.425 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 78.9 m-85 -101.33 108.22 19.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 6.5 t70 -83.94 135.78 34.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.265 -169.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.83 113.84 26.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.351 0.596 . . . . 0.0 109.981 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 20' ' ' ARG . 1.7 pp20? . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.845 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 m -75.04 -30.29 61.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.796 0.331 . . . . 0.0 111.195 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 4' ' ' MET . . . -86.65 63.6 8.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 26.8 ptm 51.12 -171.72 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.544 1.137 . . . . 0.0 112.46 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.43 124.68 5.48 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.817 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -118.3 96.3 5.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.9 ttt -101.82 111.36 63.97 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.33 70.13 7.65 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.835 2.357 . . . . 0.0 111.628 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -84.67 119.4 25.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.512 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -91.72 119.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.101 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.81 119.01 33.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.23 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.28 130.19 55.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.271 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -108.41 117.17 33.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.507 0.67 . . . . 0.0 110.406 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 HD11 ' SD ' ' A' ' 36' ' ' MET . 33.4 mt -115.75 133.06 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.06 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -120.84 107.72 13.07 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.589 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.3 132.23 24.75 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.847 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 10.2 Cg_exo -66.56 120.73 7.88 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.672 1.581 . . . . 0.0 109.547 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -53.92 -42.23 68.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.814 -167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 7.7 mtmp? -79.56 -24.11 42.34 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.492 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 17' ' ' PRO . 7.8 mpt_? -81.28 -38.03 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.53 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tp -70.75 -26.31 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.287 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.23 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.99 157.85 34.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.55 -21.72 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.335 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.52 38.94 3.14 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.465 ' O ' HD22 ' A' ' 32' ' ' LEU . 32.1 p90 -66.36 -35.94 81.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.503 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.0 -9.68 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.224 0.535 . . . . 0.0 111.29 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.38 -3.2 50.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.2 124.78 30.21 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.738 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.29 -28.98 70.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -170.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.524 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 3.1 tm? -76.51 -36.82 57.53 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.633 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -66.23 -40.33 90.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.829 177.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.31 -49.6 63.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.966 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.9 p30 -73.45 -34.06 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.91 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.633 HE21 ' HA ' ' A' ' 32' ' ' LEU . 3.5 pt20 -67.99 -41.48 82.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.926 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.437 ' SD ' HD11 ' A' ' 14' ' ' ILE . 86.7 mmm -90.32 5.82 45.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.11 -28.19 11.19 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 164.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 68.1 mttm -77.11 -73.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.344 -0.428 . . . . 0.0 111.986 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.59 50.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.722 0.772 . . . . 0.0 110.564 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -142.49 -23.9 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.404 -170.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -87.18 -18.23 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.173 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 p -133.27 57.43 27.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.25 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 42' ' ' THR . 26.5 Cg_endo -101.52 24.01 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.321 2.681 . . . . 0.0 113.814 -174.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 70.54 -58.04 0.56 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.053 0.541 . . . . 0.0 112.239 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.495 ' HB3' HD12 ' A' ' 50' ' ' LEU . 37.8 tt0 -73.09 -86.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.601 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.32 -95.7 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.171 -0.331 . . . . 0.0 110.569 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 162.18 -83.05 0.12 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.84 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.463 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 12.6 tpt -54.36 -49.89 88.08 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 48' ' ' MET . 47.9 Cg_endo -68.56 -27.78 32.46 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.402 1.401 . . . . 0.0 110.02 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 2.3 mt -57.83 -46.31 84.92 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HE1' ' A' ' 36' ' ' MET . 27.8 ttt180 -64.28 -47.0 81.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.61 -49.87 75.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.841 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.58 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 6.2 p-90 -74.06 -41.29 61.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.888 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.7 t -61.45 -51.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 HD13 ' HG3' ' A' ' 36' ' ' MET . 80.1 mt -60.28 -41.37 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.7 tmtt? -63.2 -50.43 70.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.578 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -64.14 -41.45 97.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.832 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.72 97.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.369 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.99 -49.58 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.29 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 10.4 mm-40 -61.77 -45.8 92.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.51 93.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -60.95 -46.03 92.35 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.452 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.4 -27.46 52.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -63.72 -50.3 69.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.995 0.426 . . . . 0.0 109.854 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -130.58 76.04 78.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 121.44 0.638 . . . . 0.0 109.936 177.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 42.02 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.483 2.789 . . . . 0.0 113.237 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 65' ' ' ASN . 54.0 mtmt -124.89 -1.21 7.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.407 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.0 pt -83.0 -174.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -143.04 -18.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.697 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -165.63 157.73 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.108 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.24 155.49 37.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -111.56 116.83 31.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.217 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.473 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 15.5 mt -108.44 140.22 42.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.77 0.795 . . . . 0.0 112.611 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 24.3 tptm -120.97 116.68 31.24 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.689 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.483 ' HG2' ' HB ' ' A' ' 83' ' ' VAL . 96.0 Cg_exo -33.29 143.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.766 3.644 . . . . 0.0 114.605 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -62.87 -32.24 73.44 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.305 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.11 69.9 7.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.037 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.5 -22.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.945 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -57.74 -23.77 53.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.97 -36.1 80.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m 71.51 -57.1 0.62 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.299 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 17.8 m -96.63 54.57 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.483 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -140.68 134.4 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.208 173.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.74 143.98 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -117.17 123.98 48.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.176 0.513 . . . . 0.0 109.957 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -101.68 103.61 14.4 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.017 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.7 t -95.85 112.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.1 mt -113.26 142.36 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -101.81 110.49 22.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.303 0.573 . . . . 0.0 110.131 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.49 133.03 38.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.238 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 1.4 pm0 -83.01 116.38 22.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.516 0.674 . . . . 0.0 110.026 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.498 ' CD ' ' HB2' ' A' ' 19' ' ' LYS . 5.6 pt-20 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.066 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 p -111.69 155.85 22.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.814 0.34 . . . . 0.0 110.542 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.83 143.97 49.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.09 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.36 60.26 4.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.149 0.499 . . . . 0.0 110.793 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.5 25.52 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.332 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.453 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 40.1 m80 -139.78 56.31 1.64 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 109.77 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.89 88.29 11.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.894 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 7.9 Cg_exo -72.72 138.37 28.96 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.939 2.426 . . . . 0.0 112.0 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.29 113.02 18.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.056 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.6 118.86 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.831 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.0 118.69 23.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.17 139.12 49.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -107.43 128.35 54.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.266 0.555 . . . . 0.0 110.235 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.53 HD12 ' SD ' ' A' ' 36' ' ' MET . 44.2 mt -117.13 149.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -125.96 123.14 37.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.977 0.418 . . . . 0.0 111.099 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 22.1 m-85 -126.09 108.29 24.69 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.814 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 36.7 Cg_exo -57.55 124.16 15.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.02 1.813 . . . . 0.0 111.546 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -49.83 9.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -170.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -77.04 -29.17 55.1 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.232 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -79.92 -34.33 39.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.82 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 5.4 tp -73.63 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.975 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.4 -7.78 54.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.19 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 26' ' ' TYR . . . -83.58 149.13 26.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.941 0.401 . . . . 0.0 110.689 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.66 -40.07 29.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.278 0.561 . . . . 0.0 109.826 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.21 44.8 2.63 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.639 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.531 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 26.2 p90 -70.1 -10.6 59.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.381 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.75 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.539 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -80.53 -16.96 52.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.894 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 31.1 m-20 -81.72 94.55 7.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.636 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -60.4 -31.29 70.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.74 -173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.607 HD11 ' NE2' ' A' ' 35' ' ' GLN . 1.3 tm? -57.08 -42.94 81.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.2 -43.65 94.38 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.015 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.617 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.31 -46.14 79.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.748 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' HD11 ' A' ' 31' ' ' LEU . 6.3 mt-30 -64.74 -44.56 89.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.53 ' SD ' HD12 ' A' ' 14' ' ' ILE . 82.3 mmm -91.78 18.0 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.735 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.73 -31.5 3.16 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 163.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -70.54 -63.78 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -0.634 . . . . 0.0 111.086 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 35' ' ' GLN . 26.8 m -90.84 41.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.846 0.831 . . . . 0.0 110.088 -175.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 51' ' ' ARG . 28.3 t-20 -137.25 -21.99 1.17 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.584 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.57 -43.72 96.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.5 t -135.26 79.2 50.12 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.856 0.836 . . . . 0.0 110.192 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.33 14.44 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.077 2.518 . . . . 0.0 112.609 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 72.74 -47.45 0.67 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.684 0.794 . . . . 0.0 111.297 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 54.9 mm-40 -56.32 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.204 0.525 . . . . 0.0 111.066 174.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -146.04 -98.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.582 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . 174.1 -83.23 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 168.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.23 -45.73 99.1 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 11.7 Cg_exo -72.84 -28.24 13.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.081 1.854 . . . . 0.0 110.715 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.7 tm? -57.34 -44.77 84.55 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 36' ' ' MET . 34.4 ttp180 -67.06 -49.32 65.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.159 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.49 80.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.75 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.559 ' HE1' HD22 ' A' ' 50' ' ' LEU . 5.6 p-90 -72.75 -39.07 67.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.022 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.17 -43.1 79.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.743 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.73 -41.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 110.518 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -65.33 -44.99 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.113 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 t -63.76 -44.87 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.458 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.412 . . . . 0.0 110.394 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -60.05 -50.95 71.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.299 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.23 -34.89 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.211 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.02 -42.44 76.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.97 0.414 . . . . 0.0 111.185 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.402 ' C ' HD11 ' A' ' 62' ' ' LEU . 2.9 tm? -72.14 -47.32 51.89 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.486 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.99 -28.8 63.64 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 111.841 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HZ3' ' HB3' ' A' ' 64' ' ' LYS . 7.4 ttpm? -86.26 -12.64 49.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.91 0.862 . . . . 0.0 109.173 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' O ' HG12 ' A' ' 68' ' ' ILE . 8.7 t30 -154.64 73.43 5.95 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.041 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -85.86 34.34 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.605 2.203 . . . . 0.0 112.629 -170.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.41 -2.78 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.75 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 65' ' ' ASN . 6.1 pt -84.96 166.9 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.371 0.605 . . . . 0.0 111.388 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HA ' ' HB2' ' A' ' 89' ' ' PHE . 35.4 ptt180 -138.46 -4.16 1.66 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.509 176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -167.75 149.47 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.479 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.2 m -136.83 156.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 122.706 0.402 . . . . 0.0 110.015 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.84 117.74 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.879 0.371 . . . . 0.0 110.052 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.33 141.09 45.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 112.361 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -108.78 122.18 40.87 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.483 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 59.3 Cg_endo -70.3 -179.97 3.55 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.878 2.385 . . . . 0.0 114.542 -171.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -65.12 -54.74 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.73 -167.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB1' ' OE2' ' A' ' 45' ' ' GLU . . . -58.96 107.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 0.0 111.828 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.82 -37.93 79.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.672 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -70.68 -25.05 62.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.151 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.467 ' ND2' HG11 ' A' ' 83' ' ' VAL . 59.8 t30 -65.14 -36.48 84.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t 67.24 -89.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 163.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.7 m -80.46 63.91 5.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.604 0.716 . . . . 0.0 111.592 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.467 HG11 ' ND2' ' A' ' 80' ' ' ASN . 4.9 p -139.92 129.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.511 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -128.39 137.12 51.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.229 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -115.3 122.49 46.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.314 0.578 . . . . 0.0 110.28 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -95.81 108.64 20.99 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.226 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -92.12 108.88 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.597 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 72.2 m-85 -100.77 111.61 23.87 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 13.4 t70 -74.94 142.88 43.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.2 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.16 112.74 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.488 0.661 . . . . 0.0 109.33 -167.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--O 1.247 0.93 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.288 -172.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 m -67.12 -59.04 3.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.739 0.304 . . . . 0.0 110.43 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -161.77 129.96 4.21 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -72.8 126.48 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.593 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.15 -35.8 4.26 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.079 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.432 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 37.8 m80 -142.95 80.91 1.7 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.468 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 22.5 mmt -65.04 -47.92 72.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.802 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 16.3 Cg_exo -69.1 131.68 22.7 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.844 1.696 . . . . 0.0 111.831 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -86.11 122.84 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.5 t -125.95 125.46 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -120.16 132.95 55.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.175 0.512 . . . . 0.0 110.028 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.01 119.71 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.4 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 7.1 pt-20 -102.21 113.77 27.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.341 0.591 . . . . 0.0 110.846 -174.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.472 HD11 ' SD ' ' A' ' 36' ' ' MET . 5.9 mt -105.66 142.73 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.104 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.522 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 73.1 m80 -113.07 112.67 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.076 0.465 . . . . 0.0 110.579 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 14.7 m-30 -104.08 120.62 50.43 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.533 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' HE ' ' A' ' 20' ' ' ARG . 32.3 Cg_exo -58.96 116.37 3.21 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.048 1.832 . . . . 0.0 111.081 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 18' ' ' LEU . 2.2 tm? -46.68 -43.28 17.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.55 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.581 ' HD2' ' O ' ' A' ' 92' ' ' GLU . 21.4 mtpp -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.136 -172.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.577 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -88.63 -29.47 19.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.253 -173.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 6.1 tp -74.47 -25.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.29 11.95 9.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.642 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.95 173.94 7.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.813 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -116.13 144.35 44.27 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.1 22.83 16.25 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -168.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -59.84 -18.66 45.81 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.909 -0.646 . . . . 0.0 111.688 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.9 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.74 1.36 57.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.967 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 35.6 t70 -85.6 104.02 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.21 -28.12 69.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.732 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.2 mt -62.07 -42.94 99.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.123 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.562 HD23 ' NH1' ' A' ' 20' ' ' ARG . 51.9 tp -70.94 -41.58 70.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.23 -46.52 73.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.086 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.3 p30 -72.58 -32.39 65.97 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.039 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.732 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.97 -45.33 82.06 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.373 0.606 . . . . 0.0 110.085 177.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.472 ' SD ' HD11 ' A' ' 14' ' ' ILE . 83.0 mmm -91.24 12.3 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.363 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.7 -33.24 6.5 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 162.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 43.8 mmtm -72.28 -75.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.263 -0.469 . . . . 0.0 111.557 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -84.84 60.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 122.138 0.97 . . . . 0.0 110.178 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -161.82 -23.42 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.396 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.63 -39.41 67.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 0.0 110.592 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -134.81 63.98 60.79 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.976 0.893 . . . . 0.0 110.528 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 46.3 Cg_endo -97.3 23.54 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.364 2.709 . . . . 0.0 113.466 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 71.97 -56.13 0.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.768 0.668 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 50' ' ' LEU . 3.7 tp10 -65.86 -77.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.405 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 41.8 mt-10 -143.7 -91.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.682 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 160.59 -90.72 0.11 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.837 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.499 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 6.8 ttp -57.24 -47.35 99.2 Favored Pre-proline 0 C--N 1.314 -0.969 0 O-C-N 122.172 -0.605 . . . . 0.0 112.156 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 48' ' ' MET . 54.4 Cg_endo -69.69 -24.02 30.44 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.34 1.36 . . . . 0.0 110.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 3.0 mt -59.1 -47.63 84.54 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.204 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' MET . 32.0 ptt180 -73.73 -33.62 64.43 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.68 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.7 73.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.254 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.516 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 7.0 p-90 -73.75 -42.06 61.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.247 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.1 t -60.0 -51.03 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.611 0.243 . . . . 0.0 111.132 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -41.49 92.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.971 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 46.5 tttm -69.91 -41.47 74.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.927 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.1 m -67.46 -41.46 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.465 0.174 . . . . 0.0 110.803 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.09 85.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 109.914 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.46 -53.69 53.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.84 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 17.0 mm-40 -59.0 -47.19 86.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.155 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.8 99.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.333 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.88 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.483 -175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.3 -32.15 73.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -78.96 -20.1 50.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.172 -176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.68 70.13 13.72 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.371 0.605 . . . . 0.0 109.697 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.09 45.78 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.18 2.587 . . . . 0.0 112.787 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -127.01 -1.19 6.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.522 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 pt -86.66 -172.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.739 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -153.19 -0.55 0.24 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.17 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -166.43 157.18 12.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.524 0.202 . . . . 0.0 110.593 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.44 156.73 42.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.989 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -110.35 113.39 26.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.088 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 12.1 mt -112.27 134.65 53.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -115.03 127.93 26.39 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.252 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 56.0 Cg_endo -69.03 -173.0 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.316 2.011 . . . . 0.0 112.649 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' H ' ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -80.64 -38.87 28.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.684 -174.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.454 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . . . -76.28 78.6 3.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.562 0.696 . . . . 0.0 110.365 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.68 -17.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.421 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -57.35 -24.94 58.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -63.14 -27.95 69.73 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 109.898 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.3 m 67.22 -77.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.834 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 47.9 m -103.38 29.86 5.34 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -101.23 136.68 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.38 160.16 38.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.9 120.13 29.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.7 t-160 -110.05 102.64 11.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.051 -176.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.88 113.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.846 0.355 . . . . 0.0 110.33 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.5 141.69 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 66.0 m-85 -103.23 114.53 28.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 15.7 m-20 -76.08 115.34 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.43 115.76 28.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.319 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.581 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 19.3 mm-40 . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.106 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -134.44 15.81 3.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.01 -176.33 0.19 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.233 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 68.8 5.29 4.88 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.353 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.7 120.5 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.376 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -76.67 -43.11 39.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -117.13 141.69 28.86 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.376 174.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 7' ' ' MET . 2.9 Cg_exo -73.57 73.08 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.656 2.237 . . . . 0.0 111.619 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -89.64 131.99 35.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.832 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 83' ' ' VAL . 6.7 m -101.16 137.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.835 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.35 138.81 50.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.799 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.46 140.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.78 117.98 35.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.171 0.51 . . . . 0.0 110.499 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.665 HD11 ' SD ' ' A' ' 36' ' ' MET . 22.1 mt -115.24 123.3 70.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.557 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 48.4 m80 -110.74 112.0 23.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.518 0.675 . . . . 0.0 111.11 -177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.502 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 17.1 m-85 -106.52 116.97 58.17 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.461 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 35.9 Cg_exo -58.75 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.214 1.942 . . . . 0.0 110.543 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.5 tp -52.61 -39.28 61.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.897 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HE3' ' CB ' ' A' ' 92' ' ' GLU . 15.2 pttp -79.19 -28.57 42.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.605 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 9.1 mmm180 -81.5 -38.79 25.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.406 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.11 -28.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.859 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.91 59.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 110.83 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.26 -179.97 6.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.709 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -115.79 18.5 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.939 0.876 . . . . 0.0 109.844 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.5 25.36 10.45 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' HB2' HD22 ' A' ' 32' ' ' LEU . 45.0 p90 -71.14 -35.31 71.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.67 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -17.32 60.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 0.0 110.414 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -91.53 -2.06 57.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.608 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 22.3 t70 -90.71 116.08 28.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.032 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.61 -28.89 64.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.448 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.524 ' HG ' HE22 ' A' ' 35' ' ' GLN . 9.6 tp -70.23 -43.79 69.89 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.7 tp -63.9 -39.5 94.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.623 0.725 . . . . 0.0 109.423 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -41.72 92.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.397 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.633 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 m-20 -60.22 -49.24 78.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.612 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 1.4 mp0 -64.99 -45.1 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.665 ' SD ' HD11 ' A' ' 14' ' ' ILE . 88.7 mmm -97.53 21.26 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.511 . . . . 0.0 111.038 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.98 -34.07 4.13 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 31.9 mmtp -67.95 -68.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.03 76.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.54 -41.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.842 -171.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -40.4 75.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 p -142.14 67.2 21.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.199 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 80.8 Cg_endo -89.69 28.21 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.831 2.354 . . . . 0.0 112.352 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 72.58 -50.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.641 0.776 . . . . 0.0 111.414 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.56 -82.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -176.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.22 -86.63 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.477 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.678 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 161.98 -101.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.122 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.426 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 12.5 tpt -56.22 -44.82 99.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 39.5 Cg_exo -60.77 -33.78 92.51 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.374 2.049 . . . . 0.0 111.414 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.691 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.93 -45.4 86.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.515 176.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HE1' ' A' ' 36' ' ' MET . 22.7 ttt180 -63.38 -47.72 80.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.004 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.53 -47.72 84.42 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.456 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.691 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.34 -44.57 62.42 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.886 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -40.88 78.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.206 -174.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.502 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 69.5 mt -64.45 -45.82 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.834 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 61.0 tttp -64.76 -47.87 76.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.14 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 88.9 m -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.491 0.186 . . . . 0.0 111.163 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.14 92.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.652 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -61.08 -50.85 71.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.158 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 34.7 mm-40 -61.34 -44.34 97.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.136 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 tp -71.06 -45.34 63.99 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.77 -25.56 67.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.47 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -97.84 -2.2 41.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.517 0.675 . . . . 0.0 109.725 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.74 55.0 1.88 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.91 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.83 48.52 2.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.485 2.124 . . . . 0.0 112.438 -168.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -125.83 -11.64 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.807 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 69' ' ' ARG . 2.8 pp -92.73 -172.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' H ' ' HB ' ' A' ' 68' ' ' ILE . 49.4 mtp180 -143.61 -11.91 0.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.986 -169.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -165.95 150.35 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.143 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.54 155.66 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.948 0.404 . . . . 0.0 110.298 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -111.48 117.28 32.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.335 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -121.59 144.19 48.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.28 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -118.05 120.83 32.07 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.95 174.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 26.5 Cg_endo -61.41 160.41 27.58 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.978 2.452 . . . . 0.0 112.964 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 76' ' ' ARG . 11.7 mtp180 -58.26 -28.62 65.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.151 -172.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.92 86.63 0.71 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.5 0.667 . . . . 0.0 110.708 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 12.0 p -64.77 -28.09 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.815 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -63.58 -24.69 67.91 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.883 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -64.33 -31.74 73.06 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m 65.98 -74.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 15.7 m -98.15 54.05 1.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.136 0.493 . . . . 0.0 112.113 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 10' ' ' VAL . 14.3 p -134.58 130.53 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -132.87 137.76 46.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.36 124.33 47.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.264 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -104.1 103.43 13.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.97 110.38 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -109.72 139.34 33.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.217 -173.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 83.3 m-85 -102.65 108.95 20.39 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.924 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.557 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 7.0 m-20 -75.76 116.89 16.93 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.5 115.29 21.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.406 0.622 . . . . 0.0 109.843 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.465 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 39.9 mt-10 . . . . . 0 C--O 1.247 0.921 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.45 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -89.8 28.13 1.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.23 6.02 7.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -76.03 141.6 42.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.068 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.32 -84.57 0.84 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -171.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -138.3 -66.25 0.49 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptm -176.55 80.06 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.76 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.84 -52.28 4.65 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.723 2.282 . . . . 0.0 111.517 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -95.22 131.48 41.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.767 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.0 t -89.87 118.15 34.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -104.82 118.37 36.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.909 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.17 121.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.191 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 2.6 pt-20 -98.38 118.41 34.97 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.005 0.431 . . . . 0.0 109.862 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 HD11 ' SD ' ' A' ' 36' ' ' MET . 29.1 mt -114.47 142.94 25.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 67.2 m80 -124.12 125.36 44.35 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.2 m-30 -122.46 131.26 24.41 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 18.4 Cg_endo -60.13 121.52 9.93 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.813 2.342 . . . . 0.0 111.279 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.8 tp -51.42 -36.91 45.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.724 -173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG3' ' OXT' ' A' ' 92' ' ' GLU . 57.3 mtmt -75.88 -38.86 57.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . 22.2 mtt180 -80.93 -29.86 35.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.2 -15.84 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.553 0.692 . . . . 0.0 109.528 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.77 24.02 7.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.087 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 144.18 44.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.4 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.27 -11.49 46.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.424 . . . . 0.0 110.542 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -99.93 32.6 7.08 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.456 ' HB2' HD21 ' A' ' 32' ' ' LEU . 52.6 p90 -63.56 -21.83 66.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.009 -0.595 . . . . 0.0 112.003 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.33 -17.59 64.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.017 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -97.67 -9.44 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.934 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 45.4 m-20 -81.36 103.32 11.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.705 0.764 . . . . 0.0 110.606 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.08 -38.94 71.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.031 -171.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 17.7 tp -61.75 -39.4 91.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.06 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 26' ' ' TYR . 1.2 tp -68.81 -44.66 73.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.32 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.14 -48.22 68.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.959 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 p30 -70.21 -32.02 69.72 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.363 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -65.23 -43.33 91.78 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.223 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 14' ' ' ILE . 81.7 mmm -83.87 4.11 30.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.656 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.34 -29.29 9.65 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 60.5 mtpt -68.2 -69.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.233 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.9 p -100.37 82.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.428 1.108 . . . . 0.0 110.424 -175.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -172.08 -26.82 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.842 -170.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -74.84 -36.04 62.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.894 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 p -135.87 67.96 64.33 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.366 0.603 . . . . 0.0 110.781 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -98.62 2.19 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.836 3.024 . . . . 0.0 113.168 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 73.61 -44.23 0.57 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.73 0.812 . . . . 0.0 111.922 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 42.7 tp10 -60.25 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.263 0.225 . . . . 0.0 111.241 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' OE2' ' HD3' ' A' ' 76' ' ' ARG . 47.2 mt-10 -145.38 -102.01 0.1 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.614 0.245 . . . . 0.0 110.797 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 168.66 -106.74 0.26 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.375 176.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.585 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 tpt -49.71 -45.94 79.51 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 48' ' ' MET . 18.6 Cg_endo -58.44 -33.19 97.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.977 1.784 . . . . 0.0 111.914 174.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 82.1 mt -57.13 -48.1 79.49 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.184 0.516 . . . . 0.0 109.652 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -61.4 -46.4 90.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.608 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.17 70.62 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.6 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.612 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 7.4 p-90 -73.87 -37.82 64.62 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.46 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -69.64 -44.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.99 -39.79 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.626 0.251 . . . . 0.0 110.744 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -62.72 -48.85 77.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 48.4 t -65.04 -46.98 79.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.872 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.65 84.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -60.77 -46.73 89.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.858 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -63.18 -47.44 82.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.64 97.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.501 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD11 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -66.34 -46.0 78.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 -178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.54 -27.71 62.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 0.0 111.555 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -66.06 -34.32 77.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.573 . . . . 0.0 110.607 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.73 74.55 12.32 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.661 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.92 33.51 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.244 2.629 . . . . 0.0 113.721 -169.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.29 18.42 9.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -97.53 -179.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -145.23 -8.35 0.6 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -167.88 156.04 8.93 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 111.213 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 87' ' ' VAL . 34.2 m -141.43 159.47 22.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.056 0.455 . . . . 0.0 110.648 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -108.28 120.09 41.38 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.8 0.809 . . . . 0.0 108.983 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.425 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 28.9 tp -123.0 141.1 52.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.565 -168.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 125.64 28.31 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.476 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 52.9 Cg_endo -74.33 173.61 13.92 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.819 1.679 . . . . 0.0 112.77 -175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 57.1 mtp180 -65.72 -36.62 84.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.678 -162.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -68.93 93.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.658 0.742 . . . . 0.0 111.037 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.2 t -61.92 -32.17 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.783 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.24 -23.98 67.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 70.1 m-20 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.065 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p 57.06 -70.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.705 1.253 . . . . 0.0 112.864 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 8.1 m -90.89 57.84 3.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.259 0.552 . . . . 0.0 111.655 -172.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.21 130.46 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.53 138.39 36.26 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.133 0.492 . . . . 0.0 111.108 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -102.95 120.97 41.57 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.583 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -108.49 102.81 11.86 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.416 ' CG1' HG21 ' A' ' 71' ' ' VAL . 8.7 p -97.81 124.05 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.568 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.435 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 77.8 mt -112.8 135.71 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.354 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.52 113.07 26.29 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.251 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.09 120.92 22.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.75 124.25 29.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 110.492 -173.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' OXT' ' HG3' ' A' ' 19' ' ' LYS . 8.8 pt-20 . . . . . 0 C--O 1.246 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.032 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -141.7 -51.82 0.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.0 110.697 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.98 99.59 2.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -98.01 -4.34 36.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.9 3.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.067 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.417 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 21.4 m80 -91.5 36.13 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.164 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.499 ' HA ' ' HE1' ' A' ' 7' ' ' MET . 5.7 mmt -92.83 106.36 18.6 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 25.8 Cg_exo -62.7 104.15 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.815 2.343 . . . . 0.0 113.076 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.39 108.97 18.71 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -93.1 127.77 44.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.896 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 4.5 p-10 -122.65 121.65 36.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.424 0.63 . . . . 0.0 110.066 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.2 121.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.477 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 50.0 mt-10 -93.95 111.97 23.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 110.855 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.494 HD12 ' SD ' ' A' ' 36' ' ' MET . 13.4 mt -102.33 142.81 15.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.529 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 33.6 m80 -119.64 111.88 18.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.998 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-85 -110.46 117.29 51.4 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.154 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 32.5 Cg_exo -58.51 127.49 24.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.241 1.961 . . . . 0.0 110.954 174.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.44 -44.98 45.93 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.36 -173.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 92' ' ' GLU . 17.4 pttp -77.9 -19.78 54.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 20.4 mmm180 -91.24 -36.88 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -73.44 -14.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.304 0.574 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.65 -0.56 57.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.486 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.37 153.59 17.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.316 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.21 -23.34 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.161 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.87 18.73 52.32 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.661 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -22.88 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.959 0.504 . . . . 0.0 112.018 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.15 -13.61 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.118 0.485 . . . . 0.0 110.794 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -116.8 10.17 14.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.067 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.9 119.55 25.01 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.805 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.12 -33.37 73.27 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.931 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.63 -46.65 84.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.328 0.585 . . . . 0.0 109.977 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.42 -38.99 91.57 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.855 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.19 -41.82 80.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.012 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 96.0 m-20 -65.94 -49.37 68.19 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.054 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.55 -46.64 72.17 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.309 0.576 . . . . 0.0 110.265 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.777 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 11.1 tpt -67.45 -44.71 78.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.185 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.98 -34.13 57.68 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.634 0.584 . . . . 0.0 112.581 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 71.3 mmtt -60.92 -48.26 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.79 42.79 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.236 0.541 . . . . 0.0 111.611 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.777 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -117.64 -35.61 3.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.015 -171.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -81.9 -29.07 32.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.211 0.529 . . . . 0.0 110.537 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 p -127.82 65.45 68.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.226 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 82.3 Cg_endo -90.75 7.29 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.432 2.088 . . . . 0.0 111.533 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.12 -49.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.393 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.17 -80.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.13 -69.93 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 0.0 111.493 -172.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . 134.96 -95.01 0.25 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.762 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.463 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 6.8 ttp -64.91 -43.56 68.82 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' A' ' 50' ' ' LEU . 5.3 Cg_exo -79.37 -26.79 4.72 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.526 2.151 . . . . 0.0 108.915 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.606 HD21 ' HE1' ' A' ' 53' ' ' TRP . 2.3 tm? -58.0 -45.53 86.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 112.524 -2.126 . . . . 0.0 109.235 172.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 12.5 ttm180 -62.97 -49.79 73.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.069 173.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.22 81.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.576 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.606 ' HE1' HD21 ' A' ' 50' ' ' LEU . 2.5 p-90 -72.16 -39.69 68.55 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.704 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -69.22 -42.63 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.377 -174.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.501 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 65.2 mt -67.53 -41.95 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.058 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -61.31 -50.6 72.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.498 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.8 t -63.87 -40.85 97.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.67 87.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.793 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -57.51 -58.09 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.556 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.3 -32.84 72.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.698 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.74 94.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -67.39 -48.0 68.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.05 -27.49 66.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -64.15 -43.59 94.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' C ' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -135.8 75.28 56.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.428 0.632 . . . . 0.0 110.113 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 38.51 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.104 2.536 . . . . 0.0 112.444 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 65' ' ' ASN . 34.7 mmtp -131.58 22.39 4.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.11 -174.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.358 0.599 . . . . 0.0 111.337 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -118.11 -49.78 2.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.235 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.2 pt-20 -163.56 163.19 24.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.425 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.71 149.93 32.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.855 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -110.37 118.58 36.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.513 0.673 . . . . 0.0 109.645 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.9 mt -108.02 144.4 35.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.655 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 12.8 tmtt? -121.45 120.04 29.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 28.8 Cg_endo -61.15 162.2 20.49 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.479 2.786 . . . . 0.0 113.634 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -66.3 -17.63 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.844 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.79 89.21 1.35 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.326 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.3 t -63.22 -21.92 29.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.846 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -56.93 -32.17 65.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.462 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -73.83 -38.66 64.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t 70.87 -63.74 0.4 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.761 0.663 . . . . 0.0 111.838 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.5 m -109.0 47.98 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.35 138.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.971 -0.456 . . . . 0.0 109.884 170.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 46.2 mt-30 -138.9 150.79 46.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.29 0.567 . . . . 0.0 110.714 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.69 117.82 35.11 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.4 t-160 -95.29 102.09 13.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.899 -173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 63.1 t -97.94 113.27 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.26 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.47 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.9 mp -101.9 139.8 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 70.9 m-85 -102.4 109.78 21.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.926 0.393 . . . . 0.0 110.172 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 16.7 m-20 -77.39 115.4 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.385 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.02 123.03 31.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.469 ' OE1' ' HB3' ' A' ' 17' ' ' PRO . 40.4 mt-10 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.561 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 p 51.01 57.61 6.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.599 0.76 . . . . 0.0 111.125 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.26 10.02 42.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.481 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.0 ttm -50.03 124.32 9.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.562 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.807 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -71.77 -43.46 65.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmt -126.97 113.83 22.0 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.901 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.5 -49.48 16.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.985 2.457 . . . . 0.0 111.865 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.7 142.74 51.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.7 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.02 118.05 55.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -105.38 118.74 37.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.191 0.52 . . . . 0.0 111.1 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 28.0 t -119.38 138.79 48.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -121.96 131.23 53.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.279 0.561 . . . . 0.0 111.941 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.548 HD13 ' SD ' ' A' ' 36' ' ' MET . 8.2 mt -106.98 136.09 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.693 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -109.01 127.84 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 22.7 m-85 -127.8 125.29 23.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.382 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 19.1 Cg_exo -66.8 120.79 7.91 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 121.934 1.756 . . . . 0.0 111.046 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 tp -42.18 -44.6 3.79 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.578 1.151 . . . . 0.0 113.645 -167.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -75.7 -40.59 55.48 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 14.3 ptp180 -90.75 -19.06 23.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 6.5 tp -72.26 -21.04 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.17 -14.44 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.552 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.61 151.76 34.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.575 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -78.46 -28.54 46.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.379 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.24 3.02 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -66.15 -38.64 88.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.641 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -1.37 21.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.92 -7.95 18.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.533 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 t70 -81.17 121.32 25.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.216 0.531 . . . . 0.0 110.966 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.18 -35.33 78.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.206 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.711 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 4.4 mt -65.44 -42.44 92.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.034 0.445 . . . . 0.0 110.005 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.3 -41.89 76.16 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.336 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.7 mt -66.37 -49.04 68.22 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.407 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 2.7 p30 -74.88 -28.66 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.811 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.711 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -69.65 -47.03 64.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.776 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 15.5 tpt -72.25 -42.6 65.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.67 -32.31 46.74 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.377 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.03 -53.38 39.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 39' ' ' VAL . 48.3 t -85.17 39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.132 0.968 . . . . 0.0 110.535 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.776 ' HB2' ' O ' ' A' ' 36' ' ' MET . 2.5 t-20 -133.44 -30.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.103 -0.998 . . . . 0.0 112.918 -170.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 26.2 t70 -80.04 -27.35 39.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -172.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.1 p -122.67 60.78 14.88 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 26.8 Cg_endo -98.86 1.74 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.846 2.364 . . . . 0.0 113.711 -173.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 74.04 -46.83 0.63 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.554 0.742 . . . . 0.0 111.92 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' CB ' HD22 ' A' ' 50' ' ' LEU . 37.5 mt-10 -65.6 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 111.739 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -126.09 -77.95 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.266 0.555 . . . . 0.0 110.464 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.74 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 148.96 -96.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.834 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.715 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 1.5 tmt? -59.8 -40.68 80.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 O-C-N 122.121 -0.635 . . . . 0.0 112.34 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 48' ' ' MET . 38.2 Cg_exo -64.54 -29.78 61.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.706 1.604 . . . . 0.0 110.742 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.74 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -59.88 -47.77 84.39 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.581 178.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -67.46 -40.72 85.35 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.993 178.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.32 78.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.385 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.649 ' CH2' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -71.67 -46.13 59.83 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.984 -176.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.68 -41.78 77.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.462 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 90.4 mt -64.64 -42.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.713 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.9 tttp -65.22 -46.6 79.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.141 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.6 -43.53 89.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.608 0.242 . . . . 0.0 110.904 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.7 95.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -60.09 -52.24 66.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.565 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 32.5 mm-40 -58.78 -44.18 90.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.254 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.83 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.747 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD23 HG22 ' A' ' 21' ' ' ILE . 6.6 tp -67.31 -46.34 73.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.605 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.44 -25.92 65.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.342 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -63.96 -48.55 76.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -131.47 75.58 76.8 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.208 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.83 43.61 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.078 2.519 . . . . 0.0 112.675 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -128.46 10.38 6.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.846 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 pt -98.34 179.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.173 0.511 . . . . 0.0 110.989 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -128.36 -18.4 4.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.839 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.95 158.41 17.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.304 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.0 p -129.09 151.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -109.61 112.74 25.01 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 122.17 0.986 . . . . 0.0 109.36 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD23 ' CH2' ' A' ' 53' ' ' TRP . 8.8 tt -125.95 144.7 50.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.558 -163.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HZ1' ' HA ' ' A' ' 81' ' ' SER . 72.8 tttt -126.95 132.32 24.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.236 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.558 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -33.82 140.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.141 3.894 . . . . 0.0 115.764 175.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -58.78 -38.93 79.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.007 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 74.31 4.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.409 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.18 -19.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.129 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.78 -23.77 65.27 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.63 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -63.24 -33.75 76.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.074 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.456 ' HA ' ' HZ1' ' A' ' 74' ' ' LYS . 16.2 m 69.84 -68.05 0.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.121 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 m -73.95 -19.5 60.65 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HG2' ' A' ' 75' ' ' PRO . 5.6 p -86.47 129.4 38.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.304 0.573 . . . . 0.0 110.669 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -130.69 137.53 49.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.041 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.558 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 19.9 m-85 -106.67 125.94 51.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.579 0.704 . . . . 0.0 110.652 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -105.14 104.92 14.74 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.401 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 48.1 t -92.4 112.09 25.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.66 137.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.33 109.67 21.37 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.676 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 115.52 16.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 0.0 110.231 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.89 134.05 34.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.074 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.605 -0.712 . . . . 0.0 110.318 -176.291 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -58.03 -41.23 82.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.43 122.04 28.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.9 tpp 74.06 -58.21 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.956 0.785 . . . . 0.0 112.275 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.75 -43.57 97.56 Favored Glycine 0 C--O 1.234 0.155 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.389 -174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -77.44 65.69 3.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.217 0.532 . . . . 0.0 110.248 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.452 ' HB3' ' CD ' ' A' ' 8' ' ' PRO . 50.8 ttp -164.24 -58.43 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.416 177.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.452 ' CD ' ' HB3' ' A' ' 7' ' ' MET . 43.9 Cg_endo -68.96 -37.94 10.38 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.616 1.544 . . . . 0.0 110.755 171.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.87 115.73 30.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.178 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.85 118.99 38.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.208 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -123.47 119.45 30.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.403 0.62 . . . . 0.0 109.595 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 96.3 t -120.95 125.48 74.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.065 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -105.54 112.92 26.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.459 0.647 . . . . 0.0 111.265 -174.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 4.1 mt -101.6 128.01 54.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 79.8 m80 -104.13 109.6 21.46 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.288 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 18.6 m-30 -107.14 117.58 55.99 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.151 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' HG23 ' A' ' 21' ' ' ILE . 31.6 Cg_exo -59.7 120.56 8.44 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.07 1.847 . . . . 0.0 110.982 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HG ' HD11 ' A' ' 62' ' ' LEU . 2.9 tt -50.57 -36.24 33.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.91 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 18.6 ptpt -72.2 -32.76 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.169 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.566 ' HD3' ' OD2' ' A' ' 29' ' ' ASP . 3.0 mmp_? -92.76 -39.03 11.47 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -72.43 -21.99 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.278 0.561 . . . . 0.0 109.638 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.69 -26.96 64.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.846 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.07 155.59 25.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.855 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.18 -31.35 30.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.592 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.47 49.27 2.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.942 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -73.48 -18.34 61.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.614 0.245 . . . . 0.0 111.598 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.61 -13.39 62.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 -24.32 52.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.166 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.566 ' OD2' ' HD3' ' A' ' 20' ' ' ARG . 7.7 m-20 -83.72 110.81 18.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.87 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.3 -25.11 67.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.797 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.2 pp -54.41 -41.63 69.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.196 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 31' ' ' LEU . 15.5 tp -73.18 -27.92 61.92 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.499 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.28 -45.82 65.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.901 172.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -61.07 -38.17 85.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.45 -46.68 82.06 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.994 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.487 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 83.9 mmm -94.46 17.6 12.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.702 0.763 . . . . 0.0 110.11 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.31 -24.44 7.15 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 164.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -82.81 -65.65 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.256 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 12' ' ' VAL . 30.1 m -100.83 45.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.639 0.733 . . . . 0.0 111.072 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -139.79 -17.71 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.896 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.4 -38.2 68.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.866 0.365 . . . . 0.0 110.512 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 p -127.59 70.84 77.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.443 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.2 Cg_endo -92.65 13.28 1.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.949 2.433 . . . . 0.0 112.393 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 73.44 -40.45 0.47 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.203 1.001 . . . . 0.0 112.343 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HB2' HD13 ' A' ' 50' ' ' LEU . 37.7 mt-10 -74.53 -78.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 111.414 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.63 -80.06 0.33 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 111.103 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.778 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 154.31 -92.79 0.13 Allowed Glycine 0 C--O 1.222 -0.624 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.697 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.452 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.5 tmt? -62.79 -43.93 84.51 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.931 -0.747 . . . . 0.0 112.692 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 48' ' ' MET . 41.4 Cg_endo -70.63 -24.44 25.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 120.913 1.075 . . . . 0.0 109.765 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.778 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -58.37 -45.86 87.43 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.115 172.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 33.4 ttt180 -61.51 -48.74 79.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.191 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.57 77.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.72 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 8.2 p-90 -73.52 -37.76 65.55 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.272 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -69.3 -41.4 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.0 110.165 -174.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.58 -41.7 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.673 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.94 -50.11 73.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.207 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.6 t -62.36 -46.19 89.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.995 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 0.0 110.501 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -62.59 -50.5 71.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.129 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.02 -34.86 79.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.837 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.99 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD11 ' HG ' ' A' ' 18' ' ' LEU . 4.7 tt -71.23 -48.41 51.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.403 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.15 -25.7 67.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.693 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.81 -33.27 75.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 110.25 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -151.36 72.38 8.37 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.078 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.27 39.29 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.965 2.443 . . . . 0.0 113.924 -168.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 34.0 4.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.425 0.631 . . . . 0.0 109.532 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.8 pt -106.47 -175.45 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.577 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 16.9 mtm180 -117.52 -51.21 2.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.235 -177.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' OE2' ' HB2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -156.22 161.47 40.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.18 -177.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -132.46 158.4 43.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.435 0.636 . . . . 0.0 111.401 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.35 113.37 26.12 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.03 0.919 . . . . 0.0 109.428 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.613 HD23 ' CH2' ' A' ' 53' ' ' TRP . 6.1 tt -110.02 139.26 45.34 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.858 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.55 129.38 25.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.157 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HG2' HG13 ' A' ' 83' ' ' VAL . 75.3 Cg_exo -46.11 151.03 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.809 3.006 . . . . 0.0 113.292 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -66.98 -37.69 84.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.565 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.6 75.78 2.61 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.737 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.15 -10.72 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.338 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' CB ' HG11 ' A' ' 83' ' ' VAL . 83.1 m-20 -64.74 -37.1 86.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.184 0.516 . . . . 0.0 110.436 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.3 t 71.46 -67.15 0.27 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.744 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -82.27 6.35 17.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.8 p -108.39 131.83 57.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.034 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -139.21 144.36 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.186 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.514 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 81.0 m-85 -107.62 124.63 50.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.145 0.498 . . . . 0.0 109.789 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.1 t60 -103.0 106.0 16.43 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 91.8 t -93.22 116.83 35.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.393 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.428 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.4 mp -100.05 136.41 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 40.7 m-85 -103.08 106.68 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.94 0.4 . . . . 0.0 110.381 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 22.1 m-20 -79.69 114.86 18.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.013 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.95 39.89 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.145 -174.223 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -100.14 37.33 1.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.843 0.354 . . . . 0.0 111.263 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.61 75.88 4.15 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.745 0.307 . . . . 0.0 110.323 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.6 mtp 61.89 -96.02 0.06 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.413 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA3' ' HB1' ' A' ' 9' ' ' ALA . . . -141.43 22.95 2.54 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 69.88 -59.99 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.864 0.866 . . . . 0.0 110.531 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.47 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 39.1 tpp -165.35 -55.23 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.552 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 7' ' ' MET . 58.7 Cg_endo -71.46 -29.13 16.98 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.894 1.729 . . . . 0.0 113.329 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -96.12 145.69 25.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 39.8 t -107.23 134.74 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.054 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -136.11 134.93 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.37 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.23 138.66 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.243 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -106.82 121.22 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.472 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.3 mt -115.91 122.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.599 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 79.6 m80 -99.73 132.01 45.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.182 0.515 . . . . 0.0 110.288 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CD1' HG12 ' A' ' 87' ' ' VAL . 3.3 m-85 -119.76 129.07 25.55 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.233 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 21.4 Cg_exo -65.25 110.92 1.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.005 1.804 . . . . 0.0 110.389 171.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.88 -42.51 12.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.953 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HG3' ' HD2' ' A' ' 20' ' ' ARG . 17.1 ptpt -78.1 -28.53 48.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 3.7 mpt_? -89.68 -35.27 15.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 112.049 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.58 -25.74 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.463 . . . . 0.0 110.129 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.36 12.66 15.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.16 173.02 7.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.975 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.98 -26.86 20.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.229 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.79 46.72 3.48 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.604 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -79.09 -34.6 43.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.735 0.303 . . . . 0.0 111.277 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.04 59.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.303 0.573 . . . . 0.0 110.415 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -83.71 -9.41 58.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.3 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -85.15 110.54 19.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.244 0.545 . . . . 0.0 110.708 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.84 -34.81 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.764 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.77 -46.69 89.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.87 -40.29 65.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.567 0.698 . . . . 0.0 109.794 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.15 -46.06 78.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.343 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -73.34 -30.78 63.57 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.395 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.599 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 45.3 mt-30 -73.52 -44.84 56.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.346 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.531 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -75.09 -15.64 60.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.633 177.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 -21.2 41.29 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -76.2 -54.83 6.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 35' ' ' GLN . 14.7 m -85.71 59.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.739 0.78 . . . . 0.0 109.782 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.1 t-20 -137.66 -39.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.398 -170.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -70.23 -41.14 73.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.849 -170.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 p -140.98 66.0 24.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.723 0.297 . . . . 0.0 111.51 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.2 Cg_endo -67.46 -62.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.252 1.968 . . . . 0.0 112.011 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 13.4 tp10 152.53 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -76.79 -85.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.587 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -135.7 -79.04 0.43 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.09 0.471 . . . . 0.0 109.988 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 151.17 -109.71 0.43 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.992 176.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.453 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -51.35 -48.21 86.59 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 36.2 Cg_exo -61.41 -40.43 48.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.032 1.821 . . . . 0.0 112.013 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.774 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -61.07 -43.68 98.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.958 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -67.63 -34.34 76.77 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.506 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.86 79.98 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.774 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.2 p-90 -72.44 -38.2 68.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.332 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.95 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.047 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.0 mt -57.86 -44.06 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.347 0.117 . . . . 0.0 110.752 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 53.3 tptt -63.85 -49.54 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.85 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.0 t -64.07 -43.86 94.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.051 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.85 92.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.0 109.977 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 6.4 t-160 -58.22 -58.93 6.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.544 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 11.8 pt-20 -66.98 -34.51 77.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.78 98.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 110.552 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tp -66.84 -45.96 76.59 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.135 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 51.6 mt-10 -63.31 -27.85 69.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.404 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.46 -39.54 85.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.458 . . . . 0.0 110.168 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -141.28 71.74 26.96 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.279 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.95 42.31 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.04 2.493 . . . . 0.0 113.065 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -128.79 11.6 6.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.008 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt -89.34 178.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.632 0.729 . . . . 0.0 112.268 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -110.37 -43.74 3.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.545 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.9 pt-20 -163.64 151.27 12.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.832 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.6 150.08 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.63 111.46 22.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD12 ' CH2' ' A' ' 53' ' ' TRP . 3.7 pp -109.85 133.23 53.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.464 0.65 . . . . 0.0 110.833 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -103.24 124.28 38.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 81.1 Cg_endo -80.03 175.97 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.201 1.934 . . . . 0.0 114.178 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.98 -13.88 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.551 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.49 74.99 3.23 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.52 -24.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.042 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -63.74 -27.47 69.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.563 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.42 -34.43 47.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.966 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.2 p 58.84 -72.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.709 1.256 . . . . 0.0 112.382 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m -84.07 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 8.5 p -134.32 130.65 54.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -136.92 139.0 41.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.154 0.502 . . . . 0.0 111.437 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.498 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 79.7 m-85 -101.92 128.1 48.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.688 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -96.74 107.95 20.51 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 16' ' ' PHE . 54.0 t -91.81 109.63 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 66.4 mt -102.42 135.04 41.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.76 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -102.62 110.25 22.13 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -99.36 122.95 43.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.804 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -84.58 113.77 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.123 178.229 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -101.4 104.79 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.911 0.386 . . . . 0.0 110.397 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.35 73.67 10.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.126 0.489 . . . . 0.0 110.218 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptp -82.24 -9.73 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.945 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 71.22 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.124 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -94.78 -0.9 53.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 0.0 110.479 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.4 tpt 70.64 110.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.83 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.66 141.43 90.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.46 120.78 27.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.946 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.96 118.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.22 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -127.35 133.58 50.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.967 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 p -117.31 138.56 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.68 111.49 23.73 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.309 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.464 HD13 ' SD ' ' A' ' 36' ' ' MET . 17.1 mt -102.79 123.69 56.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.184 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.87 127.11 46.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -120.84 126.96 26.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.17 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -59.97 117.03 3.73 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.147 1.898 . . . . 0.0 110.945 171.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.07 -36.89 66.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.931 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.49 -29.16 56.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.651 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HD3' ' HB2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -91.82 -31.38 15.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.862 -177.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.32 -19.1 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 109.983 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.12 -7.21 56.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.04 149.64 21.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.781 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.73 -21.03 41.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.63 34.92 4.57 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.402 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.54 -5.72 38.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 111.173 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.23 -2.94 35.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.855 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.49 117.16 28.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -63.91 -31.59 72.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.076 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.708 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.5 mm? -61.67 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.336 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -72.12 -37.59 69.47 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.595 0.712 . . . . 0.0 109.577 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.97 -45.64 63.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.349 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -73.44 -33.6 64.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.675 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.708 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.23 -46.72 32.0 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -176.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.464 ' SD ' HD13 ' A' ' 14' ' ' ILE . 9.7 tpt -95.06 3.62 54.63 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.22 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.27 -24.01 23.03 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 165.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.37 -68.75 0.42 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.879 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 m -87.73 65.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.87 0.843 . . . . 0.0 110.396 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.41 HD21 HD13 ' A' ' 50' ' ' LEU . 4.5 t-20 -149.56 -27.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.78 -169.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.18 -44.97 71.1 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.665 0.745 . . . . 0.0 110.196 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -124.74 71.2 59.37 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.249 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 45' ' ' GLU . 73.5 Cg_endo -91.86 -2.12 4.27 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.774 2.316 . . . . 0.0 112.37 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 71.39 -42.58 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.56 0.744 . . . . 0.0 110.428 -173.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.523 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -50.67 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.026 175.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' OE1' ' HB2' ' A' ' 49' ' ' PRO . 44.4 mt-10 -144.07 -73.77 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.595 0.712 . . . . 0.0 109.879 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 146.27 -105.81 0.35 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.528 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.414 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.7 tpt -57.3 -46.29 99.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 12.1 Cg_exo -68.7 -32.29 24.02 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.185 1.924 . . . . 0.0 110.742 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.62 HD23 ' CE2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -57.76 -45.24 86.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.853 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -65.6 -45.91 81.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.013 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -48.32 81.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.716 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.586 ' CZ2' ' HA ' ' A' ' 75' ' ' PRO . 3.8 p-90 -72.29 -39.18 68.5 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.019 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -41.15 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.716 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.8 -40.9 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.586 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -58.86 -50.44 74.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 111.009 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.491 ' SG ' HD21 ' A' ' 73' ' ' LEU . 44.6 t -61.97 -44.47 96.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.739 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.09 94.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.52 -51.11 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.83 -45.73 81.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.343 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.34 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -47.26 73.63 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.669 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.7 -36.76 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 110.324 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.74 75.07 12.2 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.828 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.21 39.99 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.214 2.609 . . . . 0.0 113.206 -170.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -136.3 26.15 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.5 -172.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.401 0.62 . . . . 0.0 111.835 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -123.99 -45.92 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.37 159.51 17.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.27 155.99 42.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.841 0.353 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.87 114.86 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.026 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 HD21 ' SG ' ' A' ' 57' ' ' CYS . 7.3 mt -108.12 140.14 41.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -101.86 122.5 47.15 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 91.1 Cg_endo -76.84 -171.19 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.121 1.881 . . . . 0.0 113.626 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -73.81 -47.03 41.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.24 76.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 111.063 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.96 -16.97 21.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.158 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -68.19 -25.31 65.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 110.293 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.469 ' ND2' ' HB ' ' A' ' 83' ' ' VAL . 66.2 t30 -64.46 -25.1 67.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 68.13 -81.49 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.6 173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -83.48 61.48 6.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.223 0.535 . . . . 0.0 111.53 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.469 ' HB ' ' ND2' ' A' ' 80' ' ' ASN . 10.0 p -140.13 135.32 37.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -140.22 137.68 34.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.887 0.375 . . . . 0.0 110.498 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.62 ' CE2' HD23 ' A' ' 50' ' ' LEU . 20.9 m-85 -105.48 119.09 38.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.465 0.65 . . . . 0.0 109.407 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.71 102.87 13.08 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.698 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.1 t -92.8 113.44 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.47 135.61 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.03 106.86 17.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.171 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -79.4 142.43 35.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.64 106.4 13.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.777 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 126.163 1.785 . . . . 0.0 107.896 174.239 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 m -90.29 -35.55 15.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.918 0.39 . . . . 0.0 111.016 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.76 77.16 1.24 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -99.64 170.16 8.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.22 75.6 2.05 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.83 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -67.12 -30.79 70.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.892 0.377 . . . . 0.0 110.311 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 74.0 mtm -67.27 122.27 82.2 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.934 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.52 -37.92 76.97 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.683 2.255 . . . . 0.0 111.332 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.63 122.13 36.67 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.881 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.17 118.42 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -108.53 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.045 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 43.1 t -108.93 135.79 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -104.29 112.25 25.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.454 -175.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.406 HD12 ' SD ' ' A' ' 36' ' ' MET . 26.9 mt -108.3 129.14 63.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.418 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 68.8 m80 -113.91 127.76 56.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.13 0.49 . . . . 0.0 110.776 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 25.0 m-85 -125.51 121.87 24.83 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.223 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.538 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 27.9 Cg_exo -61.11 129.96 30.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.746 1.631 . . . . 0.0 110.84 175.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CD2' HD22 ' A' ' 62' ' ' LEU . 2.5 tm? -50.54 -38.66 46.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.043 -175.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.05 -29.68 60.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.34 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 21.3 mmm180 -90.35 -37.19 14.19 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.452 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 tp -73.17 -16.9 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 109.659 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.94 18.84 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.305 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.95 169.79 8.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.613 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.79 -38.47 18.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.03 42.38 2.28 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.314 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 27.1 p90 -73.77 -26.76 60.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.14 -4.02 36.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -114.69 4.7 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.752 0.787 . . . . 0.0 109.394 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 31' ' ' LEU . 19.2 t70 -87.18 119.6 27.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.511 -175.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.65 -36.71 67.35 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.71 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 3.9 mm? -63.9 -46.0 86.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.557 0.694 . . . . 0.0 110.665 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -35.84 75.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.358 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.1 -48.01 59.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.241 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.85 -35.67 64.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.728 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -71.66 -46.6 58.46 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.974 0.416 . . . . 0.0 110.723 -177.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.609 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -93.14 3.75 55.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.21 0.528 . . . . 0.0 110.467 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.62 -26.95 12.18 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 167.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -74.52 -58.86 3.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 35' ' ' GLN . 20.2 m -86.45 53.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.744 0.783 . . . . 0.0 110.338 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.5 t-20 -134.34 -35.25 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.85 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.6 -35.6 67.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 p -128.69 70.17 80.3 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -92.63 5.54 3.31 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.878 2.385 . . . . 0.0 112.52 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 72.27 -43.14 0.55 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.786 0.834 . . . . 0.0 111.564 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' A' ' 75' ' ' PRO . 10.8 tp10 -67.46 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.841 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -139.85 -88.97 0.19 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.51 0.195 . . . . 0.0 111.064 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 161.42 -92.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.725 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.618 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 1.7 tmt? -64.65 -45.22 75.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 31.9 Cg_exo -65.35 -31.1 53.13 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 121.526 1.484 . . . . 0.0 110.345 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.563 HD23 ' HE1' ' A' ' 53' ' ' TRP . 2.5 tm? -58.61 -47.1 85.47 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.045 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.4 ptm180 -69.72 -40.98 75.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.806 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.13 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.563 ' HE1' HD23 ' A' ' 50' ' ' LEU . 11.2 p-90 -73.63 -37.32 65.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.854 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.0 -42.27 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.422 0.153 . . . . 0.0 110.931 -175.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.497 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 93.0 mt -67.2 -39.53 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.6 mmmm -62.66 -50.18 72.2 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.707 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.29 -43.42 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.733 0.301 . . . . 0.0 110.747 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.22 98.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.541 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -63.44 -45.19 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.366 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 43.9 mm-40 -62.07 -47.18 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.38 83.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.155 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 18' ' ' LEU . 3.1 tm? -65.17 -47.18 77.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.135 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.66 -27.05 62.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.789 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 3.0 ttmp? -71.5 -38.84 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.173 0.511 . . . . 0.0 110.125 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -135.81 74.98 56.76 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.25 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.45 29.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.455 2.77 . . . . 0.0 113.506 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -125.86 25.72 6.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.222 0.534 . . . . 0.0 110.232 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.71 179.39 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.809 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -118.97 -36.75 3.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.863 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -164.32 168.34 18.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.914 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 13.9 p -135.86 148.97 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.96 117.21 33.18 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.449 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 49.8 tp -130.71 132.29 45.28 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.54 -164.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -109.77 134.05 20.74 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.488 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 29.0 Cg_endo -61.23 158.78 33.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.639 2.226 . . . . 0.0 113.2 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -61.88 -42.86 99.57 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.399 -165.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.84 116.83 8.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.843 0.83 . . . . 0.0 110.946 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.86 -16.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.543 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -58.04 -40.59 81.29 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.149 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -75.09 -36.53 61.7 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.915 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.4 m 70.68 -63.55 0.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.425 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 p -111.18 58.85 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.37 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -135.43 142.13 45.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.952 0.406 . . . . 0.0 111.13 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.442 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 99.9 m-85 -105.16 124.29 49.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -97.31 103.89 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 75.2 t -91.42 110.76 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.433 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 89.8 mt -105.48 134.61 46.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.177 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 57.4 m-85 -103.02 106.26 16.75 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.181 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -86.07 126.47 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.18 126.07 42.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.694 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.586 176.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -91.06 114.25 26.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.833 0.349 . . . . 0.0 110.315 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.61 -61.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.952 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.3 mmm -91.45 78.37 5.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 110.764 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.65 -176.23 18.35 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -88.7 -47.09 8.5 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.9 tpp -132.91 81.77 57.07 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.701 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.19 -178.57 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.887 2.391 . . . . 0.0 112.285 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.51 139.75 53.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.38 121.08 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.935 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.25 118.55 36.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.285 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 21.4 t -121.07 121.78 65.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -112.04 132.59 54.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.919 -166.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.18 152.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.568 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.406 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 64.7 m80 -120.71 128.15 52.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.827 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 8.4 m-85 -127.75 105.63 20.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.835 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.745 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 26.3 Cg_exo -60.67 120.55 8.35 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 121.588 1.525 . . . . 0.0 110.888 172.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -54.6 -42.33 70.98 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.804 -169.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -61.25 -32.0 71.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.251 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 5.0 mtt180 -95.55 -35.65 11.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 17' ' ' PRO . 4.8 tp -69.7 -27.13 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.069 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.46 59.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 110.967 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.63 -169.45 1.66 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -125.91 138.36 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.87 17.37 18.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -170.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.585 ' CD1' ' HB3' ' A' ' 20' ' ' ARG . 7.9 t80 -67.03 -23.87 65.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.957 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.1 -9.36 38.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.661 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -103.41 1.66 32.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.708 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.57 112.66 6.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.57 -42.47 88.06 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.793 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.26 -42.21 90.64 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.517 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.522 HD22 ' HH ' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -64.52 -39.83 94.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.047 0.451 . . . . 0.0 110.046 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.24 -40.99 87.69 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.996 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -73.49 -41.63 62.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.137 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -70.13 -50.39 41.03 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.307 0.575 . . . . 0.0 111.899 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.636 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -80.68 -22.35 40.48 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.8 95.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.245 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -62.87 -56.72 14.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 39' ' ' VAL . 85.8 t -85.19 69.67 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.643 0.735 . . . . 0.0 110.242 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.636 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -154.08 -34.96 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.748 -175.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.57 -36.8 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.205 -169.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -134.27 66.66 71.53 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.813 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -98.11 4.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.585 2.19 . . . . 0.0 112.948 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.85 -39.56 0.45 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.931 . . . . 0.0 112.417 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.6 OUTLIER -64.9 -79.25 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.363 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -143.95 -81.56 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.005 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 156.0 -110.93 0.46 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.194 177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.451 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 5.6 ttp -60.07 -41.35 84.29 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 48' ' ' MET . 43.3 Cg_exo -59.67 -44.47 31.37 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.84 1.693 . . . . 0.0 111.531 174.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.786 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -60.01 -37.68 80.43 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.503 ' HB2' HD22 ' A' ' 40' ' ' ASN . 22.1 ttt180 -55.51 -49.73 71.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.186 173.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.46 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.747 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.786 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.7 p-90 -72.1 -39.27 69.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.62 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -62.42 -51.04 77.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.639 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 96.0 mt -59.63 -36.91 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -48.52 67.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.987 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.1 m -70.58 -41.06 72.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.589 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.63 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.506 0.669 . . . . 0.0 109.626 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.639 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.3 t-160 -56.62 -54.03 50.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.954 175.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.41 -39.08 93.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.325 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.39 98.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 21' ' ' ILE . 13.2 tp -68.31 -46.65 69.69 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 39.4 mt-10 -65.31 -27.62 68.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.799 0.333 . . . . 0.0 110.986 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 12.3 tmtt? -65.33 -34.45 78.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 109.817 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.409 ' ND2' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -149.86 75.25 9.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.681 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 46.67 2.12 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.323 2.682 . . . . 0.0 113.285 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -143.38 34.87 1.32 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.304 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.409 HD13 ' ND2' ' A' ' 65' ' ' ASN . 23.3 pt -110.7 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.512 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -144.39 -19.85 0.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.467 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -166.34 149.91 7.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -139.05 157.84 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.379 . . . . 0.0 110.677 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -116.46 113.27 22.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.579 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.5 pp -109.28 136.31 48.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.566 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -109.87 129.16 24.24 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 90.5 Cg_endo -77.56 162.75 30.13 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.779 1.653 . . . . 0.0 114.097 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -65.31 -13.67 59.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.499 -172.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.4 88.08 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.224 0.535 . . . . 0.0 110.035 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.59 -33.06 57.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.607 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.8 -27.44 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.663 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . 5.0 m-20 -65.78 -38.9 90.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.627 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m 61.25 -77.43 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.344 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -83.53 33.74 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.663 ' CG2' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -112.01 130.45 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.85 139.57 51.17 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.763 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.526 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 69.8 m-85 -97.59 120.38 37.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.544 0.687 . . . . 0.0 109.252 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.76 100.61 13.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.547 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.7 t -98.37 112.2 29.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.195 0.521 . . . . 0.0 110.129 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.0 mp -99.24 141.1 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.259 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 58.7 m-85 -101.32 106.46 17.64 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.745 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 m-20 -83.81 136.52 34.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.724 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -109.28 125.52 52.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.572 -0.728 . . . . 0.0 109.839 -179.252 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.048 0.451 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.64 118.75 37.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 39' ' ' VAL . 38.2 t -111.83 119.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.417 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 30.0 mt-10 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.272 0.558 . . . . 0.0 110.687 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.758 HG21 ' SD ' ' A' ' 36' ' ' MET . 4.8 mt -98.08 152.48 4.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.378 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -122.33 126.07 47.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.922 0.391 . . . . 0.0 110.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE1' ' SD ' ' A' ' 36' ' ' MET . 8.0 m-30 -116.89 125.8 28.01 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.249 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 38.9 Cg_exo -59.4 108.5 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.036 1.824 . . . . 0.0 110.788 171.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.8 -36.07 35.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.743 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -38.55 75.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.637 0.256 . . . . 0.0 111.588 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.414 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.7 mpt_? -86.59 -35.56 19.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.379 -173.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.499 HG23 HD22 ' A' ' 62' ' ' LEU . 9.6 tp -66.12 -22.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 109.626 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.17 24.52 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.216 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.27 170.65 15.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.74 136.9 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.92 26.31 19.8 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -63.34 -29.17 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.579 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.88 -4.3 23.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.487 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.23 -8.41 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.898 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -80.43 115.69 20.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.345 0.593 . . . . 0.0 109.897 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.29 -33.46 75.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.325 -168.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -43.31 75.8 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.841 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -64.45 -40.07 95.03 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.719 0.771 . . . . 0.0 109.02 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.77 -44.76 66.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -74.19 -26.8 60.49 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.559 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.9 50.49 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.388 0.613 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.758 ' SD ' HG21 ' A' ' 14' ' ' ILE . 94.8 mmm -72.69 -29.37 63.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.445 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.47 -27.84 70.64 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.88 -41.57 91.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 110.17 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 12' ' ' VAL . 3.6 p -108.65 77.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.161 0.981 . . . . 0.0 110.202 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -150.6 -25.47 0.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.401 -174.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.18 -32.56 16.57 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.103 -174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 t -143.45 63.77 12.91 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.407 0.622 . . . . 0.0 110.695 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 17.5 Cg_endo -93.58 14.86 1.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.96 2.44 . . . . 0.0 113.332 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 75.36 -39.32 0.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.444 0.698 . . . . 0.0 112.117 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 27.4 tt0 -84.42 -104.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.937 -0.477 . . . . 0.0 110.632 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -102.05 -90.5 0.35 Allowed 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.028 0.442 . . . . 0.0 110.735 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 162.97 -111.71 0.48 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.45 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.5 tmt? -57.95 -44.86 99.7 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 51.8 Cg_exo -58.2 -41.85 62.78 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.971 1.78 . . . . 0.0 111.976 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.91 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.83 -40.59 93.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.317 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.517 ' HB2' HD21 ' A' ' 40' ' ' ASN . 5.1 ttp85 -54.95 -46.21 74.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.602 0.239 . . . . 0.0 110.583 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -58.76 -48.53 80.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.675 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.91 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.0 p-90 -72.73 -40.05 66.42 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.235 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 t -61.2 -51.04 77.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.576 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 36' ' ' MET . 50.5 mt -57.75 -43.25 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.249 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 52' ' ' ALA . 62.4 mttp -63.23 -50.23 71.03 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.26 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.8 m -61.39 -45.85 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.21 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.31 . . . . 0.0 110.859 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.97 -52.49 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.934 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 46.8 mt-10 -69.09 -39.73 78.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.28 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.83 88.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 21' ' ' ILE . 6.4 tp -70.71 -45.55 64.74 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.95 -32.87 74.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 28.4 mmmt -80.03 -22.71 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.349 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -140.94 69.56 29.16 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.475 0.655 . . . . 0.0 109.707 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.47 50.34 3.35 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.406 2.737 . . . . 0.0 113.182 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -142.18 28.33 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.374 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.07 -172.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.35 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -131.57 -39.86 1.12 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.143 -173.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -164.3 156.75 16.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.797 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.11 122.55 48.17 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.442 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 7.9 mt -106.56 136.71 45.87 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.125 -173.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.99 117.62 61.06 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.448 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.728 ' HG2' HG13 ' A' ' 83' ' ' VAL . 43.1 Cg_exo -40.05 135.5 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.58 2.853 . . . . 0.0 113.347 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -62.65 -25.67 68.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.355 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -82.87 68.3 9.3 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 t -57.35 -23.19 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.363 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.514 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 3.5 mptp? -61.56 -24.05 66.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.476 ' OD1' HG11 ' A' ' 83' ' ' VAL . 1.1 t-20 -65.9 -17.94 65.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.34 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.1 p 62.17 -96.57 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 168.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -78.11 53.69 1.24 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.33 0.586 . . . . 0.0 112.555 -167.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.1 p -142.11 134.53 27.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.928 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -139.37 145.4 38.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.693 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.0 117.29 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.713 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 13.2 t-160 -98.01 102.64 14.44 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.7 t -91.77 112.92 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.101 0.477 . . . . 0.0 109.985 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.2 mt -104.3 139.03 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.051 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -102.71 106.91 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.49 135.91 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.77 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 9.3 p-10 -101.43 119.2 38.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.578 0.704 . . . . 0.0 109.771 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -95.3 139.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.791 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -92.25 130.95 37.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.381 0.61 . . . . 0.0 110.337 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.516 HD13 ' SD ' ' A' ' 36' ' ' MET . 25.5 mt -128.59 133.19 67.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.6 m-70 -120.26 126.29 50.23 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 110.795 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.2 m-85 -127.57 115.01 21.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 37.3 Cg_exo -61.27 121.95 10.4 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.292 1.994 . . . . 0.0 111.861 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -43.35 -44.01 5.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 113.851 -1.522 . . . . 0.0 113.901 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -77.41 -38.31 49.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HD2' ' HG2' ' A' ' 17' ' ' PRO . 17.7 ptp180 -89.34 -25.14 21.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.741 -172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HD22 ' A' ' 62' ' ' LEU . 7.2 tp -71.65 -22.57 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.08 -11.89 58.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 142.3 44.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.198 0.523 . . . . 0.0 110.845 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.44 -19.43 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.75 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.54 55.36 0.83 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -67.85 -40.46 83.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.489 0.185 . . . . 0.0 111.211 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 61.92 1.51 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.696 0.76 . . . . 0.0 110.032 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.21 -34.9 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.247 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 29.2 t70 -75.1 119.97 19.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.813 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 29.5 tt0 -64.57 -35.24 80.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.36 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.36 -43.06 92.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.252 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -65.59 -41.9 92.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.73 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -70.3 -45.09 66.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.092 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 90.4 m-20 -61.8 -37.6 84.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.379 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 43.6 mt-30 -73.76 -41.93 61.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.609 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 70.8 mmm -86.84 12.24 11.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.9 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.19 -27.14 6.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 164.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.77 -62.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.076 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.09 71.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 122.07 0.938 . . . . 0.0 109.771 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 36' ' ' MET . 21.7 t30 -147.5 -44.65 0.17 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -165.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.27 -39.56 54.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.838 0.352 . . . . 0.0 111.034 -171.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -128.55 69.77 79.48 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.694 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HB2' HD12 ' A' ' 50' ' ' LEU . 53.2 Cg_endo -98.96 25.52 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.312 2.674 . . . . 0.0 112.816 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 73.38 -39.39 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.552 0.741 . . . . 0.0 112.114 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.562 ' CB ' HD21 ' A' ' 50' ' ' LEU . 32.5 mt-10 -85.56 -88.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.266 0.555 . . . . 0.0 111.441 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.01 -86.61 0.44 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.054 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.672 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 158.49 -78.45 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.972 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.48 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -63.0 -47.62 86.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 17.3 Cg_exo -69.02 -24.32 33.19 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.857 1.705 . . . . 0.0 110.326 175.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -59.77 -48.2 82.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.649 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 36.3 ptt180 -75.11 -38.86 60.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.584 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.29 81.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.209 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.0 p-90 -72.45 -43.83 63.21 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.91 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -40.99 78.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.383 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.492 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 83.1 mt -66.54 -45.59 88.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.522 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 38.6 ttmt -63.96 -47.7 79.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.5 m -65.26 -42.61 93.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.193 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.73 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.395 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.21 -52.63 64.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.575 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 19.2 mm-40 -61.53 -42.47 98.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.863 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.03 93.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 HG23 ' A' ' 21' ' ' ILE . 8.4 tp -63.65 -46.97 83.21 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.511 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.1 -26.89 63.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.18 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.77 -40.03 91.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 110.082 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -135.86 73.78 59.25 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.322 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 55.84 4.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.037 2.492 . . . . 0.0 112.322 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -132.16 -6.58 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.631 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 pt -93.52 -175.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.177 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.82 -9.51 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.418 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -166.37 152.72 8.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.973 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.89 156.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.353 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -111.17 115.66 29.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.325 0.583 . . . . 0.0 109.898 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.123 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -118.93 131.84 24.17 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.43 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.641 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -26.9 137.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 1 C-N-CA 125.709 4.272 . . . . 0.0 115.905 173.317 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -55.47 -45.1 76.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.578 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.68 83.25 2.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.59 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.38 -21.37 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.394 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -65.07 -24.09 67.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' OD1' HG11 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -64.75 -22.76 67.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m 68.54 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 m -79.24 49.45 0.97 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -167.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 75' ' ' PRO . 6.7 p -142.85 136.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -146.79 154.59 41.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.539 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.07 135.06 54.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.126 0.489 . . . . 0.0 110.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -106.11 103.47 12.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.608 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.0 111.95 24.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.71 137.76 35.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.172 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 71.4 m-85 -102.46 108.53 19.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.391 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 15' ' ' HIS . 10.5 m-20 -76.38 120.39 21.56 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 121.573 0.701 . . . . 0.0 110.914 -174.135 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 3.3 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.42 118.62 37.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.233 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.72 117.78 43.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 31.7 mt-10 -103.93 112.04 24.85 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.202 0.525 . . . . 0.0 110.449 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 2.3 mt -108.5 124.42 64.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 79.6 m80 -101.83 112.37 24.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -99.94 128.93 29.64 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.526 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 40.5 Cg_endo -68.13 111.43 2.46 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.048 1.832 . . . . 0.0 111.133 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HG22 ' A' ' 21' ' ' ILE . 10.4 tt -51.09 -37.87 48.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.223 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -70.34 -34.95 73.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -93.49 -30.79 14.85 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.304 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 18' ' ' LEU . 7.3 tp -66.08 -24.85 34.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 121.076 0.465 . . . . 0.0 109.901 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.03 68.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.26 148.53 41.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.521 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.86 -22.01 29.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.327 0.584 . . . . 0.0 109.77 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.57 3.24 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 173.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -71.87 -13.93 61.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.807 0.337 . . . . 0.0 111.627 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.13 -12.08 61.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.304 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.14 -5.42 56.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.48 107.05 18.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.253 0.549 . . . . 0.0 110.876 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.58 -32.15 72.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.5 mt -58.5 -45.78 88.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.001 0.429 . . . . 0.0 110.507 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.17 -40.8 67.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.46 0.648 . . . . 0.0 110.001 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' LEU . 12.4 tp -70.76 -44.08 67.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.621 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 2.5 p30 -71.94 -34.24 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.792 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -69.87 -38.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.807 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.24 5.68 29.25 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.762 175.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.88 -28.68 8.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 32.3 mmtp -77.02 -70.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.38 34.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.975 0.893 . . . . 0.0 110.596 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 36' ' ' MET . 26.8 t-20 -138.63 -8.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.812 -173.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.14 -32.27 63.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.453 0.644 . . . . 0.0 109.866 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -138.45 67.75 45.47 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.462 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -88.9 7.96 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 112.636 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 72.64 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.711 0.804 . . . . 0.0 111.873 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 10.2 tt0 -64.1 -70.05 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.828 0.346 . . . . 0.0 111.05 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.63 -129.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.675 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -154.61 -94.88 0.11 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 167.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 11.1 ttp -53.16 -42.89 93.3 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.675 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 14.4 Cg_exo -70.5 -28.36 21.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.912 1.742 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.8 tm? -57.69 -45.69 85.32 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -60.19 -49.22 78.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.46 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.72 76.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 -175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.5 p-90 -73.41 -37.38 65.93 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.523 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.96 -51.34 67.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.61 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.707 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 4.8 tppp? -64.1 -50.37 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.863 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 73' ' ' LEU . 50.0 t -61.7 -46.46 89.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.342 . . . . 0.0 110.724 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.43 89.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.461 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -62.37 -45.35 93.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.114 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 56' ' ' LYS . 58.6 mt-10 -62.45 -47.21 85.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.2 96.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.199 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 62' ' ' LEU . 3.2 tm? -74.37 -37.88 63.33 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.436 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.27 -26.07 36.05 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.449 -0.782 . . . . 0.0 112.024 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.7 tmtp? -82.72 -37.12 25.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.489 ' OD1' HG23 ' A' ' 68' ' ' ILE . 21.0 t-20 -131.4 90.43 37.88 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.864 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -88.14 31.68 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.611 2.207 . . . . 0.0 111.365 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -118.34 11.29 13.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.489 HG23 ' OD1' ' A' ' 65' ' ' ASN . 7.3 pt -95.49 166.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.243 173.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -129.4 -3.58 4.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.92 157.35 9.82 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.984 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.38 156.94 39.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.981 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -110.39 117.45 33.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.384 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.5 mt -111.1 140.76 45.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.627 0.727 . . . . 0.0 112.383 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.472 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 23.6 tptm -117.58 123.93 29.38 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.425 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HG2' HG13 ' A' ' 83' ' ' VAL . 68.7 Cg_exo -38.97 144.44 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.247 3.298 . . . . 0.0 113.799 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -65.79 -30.96 71.68 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -79.11 76.62 5.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.844 169.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.73 -25.14 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -57.09 -24.0 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.683 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HB3' HG12 ' A' ' 83' ' ' VAL . 8.7 m-20 -62.93 -36.57 83.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.107 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m 65.67 -76.38 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -86.68 36.33 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.4 p -140.79 130.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -127.9 151.15 49.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.208 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.412 ' CE2' HD21 ' A' ' 50' ' ' LEU . 74.4 m-85 -112.19 123.65 50.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.239 0.542 . . . . 0.0 110.2 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 12.1 t-160 -112.14 102.25 10.46 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 90.1 t -95.52 113.68 30.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.135 0.493 . . . . 0.0 110.206 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 88.0 mt -101.82 140.78 19.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -103.13 107.62 18.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.676 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 33.8 m-20 -94.72 116.69 29.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 121.574 0.702 . . . . 0.0 111.083 -176.139 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.08 121.53 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.549 0.69 . . . . 0.0 110.27 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 39' ' ' VAL . 87.3 t -92.28 139.58 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.719 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.62 112.8 26.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.0 110.519 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.0 mt -103.07 152.21 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 56.3 m80 -130.43 142.84 50.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.488 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -141.96 132.53 12.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.075 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 21' ' ' ILE . 19.4 Cg_endo -58.3 115.26 2.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.503 2.135 . . . . 0.0 111.706 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 62' ' ' LEU . 1.5 tm? -43.07 -50.82 6.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.584 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.55 -18.82 58.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 9.5 ttt180 -100.77 -35.3 9.5 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.881 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -69.4 -25.72 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.223 0.535 . . . . 0.0 109.81 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.85 -12.13 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.92 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.6 171.31 12.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.002 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.24 -52.3 17.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 109.783 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.06 71.32 3.03 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.103 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.552 ' O ' HD22 ' A' ' 32' ' ' LEU . 16.7 p90 -65.24 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.909 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.04 4.97 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.0 111.251 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 20' ' ' ARG . 36.3 t70 -75.39 113.96 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.51 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -63.03 -34.8 78.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.466 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.481 ' HG ' ' CD ' ' A' ' 35' ' ' GLN . 32.1 tp -61.5 -40.33 94.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.522 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -55.84 -42.73 76.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 109.58 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD13 ' NH2' ' A' ' 51' ' ' ARG . 3.5 mm? -65.08 -47.7 76.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.407 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.53 -41.83 88.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.83 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.481 ' CD ' ' HG ' ' A' ' 31' ' ' LEU . 74.1 mt-30 -66.42 -44.09 83.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.343 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.5 mmm -87.68 -1.09 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.3 -26.68 15.12 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 165.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' GLN . 60.6 tttp -64.81 -66.58 0.52 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.274 -0.963 . . . . 0.0 110.829 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 12' ' ' VAL . 7.5 p -108.61 97.59 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.748 0.785 . . . . 0.0 110.229 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -176.59 -26.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.55 -44.56 96.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.043 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -145.1 73.98 14.44 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.745 0.783 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -91.44 21.03 0.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.838 2.359 . . . . 0.0 112.45 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 71.59 -37.76 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 112.366 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 75' ' ' PRO . 23.6 tp10 -82.4 -94.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.332 -0.23 . . . . 0.0 111.169 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.668 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 32.7 mt-10 -114.82 -109.16 0.36 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.737 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 167.67 -106.27 0.25 Allowed Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.658 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.689 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 10.8 tpt -49.77 -48.39 77.34 Favored Pre-proline 0 C--O 1.247 0.954 0 CA-C-O 120.958 0.409 . . . . 0.0 111.317 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HG2' ' HB3' ' A' ' 46' ' ' GLU . 31.4 Cg_endo -60.58 -34.15 92.81 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.043 1.162 . . . . 0.0 110.366 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.711 ' O ' ' HE3' ' A' ' 53' ' ' TRP . 4.0 mt -60.28 -44.41 95.38 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.2 ptm180 -62.83 -39.21 93.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.211 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.36 94.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.722 0.772 . . . . 0.0 110.047 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.711 ' HE3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -51.15 69.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.95 1.3 . . . . 0.0 112.881 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -73.35 -43.71 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -58.52 -38.98 73.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.628 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 12.5 mmmm -69.62 -49.1 57.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.698 174.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.697 ' SG ' HD11 ' A' ' 73' ' ' LEU . 49.7 t -59.18 -44.45 92.17 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.777 0.322 . . . . 0.0 110.942 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -65.38 -42.18 92.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.301 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -61.35 -48.14 82.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.424 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 33.3 mm-40 -64.54 -44.0 92.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.514 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.45 95.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.439 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 18' ' ' LEU . 10.1 tt -68.63 -48.19 64.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.149 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -63.64 -25.51 68.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.702 0.287 . . . . 0.0 111.337 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -71.76 -33.58 68.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.219 0.533 . . . . 0.0 110.279 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -149.36 73.4 9.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.717 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.29 33.73 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.323 2.682 . . . . 0.0 113.026 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.04 18.87 10.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.525 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.0 pt -96.1 -173.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.923 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.72 -27.38 2.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.529 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -165.06 168.86 16.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 176.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.17 153.51 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -110.96 132.55 54.11 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.644 0.735 . . . . 0.0 111.303 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.697 HD11 ' SG ' ' A' ' 57' ' ' CYS . 1.8 mm? -107.87 143.9 35.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.492 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -130.83 122.62 19.6 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.696 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -32.74 140.46 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 125.273 3.982 . . . . 0.0 115.906 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 42.4 mtp180 -57.75 -37.59 73.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.989 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.96 84.6 7.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.511 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.68 -12.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.379 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -59.07 -32.14 69.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.608 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 45' ' ' GLU . 4.9 t-20 -63.13 -37.72 88.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.503 -172.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m 69.24 -59.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -77.63 -34.2 53.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -167.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.665 HG13 ' HG2' ' A' ' 75' ' ' PRO . 8.8 p -89.88 132.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 112.255 -171.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -130.6 161.66 31.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.721 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.93 136.23 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.442 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -111.92 111.12 21.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' ALA . 86.8 t -92.04 110.36 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' HIS . 82.3 mt -101.2 136.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.162 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.31 111.51 23.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.239 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -77.19 113.92 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 N--CA 1.439 -1.008 0 CA-C-O 121.725 0.774 . . . . 0.0 110.341 179.726 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.675 0.274 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.58 118.42 31.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 39' ' ' VAL . 39.2 t -106.24 119.98 56.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 23.6 mt-10 -100.27 118.98 37.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.085 0.469 . . . . 0.0 111.173 -168.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.53 HD13 ' SD ' ' A' ' 36' ' ' MET . 24.4 mt -101.32 132.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.084 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.5 m80 -112.39 112.09 23.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 110.896 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -106.21 153.51 40.28 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.0 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 21' ' ' ILE . 87.5 Cg_endo -81.69 113.89 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.281 1.988 . . . . 0.0 111.673 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -43.3 -49.1 6.86 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.95 -32.07 61.64 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 29' ' ' ASP . 2.6 ttm180 -96.86 -21.46 17.49 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.85 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.625 HG23 HD22 ' A' ' 62' ' ' LEU . 6.7 tp -72.28 -27.34 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.02 -9.11 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.13 155.27 19.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.125 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.9 pt-20 -84.01 -14.35 50.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.833 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.08 43.71 1.65 Allowed Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -60.03 -27.76 67.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 111.624 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -14.34 62.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.639 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.99 -18.47 43.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 25.5 t70 -84.7 109.0 17.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 111.57 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -29.61 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.25 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . 2.9 tm? -63.86 -40.2 95.98 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.3 -43.84 98.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.297 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.97 -44.57 92.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -58.4 -43.32 88.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.257 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 1.3 mp0 -68.44 -45.21 73.16 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 14' ' ' ILE . 66.2 mmm -90.15 13.43 15.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.172 0.51 . . . . 0.0 110.825 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.88 -38.29 3.67 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -63.4 -66.11 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.121 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 12' ' ' VAL . 7.0 p -91.36 68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 122.338 1.066 . . . . 0.0 110.267 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.11 9.8 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.145 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.34 -36.95 3.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.987 0.423 . . . . 0.0 110.055 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.1 p -141.94 59.3 9.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.989 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 42' ' ' THR . 67.1 Cg_endo -94.68 30.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.047 2.498 . . . . 0.0 113.098 -174.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 73.79 -47.9 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.31 0.644 . . . . 0.0 111.048 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -77.81 -92.64 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.95 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -130.06 -91.3 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.605 0.241 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 165.96 -102.6 0.19 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.597 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 9.1 ttp -53.55 -45.97 98.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 48' ' ' MET . 19.2 Cg_endo -60.9 -30.2 89.56 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.879 1.719 . . . . 0.0 111.05 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.81 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -59.06 -45.96 89.47 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.292 176.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.518 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 18.0 ttm180 -59.98 -48.94 79.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.2 78.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.376 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.81 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.3 p-90 -72.38 -41.93 65.8 Favored 'General case' 0 CA--C 1.522 -0.096 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.852 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.5 OUTLIER -69.48 -43.18 80.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.689 -174.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.78 -46.23 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.316 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.53 -41.81 88.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.586 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.415 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 71.7 m -66.28 -44.85 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.819 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.33 83.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.833 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -59.35 -49.35 78.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.967 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -64.56 -41.83 96.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.043 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.9 96.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.283 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.625 HD22 HG23 ' A' ' 21' ' ' ILE . 15.6 tp -69.48 -47.36 64.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.135 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.66 -26.44 67.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -42.17 98.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.494 0.664 . . . . 0.0 109.961 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -139.4 75.09 33.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.75 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.15 47.77 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.073 2.515 . . . . 0.0 112.709 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -139.26 2.83 2.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.69 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -85.64 -179.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.574 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.19 -19.75 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.878 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -165.51 155.47 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.0 t -127.28 152.36 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.681 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -110.1 116.22 31.16 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.43 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 29.8 tp -127.7 141.89 51.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.338 -167.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -126.38 126.86 24.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 18.1 Cg_endo -63.16 171.22 6.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.107 2.538 . . . . 0.0 114.733 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 3.8 mtp180 -66.41 -61.01 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.66 -168.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.99 118.01 4.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.49 -9.75 13.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.156 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -58.81 -39.57 81.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' OD1' HG12 ' A' ' 83' ' ' VAL . 1.6 p30 -73.46 -27.06 61.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.495 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m 74.49 -66.51 0.29 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 m -125.85 27.07 6.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 80' ' ' ASN . 9.9 p -90.16 134.98 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -134.86 152.25 51.59 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.996 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -108.51 118.86 37.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.632 0.73 . . . . 0.0 109.623 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.4 t-160 -94.05 102.04 14.09 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.32 112.22 25.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -113.54 139.11 40.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.528 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.57 106.65 17.12 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.201 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -86.9 127.32 35.05 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.248 179.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.21 118.39 28.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.014 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.05 119.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -98.77 112.22 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 0.0 110.26 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.2 mt -111.95 123.34 67.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -99.66 112.82 25.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.237 0.542 . . . . 0.0 110.914 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-30 -111.42 116.04 51.23 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.589 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 33.6 Cg_exo -61.79 119.74 7.01 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.008 . . . . 0.0 111.789 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 62' ' ' LEU . 1.7 tm? -42.38 -45.2 4.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.765 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -71.98 -43.54 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.785 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 11.5 ptp180 -83.13 -28.66 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.277 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 17' ' ' PRO . 7.8 tp -75.24 -17.69 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.0 109.891 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.88 -13.72 55.6 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.25 0.548 . . . . 0.0 110.395 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.35 156.94 20.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.369 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.9 -14.37 51.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.351 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.16 60.61 1.1 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -82.16 -41.53 20.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 111.158 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.37 -4.75 43.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.2 9.38 30.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.515 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 18.0 t70 -95.57 119.5 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.882 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.62 -31.56 71.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.607 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 31' ' ' LEU . 6.4 mt -69.03 -43.21 75.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.26 0.552 . . . . 0.0 110.465 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.0 -36.56 75.24 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.394 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.34 -47.9 58.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.28 -178.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.45 -35.16 70.81 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.864 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.47 -45.21 80.47 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.999 0.428 . . . . 0.0 110.64 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 7.3 tpt -93.34 16.81 12.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.133 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.09 -32.98 3.85 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 163.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.53 -62.98 1.43 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.63 -0.785 . . . . 0.0 110.576 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 39' ' ' VAL . 11.4 p -94.6 52.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.705 1.24 . . . . 0.0 110.165 -176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' MET . 4.2 t-20 -133.16 -29.37 1.43 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.583 -171.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 80.3 m-20 -79.48 -31.38 42.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.67 -169.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 p -126.1 62.38 44.92 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.906 0.384 . . . . 0.0 111.225 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 83' ' ' VAL . 11.3 Cg_endo -97.21 6.6 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.936 2.424 . . . . 0.0 113.456 -174.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 71.19 -42.03 0.52 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.698 0.799 . . . . 0.0 112.205 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 50' ' ' LEU . 3.9 tp10 -66.72 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.345 0.117 . . . . 0.0 110.983 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 31.5 mt-10 -136.28 -86.44 0.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.328 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 160.9 -110.26 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.099 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.6 tpt -52.72 -49.53 85.91 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.9 Cg_endo -67.82 -35.73 20.47 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.208 1.272 . . . . 0.0 111.566 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.731 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.38 -43.2 96.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.415 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 48' ' ' MET . 35.6 ptt180 -69.51 -29.87 67.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.997 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -49.31 77.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.668 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 12.2 p-90 -73.09 -36.84 66.87 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.148 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -49.1 82.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 79.6 mt -65.55 -38.64 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.427 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.2 tptt -63.65 -48.86 75.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.727 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.7 t -62.68 -46.95 85.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.69 83.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.667 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -62.4 -52.23 64.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.547 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 56.7 mm-40 -65.04 -38.35 90.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.661 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.71 -44.12 90.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.487 HD11 HD22 ' A' ' 18' ' ' LEU . 8.2 tt -72.94 -47.23 47.39 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.782 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.55 -26.08 63.18 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.805 -0.559 . . . . 0.0 112.09 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -84.05 -44.96 13.57 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' OD1' HG23 ' A' ' 68' ' ' ILE . 11.6 t-20 -139.45 100.14 7.69 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.866 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -96.79 25.66 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.695 2.263 . . . . 0.0 112.012 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.04 8.22 32.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.465 HG23 ' OD1' ' A' ' 65' ' ' ASN . 4.7 pt -77.51 166.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.733 0.777 . . . . 0.0 111.474 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HE ' ' HB2' ' A' ' 69' ' ' ARG . 2.0 mtm180 -106.89 -51.39 2.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.325 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.658 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.9 150.37 27.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.139 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 87' ' ' VAL . 9.1 p -119.55 156.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.772 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -111.16 115.1 28.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 57' ' ' CYS . 11.2 mt -111.69 136.68 50.6 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.636 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -113.93 119.16 41.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.674 ' HG2' HG13 ' A' ' 83' ' ' VAL . 88.2 Cg_exo -37.23 147.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 125.034 3.823 . . . . 0.0 114.301 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -61.32 -40.33 93.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.957 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.76 85.8 3.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.984 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.51 -22.67 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.075 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -57.58 -29.27 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.216 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.23 -38.56 91.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.724 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m 65.6 -56.64 0.33 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 123.945 0.778 . . . . 0.0 113.02 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 m -76.87 -37.37 55.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.674 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.8 p -87.68 140.23 16.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -146.47 153.3 40.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.69 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.15 126.43 52.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.447 0.641 . . . . 0.0 111.053 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -109.31 102.84 11.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 71' ' ' VAL . 76.0 t -91.87 114.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 77.2 mt -104.17 133.15 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.85 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 87.6 m-85 -102.65 109.91 21.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 17.5 t70 -99.58 131.91 45.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 C--N 1.32 -0.698 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.892 -179.004 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.16 119.61 26.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.688 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.1 t -118.54 130.3 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.4 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.14 127.07 53.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 110.552 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mt -116.16 129.45 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -102.22 140.12 36.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -132.46 126.87 20.42 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 22.4 Cg_endo -63.59 111.25 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.941 1.76 . . . . 0.0 110.242 172.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.31 -35.44 18.2 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.894 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 3.5 mptp? -68.23 -40.58 82.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.682 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -83.19 -36.69 24.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.832 0.348 . . . . 0.0 110.508 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.546 HG23 HD22 ' A' ' 62' ' ' LEU . 10.8 tp -74.69 -3.49 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.248 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.59 -6.36 22.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.13 168.81 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.066 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.41 -44.48 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.13 49.97 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.178 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.01 -34.9 77.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.39 32.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -95.62 2.1 53.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.19 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -89.56 123.06 33.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.094 0.473 . . . . 0.0 109.996 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.68 -32.59 74.12 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.809 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.765 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 22.4 tp -70.71 -42.36 70.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -43.04 86.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.308 0.575 . . . . 0.0 109.831 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.4 tp -70.6 -49.87 43.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.935 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 4.5 p30 -74.8 -27.58 60.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.728 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.765 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 3.2 tt0 -66.63 -45.45 79.03 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.407 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -92.17 7.03 44.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.059 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.04 -27.15 8.42 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.74 -66.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.449 . . . . 0.0 111.171 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 39' ' ' VAL . 9.8 p -85.49 41.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.924 1.345 . . . . 0.0 109.719 -172.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -145.84 -3.94 0.67 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.119 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.88 -30.83 65.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.506 0.669 . . . . 0.0 109.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.8 67.89 79.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 89.4 Cg_endo -95.37 25.48 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.257 2.638 . . . . 0.0 113.263 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.49 -55.58 0.62 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.456 0.702 . . . . 0.0 111.773 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.13 -108.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -93.88 -124.79 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.565 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.668 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -153.1 -89.17 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.562 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -58.38 -39.6 76.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 32.8 Cg_endo -77.63 -23.97 9.28 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 120.82 1.329 . . . . 0.0 110.591 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.604 HD22 ' NE1' ' A' ' 53' ' ' TRP . 3.1 tm? -58.87 -46.01 88.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.725 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 48' ' ' MET . 13.0 ptt180 -67.36 -38.6 85.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.42 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.69 80.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.891 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.604 ' NE1' HD22 ' A' ' 50' ' ' LEU . 7.6 p-90 -72.93 -37.28 67.24 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.885 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.47 -51.11 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.43 -41.15 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.734 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -62.45 -49.5 75.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.768 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.44 -45.24 94.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.99 92.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -57.79 -58.23 9.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.299 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -64.08 -41.95 97.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.72 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -76.84 -47.79 20.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.035 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.68 -27.35 65.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 2.7 mmmp? -69.36 -29.15 66.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -149.01 73.62 10.19 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.12 41.39 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.076 2.517 . . . . 0.0 113.171 -170.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -133.44 26.22 4.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.38 -172.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.3 0.571 . . . . 0.0 111.67 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -127.04 -44.01 1.64 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.555 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.46 152.87 12.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -122.73 156.96 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.985 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.47 116.88 32.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.71 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 73' ' ' LEU . 7.3 mt -106.08 144.28 33.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.3 0.571 . . . . 0.0 111.198 -174.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 13.4 tmtt? -123.83 115.38 27.96 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.887 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.598 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 90.0 Cg_exo -46.32 138.51 13.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.867 3.045 . . . . 0.0 113.521 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -56.91 -29.51 63.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.031 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.67 96.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.054 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.4 -29.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.269 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -61.69 -28.54 69.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.829 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -73.54 -39.77 64.49 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.076 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 m 64.4 -71.97 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.436 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 m -91.92 59.6 3.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.3 p -140.95 136.22 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.978 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.38 160.16 40.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.229 0.538 . . . . 0.0 111.399 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.598 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 62.0 m-85 -120.79 123.62 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.709 171.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -91.9 101.65 14.22 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.77 112.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.2 138.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.661 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -103.61 110.35 22.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 7.5 m-20 -99.34 132.36 44.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.721 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 1.1 pm0 . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 0.0 110.811 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.7 t . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 120.583 0.23 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.39 117.78 35.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -106.06 140.24 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -103.09 112.26 25.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.421 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.401 HD13 ' SD ' ' A' ' 36' ' ' MET . 40.2 mt -111.63 142.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 99.1 m-70 -125.61 119.52 28.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.632 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 21.8 m-85 -118.11 106.96 44.43 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.157 174.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_exo -59.07 123.33 13.25 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.931 1.754 . . . . 0.0 111.586 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -48.86 19.74 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -68.74 -29.11 67.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 12.4 ptp180 -94.58 -28.66 15.28 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.605 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 6.1 tp -72.91 -25.06 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.184 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -82.17 -11.22 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 110.686 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.57 177.11 6.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.438 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.58 151.93 24.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 21.61 51.15 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -170.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -61.84 -30.51 70.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.544 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.24 59.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.214 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -76.64 -27.29 55.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.425 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 102.55 0.79 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.039 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 35.8 tt0 -62.46 -31.13 71.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.008 -171.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 36.8 tp -60.65 -42.51 97.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.46 -42.14 83.51 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.618 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.432 HD11 ' NH2' ' A' ' 51' ' ' ARG . 7.3 tp -67.16 -46.3 74.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.779 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 93.5 m-20 -59.74 -42.95 94.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 43.3 mt-30 -64.86 -43.49 92.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 72.2 mmm -87.69 9.02 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.78 -29.26 5.04 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 166.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -73.19 -61.62 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.587 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -92.77 30.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.428 1.109 . . . . 0.0 110.188 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.616 HD21 ' HB2' ' A' ' 50' ' ' LEU . 26.0 t-20 -141.6 0.78 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.778 -170.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.77 -47.07 76.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.294 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.37 72.04 82.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 50' ' ' LEU . 75.6 Cg_endo -92.69 23.09 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.095 2.53 . . . . 0.0 113.577 -172.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 71.3 -57.33 0.61 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.257 0.623 . . . . 0.0 112.004 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.876 ' HB3' HD11 ' A' ' 50' ' ' LEU . 5.5 tp10 -67.0 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.895 0.478 . . . . 0.0 111.231 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -127.93 -91.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 170.63 -114.42 0.54 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.897 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -56.91 -40.14 82.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.58 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.21 -37.38 69.98 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.921 1.747 . . . . 0.0 112.11 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 45' ' ' GLU . 2.9 mt -60.08 -45.56 92.5 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 36' ' ' MET . 1.8 ttt180 -56.55 -41.83 77.5 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.106 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.76 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.1 -40.32 68.27 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.767 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -43.08 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 71.2 mt -64.06 -44.89 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 176.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.63 -48.4 77.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.603 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.0 m -67.59 -39.38 84.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.089 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.64 89.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -54.56 39.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.578 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.02 -36.74 82.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.3 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 65' ' ' ASN . . . -65.83 -33.37 75.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.191 0.52 . . . . 0.0 110.932 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.9 tm? -83.62 -41.43 17.82 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.717 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -79.64 -29.13 40.87 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.107 -0.37 . . . . 0.0 111.321 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 4.4 ttmp? -89.64 -14.78 34.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.822 0.82 . . . . 0.0 109.315 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 26.2 t-20 -144.45 68.9 15.34 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.373 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.24 37.93 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.767 2.312 . . . . 0.0 112.766 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -17.97 13.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.498 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 68' ' ' ILE . 2.5 pp -80.77 -173.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.426 0.632 . . . . 0.0 112.184 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -140.94 -16.42 0.87 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.643 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.25 163.06 20.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.199 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p -134.59 153.25 34.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.075 0.464 . . . . 0.0 110.422 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -109.52 113.58 26.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -121.8 143.82 49.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.544 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -116.89 131.78 23.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.33 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 83' ' ' VAL . 86.8 Cg_exo -51.41 151.62 13.22 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.382 2.721 . . . . 0.0 112.848 172.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -63.12 -33.19 74.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.733 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -65.87 112.81 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.751 0.786 . . . . 0.0 111.131 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.4 -33.54 59.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.771 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -65.02 -26.13 68.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.743 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 87.7 m-20 -64.55 -29.36 70.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.783 0.325 . . . . 0.0 110.909 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.9 t 66.67 -82.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.666 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 t -108.8 37.99 2.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 80' ' ' ASN . 13.1 p -101.03 130.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -130.36 136.31 48.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 12' ' ' VAL . 10.9 m-30 -105.61 124.2 49.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.742 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.27 102.47 12.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 40.4 t -94.43 111.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.92 140.43 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.425 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 78.9 m-85 -101.33 108.22 19.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 6.5 t70 -83.94 135.78 34.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.265 -169.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--N 1.321 -0.661 0 CA-C-O 121.351 0.596 . . . . 0.0 109.981 176.631 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.81 119.01 33.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.23 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.28 130.19 55.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.271 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -108.41 117.17 33.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.507 0.67 . . . . 0.0 110.406 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.438 HD13 ' SD ' ' A' ' 36' ' ' MET . 33.4 mt -115.75 133.06 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.06 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -120.84 107.72 13.07 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.589 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.3 132.23 24.75 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.847 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 10.2 Cg_exo -66.56 120.73 7.88 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.672 1.581 . . . . 0.0 109.547 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -53.92 -42.23 68.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.814 -167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -79.56 -24.11 42.34 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.492 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 17' ' ' PRO . 7.8 mpt_? -81.28 -38.03 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.53 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tp -70.75 -26.31 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.287 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.23 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.99 157.85 34.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.55 -21.72 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.335 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.52 38.94 3.14 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' HD22 ' A' ' 32' ' ' LEU . 32.1 p90 -66.36 -35.94 81.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.503 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.0 -9.68 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.224 0.535 . . . . 0.0 111.29 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.38 -3.2 50.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 20' ' ' ARG . 24.3 t70 -82.2 124.78 30.21 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.738 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.29 -28.98 70.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -170.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 3.1 tm? -76.51 -36.82 57.53 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.69 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -66.23 -40.33 90.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.829 177.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.31 -49.6 63.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.966 -176.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.9 p30 -73.45 -34.06 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.91 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 32' ' ' LEU . 3.5 pt20 -67.99 -41.48 82.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.926 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.459 ' HG3' HD11 ' A' ' 55' ' ' ILE . 86.7 mmm -90.32 5.82 45.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.11 -28.19 11.19 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 164.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 68.1 mttm -77.11 -73.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.344 -0.428 . . . . 0.0 111.986 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.59 50.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.722 0.772 . . . . 0.0 110.564 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -142.49 -23.9 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.404 -170.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p-10 -87.18 -18.23 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.173 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 p -133.27 57.43 27.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.25 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 42' ' ' THR . 26.5 Cg_endo -101.52 24.01 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.321 2.681 . . . . 0.0 113.814 -174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 10.9 tp10 70.54 -58.04 0.56 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.053 0.541 . . . . 0.0 112.239 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.584 ' HB3' HD11 ' A' ' 50' ' ' LEU . 37.8 tt0 -73.09 -86.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.601 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 51.3 mt-10 -127.32 -95.7 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.171 -0.331 . . . . 0.0 110.569 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 162.18 -83.05 0.12 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.84 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.477 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 12.6 tpt -54.36 -49.89 88.08 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 48' ' ' MET . 47.9 Cg_endo -68.56 -27.78 32.46 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.402 1.401 . . . . 0.0 110.02 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 2.3 mt -57.83 -46.31 84.92 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -64.28 -47.0 81.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.61 -49.87 75.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.841 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.595 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 6.2 p-90 -74.06 -41.29 61.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.888 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.7 t -61.45 -51.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 36' ' ' MET . 80.1 mt -60.28 -41.37 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.7 tmtt? -63.2 -50.43 70.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.578 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -64.14 -41.45 97.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.832 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.72 97.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.369 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.99 -49.58 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.29 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 10.4 mm-40 -61.77 -45.8 92.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.51 93.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -60.95 -46.03 92.35 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.452 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.4 -27.46 52.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -63.72 -50.3 69.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.995 0.426 . . . . 0.0 109.854 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -130.58 76.04 78.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 121.44 0.638 . . . . 0.0 109.936 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 42.02 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.483 2.789 . . . . 0.0 113.237 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -124.89 -1.21 7.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.407 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.0 pt -83.0 -174.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -143.04 -18.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.697 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -165.63 157.73 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.108 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 87' ' ' VAL . 20.1 m -135.24 155.49 37.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -111.56 116.83 31.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.217 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.479 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 15.5 mt -108.44 140.22 42.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.77 0.795 . . . . 0.0 112.611 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 24.3 tptm -120.97 116.68 31.24 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.689 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 83' ' ' VAL . 96.0 Cg_exo -33.29 143.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.766 3.644 . . . . 0.0 114.605 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -62.87 -32.24 73.44 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.305 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.11 69.9 7.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.037 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.5 -22.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.945 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -57.74 -23.77 53.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.97 -36.1 80.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m 71.51 -57.1 0.62 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.299 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -96.63 54.57 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -140.68 134.4 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.208 173.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -135.74 143.98 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -117.17 123.98 48.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.176 0.513 . . . . 0.0 109.957 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -101.68 103.61 14.4 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.017 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 71' ' ' VAL . 74.7 t -95.85 112.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.1 mt -113.26 142.36 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -101.81 110.49 22.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.303 0.573 . . . . 0.0 110.131 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.49 133.03 38.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.238 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 1.4 pm0 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.516 0.674 . . . . 0.0 110.026 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.0 118.69 23.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.17 139.12 49.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -107.43 128.35 54.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.266 0.555 . . . . 0.0 110.235 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' SD ' ' A' ' 36' ' ' MET . 44.2 mt -117.13 149.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.473 ' HB2' ' NE2' ' A' ' 35' ' ' GLN . 98.6 m-70 -125.96 123.14 37.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.977 0.418 . . . . 0.0 111.099 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 22.1 m-85 -126.09 108.29 24.69 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.814 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 36.7 Cg_exo -57.55 124.16 15.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.02 1.813 . . . . 0.0 111.546 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -49.83 9.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -170.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -77.04 -29.17 55.1 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.232 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -79.92 -34.33 39.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.82 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 5.4 tp -73.63 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.975 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.4 -7.78 54.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.19 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 26' ' ' TYR . . . -83.58 149.13 26.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.941 0.401 . . . . 0.0 110.689 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.66 -40.07 29.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.278 0.561 . . . . 0.0 109.826 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.21 44.8 2.63 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.639 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.544 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 26.2 p90 -70.1 -10.6 59.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.381 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.75 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.539 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -80.53 -16.96 52.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.894 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 31.1 m-20 -81.72 94.55 7.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.636 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -60.4 -31.29 70.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.74 -173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.47 HD13 ' OE1' ' A' ' 35' ' ' GLN . 1.3 tm? -57.08 -42.94 81.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 26' ' ' TYR . 6.9 tp -64.2 -43.65 94.38 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.617 -178.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.31 -46.14 79.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.748 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' A' ' 15' ' ' HIS . 47.3 mt-30 -64.74 -44.56 89.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.58 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 82.3 mmm -91.78 18.0 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.735 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.73 -31.5 3.16 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 163.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -70.54 -63.78 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -0.634 . . . . 0.0 111.086 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 35' ' ' GLN . 26.8 m -90.84 41.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.846 0.831 . . . . 0.0 110.088 -175.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 51' ' ' ARG . 28.3 t-20 -137.25 -21.99 1.17 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.584 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.57 -43.72 96.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.5 t -135.26 79.2 50.12 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.856 0.836 . . . . 0.0 110.192 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 72.6 Cg_endo -91.33 14.44 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.077 2.518 . . . . 0.0 112.609 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 72.74 -47.45 0.67 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.684 0.794 . . . . 0.0 111.297 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.505 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 54.9 mm-40 -56.32 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.204 0.525 . . . . 0.0 111.066 174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -146.04 -98.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.582 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.577 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . 174.1 -83.23 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 168.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.23 -45.73 99.1 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 11.7 Cg_exo -72.84 -28.24 13.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.081 1.854 . . . . 0.0 110.715 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.7 tm? -57.34 -44.77 84.55 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.58 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 34.4 ttp180 -67.06 -49.32 65.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.159 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.49 80.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.75 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.695 ' HE1' HD22 ' A' ' 50' ' ' LEU . 5.6 p-90 -72.75 -39.07 67.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.022 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.17 -43.1 79.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.743 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.73 -41.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 110.518 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -65.33 -44.99 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.113 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 t -63.76 -44.87 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.458 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.412 . . . . 0.0 110.394 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -60.05 -50.95 71.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.299 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.23 -34.89 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.211 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.02 -42.44 76.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.97 0.414 . . . . 0.0 111.185 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.9 tm? -72.14 -47.32 51.89 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.486 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.99 -28.8 63.64 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 111.841 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -86.26 -12.64 49.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.91 0.862 . . . . 0.0 109.173 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' O ' HG12 ' A' ' 68' ' ' ILE . 28.6 t-20 -154.64 73.43 5.95 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.041 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -85.86 34.34 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.605 2.203 . . . . 0.0 112.629 -170.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.41 -2.78 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.75 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 65' ' ' ASN . 6.1 pt -84.96 166.9 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.371 0.605 . . . . 0.0 111.388 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 89' ' ' PHE . 35.4 ptt180 -138.46 -4.16 1.66 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.509 176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -167.75 149.47 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.479 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.2 m -136.83 156.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 122.706 0.402 . . . . 0.0 110.015 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.84 117.74 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.879 0.371 . . . . 0.0 110.052 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.33 141.09 45.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 112.361 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -108.78 122.18 40.87 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 59.3 Cg_endo -70.3 -179.97 3.55 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.878 2.385 . . . . 0.0 114.542 -171.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 76' ' ' ARG . 47.3 mtp180 -65.12 -54.74 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.73 -167.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . . . -58.96 107.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 0.0 111.828 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.82 -37.93 79.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.672 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -70.68 -25.05 62.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.151 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.491 ' ND2' HG11 ' A' ' 83' ' ' VAL . 59.8 t30 -65.14 -36.48 84.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t 67.24 -89.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 163.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.7 m -80.46 63.91 5.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.604 0.716 . . . . 0.0 111.592 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG11 ' ND2' ' A' ' 80' ' ' ASN . 4.9 p -139.92 129.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.511 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -128.39 137.12 51.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.229 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -115.3 122.49 46.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.314 0.578 . . . . 0.0 110.28 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -95.81 108.64 20.99 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.226 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -92.12 108.88 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.597 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 72.2 m-85 -100.77 111.61 23.87 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 13.4 t70 -74.94 142.88 43.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.2 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.488 0.661 . . . . 0.0 109.33 -167.51 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.5 t . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -120.16 132.95 55.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.175 0.512 . . . . 0.0 110.028 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.01 119.71 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.4 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 7.1 pt-20 -102.21 113.77 27.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.341 0.591 . . . . 0.0 110.846 -174.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.481 HD13 ' SD ' ' A' ' 36' ' ' MET . 5.9 mt -105.66 142.73 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.104 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 96.4 m-70 -113.07 112.67 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.076 0.465 . . . . 0.0 110.579 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 14.7 m-30 -104.08 120.62 50.43 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.533 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' HE ' ' A' ' 20' ' ' ARG . 32.3 Cg_exo -58.96 116.37 3.21 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.048 1.832 . . . . 0.0 111.081 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.2 tm? -46.68 -43.28 17.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.55 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.136 -172.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HE ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -88.63 -29.47 19.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.253 -173.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.476 HG23 HD22 ' A' ' 62' ' ' LEU . 6.1 tp -74.47 -25.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.29 11.95 9.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.642 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.95 173.94 7.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.813 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -116.13 144.35 44.27 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.1 22.83 16.25 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -168.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -59.84 -18.66 45.81 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.909 -0.646 . . . . 0.0 111.688 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.9 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.74 1.36 57.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.967 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 35.6 t70 -85.6 104.02 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.21 -28.12 69.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.2 mt -62.07 -42.94 99.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.123 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.578 HD22 ' NH1' ' A' ' 20' ' ' ARG . 51.9 tp -70.94 -41.58 70.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.23 -46.52 73.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.086 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.3 p30 -72.58 -32.39 65.97 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.039 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.746 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.6 tt0 -65.97 -45.33 82.06 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.373 0.606 . . . . 0.0 110.085 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.481 ' SD ' HD13 ' A' ' 14' ' ' ILE . 83.0 mmm -91.24 12.3 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.363 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.7 -33.24 6.5 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 162.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 43.8 mmtm -72.28 -75.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.263 -0.469 . . . . 0.0 111.557 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -84.84 60.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 122.138 0.97 . . . . 0.0 110.178 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -161.82 -23.42 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.396 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.63 -39.41 67.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 0.0 110.592 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -134.81 63.98 60.79 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.976 0.893 . . . . 0.0 110.528 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 46.3 Cg_endo -97.3 23.54 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.364 2.709 . . . . 0.0 113.466 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 71.97 -56.13 0.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.768 0.668 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.731 ' HB3' HD11 ' A' ' 50' ' ' LEU . 3.7 tp10 -65.86 -77.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.405 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 41.8 mt-10 -143.7 -91.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 160.59 -90.72 0.11 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.837 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 6.8 ttp -57.24 -47.35 99.2 Favored Pre-proline 0 C--N 1.314 -0.969 0 O-C-N 122.172 -0.605 . . . . 0.0 112.156 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 48' ' ' MET . 54.4 Cg_endo -69.69 -24.02 30.44 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.34 1.36 . . . . 0.0 110.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 45' ' ' GLU . 3.0 mt -59.1 -47.63 84.54 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.204 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' MET . 32.0 ptt180 -73.73 -33.62 64.43 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.68 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.7 73.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.254 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.544 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 7.0 p-90 -73.75 -42.06 61.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.247 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.1 t -60.0 -51.03 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.611 0.243 . . . . 0.0 111.132 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' A' ' 36' ' ' MET . 97.1 mt -63.79 -41.49 92.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.971 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 46.5 tttm -69.91 -41.47 74.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.927 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.1 m -67.46 -41.46 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.465 0.174 . . . . 0.0 110.803 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.09 85.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 109.914 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 5.1 t-160 -61.46 -53.69 53.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.84 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 17.0 mm-40 -59.0 -47.19 86.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.155 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.8 99.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.333 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 21' ' ' ILE . 6.7 tp -68.88 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.483 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.3 -32.15 73.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -78.96 -20.1 50.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.172 -176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -145.68 70.13 13.72 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.371 0.605 . . . . 0.0 109.697 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.09 45.78 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.18 2.587 . . . . 0.0 112.787 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -127.01 -1.19 6.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.522 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 pt -86.66 -172.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.739 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 69' ' ' ARG . 4.8 ptp180 -153.19 -0.55 0.24 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.17 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -166.43 157.18 12.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.524 0.202 . . . . 0.0 110.593 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.44 156.73 42.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.989 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -110.35 113.39 26.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.088 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.544 HD22 ' HZ3' ' A' ' 53' ' ' TRP . 12.1 mt -112.27 134.65 53.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -115.03 127.93 26.39 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.252 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 56.0 Cg_endo -69.03 -173.0 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.316 2.011 . . . . 0.0 112.649 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.493 ' H ' ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -80.64 -38.87 28.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.684 -174.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' OE1' ' A' ' 45' ' ' GLU . . . -76.28 78.6 3.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.562 0.696 . . . . 0.0 110.365 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.68 -17.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.421 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -57.35 -24.94 58.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -63.14 -27.95 69.73 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 109.898 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.3 m 67.22 -77.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.834 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 m -103.38 29.86 5.34 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -101.23 136.68 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.38 160.16 38.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.9 120.13 29.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.7 t-160 -110.05 102.64 11.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.051 -176.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.88 113.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.846 0.355 . . . . 0.0 110.33 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.5 141.69 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 66.0 m-85 -103.23 114.53 28.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.54 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 15.7 m-20 -76.08 115.34 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.319 -176.459 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.251 0.548 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.35 138.81 50.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.799 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -114.46 140.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.78 117.98 35.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.171 0.51 . . . . 0.0 110.499 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.607 HD13 ' SD ' ' A' ' 36' ' ' MET . 22.1 mt -115.24 123.3 70.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.559 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 92.2 m-70 -110.74 112.0 23.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.518 0.675 . . . . 0.0 111.11 -177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 17.1 m-85 -106.52 116.97 58.17 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.461 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 35.9 Cg_exo -58.75 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.214 1.942 . . . . 0.0 110.543 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.5 tp -52.61 -39.28 61.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.897 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -79.19 -28.57 42.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 9.1 mmm180 -81.5 -38.79 25.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.406 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.11 -28.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.859 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.91 59.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 110.83 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.26 -179.97 6.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.709 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -115.79 18.5 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.939 0.876 . . . . 0.0 109.844 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.5 25.36 10.45 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' HD22 ' A' ' 32' ' ' LEU . 45.0 p90 -71.14 -35.31 71.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.67 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -17.32 60.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 0.0 110.414 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -91.53 -2.06 57.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.608 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 22.3 t70 -90.71 116.08 28.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.032 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.61 -28.89 64.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.448 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.48 HD12 HE22 ' A' ' 35' ' ' GLN . 9.6 tp -70.23 -43.79 69.89 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.7 tp -63.9 -39.5 94.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.623 0.725 . . . . 0.0 109.423 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -41.72 92.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.397 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 m-20 -60.22 -49.24 78.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.612 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 2.5 mp0 -64.99 -45.1 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.607 ' SD ' HD13 ' A' ' 14' ' ' ILE . 88.7 mmm -97.53 21.26 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.511 . . . . 0.0 111.038 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.98 -34.07 4.13 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 31.9 mmtp -67.95 -68.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.03 76.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -173.54 -41.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.842 -171.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -40.4 75.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 p -142.14 67.2 21.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.199 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 80.8 Cg_endo -89.69 28.21 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.831 2.354 . . . . 0.0 112.352 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 72.58 -50.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.641 0.776 . . . . 0.0 111.414 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.56 -82.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -176.14 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.22 -86.63 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.477 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 161.98 -101.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.122 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.443 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 12.5 tpt -56.22 -44.82 99.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 39.5 Cg_exo -60.77 -33.78 92.51 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.374 2.049 . . . . 0.0 111.414 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.93 -45.4 86.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.515 176.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 22.7 ttt180 -63.38 -47.72 80.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.004 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.53 -47.72 84.42 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.456 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.707 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.34 -44.57 62.42 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.886 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -40.88 78.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.206 -174.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 69.5 mt -64.45 -45.82 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.834 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 61.0 tttp -64.76 -47.87 76.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.14 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 88.9 m -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.491 0.186 . . . . 0.0 111.163 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.14 92.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.652 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -61.08 -50.85 71.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.158 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 34.7 mm-40 -61.34 -44.34 97.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.136 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 tp -71.06 -45.34 63.99 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.77 -25.56 67.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.47 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -97.84 -2.2 41.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.517 0.675 . . . . 0.0 109.725 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -148.74 55.0 1.88 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.91 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.83 48.52 2.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.485 2.124 . . . . 0.0 112.438 -168.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -125.83 -11.64 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.807 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 pp -92.73 -172.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -143.61 -11.91 0.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.986 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -165.95 150.35 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.143 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 87' ' ' VAL . 18.8 m -131.54 155.66 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.948 0.404 . . . . 0.0 110.298 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -111.48 117.28 32.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.335 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -121.59 144.19 48.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.28 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.547 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -118.05 120.83 32.07 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.95 174.085 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.613 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 26.5 Cg_endo -61.41 160.41 27.58 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.978 2.452 . . . . 0.0 112.964 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 76' ' ' ARG . 11.7 mtp180 -58.26 -28.62 65.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.151 -172.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.92 86.63 0.71 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.5 0.667 . . . . 0.0 110.708 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.547 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 12.0 p -64.77 -28.09 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.815 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -63.58 -24.69 67.91 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.883 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -64.33 -31.74 73.06 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m 65.98 -74.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -98.15 54.05 1.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.136 0.493 . . . . 0.0 112.113 -170.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 10' ' ' VAL . 14.3 p -134.58 130.53 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -132.87 137.76 46.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.2 m-85 -102.36 124.33 47.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.264 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -104.1 103.43 13.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 71' ' ' VAL . 97.3 t -91.97 110.38 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -109.72 139.34 33.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.217 -173.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 83.3 m-85 -102.65 108.95 20.39 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.924 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 7.0 m-20 -75.76 116.89 16.93 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.406 0.622 . . . . 0.0 109.843 -176.508 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -104.82 118.37 36.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.909 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 HG21 ' A' ' 39' ' ' VAL . 95.6 t -107.17 121.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.191 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -98.38 118.41 34.97 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.005 0.431 . . . . 0.0 109.862 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' SD ' ' A' ' 36' ' ' MET . 29.1 mt -114.47 142.94 25.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 67.2 m80 -124.12 125.36 44.35 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 13.2 m-30 -122.46 131.26 24.41 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 18.4 Cg_endo -60.13 121.52 9.93 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.813 2.342 . . . . 0.0 111.279 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.8 tp -51.42 -36.91 45.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.724 -173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -75.88 -38.86 57.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . 22.2 mtt180 -80.93 -29.86 35.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.2 -15.84 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.553 0.692 . . . . 0.0 109.528 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.77 24.02 7.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.087 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 144.18 44.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.4 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.27 -11.49 46.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.424 . . . . 0.0 110.542 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -99.93 32.6 7.08 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' HD22 ' A' ' 32' ' ' LEU . 52.6 p90 -63.56 -21.83 66.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.009 -0.595 . . . . 0.0 112.003 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.33 -17.59 64.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.017 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -97.67 -9.44 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.934 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 45.4 m-20 -81.36 103.32 11.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.705 0.764 . . . . 0.0 110.606 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.08 -38.94 71.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.031 -171.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 17.7 tp -61.75 -39.4 91.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.06 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.2 tp -68.81 -44.66 73.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.32 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.14 -48.22 68.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.959 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -70.21 -32.02 69.72 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.363 -176.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -65.23 -43.33 91.78 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.223 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.5 ' SD ' HD13 ' A' ' 14' ' ' ILE . 81.7 mmm -83.87 4.11 30.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.656 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.34 -29.29 9.65 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 60.5 mtpt -68.2 -69.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.233 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.9 p -100.37 82.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.428 1.108 . . . . 0.0 110.424 -175.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -172.08 -26.82 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.842 -170.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -74.84 -36.04 62.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.894 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 p -135.87 67.96 64.33 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.366 0.603 . . . . 0.0 110.781 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -98.62 2.19 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.836 3.024 . . . . 0.0 113.168 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 73.61 -44.23 0.57 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.73 0.812 . . . . 0.0 111.922 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' CG ' HD21 ' A' ' 50' ' ' LEU . 42.7 tp10 -60.25 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.263 0.225 . . . . 0.0 111.241 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 76' ' ' ARG . 47.2 mt-10 -145.38 -102.01 0.1 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.614 0.245 . . . . 0.0 110.797 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 168.66 -106.74 0.26 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.375 176.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 tpt -49.71 -45.94 79.51 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 48' ' ' MET . 18.6 Cg_endo -58.44 -33.19 97.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.977 1.784 . . . . 0.0 111.914 174.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.73 HD23 ' HE1' ' A' ' 53' ' ' TRP . 82.1 mt -57.13 -48.1 79.49 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.184 0.516 . . . . 0.0 109.652 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -61.4 -46.4 90.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.608 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.17 70.62 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.6 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.73 ' HE1' HD23 ' A' ' 50' ' ' LEU . 7.4 p-90 -73.87 -37.82 64.62 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.46 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -69.64 -44.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.065 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.99 -39.79 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.626 0.251 . . . . 0.0 110.744 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -62.72 -48.85 77.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 48.4 t -65.04 -46.98 79.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.872 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.65 84.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -60.77 -46.73 89.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.858 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -63.18 -47.44 82.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.64 97.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.501 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -66.34 -46.0 78.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 -178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.54 -27.71 62.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 0.0 111.555 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -66.06 -34.32 77.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.573 . . . . 0.0 110.607 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -146.73 74.55 12.32 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.661 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.92 33.51 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.244 2.629 . . . . 0.0 113.721 -169.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.29 18.42 9.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -97.53 -179.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -145.23 -8.35 0.6 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -167.88 156.04 8.93 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 111.213 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG22 ' CG1' ' A' ' 87' ' ' VAL . 34.2 m -141.43 159.47 22.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.056 0.455 . . . . 0.0 110.648 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -108.28 120.09 41.38 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.8 0.809 . . . . 0.0 108.983 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.425 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 28.9 tp -123.0 141.1 52.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.565 -168.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 125.64 28.31 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 52.9 Cg_endo -74.33 173.61 13.92 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.819 1.679 . . . . 0.0 112.77 -175.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 57.1 mtp180 -65.72 -36.62 84.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.678 -162.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -68.93 93.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.658 0.742 . . . . 0.0 111.037 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.2 t -61.92 -32.17 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.783 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.24 -23.98 67.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 70.1 m-20 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.065 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p 57.06 -70.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.705 1.253 . . . . 0.0 112.864 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 m -90.89 57.84 3.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.259 0.552 . . . . 0.0 111.655 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.21 130.46 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -139.53 138.39 36.26 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.133 0.492 . . . . 0.0 111.108 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -102.95 120.97 41.57 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.583 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -108.49 102.81 11.86 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 71' ' ' VAL . 8.7 p -97.81 124.05 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.568 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.447 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 77.8 mt -112.8 135.71 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.354 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.52 113.07 26.29 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.251 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.09 120.92 22.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 110.492 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 4.5 p-10 -122.65 121.65 36.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.424 0.63 . . . . 0.0 110.066 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.2 121.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.477 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 50.0 mt-10 -93.95 111.97 23.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 110.855 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 ' SD ' ' A' ' 36' ' ' MET . 13.4 mt -102.33 142.81 15.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.529 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 62.8 m-70 -119.64 111.88 18.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.998 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-85 -110.46 117.29 51.4 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.154 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -58.51 127.49 24.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.241 1.961 . . . . 0.0 110.954 174.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -49.44 -44.98 45.93 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.36 -173.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -77.9 -19.78 54.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 20.4 mmm180 -91.24 -36.88 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -73.44 -14.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.304 0.574 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.65 -0.56 57.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.486 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.37 153.59 17.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.316 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.21 -23.34 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.161 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.87 18.73 52.32 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.661 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -22.88 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.959 0.504 . . . . 0.0 112.018 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.15 -13.61 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.118 0.485 . . . . 0.0 110.794 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -116.8 10.17 14.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.067 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.9 119.55 25.01 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.805 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.12 -33.37 73.27 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.931 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.63 -46.65 84.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.328 0.585 . . . . 0.0 109.977 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.42 -38.99 91.57 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.855 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.19 -41.82 80.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.012 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 96.0 m-20 -65.94 -49.37 68.19 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.054 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.55 -46.64 72.17 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.309 0.576 . . . . 0.0 110.265 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.778 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 11.1 tpt -67.45 -44.71 78.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.185 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.98 -34.13 57.68 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.634 0.584 . . . . 0.0 112.581 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 71.3 mmtt -60.92 -48.26 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.79 42.79 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.236 0.541 . . . . 0.0 111.611 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.778 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -117.64 -35.61 3.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.015 -171.128 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -81.9 -29.07 32.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.211 0.529 . . . . 0.0 110.537 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 p -127.82 65.45 68.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.226 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 82.3 Cg_endo -90.75 7.29 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.432 2.088 . . . . 0.0 111.533 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.12 -49.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.393 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.17 -80.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.13 -69.93 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 0.0 111.493 -172.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . 134.96 -95.01 0.25 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.762 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.464 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 6.8 ttp -64.91 -43.56 68.82 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 50' ' ' LEU . 5.3 Cg_exo -79.37 -26.79 4.72 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.526 2.151 . . . . 0.0 108.915 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.3 tm? -58.0 -45.53 86.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 112.524 -2.126 . . . . 0.0 109.235 172.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -62.97 -49.79 73.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.069 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.22 81.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.576 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.693 ' HE1' HD22 ' A' ' 50' ' ' LEU . 2.5 p-90 -72.16 -39.69 68.55 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.704 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.7 OUTLIER -69.22 -42.63 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.377 -174.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 65.2 mt -67.53 -41.95 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.058 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -61.31 -50.6 72.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.421 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.8 t -63.87 -40.85 97.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.67 87.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.793 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -57.51 -58.09 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.556 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 7.8 pt-20 -69.3 -32.84 72.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.698 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.74 94.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -67.39 -48.0 68.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.05 -27.49 66.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -64.15 -43.59 94.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' LYS . 15.4 p30 -135.8 75.28 56.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.428 0.632 . . . . 0.0 110.113 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 38.51 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.104 2.536 . . . . 0.0 112.444 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 65' ' ' ASN . 34.7 mmtp -131.58 22.39 4.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.11 -174.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.358 0.599 . . . . 0.0 111.337 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -118.11 -49.78 2.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.235 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 9.2 pt-20 -163.56 163.19 24.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.425 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.71 149.93 32.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.855 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -110.37 118.58 36.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.513 0.673 . . . . 0.0 109.645 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.9 mt -108.02 144.4 35.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.655 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 12.8 tmtt? -121.45 120.04 29.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 28.8 Cg_endo -61.15 162.2 20.49 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.479 2.786 . . . . 0.0 113.634 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -66.3 -17.63 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.844 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.79 89.21 1.35 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.326 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.503 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.3 t -63.22 -21.92 29.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.846 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -56.93 -32.17 65.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.462 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -73.83 -38.66 64.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t 70.87 -63.74 0.4 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.761 0.663 . . . . 0.0 111.838 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.5 m -109.0 47.98 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.35 138.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.971 -0.456 . . . . 0.0 109.884 170.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 46.2 mt-30 -138.9 150.79 46.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.29 0.567 . . . . 0.0 110.714 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.69 117.82 35.11 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.4 t-160 -95.29 102.09 13.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.899 -173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 63.1 t -97.94 113.27 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.26 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 4.9 mp -101.9 139.8 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 70.9 m-85 -102.4 109.78 21.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.926 0.393 . . . . 0.0 110.172 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 16.7 m-20 -77.39 115.4 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.385 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.56 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -105.38 118.74 37.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.191 0.52 . . . . 0.0 111.1 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 28.0 t -119.38 138.79 48.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -121.96 131.23 53.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.279 0.561 . . . . 0.0 111.941 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 ' SD ' ' A' ' 36' ' ' MET . 8.2 mt -106.98 136.09 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.693 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -109.01 127.84 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 22.7 m-85 -127.8 125.29 23.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.382 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.521 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 19.1 Cg_exo -66.8 120.79 7.91 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 121.934 1.756 . . . . 0.0 111.046 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 tp -42.18 -44.6 3.79 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.578 1.151 . . . . 0.0 113.645 -167.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -75.7 -40.59 55.48 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.548 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 14.3 ptp180 -90.75 -19.06 23.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.566 HG23 HD22 ' A' ' 62' ' ' LEU . 6.5 tp -72.26 -21.04 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.17 -14.44 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.552 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.61 151.76 34.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.575 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -78.46 -28.54 46.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.379 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.24 3.02 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -66.15 -38.64 88.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.641 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -1.37 21.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.92 -7.95 18.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.548 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 t70 -81.17 121.32 25.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.216 0.531 . . . . 0.0 110.966 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.18 -35.33 78.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.206 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 4.4 mt -65.44 -42.44 92.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.034 0.445 . . . . 0.0 110.005 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.3 -41.89 76.16 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.336 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.7 mt -66.37 -49.04 68.22 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.407 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 2.7 p30 -74.88 -28.66 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.811 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -69.65 -47.03 64.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.784 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 15.5 tpt -72.25 -42.6 65.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.67 -32.31 46.74 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.377 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.03 -53.38 39.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 39' ' ' VAL . 48.3 t -85.17 39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.132 0.968 . . . . 0.0 110.535 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.784 ' HB2' ' O ' ' A' ' 36' ' ' MET . 2.5 t-20 -133.44 -30.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.103 -0.998 . . . . 0.0 112.918 -170.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.511 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 26.2 t70 -80.04 -27.35 39.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -172.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.1 p -122.67 60.78 14.88 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 50' ' ' LEU . 26.8 Cg_endo -98.86 1.74 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.846 2.364 . . . . 0.0 113.711 -173.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 74.04 -46.83 0.63 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.554 0.742 . . . . 0.0 111.92 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' CB ' HD21 ' A' ' 50' ' ' LEU . 37.5 mt-10 -65.6 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 111.739 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -126.09 -77.95 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.266 0.555 . . . . 0.0 110.464 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.748 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 148.96 -96.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.834 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.73 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 1.5 tmt? -59.8 -40.68 80.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 O-C-N 122.121 -0.635 . . . . 0.0 112.34 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 48' ' ' MET . 38.2 Cg_exo -64.54 -29.78 61.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.706 1.604 . . . . 0.0 110.742 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -59.88 -47.77 84.39 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.581 178.43 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -67.46 -40.72 85.35 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.993 178.429 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.32 78.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.385 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.674 ' CH2' HD21 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -71.67 -46.13 59.83 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.984 -176.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG11 ' HE1' ' A' ' 36' ' ' MET . 1.4 p -70.68 -41.78 77.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.462 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 90.4 mt -64.64 -42.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.722 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.9 tttp -65.22 -46.6 79.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.141 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.6 -43.53 89.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.608 0.242 . . . . 0.0 110.904 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.7 95.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -60.09 -52.24 66.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.565 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.722 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 32.5 mm-40 -58.78 -44.18 90.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.254 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.83 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.747 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 21' ' ' ILE . 6.6 tp -67.31 -46.34 73.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.605 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.44 -25.92 65.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.342 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -63.96 -48.55 76.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -131.47 75.58 76.8 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.208 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.83 43.61 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.078 2.519 . . . . 0.0 112.675 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -128.46 10.38 6.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.846 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 pt -98.34 179.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.173 0.511 . . . . 0.0 110.989 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -128.36 -18.4 4.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.839 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.95 158.41 17.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.304 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.0 p -129.09 151.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -109.61 112.74 25.01 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 122.17 0.986 . . . . 0.0 109.36 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.674 HD21 ' CH2' ' A' ' 53' ' ' TRP . 8.8 tt -125.95 144.7 50.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.558 -163.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -126.95 132.32 24.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.236 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.657 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -33.82 140.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.141 3.894 . . . . 0.0 115.764 175.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -58.78 -38.93 79.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.007 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 74.31 4.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.409 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.18 -19.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.129 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.78 -23.77 65.27 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.63 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -63.24 -33.75 76.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.074 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m 69.84 -68.05 0.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.121 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 m -73.95 -19.5 60.65 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 75' ' ' PRO . 5.6 p -86.47 129.4 38.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.304 0.573 . . . . 0.0 110.669 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -130.69 137.53 49.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.041 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 19.9 m-85 -106.67 125.94 51.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.579 0.704 . . . . 0.0 110.652 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -105.14 104.92 14.74 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.401 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 48.1 t -92.4 112.09 25.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.66 137.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.33 109.67 21.37 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.676 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 115.52 16.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 0.0 110.231 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.074 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 120.806 0.336 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -123.47 119.45 30.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.403 0.62 . . . . 0.0 109.595 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.568 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 96.3 t -120.95 125.48 74.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.065 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -105.54 112.92 26.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.459 0.647 . . . . 0.0 111.265 -174.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 4.1 mt -101.6 128.01 54.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.509 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 88.6 m-70 -104.13 109.6 21.46 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.288 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 18.6 m-30 -107.14 117.58 55.99 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.151 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' ILE . 31.6 Cg_exo -59.7 120.56 8.44 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.07 1.847 . . . . 0.0 110.982 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 62' ' ' LEU . 2.9 tt -50.57 -36.24 33.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.91 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 18.6 ptpt -72.2 -32.76 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.169 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 29' ' ' ASP . 3.0 mmp_? -92.76 -39.03 11.47 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -72.43 -21.99 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.278 0.561 . . . . 0.0 109.638 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.69 -26.96 64.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.846 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.07 155.59 25.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.855 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.18 -31.35 30.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.592 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.47 49.27 2.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.942 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' HB2' HD22 ' A' ' 32' ' ' LEU . 6.3 p90 -73.48 -18.34 61.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.614 0.245 . . . . 0.0 111.598 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.61 -13.39 62.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 -24.32 52.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.166 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 20' ' ' ARG . 7.7 m-20 -83.72 110.81 18.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.87 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.3 -25.11 67.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.797 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.2 pp -54.41 -41.63 69.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.196 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 31' ' ' LEU . 15.5 tp -73.18 -27.92 61.92 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.499 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.28 -45.82 65.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.901 172.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -61.07 -38.17 85.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.45 -46.68 82.06 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.994 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.67 ' HE1' HG11 ' A' ' 54' ' ' VAL . 83.9 mmm -94.46 17.6 12.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.702 0.763 . . . . 0.0 110.11 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.31 -24.44 7.15 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 164.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -82.81 -65.65 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.256 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' CG1' ' A' ' 12' ' ' VAL . 30.1 m -100.83 45.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.639 0.733 . . . . 0.0 111.072 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -139.79 -17.71 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.896 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.4 -38.2 68.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.866 0.365 . . . . 0.0 110.512 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 p -127.59 70.84 77.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.2 Cg_endo -92.65 13.28 1.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.949 2.433 . . . . 0.0 112.393 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 73.44 -40.45 0.47 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.203 1.001 . . . . 0.0 112.343 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 50' ' ' LEU . 37.7 mt-10 -74.53 -78.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 111.414 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 50' ' ' LEU . 44.4 mt-10 -138.63 -80.06 0.33 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 111.103 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.793 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 154.31 -92.79 0.13 Allowed Glycine 0 C--O 1.222 -0.624 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.697 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.474 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.5 tmt? -62.79 -43.93 84.51 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.931 -0.747 . . . . 0.0 112.692 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 48' ' ' MET . 41.4 Cg_endo -70.63 -24.44 25.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 120.913 1.075 . . . . 0.0 109.765 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -58.37 -45.86 87.43 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.115 172.054 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -61.51 -48.74 79.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.191 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.57 77.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.742 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 8.2 p-90 -73.52 -37.76 65.55 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.272 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.67 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.8 OUTLIER -69.3 -41.4 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.0 110.165 -174.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.58 -41.7 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.673 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.94 -50.11 73.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.207 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.6 t -62.36 -46.19 89.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.995 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 0.0 110.501 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -62.59 -50.5 71.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.129 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.02 -34.86 79.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.837 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.99 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' HG ' ' A' ' 18' ' ' LEU . 4.7 tt -71.23 -48.41 51.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.403 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.15 -25.7 67.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.693 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.81 -33.27 75.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 110.25 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.36 72.38 8.37 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.078 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.27 39.29 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.965 2.443 . . . . 0.0 113.924 -168.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 34.0 4.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.425 0.631 . . . . 0.0 109.532 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.8 pt -106.47 -175.45 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.577 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 16.9 mtm180 -117.52 -51.21 2.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.235 -177.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' HB2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -156.22 161.47 40.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.18 -177.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -132.46 158.4 43.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.435 0.636 . . . . 0.0 111.401 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.35 113.37 26.12 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.03 0.919 . . . . 0.0 109.428 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 ' CH2' ' A' ' 53' ' ' TRP . 6.1 tt -110.02 139.26 45.34 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.858 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.55 129.38 25.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.157 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.679 ' HG2' HG13 ' A' ' 83' ' ' VAL . 75.3 Cg_exo -46.11 151.03 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.809 3.006 . . . . 0.0 113.292 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -66.98 -37.69 84.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.565 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.6 75.78 2.61 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.737 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.15 -10.72 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.338 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -64.74 -37.1 86.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.184 0.516 . . . . 0.0 110.436 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.3 t 71.46 -67.15 0.27 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.744 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -82.27 6.35 17.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.8 p -108.39 131.83 57.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.034 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -139.21 144.36 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.186 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 81.0 m-85 -107.62 124.63 50.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.145 0.498 . . . . 0.0 109.789 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.1 t60 -103.0 106.0 16.43 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 91.8 t -93.22 116.83 35.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.393 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.416 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 4.4 mp -100.05 136.41 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 40.7 m-85 -103.08 106.68 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.94 0.4 . . . . 0.0 110.381 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 22.1 m-20 -79.69 114.86 18.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.013 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 39.8 t . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -136.11 134.93 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.37 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.23 138.66 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.243 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -106.82 121.22 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 85' ' ' PHE . 1.3 mt -115.91 122.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 79.6 m80 -99.73 132.01 45.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.182 0.515 . . . . 0.0 110.288 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CD1' HG13 ' A' ' 87' ' ' VAL . 3.3 m-85 -119.76 129.07 25.55 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.233 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 21.4 Cg_exo -65.25 110.92 1.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.005 1.804 . . . . 0.0 110.389 171.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.4 tm? -45.88 -42.51 12.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.953 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HG3' ' HD2' ' A' ' 20' ' ' ARG . 17.1 ptpt -78.1 -28.53 48.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 3.7 mpt_? -89.68 -35.27 15.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 112.049 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 6.4 tp -66.58 -25.74 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.463 . . . . 0.0 110.129 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.36 12.66 15.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.16 173.02 7.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.975 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.98 -26.86 20.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.229 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.79 46.72 3.48 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.604 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -79.09 -34.6 43.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.735 0.303 . . . . 0.0 111.277 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.04 59.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.303 0.573 . . . . 0.0 110.415 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -83.71 -9.41 58.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.3 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -85.15 110.54 19.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.244 0.545 . . . . 0.0 110.708 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.84 -34.81 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.764 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.8 mt -60.77 -46.69 89.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.87 -40.29 65.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.567 0.698 . . . . 0.0 109.794 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.15 -46.06 78.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.343 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 3.2 p30 -73.34 -30.78 63.57 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.395 -175.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.619 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 45.3 mt-30 -73.52 -44.84 56.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.346 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -75.09 -15.64 60.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.633 177.152 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 -21.2 41.29 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -76.2 -54.83 6.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 35' ' ' GLN . 14.7 m -85.71 59.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.739 0.78 . . . . 0.0 109.782 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.0 t30 -137.66 -39.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.398 -170.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -70.23 -41.14 73.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.849 -170.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 p -140.98 66.0 24.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.723 0.297 . . . . 0.0 111.51 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.2 Cg_endo -67.46 -62.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.252 1.968 . . . . 0.0 112.011 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 13.4 tp10 152.53 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -76.79 -85.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.587 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -135.7 -79.04 0.43 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.09 0.471 . . . . 0.0 109.988 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 151.17 -109.71 0.43 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.992 176.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.465 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -51.35 -48.21 86.59 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 36.2 Cg_exo -61.41 -40.43 48.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.032 1.821 . . . . 0.0 112.013 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.779 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -61.07 -43.68 98.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.958 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -67.63 -34.34 76.77 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.506 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.86 79.98 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.779 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.2 p-90 -72.44 -38.2 68.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.332 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.95 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.047 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.0 mt -57.86 -44.06 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.347 0.117 . . . . 0.0 110.752 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 53.3 tptt -63.85 -49.54 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.85 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.0 t -64.07 -43.86 94.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.051 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.85 92.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.0 109.977 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 1.1 t-80 -58.22 -58.93 6.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.544 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 11.8 pt-20 -66.98 -34.51 77.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.78 98.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 110.552 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -66.84 -45.96 76.59 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 51.6 mt-10 -63.31 -27.85 69.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.404 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.46 -39.54 85.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.458 . . . . 0.0 110.168 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.28 71.74 26.96 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.279 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.95 42.31 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.04 2.493 . . . . 0.0 113.065 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -128.79 11.6 6.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.008 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt -89.34 178.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.632 0.729 . . . . 0.0 112.268 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -110.37 -43.74 3.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.545 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.9 pt-20 -163.64 151.27 12.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.832 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.6 150.08 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.63 111.46 22.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.698 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.7 pp -109.85 133.23 53.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.464 0.65 . . . . 0.0 110.833 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -103.24 124.28 38.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 81.1 Cg_endo -80.03 175.97 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.201 1.934 . . . . 0.0 114.178 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.98 -13.88 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.551 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.49 74.99 3.23 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.52 -24.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.042 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -63.74 -27.47 69.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.563 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.42 -34.43 47.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.966 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.2 p 58.84 -72.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.709 1.256 . . . . 0.0 112.382 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m -84.07 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 8.5 p -134.32 130.65 54.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -136.92 139.0 41.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.154 0.502 . . . . 0.0 111.437 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 79.7 m-85 -101.92 128.1 48.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.688 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -96.74 107.95 20.51 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 16' ' ' PHE . 54.0 t -91.81 109.63 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.454 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 66.4 mt -102.42 135.04 41.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.76 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -102.62 110.25 22.13 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -99.36 122.95 43.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.804 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 . . . . . 0 C--N 1.328 -0.344 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.843 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -127.35 133.58 50.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.967 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 85' ' ' PHE . 1.4 p -117.31 138.56 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.68 111.49 23.73 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.309 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 36' ' ' MET . 17.1 mt -102.79 123.69 56.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.184 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.87 127.11 46.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -120.84 126.96 26.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.17 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -59.97 117.03 3.73 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.147 1.898 . . . . 0.0 110.945 171.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.07 -36.89 66.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.931 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.49 -29.16 56.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.651 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HD3' ' HB2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -91.82 -31.38 15.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.862 -177.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.32 -19.1 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 109.983 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -89.12 -7.21 56.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.04 149.64 21.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.781 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.73 -21.03 41.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.63 34.92 4.57 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.401 ' HB2' HD22 ' A' ' 32' ' ' LEU . 53.2 p90 -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.402 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.54 -5.72 38.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 111.173 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.23 -2.94 35.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.855 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.49 117.16 28.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -63.91 -31.59 72.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.076 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.5 mm? -61.67 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.336 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 26' ' ' TYR . 34.2 tp -72.12 -37.59 69.47 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.595 0.712 . . . . 0.0 109.577 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.97 -45.64 63.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.349 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -73.44 -33.6 64.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.675 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.72 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -75.23 -46.72 32.0 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -176.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 9.7 tpt -95.06 3.62 54.63 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.22 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.27 -24.01 23.03 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 165.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.37 -68.75 0.42 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.879 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 m -87.73 65.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.87 0.843 . . . . 0.0 110.396 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 36' ' ' MET . 59.0 t30 -149.56 -27.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.78 -169.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 30.4 t70 -69.18 -44.97 71.1 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.665 0.745 . . . . 0.0 110.196 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -124.74 71.2 59.37 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.249 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 45' ' ' GLU . 73.5 Cg_endo -91.86 -2.12 4.27 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.774 2.316 . . . . 0.0 112.37 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 71.39 -42.58 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.56 0.744 . . . . 0.0 110.428 -173.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -50.67 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.026 175.219 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 49' ' ' PRO . 44.4 mt-10 -144.07 -73.77 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.595 0.712 . . . . 0.0 109.879 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 146.27 -105.81 0.35 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.528 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.421 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.7 tpt -57.3 -46.29 99.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 12.1 Cg_exo -68.7 -32.29 24.02 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.185 1.924 . . . . 0.0 110.742 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -57.76 -45.24 86.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.853 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.587 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 27.6 ttt180 -65.6 -45.91 81.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.013 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -48.32 81.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.716 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.8 p-90 -72.29 -39.18 68.5 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.019 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -41.15 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.716 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.8 -40.9 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.586 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -58.86 -50.44 74.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 111.009 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.453 ' SG ' HD21 ' A' ' 73' ' ' LEU . 44.6 t -61.97 -44.47 96.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.739 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.09 94.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.52 -51.11 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.83 -45.73 81.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.343 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.34 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 22' ' ' ALA . 3.0 tm? -66.47 -47.26 73.63 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.669 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.7 -36.76 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 110.324 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.74 75.07 12.2 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.828 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.21 39.99 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.214 2.609 . . . . 0.0 113.206 -170.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -136.3 26.15 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.5 -172.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.401 0.62 . . . . 0.0 111.835 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -123.99 -45.92 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.37 159.51 17.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.27 155.99 42.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.841 0.353 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.87 114.86 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.026 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.453 HD21 ' SG ' ' A' ' 57' ' ' CYS . 7.3 mt -108.12 140.14 41.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -101.86 122.5 47.15 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 91.1 Cg_endo -76.84 -171.19 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.121 1.881 . . . . 0.0 113.626 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -73.81 -47.03 41.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.24 76.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 111.063 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.96 -16.97 21.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.158 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -68.19 -25.31 65.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 110.293 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.46 -25.1 67.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 68.13 -81.49 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.6 173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -83.48 61.48 6.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.223 0.535 . . . . 0.0 111.53 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.13 135.32 37.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -140.22 137.68 34.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.887 0.375 . . . . 0.0 110.498 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 50' ' ' LEU . 20.9 m-85 -105.48 119.09 38.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.465 0.65 . . . . 0.0 109.407 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.71 102.87 13.08 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.698 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.1 t -92.8 113.44 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.47 135.61 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.03 106.86 17.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.171 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -79.4 142.43 35.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.777 -177.369 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -108.53 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.045 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 43.1 t -108.93 135.79 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -104.29 112.25 25.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.454 -175.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -108.3 129.14 63.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 68.8 m80 -113.91 127.76 56.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.13 0.49 . . . . 0.0 110.776 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 25.0 m-85 -125.51 121.87 24.83 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.223 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 27.9 Cg_exo -61.11 129.96 30.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.746 1.631 . . . . 0.0 110.84 175.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CD2' HD21 ' A' ' 62' ' ' LEU . 2.5 tm? -50.54 -38.66 46.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.043 -175.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.05 -29.68 60.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.34 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 21.3 mmm180 -90.35 -37.19 14.19 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.452 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 tp -73.17 -16.9 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 109.659 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -101.94 18.84 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.305 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.95 169.79 8.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.613 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.79 -38.47 18.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.03 42.38 2.28 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.314 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 27.1 p90 -73.77 -26.76 60.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.14 -4.02 36.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -114.69 4.7 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.752 0.787 . . . . 0.0 109.394 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 31' ' ' LEU . 19.2 t70 -87.18 119.6 27.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.511 -175.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.65 -36.71 67.35 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.71 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.471 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 3.9 mm? -63.9 -46.0 86.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.557 0.694 . . . . 0.0 110.665 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -35.84 75.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.358 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.1 -48.01 59.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.241 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.85 -35.67 64.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.728 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.53 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -71.66 -46.6 58.46 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.974 0.416 . . . . 0.0 110.723 -177.446 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.614 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -93.14 3.75 55.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.21 0.528 . . . . 0.0 110.467 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.62 -26.95 12.18 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 167.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -74.52 -58.86 3.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 35' ' ' GLN . 20.2 m -86.45 53.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.744 0.783 . . . . 0.0 110.338 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.5 t-20 -134.34 -35.25 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.85 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.6 -35.6 67.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 p -128.69 70.17 80.3 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.0 Cg_endo -92.63 5.54 3.31 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.878 2.385 . . . . 0.0 112.52 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 72.27 -43.14 0.55 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.786 0.834 . . . . 0.0 111.564 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 75' ' ' PRO . 10.8 tp10 -67.46 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.841 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -139.85 -88.97 0.19 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.51 0.195 . . . . 0.0 111.064 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 161.42 -92.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.725 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 1.7 tmt? -64.65 -45.22 75.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 31.9 Cg_exo -65.35 -31.1 53.13 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 121.526 1.484 . . . . 0.0 110.345 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.734 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.5 tm? -58.61 -47.1 85.47 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.045 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.4 ptm180 -69.72 -40.98 75.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.806 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.13 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.734 ' HE1' HD22 ' A' ' 50' ' ' LEU . 11.2 p-90 -73.63 -37.32 65.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.854 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.0 -42.27 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.422 0.153 . . . . 0.0 110.931 -175.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.518 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 93.0 mt -67.2 -39.53 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.6 mmmm -62.66 -50.18 72.2 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.707 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.29 -43.42 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.733 0.301 . . . . 0.0 110.747 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.22 98.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.541 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -63.44 -45.19 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.366 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 43.9 mm-40 -62.07 -47.18 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.38 83.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.155 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.1 tm? -65.17 -47.18 77.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.135 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.66 -27.05 62.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.789 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 3.0 ttmp? -71.5 -38.84 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.173 0.511 . . . . 0.0 110.125 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -135.81 74.98 56.76 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.25 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.45 29.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.455 2.77 . . . . 0.0 113.506 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -125.86 25.72 6.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.222 0.534 . . . . 0.0 110.232 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.71 179.39 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.809 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -118.97 -36.75 3.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.863 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -164.32 168.34 18.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.914 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 13.9 p -135.86 148.97 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.96 117.21 33.18 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.442 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 49.8 tp -130.71 132.29 45.28 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.54 -164.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -109.77 134.05 20.74 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.488 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 29.0 Cg_endo -61.23 158.78 33.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.639 2.226 . . . . 0.0 113.2 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -61.88 -42.86 99.57 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.399 -165.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.84 116.83 8.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.843 0.83 . . . . 0.0 110.946 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.86 -16.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.543 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -58.04 -40.59 81.29 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.149 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -75.09 -36.53 61.7 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.915 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.4 m 70.68 -63.55 0.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.425 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 p -111.18 58.85 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.37 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -135.43 142.13 45.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.952 0.406 . . . . 0.0 111.13 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 99.9 m-85 -105.16 124.29 49.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -97.31 103.89 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 75.2 t -91.42 110.76 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 89.8 mt -105.48 134.61 46.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.177 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 57.4 m-85 -103.02 106.26 16.75 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.181 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -86.07 126.47 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.694 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.25 118.55 36.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.285 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 21.4 t -121.07 121.78 65.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -112.04 132.59 54.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.919 -166.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.18 152.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.568 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -120.71 128.15 52.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.827 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 8.4 m-85 -127.75 105.63 20.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.835 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.768 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 26.3 Cg_exo -60.67 120.55 8.35 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 121.588 1.525 . . . . 0.0 110.888 172.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -54.6 -42.33 70.98 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.804 -169.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG3' HD23 ' A' ' 18' ' ' LEU . 54.8 mtmt -61.25 -32.0 71.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.251 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 5.0 mtt180 -95.55 -35.65 11.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 62' ' ' LEU . 4.8 tp -69.7 -27.13 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.069 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.46 59.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 110.967 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.63 -169.45 1.66 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -125.91 138.36 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.87 17.37 18.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -170.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 20' ' ' ARG . 7.9 t80 -67.03 -23.87 65.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.957 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.1 -9.36 38.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.661 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -103.41 1.66 32.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.708 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.57 112.66 6.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.57 -42.47 88.06 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.793 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.26 -42.21 90.64 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.517 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -64.52 -39.83 94.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.047 0.451 . . . . 0.0 110.046 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.24 -40.99 87.69 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.996 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -73.49 -41.63 62.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.137 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -70.13 -50.39 41.03 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.307 0.575 . . . . 0.0 111.899 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.625 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -80.68 -22.35 40.48 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.8 95.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.245 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -62.87 -56.72 14.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 39' ' ' VAL . 85.8 t -85.19 69.67 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.643 0.735 . . . . 0.0 110.242 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.625 ' HB2' ' O ' ' A' ' 36' ' ' MET . 1.8 t30 -154.08 -34.96 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.748 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.57 -36.8 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.205 -169.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -134.27 66.66 71.53 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.813 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -98.11 4.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.585 2.19 . . . . 0.0 112.948 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.85 -39.56 0.45 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.931 . . . . 0.0 112.417 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.6 OUTLIER -64.9 -79.25 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.363 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -143.95 -81.56 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.005 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 156.0 -110.93 0.46 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.194 177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.599 ' HA ' HD22 ' A' ' 40' ' ' ASN . 5.6 ttp -60.07 -41.35 84.29 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 48' ' ' MET . 43.3 Cg_exo -59.67 -44.47 31.37 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.84 1.693 . . . . 0.0 111.531 174.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -60.01 -37.68 80.43 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 48' ' ' MET . 22.1 ttt180 -55.51 -49.73 71.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.186 173.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.46 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.747 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.797 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.7 p-90 -72.1 -39.27 69.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.62 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -62.42 -51.04 77.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 96.0 mt -59.63 -36.91 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -48.52 67.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.987 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.432 ' HG ' ' HE3' ' A' ' 53' ' ' TRP . 95.1 m -70.58 -41.06 72.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.63 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.506 0.669 . . . . 0.0 109.626 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.661 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.3 t-160 -56.62 -54.03 50.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.954 175.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.41 -39.08 93.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.325 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.39 98.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 21' ' ' ILE . 13.2 tp -68.31 -46.65 69.69 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 39.4 mt-10 -65.31 -27.62 68.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.799 0.333 . . . . 0.0 110.986 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 12.3 tmtt? -65.33 -34.45 78.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 109.817 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.458 HD21 ' HD2' ' A' ' 64' ' ' LYS . 2.1 p30 -149.86 75.25 9.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.681 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 46.67 2.12 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.323 2.682 . . . . 0.0 113.285 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -143.38 34.87 1.32 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.304 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.3 pt -110.7 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.512 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -144.39 -19.85 0.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.467 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -166.34 149.91 7.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -139.05 157.84 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.379 . . . . 0.0 110.677 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -116.46 113.27 22.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.657 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.5 pp -109.28 136.31 48.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.566 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -109.87 129.16 24.24 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 90.5 Cg_endo -77.56 162.75 30.13 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.779 1.653 . . . . 0.0 114.097 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -65.31 -13.67 59.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.499 -172.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.4 88.08 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.224 0.535 . . . . 0.0 110.035 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.59 -33.06 57.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.607 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.8 -27.44 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.686 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . 5.0 m-20 -65.78 -38.9 90.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.627 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m 61.25 -77.43 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.344 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -83.53 33.74 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.686 ' CG2' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -112.01 130.45 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.85 139.57 51.17 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.763 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.526 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 69.8 m-85 -97.59 120.38 37.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.544 0.687 . . . . 0.0 109.252 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.76 100.61 13.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.547 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.7 t -98.37 112.2 29.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.195 0.521 . . . . 0.0 110.129 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.24 141.1 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.259 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 58.7 m-85 -101.32 106.46 17.64 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.768 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 m-20 -83.81 136.52 34.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.724 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HA ' HD21 ' A' ' 18' ' ' LEU . 6.1 pt-20 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -83.98 50.31 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.143 0.497 . . . . 0.0 111.392 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.0 76.06 1.36 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.831 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.3 mtp -83.06 60.27 5.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.091 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.51 -85.29 0.41 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.179 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -147.96 137.88 22.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 55.7 ttp -103.31 104.8 43.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.59 -9.09 23.57 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.938 2.425 . . . . 0.0 113.438 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.75 108.86 17.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.13 0.49 . . . . 0.0 110.015 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -103.16 119.27 51.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.877 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.64 118.75 37.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 39' ' ' VAL . 38.2 t -111.83 119.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 30.0 mt-10 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.272 0.558 . . . . 0.0 110.687 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.758 HG21 ' SD ' ' A' ' 36' ' ' MET . 4.8 mt -98.08 152.48 4.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.378 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -122.33 126.07 47.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.922 0.391 . . . . 0.0 110.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE1' ' SD ' ' A' ' 36' ' ' MET . 8.0 m-30 -116.89 125.8 28.01 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.249 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 38.9 Cg_exo -59.4 108.5 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.036 1.824 . . . . 0.0 110.788 171.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.8 -36.07 35.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.743 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -38.55 75.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.637 0.256 . . . . 0.0 111.588 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.414 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.7 mpt_? -86.59 -35.56 19.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.379 -173.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.499 HG23 HD22 ' A' ' 62' ' ' LEU . 9.6 tp -66.12 -22.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 109.626 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.17 24.52 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.216 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.27 170.65 15.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.74 136.9 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.92 26.31 19.8 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -63.34 -29.17 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.579 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.88 -4.3 23.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.487 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.23 -8.41 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.898 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -80.43 115.69 20.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.345 0.593 . . . . 0.0 109.897 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.29 -33.46 75.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.325 -168.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -43.31 75.8 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.841 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -64.45 -40.07 95.03 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.719 0.771 . . . . 0.0 109.02 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.77 -44.76 66.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -74.19 -26.8 60.49 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.559 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.9 50.49 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.388 0.613 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.758 ' SD ' HG21 ' A' ' 14' ' ' ILE . 94.8 mmm -72.69 -29.37 63.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.445 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.47 -27.84 70.64 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.88 -41.57 91.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 110.17 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 12' ' ' VAL . 3.6 p -108.65 77.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.161 0.981 . . . . 0.0 110.202 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -150.6 -25.47 0.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.401 -174.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.18 -32.56 16.57 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.103 -174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 t -143.45 63.77 12.91 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.407 0.622 . . . . 0.0 110.695 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 17.5 Cg_endo -93.58 14.86 1.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.96 2.44 . . . . 0.0 113.332 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 75.36 -39.32 0.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.444 0.698 . . . . 0.0 112.117 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 27.4 tt0 -84.42 -104.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.937 -0.477 . . . . 0.0 110.632 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -102.05 -90.5 0.35 Allowed 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.028 0.442 . . . . 0.0 110.735 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 162.97 -111.71 0.48 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.45 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.5 tmt? -57.95 -44.86 99.7 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 51.8 Cg_exo -58.2 -41.85 62.78 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.971 1.78 . . . . 0.0 111.976 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.91 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.83 -40.59 93.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.317 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.517 ' HB2' HD21 ' A' ' 40' ' ' ASN . 5.1 ttp85 -54.95 -46.21 74.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.602 0.239 . . . . 0.0 110.583 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -58.76 -48.53 80.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.675 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.91 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.0 p-90 -72.73 -40.05 66.42 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.235 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 t -61.2 -51.04 77.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.576 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 36' ' ' MET . 50.5 mt -57.75 -43.25 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.249 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 52' ' ' ALA . 62.4 mttp -63.23 -50.23 71.03 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.26 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.8 m -61.39 -45.85 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.21 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.31 . . . . 0.0 110.859 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.97 -52.49 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.934 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 46.8 mt-10 -69.09 -39.73 78.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.28 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.83 88.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 21' ' ' ILE . 6.4 tp -70.71 -45.55 64.74 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.95 -32.87 74.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 28.4 mmmt -80.03 -22.71 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.349 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -140.94 69.56 29.16 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.475 0.655 . . . . 0.0 109.707 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.47 50.34 3.35 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.406 2.737 . . . . 0.0 113.182 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -142.18 28.33 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.374 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.07 -172.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.35 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -131.57 -39.86 1.12 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.143 -173.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -164.3 156.75 16.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.797 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.11 122.55 48.17 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 7.9 mt -106.56 136.71 45.87 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.125 -173.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.99 117.62 61.06 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.448 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.728 ' HG2' HG13 ' A' ' 83' ' ' VAL . 43.1 Cg_exo -40.05 135.5 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.58 2.853 . . . . 0.0 113.347 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -62.65 -25.67 68.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.355 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -82.87 68.3 9.3 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 t -57.35 -23.19 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.363 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.514 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 3.5 mptp? -61.56 -24.05 66.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' OD1' HG11 ' A' ' 83' ' ' VAL . 1.1 t-20 -65.9 -17.94 65.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.34 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.1 p 62.17 -96.57 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 168.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -78.11 53.69 1.24 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.33 0.586 . . . . 0.0 112.555 -167.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.1 p -142.11 134.53 27.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.928 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -139.37 145.4 38.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.693 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.0 117.29 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.713 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 13.2 t-160 -98.01 102.64 14.44 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.7 t -91.77 112.92 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.101 0.477 . . . . 0.0 109.985 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.2 mt -104.3 139.03 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.051 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -102.71 106.91 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.49 135.91 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.77 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -90.13 112.99 24.66 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.697 -175.257 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 73.55 -51.52 0.7 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.2 55.63 7.35 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.405 0.621 . . . . 0.0 110.631 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -127.18 146.83 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.803 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.16 124.37 8.98 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.409 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.475 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 m170 -77.93 62.77 2.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.231 0.539 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.68 90.56 9.11 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.417 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 36.7 Cg_exo -60.05 132.97 47.4 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.241 2.627 . . . . 0.0 112.615 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.17 108.77 17.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.55 119.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.1 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 9.3 p-10 -101.43 119.2 38.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.578 0.704 . . . . 0.0 109.771 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -95.3 139.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.791 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -92.25 130.95 37.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.381 0.61 . . . . 0.0 110.337 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.516 HD13 ' SD ' ' A' ' 36' ' ' MET . 25.5 mt -128.59 133.19 67.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.6 m-70 -120.26 126.29 50.23 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 110.795 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.2 m-85 -127.57 115.01 21.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 37.3 Cg_exo -61.27 121.95 10.4 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.292 1.994 . . . . 0.0 111.861 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -43.35 -44.01 5.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 113.851 -1.522 . . . . 0.0 113.901 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -77.41 -38.31 49.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HD2' ' HG2' ' A' ' 17' ' ' PRO . 17.7 ptp180 -89.34 -25.14 21.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.741 -172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HD22 ' A' ' 62' ' ' LEU . 7.2 tp -71.65 -22.57 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.08 -11.89 58.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 142.3 44.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.198 0.523 . . . . 0.0 110.845 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.44 -19.43 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.75 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.54 55.36 0.83 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -67.85 -40.46 83.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.489 0.185 . . . . 0.0 111.211 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 61.92 1.51 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.696 0.76 . . . . 0.0 110.032 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.21 -34.9 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.247 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 29.2 t70 -75.1 119.97 19.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.813 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 29.5 tt0 -64.57 -35.24 80.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.36 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.36 -43.06 92.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.252 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -65.59 -41.9 92.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.73 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -70.3 -45.09 66.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.092 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 90.4 m-20 -61.8 -37.6 84.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.379 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 43.6 mt-30 -73.76 -41.93 61.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.609 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 70.8 mmm -86.84 12.24 11.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.9 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.19 -27.14 6.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 164.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.77 -62.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.076 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.09 71.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 122.07 0.938 . . . . 0.0 109.771 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 36' ' ' MET . 21.7 t30 -147.5 -44.65 0.17 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -165.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.27 -39.56 54.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.838 0.352 . . . . 0.0 111.034 -171.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -128.55 69.77 79.48 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.694 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HB2' HD12 ' A' ' 50' ' ' LEU . 53.2 Cg_endo -98.96 25.52 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.312 2.674 . . . . 0.0 112.816 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 73.38 -39.39 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.552 0.741 . . . . 0.0 112.114 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.562 ' CB ' HD21 ' A' ' 50' ' ' LEU . 32.5 mt-10 -85.56 -88.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.266 0.555 . . . . 0.0 111.441 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.01 -86.61 0.44 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.054 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.672 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 158.49 -78.45 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.972 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.48 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -63.0 -47.62 86.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 17.3 Cg_exo -69.02 -24.32 33.19 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.857 1.705 . . . . 0.0 110.326 175.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -59.77 -48.2 82.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.649 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 36.3 ptt180 -75.11 -38.86 60.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.584 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.29 81.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.209 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.0 p-90 -72.45 -43.83 63.21 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.91 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -40.99 78.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.383 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.492 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 83.1 mt -66.54 -45.59 88.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.522 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 38.6 ttmt -63.96 -47.7 79.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.5 m -65.26 -42.61 93.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.193 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.73 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.395 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.21 -52.63 64.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.575 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 19.2 mm-40 -61.53 -42.47 98.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.863 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.03 93.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 HG23 ' A' ' 21' ' ' ILE . 8.4 tp -63.65 -46.97 83.21 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.511 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.1 -26.89 63.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.18 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.77 -40.03 91.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 110.082 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -135.86 73.78 59.25 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.322 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 55.84 4.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.037 2.492 . . . . 0.0 112.322 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -132.16 -6.58 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.631 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 pt -93.52 -175.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.177 -170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.82 -9.51 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.418 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -166.37 152.72 8.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.973 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.89 156.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.353 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -111.17 115.66 29.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.325 0.583 . . . . 0.0 109.898 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.123 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -118.93 131.84 24.17 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.43 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.641 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -26.9 137.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 1 C-N-CA 125.709 4.272 . . . . 0.0 115.905 173.317 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -55.47 -45.1 76.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.578 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.68 83.25 2.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.59 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.38 -21.37 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.394 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -65.07 -24.09 67.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' OD1' HG11 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -64.75 -22.76 67.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 -177.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m 68.54 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 m -79.24 49.45 0.97 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -167.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 75' ' ' PRO . 6.7 p -142.85 136.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -146.79 154.59 41.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.539 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.07 135.06 54.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.126 0.489 . . . . 0.0 110.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -106.11 103.47 12.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.608 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.0 111.95 24.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.71 137.76 35.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.172 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 71.4 m-85 -102.46 108.53 19.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.391 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 15' ' ' HIS . 10.5 m-20 -76.38 120.39 21.56 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.39 115.55 21.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.573 0.701 . . . . 0.0 110.914 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 C--O 1.244 0.769 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.421 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m 71.27 -55.16 0.66 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.405 0.682 . . . . 0.0 112.332 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.21 59.68 2.63 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.451 0.643 . . . . 0.0 110.451 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -89.59 -22.3 22.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.38 -119.68 3.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.402 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 56.05 52.3 10.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 110.53 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.3 mtp -71.25 120.91 82.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.145 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.37 152.57 59.9 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.462 2.108 . . . . 0.0 111.479 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 82' ' ' SER . . . -83.76 114.33 21.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 3.3 m -94.29 140.44 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.466 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.42 118.62 37.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.233 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.72 117.78 43.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 31.7 mt-10 -103.93 112.04 24.85 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.202 0.525 . . . . 0.0 110.449 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 2.3 mt -108.5 124.42 64.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 79.6 m80 -101.83 112.37 24.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -99.94 128.93 29.64 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.526 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 40.5 Cg_endo -68.13 111.43 2.46 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.048 1.832 . . . . 0.0 111.133 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HG22 ' A' ' 21' ' ' ILE . 10.4 tt -51.09 -37.87 48.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.223 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -70.34 -34.95 73.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -93.49 -30.79 14.85 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.304 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 18' ' ' LEU . 7.3 tp -66.08 -24.85 34.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 121.076 0.465 . . . . 0.0 109.901 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.03 68.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.26 148.53 41.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.521 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.86 -22.01 29.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.327 0.584 . . . . 0.0 109.77 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.57 3.24 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 173.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -71.87 -13.93 61.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.807 0.337 . . . . 0.0 111.627 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.13 -12.08 61.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.304 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.14 -5.42 56.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.48 107.05 18.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.253 0.549 . . . . 0.0 110.876 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.58 -32.15 72.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.5 mt -58.5 -45.78 88.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.001 0.429 . . . . 0.0 110.507 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.17 -40.8 67.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.46 0.648 . . . . 0.0 110.001 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' LEU . 12.4 tp -70.76 -44.08 67.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.621 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 2.5 p30 -71.94 -34.24 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.792 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -69.87 -38.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.807 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.24 5.68 29.25 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.762 175.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.88 -28.68 8.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 32.3 mmtp -77.02 -70.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.38 34.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.975 0.893 . . . . 0.0 110.596 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 36' ' ' MET . 26.8 t-20 -138.63 -8.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.812 -173.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.14 -32.27 63.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.453 0.644 . . . . 0.0 109.866 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -138.45 67.75 45.47 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.462 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -88.9 7.96 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 112.636 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 72.64 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.711 0.804 . . . . 0.0 111.873 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 10.2 tt0 -64.1 -70.05 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.828 0.346 . . . . 0.0 111.05 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.63 -129.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.675 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -154.61 -94.88 0.11 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 167.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 11.1 ttp -53.16 -42.89 93.3 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.675 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 14.4 Cg_exo -70.5 -28.36 21.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.912 1.742 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.8 tm? -57.69 -45.69 85.32 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -60.19 -49.22 78.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.46 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.72 76.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 -175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.5 p-90 -73.41 -37.38 65.93 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.523 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.96 -51.34 67.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.61 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.707 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 4.8 tppp? -64.1 -50.37 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.863 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 73' ' ' LEU . 50.0 t -61.7 -46.46 89.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.342 . . . . 0.0 110.724 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.43 89.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.461 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -62.37 -45.35 93.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.114 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 56' ' ' LYS . 58.6 mt-10 -62.45 -47.21 85.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.2 96.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.199 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 62' ' ' LEU . 3.2 tm? -74.37 -37.88 63.33 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.436 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.27 -26.07 36.05 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.449 -0.782 . . . . 0.0 112.024 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.7 tmtp? -82.72 -37.12 25.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' OD1' HG23 ' A' ' 68' ' ' ILE . 21.0 t-20 -131.4 90.43 37.88 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.864 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -88.14 31.68 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.611 2.207 . . . . 0.0 111.365 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -118.34 11.29 13.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.489 HG23 ' OD1' ' A' ' 65' ' ' ASN . 7.3 pt -95.49 166.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.243 173.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -129.4 -3.58 4.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.92 157.35 9.82 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.984 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.38 156.94 39.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.981 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -110.39 117.45 33.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.384 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.5 mt -111.1 140.76 45.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.627 0.727 . . . . 0.0 112.383 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.472 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 23.6 tptm -117.58 123.93 29.38 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.425 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HG2' HG13 ' A' ' 83' ' ' VAL . 68.7 Cg_exo -38.97 144.44 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.247 3.298 . . . . 0.0 113.799 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -65.79 -30.96 71.68 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -79.11 76.62 5.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.844 169.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.73 -25.14 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -57.09 -24.0 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.683 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HB3' HG12 ' A' ' 83' ' ' VAL . 8.7 m-20 -62.93 -36.57 83.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.107 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m 65.67 -76.38 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 16.0 m -86.68 36.33 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -167.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.4 p -140.79 130.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -127.9 151.15 49.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.208 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.412 ' CE2' HD21 ' A' ' 50' ' ' LEU . 74.4 m-85 -112.19 123.65 50.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.239 0.542 . . . . 0.0 110.2 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 12.1 t-160 -112.14 102.25 10.46 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 90.1 t -95.52 113.68 30.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.135 0.493 . . . . 0.0 110.206 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 88.0 mt -101.82 140.78 19.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -103.13 107.62 18.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.676 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 33.8 m-20 -94.72 116.69 29.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.96 114.21 25.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.574 0.702 . . . . 0.0 111.083 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 C--O 1.246 0.908 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.224 178.443 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.924 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 m -82.15 69.12 8.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 111.199 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.31 -49.56 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.485 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.0 mtt -105.81 6.25 31.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 171.29 40.27 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.155 -174.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -145.83 -31.67 0.38 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.1 mmm -130.91 71.1 82.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.735 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.64 78.03 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.044 2.496 . . . . 0.0 111.787 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.59 109.53 18.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.101 0.477 . . . . 0.0 110.448 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.66 119.06 48.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.879 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.08 121.53 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.549 0.69 . . . . 0.0 110.27 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 39' ' ' VAL . 87.3 t -92.28 139.58 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.719 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.62 112.8 26.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.0 110.519 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.0 mt -103.07 152.21 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 56.3 m80 -130.43 142.84 50.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.488 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -141.96 132.53 12.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.075 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 21' ' ' ILE . 19.4 Cg_endo -58.3 115.26 2.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.503 2.135 . . . . 0.0 111.706 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 62' ' ' LEU . 1.5 tm? -43.07 -50.82 6.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.584 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.55 -18.82 58.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 9.5 ttt180 -100.77 -35.3 9.5 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.881 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -69.4 -25.72 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.223 0.535 . . . . 0.0 109.81 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.85 -12.13 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.92 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.6 171.31 12.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.002 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.24 -52.3 17.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 109.783 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.06 71.32 3.03 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.103 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' O ' HD22 ' A' ' 32' ' ' LEU . 16.7 p90 -65.24 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.909 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.04 4.97 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.0 111.251 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 20' ' ' ARG . 36.3 t70 -75.39 113.96 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.51 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -63.03 -34.8 78.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.466 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.481 ' HG ' ' CD ' ' A' ' 35' ' ' GLN . 32.1 tp -61.5 -40.33 94.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.522 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -55.84 -42.73 76.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 109.58 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD13 ' NH2' ' A' ' 51' ' ' ARG . 3.5 mm? -65.08 -47.7 76.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.407 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.53 -41.83 88.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.83 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.481 ' CD ' ' HG ' ' A' ' 31' ' ' LEU . 74.1 mt-30 -66.42 -44.09 83.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.343 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.5 mmm -87.68 -1.09 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.3 -26.68 15.12 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 165.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' GLN . 60.6 tttp -64.81 -66.58 0.52 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.274 -0.963 . . . . 0.0 110.829 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 12' ' ' VAL . 7.5 p -108.61 97.59 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.748 0.785 . . . . 0.0 110.229 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -176.59 -26.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.55 -44.56 96.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.043 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -145.1 73.98 14.44 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.745 0.783 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -91.44 21.03 0.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.838 2.359 . . . . 0.0 112.45 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 71.59 -37.76 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 112.366 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 75' ' ' PRO . 23.6 tp10 -82.4 -94.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.332 -0.23 . . . . 0.0 111.169 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.668 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 32.7 mt-10 -114.82 -109.16 0.36 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.737 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 167.67 -106.27 0.25 Allowed Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.658 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.689 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 10.8 tpt -49.77 -48.39 77.34 Favored Pre-proline 0 C--O 1.247 0.954 0 CA-C-O 120.958 0.409 . . . . 0.0 111.317 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HG2' ' HB3' ' A' ' 46' ' ' GLU . 31.4 Cg_endo -60.58 -34.15 92.81 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.043 1.162 . . . . 0.0 110.366 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.711 ' O ' ' HE3' ' A' ' 53' ' ' TRP . 4.0 mt -60.28 -44.41 95.38 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.2 ptm180 -62.83 -39.21 93.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.211 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.36 94.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.722 0.772 . . . . 0.0 110.047 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.711 ' HE3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -51.15 69.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.95 1.3 . . . . 0.0 112.881 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -73.35 -43.71 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -58.52 -38.98 73.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.628 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 12.5 mmmm -69.62 -49.1 57.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.698 174.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.697 ' SG ' HD11 ' A' ' 73' ' ' LEU . 49.7 t -59.18 -44.45 92.17 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.777 0.322 . . . . 0.0 110.942 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -65.38 -42.18 92.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.301 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -61.35 -48.14 82.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.424 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 33.3 mm-40 -64.54 -44.0 92.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.514 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.45 95.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.439 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 18' ' ' LEU . 10.1 tt -68.63 -48.19 64.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.149 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -63.64 -25.51 68.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.702 0.287 . . . . 0.0 111.337 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -71.76 -33.58 68.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.219 0.533 . . . . 0.0 110.279 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -149.36 73.4 9.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.717 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.29 33.73 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.323 2.682 . . . . 0.0 113.026 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.04 18.87 10.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.525 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.0 pt -96.1 -173.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.923 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.72 -27.38 2.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.529 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -165.06 168.86 16.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 176.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.17 153.51 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -110.96 132.55 54.11 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.644 0.735 . . . . 0.0 111.303 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.697 HD11 ' SG ' ' A' ' 57' ' ' CYS . 1.8 mm? -107.87 143.9 35.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.492 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -130.83 122.62 19.6 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.696 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -32.74 140.46 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 125.273 3.982 . . . . 0.0 115.906 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 42.4 mtp180 -57.75 -37.59 73.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.989 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.96 84.6 7.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.511 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.68 -12.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.379 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -59.07 -32.14 69.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.608 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 45' ' ' GLU . 4.9 t-20 -63.13 -37.72 88.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.503 -172.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m 69.24 -59.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -77.63 -34.2 53.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -167.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.665 HG13 ' HG2' ' A' ' 75' ' ' PRO . 8.8 p -89.88 132.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 112.255 -171.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -130.6 161.66 31.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.721 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.93 136.23 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.442 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -111.92 111.12 21.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' ALA . 86.8 t -92.04 110.36 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' HIS . 82.3 mt -101.2 136.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.162 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.31 111.51 23.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.239 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -77.19 113.92 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -89.66 110.64 21.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.725 0.774 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.301 170.823 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.633 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -80.53 -67.29 0.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.701 0.286 . . . . 0.0 111.425 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.86 -74.18 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.4 mmt 58.37 67.54 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.679 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 37.03 51.0 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.285 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -141.93 114.14 8.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.931 0.396 . . . . 0.0 110.605 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.5 ptm -154.44 156.26 31.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.616 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.25 43.08 0.95 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.769 2.312 . . . . 0.0 113.077 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 82' ' ' SER . . . -108.86 115.93 31.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.719 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.1 t -114.52 119.35 61.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.923 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.58 118.42 31.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 39' ' ' VAL . 39.2 t -106.24 119.98 56.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 23.6 mt-10 -100.27 118.98 37.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.085 0.469 . . . . 0.0 111.173 -168.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.53 HD13 ' SD ' ' A' ' 36' ' ' MET . 24.4 mt -101.32 132.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.084 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.5 m80 -112.39 112.09 23.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 110.896 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -106.21 153.51 40.28 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.0 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 21' ' ' ILE . 87.5 Cg_endo -81.69 113.89 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.281 1.988 . . . . 0.0 111.673 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -43.3 -49.1 6.86 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -74.95 -32.07 61.64 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 29' ' ' ASP . 2.6 ttm180 -96.86 -21.46 17.49 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.85 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.625 HG23 HD22 ' A' ' 62' ' ' LEU . 6.7 tp -72.28 -27.34 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.02 -9.11 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.13 155.27 19.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.125 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.9 pt-20 -84.01 -14.35 50.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.833 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.08 43.71 1.65 Allowed Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -60.03 -27.76 67.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 111.624 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -14.34 62.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.639 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.99 -18.47 43.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 25.5 t70 -84.7 109.0 17.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 111.57 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -29.61 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.25 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . 2.9 tm? -63.86 -40.2 95.98 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.3 -43.84 98.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.297 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.97 -44.57 92.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -58.4 -43.32 88.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.257 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 1.3 mp0 -68.44 -45.21 73.16 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 14' ' ' ILE . 66.2 mmm -90.15 13.43 15.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.172 0.51 . . . . 0.0 110.825 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.88 -38.29 3.67 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -63.4 -66.11 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.121 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 12' ' ' VAL . 7.0 p -91.36 68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 122.338 1.066 . . . . 0.0 110.267 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.11 9.8 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.145 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.34 -36.95 3.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.987 0.423 . . . . 0.0 110.055 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.1 p -141.94 59.3 9.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.989 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 42' ' ' THR . 67.1 Cg_endo -94.68 30.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.047 2.498 . . . . 0.0 113.098 -174.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 73.79 -47.9 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.31 0.644 . . . . 0.0 111.048 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -77.81 -92.64 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.95 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -130.06 -91.3 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.605 0.241 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 165.96 -102.6 0.19 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.597 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 9.1 ttp -53.55 -45.97 98.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 48' ' ' MET . 19.2 Cg_endo -60.9 -30.2 89.56 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.879 1.719 . . . . 0.0 111.05 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.81 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -59.06 -45.96 89.47 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.292 176.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.518 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 18.0 ttm180 -59.98 -48.94 79.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.2 78.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.376 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.81 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.3 p-90 -72.38 -41.93 65.8 Favored 'General case' 0 CA--C 1.522 -0.096 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.852 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.5 OUTLIER -69.48 -43.18 80.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.689 -174.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.78 -46.23 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.316 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.53 -41.81 88.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.586 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.415 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 71.7 m -66.28 -44.85 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.819 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.33 83.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.833 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -59.35 -49.35 78.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.967 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -64.56 -41.83 96.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.043 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.9 96.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.283 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.625 HD22 HG23 ' A' ' 21' ' ' ILE . 15.6 tp -69.48 -47.36 64.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.135 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.66 -26.44 67.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -42.17 98.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.494 0.664 . . . . 0.0 109.961 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -139.4 75.09 33.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.75 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.15 47.77 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.073 2.515 . . . . 0.0 112.709 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -139.26 2.83 2.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.69 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -85.64 -179.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.574 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.19 -19.75 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.878 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -165.51 155.47 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.0 t -127.28 152.36 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.681 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -110.1 116.22 31.16 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.43 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 29.8 tp -127.7 141.89 51.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.338 -167.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -126.38 126.86 24.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 18.1 Cg_endo -63.16 171.22 6.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.107 2.538 . . . . 0.0 114.733 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 3.8 mtp180 -66.41 -61.01 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.66 -168.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.99 118.01 4.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.49 -9.75 13.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.156 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -58.81 -39.57 81.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' OD1' HG12 ' A' ' 83' ' ' VAL . 1.6 p30 -73.46 -27.06 61.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.495 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m 74.49 -66.51 0.29 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 26.8 m -125.85 27.07 6.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 80' ' ' ASN . 9.9 p -90.16 134.98 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -134.86 152.25 51.59 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.996 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -108.51 118.86 37.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.632 0.73 . . . . 0.0 109.623 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.4 t-160 -94.05 102.04 14.09 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.32 112.22 25.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -113.54 139.11 40.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.528 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.57 106.65 17.12 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.201 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -86.9 127.32 35.05 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.29 114.85 21.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.462 ' OE2' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.664 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -78.47 124.96 28.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.911 0.386 . . . . 0.0 111.089 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.13 -42.48 2.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.555 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttp 54.94 71.49 0.53 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.89 -175.21 46.67 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.448 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -139.85 149.22 43.17 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.8 mtm -64.25 117.65 38.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 82' ' ' SER . 36.1 Cg_endo -64.94 95.94 0.25 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.89 2.393 . . . . 0.0 113.072 -172.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.22 113.55 21.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.489 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -98.99 119.71 47.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.21 118.39 28.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.014 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.05 119.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -98.77 112.22 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 0.0 110.26 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.2 mt -111.95 123.34 67.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -99.66 112.82 25.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.237 0.542 . . . . 0.0 110.914 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-30 -111.42 116.04 51.23 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.589 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 33.6 Cg_exo -61.79 119.74 7.01 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.008 . . . . 0.0 111.789 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 62' ' ' LEU . 1.7 tm? -42.38 -45.2 4.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.765 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -71.98 -43.54 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.785 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 11.5 ptp180 -83.13 -28.66 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.277 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 17' ' ' PRO . 7.8 tp -75.24 -17.69 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.0 109.891 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.88 -13.72 55.6 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.25 0.548 . . . . 0.0 110.395 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.35 156.94 20.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.369 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.9 -14.37 51.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.351 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.16 60.61 1.1 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -82.16 -41.53 20.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 111.158 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.37 -4.75 43.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.2 9.38 30.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.515 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 18.0 t70 -95.57 119.5 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.882 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.62 -31.56 71.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.607 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 31' ' ' LEU . 6.4 mt -69.03 -43.21 75.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.26 0.552 . . . . 0.0 110.465 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.0 -36.56 75.24 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.394 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.34 -47.9 58.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.28 -178.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.45 -35.16 70.81 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.864 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.47 -45.21 80.47 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.999 0.428 . . . . 0.0 110.64 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 7.3 tpt -93.34 16.81 12.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.133 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.09 -32.98 3.85 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 163.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.53 -62.98 1.43 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.63 -0.785 . . . . 0.0 110.576 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 39' ' ' VAL . 11.4 p -94.6 52.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.705 1.24 . . . . 0.0 110.165 -176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' MET . 4.2 t-20 -133.16 -29.37 1.43 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.583 -171.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 80.3 m-20 -79.48 -31.38 42.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.67 -169.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 p -126.1 62.38 44.92 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.906 0.384 . . . . 0.0 111.225 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 83' ' ' VAL . 11.3 Cg_endo -97.21 6.6 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.936 2.424 . . . . 0.0 113.456 -174.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 71.19 -42.03 0.52 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.698 0.799 . . . . 0.0 112.205 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 50' ' ' LEU . 3.9 tp10 -66.72 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.345 0.117 . . . . 0.0 110.983 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 31.5 mt-10 -136.28 -86.44 0.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.328 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 160.9 -110.26 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.099 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.6 tpt -52.72 -49.53 85.91 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.9 Cg_endo -67.82 -35.73 20.47 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.208 1.272 . . . . 0.0 111.566 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.731 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.38 -43.2 96.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.415 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 48' ' ' MET . 35.6 ptt180 -69.51 -29.87 67.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.997 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -49.31 77.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.668 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 12.2 p-90 -73.09 -36.84 66.87 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.148 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -49.1 82.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 79.6 mt -65.55 -38.64 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.427 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.2 tptt -63.65 -48.86 75.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.727 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.7 t -62.68 -46.95 85.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.69 83.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.667 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -62.4 -52.23 64.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.547 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 56.7 mm-40 -65.04 -38.35 90.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.661 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.71 -44.12 90.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.487 HD11 HD22 ' A' ' 18' ' ' LEU . 8.2 tt -72.94 -47.23 47.39 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.782 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.55 -26.08 63.18 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.805 -0.559 . . . . 0.0 112.09 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -84.05 -44.96 13.57 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' OD1' HG23 ' A' ' 68' ' ' ILE . 11.6 t-20 -139.45 100.14 7.69 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.866 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -96.79 25.66 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.695 2.263 . . . . 0.0 112.012 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.04 8.22 32.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.465 HG23 ' OD1' ' A' ' 65' ' ' ASN . 4.7 pt -77.51 166.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.733 0.777 . . . . 0.0 111.474 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HE ' ' HB2' ' A' ' 69' ' ' ARG . 2.0 mtm180 -106.89 -51.39 2.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.325 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.658 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.9 150.37 27.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.139 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 87' ' ' VAL . 9.1 p -119.55 156.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.772 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -111.16 115.1 28.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 57' ' ' CYS . 11.2 mt -111.69 136.68 50.6 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.636 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -113.93 119.16 41.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.674 ' HG2' HG13 ' A' ' 83' ' ' VAL . 88.2 Cg_exo -37.23 147.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 125.034 3.823 . . . . 0.0 114.301 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -61.32 -40.33 93.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.957 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.76 85.8 3.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.984 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.51 -22.67 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.075 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -57.58 -29.27 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.216 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.23 -38.56 91.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.724 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m 65.6 -56.64 0.33 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 123.945 0.778 . . . . 0.0 113.02 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 8' ' ' PRO . 5.7 m -76.87 -37.37 55.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.674 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.8 p -87.68 140.23 16.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -146.47 153.3 40.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.69 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.15 126.43 52.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.447 0.641 . . . . 0.0 111.053 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -109.31 102.84 11.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 71' ' ' VAL . 76.0 t -91.87 114.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 77.2 mt -104.17 133.15 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.85 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 87.6 m-85 -102.65 109.91 21.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 17.5 t70 -99.58 131.91 45.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.68 108.32 18.6 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.892 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.245 0.847 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.885 172.324 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -138.44 143.83 39.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.689 0.244 . . . . 0.0 110.467 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.89 39.02 20.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.476 0.655 . . . . 0.0 110.596 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.75 116.02 26.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.115 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.83 70.18 2.93 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.197 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 26.3 p80 -83.22 26.54 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 0.0 111.272 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.62 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 26.4 ttt -108.88 -54.48 0.06 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.737 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 7' ' ' MET . 29.9 Cg_endo -64.85 -34.18 50.15 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.355 1.37 . . . . 0.0 111.177 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . -124.81 108.54 12.05 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.49 119.39 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.16 119.61 26.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.688 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.1 t -118.54 130.3 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.4 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.14 127.07 53.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 110.552 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mt -116.16 129.45 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -102.22 140.12 36.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -132.46 126.87 20.42 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 22.4 Cg_endo -63.59 111.25 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.941 1.76 . . . . 0.0 110.242 172.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.31 -35.44 18.2 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.894 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 3.5 mptp? -68.23 -40.58 82.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.682 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -83.19 -36.69 24.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.832 0.348 . . . . 0.0 110.508 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.546 HG23 HD22 ' A' ' 62' ' ' LEU . 10.8 tp -74.69 -3.49 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.248 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.59 -6.36 22.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.13 168.81 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.066 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.41 -44.48 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.13 49.97 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.178 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.01 -34.9 77.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.39 32.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -95.62 2.1 53.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.19 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -89.56 123.06 33.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.094 0.473 . . . . 0.0 109.996 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.68 -32.59 74.12 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.809 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.765 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 22.4 tp -70.71 -42.36 70.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -43.04 86.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.308 0.575 . . . . 0.0 109.831 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.4 tp -70.6 -49.87 43.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.935 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 4.5 p30 -74.8 -27.58 60.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.728 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.765 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 3.2 tt0 -66.63 -45.45 79.03 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.407 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -92.17 7.03 44.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.059 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.04 -27.15 8.42 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.74 -66.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.449 . . . . 0.0 111.171 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 39' ' ' VAL . 9.8 p -85.49 41.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.924 1.345 . . . . 0.0 109.719 -172.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -145.84 -3.94 0.67 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.119 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.88 -30.83 65.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.506 0.669 . . . . 0.0 109.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.8 67.89 79.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 89.4 Cg_endo -95.37 25.48 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.257 2.638 . . . . 0.0 113.263 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.49 -55.58 0.62 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.456 0.702 . . . . 0.0 111.773 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.13 -108.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -93.88 -124.79 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.565 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.668 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -153.1 -89.17 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.562 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -58.38 -39.6 76.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 32.8 Cg_endo -77.63 -23.97 9.28 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 120.82 1.329 . . . . 0.0 110.591 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.604 HD22 ' NE1' ' A' ' 53' ' ' TRP . 3.1 tm? -58.87 -46.01 88.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.725 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 48' ' ' MET . 13.0 ptt180 -67.36 -38.6 85.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.42 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.69 80.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.891 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.604 ' NE1' HD22 ' A' ' 50' ' ' LEU . 7.6 p-90 -72.93 -37.28 67.24 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.885 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.47 -51.11 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.43 -41.15 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.734 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -62.45 -49.5 75.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.768 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.44 -45.24 94.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.99 92.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -57.79 -58.23 9.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.299 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -64.08 -41.95 97.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.72 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -76.84 -47.79 20.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.035 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.68 -27.35 65.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 2.7 mmmp? -69.36 -29.15 66.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -149.01 73.62 10.19 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.12 41.39 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.076 2.517 . . . . 0.0 113.171 -170.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -133.44 26.22 4.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.38 -172.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.3 0.571 . . . . 0.0 111.67 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -127.04 -44.01 1.64 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.555 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.46 152.87 12.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -122.73 156.96 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.985 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.47 116.88 32.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.71 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 73' ' ' LEU . 7.3 mt -106.08 144.28 33.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.3 0.571 . . . . 0.0 111.198 -174.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 13.4 tmtt? -123.83 115.38 27.96 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.887 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.598 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 90.0 Cg_exo -46.32 138.51 13.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.867 3.045 . . . . 0.0 113.521 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -56.91 -29.51 63.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.031 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.67 96.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.054 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.4 -29.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.269 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -61.69 -28.54 69.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.829 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -73.54 -39.77 64.49 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.076 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 m 64.4 -71.97 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.436 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 m -91.92 59.6 3.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.3 p -140.95 136.22 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.978 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.38 160.16 40.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.229 0.538 . . . . 0.0 111.399 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.598 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 62.0 m-85 -120.79 123.62 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.709 171.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -91.9 101.65 14.22 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.77 112.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.2 138.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.661 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -103.61 110.35 22.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 7.5 m-20 -99.34 132.36 44.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.721 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 1.1 pm0 -94.59 120.9 35.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 0.0 110.811 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.139 175.476 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 m -70.94 -33.29 70.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.92 83.0 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.417 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -58.56 -46.15 87.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.279 0.561 . . . . 0.0 109.708 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.81 179.27 41.24 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.253 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 41.7 m80 -78.95 91.32 4.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.548 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 21.8 mmt -64.22 -53.73 44.78 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.9 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 64.0 Cg_endo -92.63 37.3 0.23 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.009 1.806 . . . . 0.0 112.452 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 6' ' ' HIS . . . -107.52 135.99 48.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.98 118.6 44.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.503 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.39 117.78 35.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -106.06 140.24 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -103.09 112.26 25.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.421 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.401 HD13 ' SD ' ' A' ' 36' ' ' MET . 40.2 mt -111.63 142.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 99.1 m-70 -125.61 119.52 28.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.632 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 21.8 m-85 -118.11 106.96 44.43 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.157 174.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_exo -59.07 123.33 13.25 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.931 1.754 . . . . 0.0 111.586 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -48.86 19.74 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -68.74 -29.11 67.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.431 HH21 ' CD ' ' A' ' 92' ' ' GLU . 12.4 ptp180 -94.58 -28.66 15.28 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.605 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 6.1 tp -72.91 -25.06 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.184 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -82.17 -11.22 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 110.686 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.57 177.11 6.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.438 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.58 151.93 24.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 21.61 51.15 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -170.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -61.84 -30.51 70.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.544 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.24 59.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.214 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -76.64 -27.29 55.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.425 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 102.55 0.79 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.039 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 35.8 tt0 -62.46 -31.13 71.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.008 -171.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 36.8 tp -60.65 -42.51 97.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.46 -42.14 83.51 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.618 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.432 HD11 ' NH2' ' A' ' 51' ' ' ARG . 7.3 tp -67.16 -46.3 74.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.779 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 93.5 m-20 -59.74 -42.95 94.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 43.3 mt-30 -64.86 -43.49 92.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 72.2 mmm -87.69 9.02 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.78 -29.26 5.04 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 166.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -73.19 -61.62 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.587 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -92.77 30.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.428 1.109 . . . . 0.0 110.188 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.616 HD21 ' HB2' ' A' ' 50' ' ' LEU . 26.0 t-20 -141.6 0.78 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.778 -170.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.77 -47.07 76.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.294 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.37 72.04 82.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 50' ' ' LEU . 75.6 Cg_endo -92.69 23.09 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.095 2.53 . . . . 0.0 113.577 -172.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 71.3 -57.33 0.61 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.257 0.623 . . . . 0.0 112.004 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.876 ' HB3' HD11 ' A' ' 50' ' ' LEU . 5.5 tp10 -67.0 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.895 0.478 . . . . 0.0 111.231 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -127.93 -91.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 170.63 -114.42 0.54 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.897 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -56.91 -40.14 82.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.58 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.21 -37.38 69.98 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.921 1.747 . . . . 0.0 112.11 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 45' ' ' GLU . 2.9 mt -60.08 -45.56 92.5 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 36' ' ' MET . 1.8 ttt180 -56.55 -41.83 77.5 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.106 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.76 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.1 -40.32 68.27 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.767 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -43.08 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 71.2 mt -64.06 -44.89 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 176.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.63 -48.4 77.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.603 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.0 m -67.59 -39.38 84.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.089 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.64 89.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -54.56 39.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.578 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.02 -36.74 82.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.3 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 65' ' ' ASN . . . -65.83 -33.37 75.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.191 0.52 . . . . 0.0 110.932 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.9 tm? -83.62 -41.43 17.82 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.717 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -79.64 -29.13 40.87 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.107 -0.37 . . . . 0.0 111.321 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 4.4 ttmp? -89.64 -14.78 34.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.822 0.82 . . . . 0.0 109.315 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 26.2 t-20 -144.45 68.9 15.34 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.373 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.24 37.93 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.767 2.312 . . . . 0.0 112.766 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -17.97 13.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.498 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 68' ' ' ILE . 2.5 pp -80.77 -173.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.426 0.632 . . . . 0.0 112.184 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -140.94 -16.42 0.87 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.643 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.25 163.06 20.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.199 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p -134.59 153.25 34.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.075 0.464 . . . . 0.0 110.422 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -109.52 113.58 26.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -121.8 143.82 49.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.544 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -116.89 131.78 23.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.33 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 83' ' ' VAL . 86.8 Cg_exo -51.41 151.62 13.22 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.382 2.721 . . . . 0.0 112.848 172.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -63.12 -33.19 74.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.733 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -65.87 112.81 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.751 0.786 . . . . 0.0 111.131 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.4 -33.54 59.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.771 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -65.02 -26.13 68.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.743 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 87.7 m-20 -64.55 -29.36 70.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.783 0.325 . . . . 0.0 110.909 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.9 t 66.67 -82.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.666 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 t -108.8 37.99 2.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 80' ' ' ASN . 13.1 p -101.03 130.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -130.36 136.31 48.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 12' ' ' VAL . 10.9 m-30 -105.61 124.2 49.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.742 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.27 102.47 12.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 40.4 t -94.43 111.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.92 140.43 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.425 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 78.9 m-85 -101.33 108.22 19.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 6.5 t70 -83.94 135.78 34.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.265 -169.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.83 113.84 26.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.351 0.596 . . . . 0.0 109.981 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HG3' ' HB3' ' A' ' 17' ' ' PRO . 1.7 pp20? . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.845 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 m -75.04 -30.29 61.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.796 0.331 . . . . 0.0 111.195 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 4' ' ' MET . . . -86.65 63.6 8.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 26.8 ptm 51.12 -171.72 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.544 1.137 . . . . 0.0 112.46 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.43 124.68 5.48 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.817 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -118.3 96.3 5.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.9 ttt -101.82 111.36 63.97 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.33 70.13 7.65 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.835 2.357 . . . . 0.0 111.628 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -84.67 119.4 25.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.512 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -91.72 119.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.101 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.81 119.01 33.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.23 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.28 130.19 55.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.271 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -108.41 117.17 33.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.507 0.67 . . . . 0.0 110.406 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.438 HD13 ' SD ' ' A' ' 36' ' ' MET . 33.4 mt -115.75 133.06 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.06 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -120.84 107.72 13.07 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.589 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.3 132.23 24.75 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.847 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 10.2 Cg_exo -66.56 120.73 7.88 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.672 1.581 . . . . 0.0 109.547 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -53.92 -42.23 68.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.814 -167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 7.7 mtmp? -79.56 -24.11 42.34 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.492 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 17' ' ' PRO . 7.8 mpt_? -81.28 -38.03 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.53 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tp -70.75 -26.31 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.287 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.23 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.99 157.85 34.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.55 -21.72 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.335 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.52 38.94 3.14 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' HD22 ' A' ' 32' ' ' LEU . 32.1 p90 -66.36 -35.94 81.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.503 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.0 -9.68 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.224 0.535 . . . . 0.0 111.29 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.38 -3.2 50.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 20' ' ' ARG . 24.3 t70 -82.2 124.78 30.21 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.738 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.29 -28.98 70.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -170.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 3.1 tm? -76.51 -36.82 57.53 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.69 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -66.23 -40.33 90.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.829 177.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.31 -49.6 63.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.966 -176.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.9 p30 -73.45 -34.06 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.91 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 32' ' ' LEU . 3.5 pt20 -67.99 -41.48 82.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.926 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.459 ' HG3' HD11 ' A' ' 55' ' ' ILE . 86.7 mmm -90.32 5.82 45.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.11 -28.19 11.19 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 164.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 68.1 mttm -77.11 -73.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.344 -0.428 . . . . 0.0 111.986 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.59 50.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.722 0.772 . . . . 0.0 110.564 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -142.49 -23.9 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.404 -170.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p-10 -87.18 -18.23 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.173 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 p -133.27 57.43 27.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.25 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 42' ' ' THR . 26.5 Cg_endo -101.52 24.01 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.321 2.681 . . . . 0.0 113.814 -174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 10.9 tp10 70.54 -58.04 0.56 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.053 0.541 . . . . 0.0 112.239 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.584 ' HB3' HD11 ' A' ' 50' ' ' LEU . 37.8 tt0 -73.09 -86.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.601 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 51.3 mt-10 -127.32 -95.7 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.171 -0.331 . . . . 0.0 110.569 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 162.18 -83.05 0.12 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.84 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.477 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 12.6 tpt -54.36 -49.89 88.08 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 48' ' ' MET . 47.9 Cg_endo -68.56 -27.78 32.46 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.402 1.401 . . . . 0.0 110.02 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 2.3 mt -57.83 -46.31 84.92 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -64.28 -47.0 81.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.61 -49.87 75.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.841 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.595 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 6.2 p-90 -74.06 -41.29 61.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.888 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.7 t -61.45 -51.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 36' ' ' MET . 80.1 mt -60.28 -41.37 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.7 tmtt? -63.2 -50.43 70.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.578 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -64.14 -41.45 97.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.832 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.72 97.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.369 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.99 -49.58 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.29 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 10.4 mm-40 -61.77 -45.8 92.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.51 93.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -60.95 -46.03 92.35 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.452 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.4 -27.46 52.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -63.72 -50.3 69.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.995 0.426 . . . . 0.0 109.854 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -130.58 76.04 78.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 121.44 0.638 . . . . 0.0 109.936 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 42.02 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.483 2.789 . . . . 0.0 113.237 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -124.89 -1.21 7.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.407 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.0 pt -83.0 -174.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -143.04 -18.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.697 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -165.63 157.73 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.108 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 87' ' ' VAL . 20.1 m -135.24 155.49 37.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -111.56 116.83 31.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.217 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.479 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 15.5 mt -108.44 140.22 42.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.77 0.795 . . . . 0.0 112.611 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 24.3 tptm -120.97 116.68 31.24 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.689 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 83' ' ' VAL . 96.0 Cg_exo -33.29 143.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.766 3.644 . . . . 0.0 114.605 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -62.87 -32.24 73.44 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.305 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.11 69.9 7.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.037 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.5 -22.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.945 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -57.74 -23.77 53.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.97 -36.1 80.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m 71.51 -57.1 0.62 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.299 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 17.8 m -96.63 54.57 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -140.68 134.4 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.208 173.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -135.74 143.98 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -117.17 123.98 48.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.176 0.513 . . . . 0.0 109.957 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -101.68 103.61 14.4 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.017 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 71' ' ' VAL . 74.7 t -95.85 112.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.1 mt -113.26 142.36 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -101.81 110.49 22.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.303 0.573 . . . . 0.0 110.131 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.49 133.03 38.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.238 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 1.4 pm0 -83.01 116.38 22.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.516 0.674 . . . . 0.0 110.026 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.504 ' CD ' ' HB2' ' A' ' 19' ' ' LYS . 5.6 pt-20 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.066 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 p -111.69 155.85 22.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.814 0.34 . . . . 0.0 110.542 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.83 143.97 49.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.09 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.36 60.26 4.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.149 0.499 . . . . 0.0 110.793 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.5 25.52 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.332 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 40.1 m80 -139.78 56.31 1.64 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 109.77 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.89 88.29 11.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.894 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 7.9 Cg_exo -72.72 138.37 28.96 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.939 2.426 . . . . 0.0 112.0 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.29 113.02 18.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.056 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.6 118.86 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.831 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.0 118.69 23.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.17 139.12 49.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -107.43 128.35 54.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.266 0.555 . . . . 0.0 110.235 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' SD ' ' A' ' 36' ' ' MET . 44.2 mt -117.13 149.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.473 ' HB2' ' NE2' ' A' ' 35' ' ' GLN . 98.6 m-70 -125.96 123.14 37.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.977 0.418 . . . . 0.0 111.099 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 22.1 m-85 -126.09 108.29 24.69 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.814 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 36.7 Cg_exo -57.55 124.16 15.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.02 1.813 . . . . 0.0 111.546 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -49.83 9.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -170.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -77.04 -29.17 55.1 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.232 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -79.92 -34.33 39.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.82 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 5.4 tp -73.63 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.975 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.4 -7.78 54.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.19 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 26' ' ' TYR . . . -83.58 149.13 26.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.941 0.401 . . . . 0.0 110.689 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.66 -40.07 29.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.278 0.561 . . . . 0.0 109.826 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.21 44.8 2.63 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.639 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.544 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 26.2 p90 -70.1 -10.6 59.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.381 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.75 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.539 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -80.53 -16.96 52.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.894 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 31.1 m-20 -81.72 94.55 7.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.636 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -60.4 -31.29 70.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.74 -173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD13 ' OE1' ' A' ' 35' ' ' GLN . 1.3 tm? -57.08 -42.94 81.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 26' ' ' TYR . 6.9 tp -64.2 -43.65 94.38 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.617 -178.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.31 -46.14 79.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.748 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' A' ' 15' ' ' HIS . 47.3 mt-30 -64.74 -44.56 89.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.58 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 82.3 mmm -91.78 18.0 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.735 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.73 -31.5 3.16 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 163.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -70.54 -63.78 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -0.634 . . . . 0.0 111.086 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 35' ' ' GLN . 26.8 m -90.84 41.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.846 0.831 . . . . 0.0 110.088 -175.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 51' ' ' ARG . 28.3 t-20 -137.25 -21.99 1.17 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.584 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.57 -43.72 96.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.5 t -135.26 79.2 50.12 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.856 0.836 . . . . 0.0 110.192 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 72.6 Cg_endo -91.33 14.44 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.077 2.518 . . . . 0.0 112.609 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 72.74 -47.45 0.67 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.684 0.794 . . . . 0.0 111.297 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 54.9 mm-40 -56.32 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.204 0.525 . . . . 0.0 111.066 174.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -146.04 -98.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.582 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.577 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . 174.1 -83.23 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 168.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.23 -45.73 99.1 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 11.7 Cg_exo -72.84 -28.24 13.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.081 1.854 . . . . 0.0 110.715 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.7 tm? -57.34 -44.77 84.55 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.58 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 34.4 ttp180 -67.06 -49.32 65.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.159 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.49 80.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.75 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.695 ' HE1' HD22 ' A' ' 50' ' ' LEU . 5.6 p-90 -72.75 -39.07 67.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.022 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.17 -43.1 79.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.743 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.73 -41.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 110.518 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -65.33 -44.99 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.113 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 t -63.76 -44.87 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.458 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.412 . . . . 0.0 110.394 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -60.05 -50.95 71.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.299 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.23 -34.89 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.211 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.02 -42.44 76.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.97 0.414 . . . . 0.0 111.185 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 62' ' ' LEU . 2.9 tm? -72.14 -47.32 51.89 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.486 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.99 -28.8 63.64 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 111.841 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -86.26 -12.64 49.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.91 0.862 . . . . 0.0 109.173 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' O ' HG12 ' A' ' 68' ' ' ILE . 28.6 t-20 -154.64 73.43 5.95 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.041 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -85.86 34.34 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.605 2.203 . . . . 0.0 112.629 -170.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.41 -2.78 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.75 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 65' ' ' ASN . 6.1 pt -84.96 166.9 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.371 0.605 . . . . 0.0 111.388 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 89' ' ' PHE . 35.4 ptt180 -138.46 -4.16 1.66 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.509 176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -167.75 149.47 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.479 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.2 m -136.83 156.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 122.706 0.402 . . . . 0.0 110.015 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.84 117.74 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.879 0.371 . . . . 0.0 110.052 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.33 141.09 45.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 112.361 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -108.78 122.18 40.87 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 59.3 Cg_endo -70.3 -179.97 3.55 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.878 2.385 . . . . 0.0 114.542 -171.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 76' ' ' ARG . 47.3 mtp180 -65.12 -54.74 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.73 -167.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . . . -58.96 107.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 0.0 111.828 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.82 -37.93 79.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.672 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -70.68 -25.05 62.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.151 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' ND2' HG11 ' A' ' 83' ' ' VAL . 59.8 t30 -65.14 -36.48 84.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t 67.24 -89.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 163.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.7 m -80.46 63.91 5.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.604 0.716 . . . . 0.0 111.592 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG11 ' ND2' ' A' ' 80' ' ' ASN . 4.9 p -139.92 129.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.511 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -128.39 137.12 51.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.229 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -115.3 122.49 46.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.314 0.578 . . . . 0.0 110.28 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -95.81 108.64 20.99 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.226 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -92.12 108.88 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.597 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 72.2 m-85 -100.77 111.61 23.87 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 13.4 t70 -74.94 142.88 43.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.2 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.16 112.74 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.488 0.661 . . . . 0.0 109.33 -167.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--O 1.247 0.93 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.288 -172.742 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 m -67.12 -59.04 3.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.739 0.304 . . . . 0.0 110.43 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -161.77 129.96 4.21 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -72.8 126.48 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.593 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.15 -35.8 4.26 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.079 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.424 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 37.8 m80 -142.95 80.91 1.7 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.488 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 22.5 mmt -65.04 -47.92 72.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.802 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 16.3 Cg_exo -69.1 131.68 22.7 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.844 1.696 . . . . 0.0 111.831 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -86.11 122.84 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.5 t -125.95 125.46 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -120.16 132.95 55.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.175 0.512 . . . . 0.0 110.028 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.01 119.71 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.4 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 7.1 pt-20 -102.21 113.77 27.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.341 0.591 . . . . 0.0 110.846 -174.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.481 HD13 ' SD ' ' A' ' 36' ' ' MET . 5.9 mt -105.66 142.73 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.104 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 96.4 m-70 -113.07 112.67 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.076 0.465 . . . . 0.0 110.579 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 14.7 m-30 -104.08 120.62 50.43 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.533 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' HE ' ' A' ' 20' ' ' ARG . 32.3 Cg_exo -58.96 116.37 3.21 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.048 1.832 . . . . 0.0 111.081 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.2 tm? -46.68 -43.28 17.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.55 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' A' ' 92' ' ' GLU . 21.4 mtpp -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.136 -172.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HE ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -88.63 -29.47 19.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.253 -173.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.476 HG23 HD22 ' A' ' 62' ' ' LEU . 6.1 tp -74.47 -25.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.29 11.95 9.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.642 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.95 173.94 7.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.813 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -116.13 144.35 44.27 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.1 22.83 16.25 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -168.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -59.84 -18.66 45.81 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.909 -0.646 . . . . 0.0 111.688 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.9 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.74 1.36 57.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.967 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 35.6 t70 -85.6 104.02 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.21 -28.12 69.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.2 mt -62.07 -42.94 99.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.123 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.578 HD22 ' NH1' ' A' ' 20' ' ' ARG . 51.9 tp -70.94 -41.58 70.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.23 -46.52 73.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.086 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.3 p30 -72.58 -32.39 65.97 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.039 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.746 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.6 tt0 -65.97 -45.33 82.06 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.373 0.606 . . . . 0.0 110.085 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.481 ' SD ' HD13 ' A' ' 14' ' ' ILE . 83.0 mmm -91.24 12.3 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.363 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.7 -33.24 6.5 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 162.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 43.8 mmtm -72.28 -75.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.263 -0.469 . . . . 0.0 111.557 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -84.84 60.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 122.138 0.97 . . . . 0.0 110.178 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -161.82 -23.42 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.396 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.63 -39.41 67.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 0.0 110.592 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -134.81 63.98 60.79 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.976 0.893 . . . . 0.0 110.528 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 46.3 Cg_endo -97.3 23.54 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.364 2.709 . . . . 0.0 113.466 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 71.97 -56.13 0.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.768 0.668 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.731 ' HB3' HD11 ' A' ' 50' ' ' LEU . 3.7 tp10 -65.86 -77.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.405 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 41.8 mt-10 -143.7 -91.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 160.59 -90.72 0.11 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.837 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 6.8 ttp -57.24 -47.35 99.2 Favored Pre-proline 0 C--N 1.314 -0.969 0 O-C-N 122.172 -0.605 . . . . 0.0 112.156 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 48' ' ' MET . 54.4 Cg_endo -69.69 -24.02 30.44 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.34 1.36 . . . . 0.0 110.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 45' ' ' GLU . 3.0 mt -59.1 -47.63 84.54 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.204 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' MET . 32.0 ptt180 -73.73 -33.62 64.43 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.68 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.7 73.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.254 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.544 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 7.0 p-90 -73.75 -42.06 61.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.247 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.1 t -60.0 -51.03 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.611 0.243 . . . . 0.0 111.132 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' A' ' 36' ' ' MET . 97.1 mt -63.79 -41.49 92.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.971 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 46.5 tttm -69.91 -41.47 74.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.927 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.1 m -67.46 -41.46 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.465 0.174 . . . . 0.0 110.803 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.09 85.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 109.914 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 5.1 t-160 -61.46 -53.69 53.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.84 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 17.0 mm-40 -59.0 -47.19 86.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.155 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.8 99.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.333 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 21' ' ' ILE . 6.7 tp -68.88 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.483 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.3 -32.15 73.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -78.96 -20.1 50.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.172 -176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -145.68 70.13 13.72 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.371 0.605 . . . . 0.0 109.697 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.09 45.78 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.18 2.587 . . . . 0.0 112.787 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -127.01 -1.19 6.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.522 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 pt -86.66 -172.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.739 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 69' ' ' ARG . 4.8 ptp180 -153.19 -0.55 0.24 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.17 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -166.43 157.18 12.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.524 0.202 . . . . 0.0 110.593 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.44 156.73 42.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.989 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -110.35 113.39 26.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.088 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.544 HD22 ' HZ3' ' A' ' 53' ' ' TRP . 12.1 mt -112.27 134.65 53.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -115.03 127.93 26.39 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.252 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 56.0 Cg_endo -69.03 -173.0 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.316 2.011 . . . . 0.0 112.649 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.493 ' H ' ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -80.64 -38.87 28.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.684 -174.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' OE1' ' A' ' 45' ' ' GLU . . . -76.28 78.6 3.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.562 0.696 . . . . 0.0 110.365 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.68 -17.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.421 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -57.35 -24.94 58.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -63.14 -27.95 69.73 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 109.898 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.3 m 67.22 -77.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.834 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 47.9 m -103.38 29.86 5.34 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -101.23 136.68 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.38 160.16 38.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.9 120.13 29.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.7 t-160 -110.05 102.64 11.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.051 -176.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.88 113.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.846 0.355 . . . . 0.0 110.33 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.5 141.69 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 66.0 m-85 -103.23 114.53 28.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.54 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 15.7 m-20 -76.08 115.34 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.43 115.76 28.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.319 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 19.3 mm-40 . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.106 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -134.44 15.81 3.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.01 -176.33 0.19 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.233 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 68.8 5.29 4.88 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.353 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.7 120.5 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.376 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -76.67 -43.11 39.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -117.13 141.69 28.86 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.376 174.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' MET . 2.9 Cg_exo -73.57 73.08 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.656 2.237 . . . . 0.0 111.619 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -89.64 131.99 35.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.832 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 6.7 m -101.16 137.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.835 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.35 138.81 50.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.799 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -114.46 140.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.78 117.98 35.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.171 0.51 . . . . 0.0 110.499 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.607 HD13 ' SD ' ' A' ' 36' ' ' MET . 22.1 mt -115.24 123.3 70.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.559 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 92.2 m-70 -110.74 112.0 23.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.518 0.675 . . . . 0.0 111.11 -177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 17.1 m-85 -106.52 116.97 58.17 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.461 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 35.9 Cg_exo -58.75 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.214 1.942 . . . . 0.0 110.543 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.5 tp -52.61 -39.28 61.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.897 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HE3' ' CB ' ' A' ' 92' ' ' GLU . 15.2 pttp -79.19 -28.57 42.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 9.1 mmm180 -81.5 -38.79 25.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.406 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.11 -28.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.859 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.91 59.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 110.83 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.26 -179.97 6.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.709 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -115.79 18.5 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.939 0.876 . . . . 0.0 109.844 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.5 25.36 10.45 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' HD22 ' A' ' 32' ' ' LEU . 45.0 p90 -71.14 -35.31 71.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.67 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -17.32 60.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 0.0 110.414 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -91.53 -2.06 57.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.608 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 22.3 t70 -90.71 116.08 28.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.032 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.61 -28.89 64.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.448 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.48 HD12 HE22 ' A' ' 35' ' ' GLN . 9.6 tp -70.23 -43.79 69.89 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.7 tp -63.9 -39.5 94.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.623 0.725 . . . . 0.0 109.423 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -41.72 92.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.397 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 m-20 -60.22 -49.24 78.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.612 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 2.5 mp0 -64.99 -45.1 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.607 ' SD ' HD13 ' A' ' 14' ' ' ILE . 88.7 mmm -97.53 21.26 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.511 . . . . 0.0 111.038 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.98 -34.07 4.13 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 31.9 mmtp -67.95 -68.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.03 76.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -173.54 -41.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.842 -171.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -40.4 75.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 p -142.14 67.2 21.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.199 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 80.8 Cg_endo -89.69 28.21 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.831 2.354 . . . . 0.0 112.352 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 72.58 -50.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.641 0.776 . . . . 0.0 111.414 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.56 -82.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -176.14 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.22 -86.63 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.477 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 161.98 -101.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.122 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.443 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 12.5 tpt -56.22 -44.82 99.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 39.5 Cg_exo -60.77 -33.78 92.51 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.374 2.049 . . . . 0.0 111.414 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.93 -45.4 86.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.515 176.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 22.7 ttt180 -63.38 -47.72 80.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.004 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.53 -47.72 84.42 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.456 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.707 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.34 -44.57 62.42 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.886 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -40.88 78.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.206 -174.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 69.5 mt -64.45 -45.82 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.834 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 61.0 tttp -64.76 -47.87 76.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.14 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 88.9 m -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.491 0.186 . . . . 0.0 111.163 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.14 92.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.652 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -61.08 -50.85 71.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.158 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 34.7 mm-40 -61.34 -44.34 97.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.136 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 tp -71.06 -45.34 63.99 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.77 -25.56 67.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.47 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -97.84 -2.2 41.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.517 0.675 . . . . 0.0 109.725 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -148.74 55.0 1.88 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.91 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.83 48.52 2.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.485 2.124 . . . . 0.0 112.438 -168.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -125.83 -11.64 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.807 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 pp -92.73 -172.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -143.61 -11.91 0.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.986 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -165.95 150.35 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.143 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 87' ' ' VAL . 18.8 m -131.54 155.66 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.948 0.404 . . . . 0.0 110.298 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -111.48 117.28 32.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.335 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -121.59 144.19 48.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.28 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.547 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -118.05 120.83 32.07 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.95 174.085 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.613 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 26.5 Cg_endo -61.41 160.41 27.58 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.978 2.452 . . . . 0.0 112.964 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 76' ' ' ARG . 11.7 mtp180 -58.26 -28.62 65.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.151 -172.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.92 86.63 0.71 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.5 0.667 . . . . 0.0 110.708 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.547 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 12.0 p -64.77 -28.09 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.815 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -63.58 -24.69 67.91 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.883 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -64.33 -31.74 73.06 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m 65.98 -74.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 15.7 m -98.15 54.05 1.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.136 0.493 . . . . 0.0 112.113 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 10' ' ' VAL . 14.3 p -134.58 130.53 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -132.87 137.76 46.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.2 m-85 -102.36 124.33 47.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.264 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -104.1 103.43 13.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 71' ' ' VAL . 97.3 t -91.97 110.38 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -109.72 139.34 33.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.217 -173.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 83.3 m-85 -102.65 108.95 20.39 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.924 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 7.0 m-20 -75.76 116.89 16.93 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.5 115.29 21.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.406 0.622 . . . . 0.0 109.843 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 39.9 mt-10 . . . . . 0 C--O 1.247 0.921 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.45 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -89.8 28.13 1.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.23 6.02 7.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -76.03 141.6 42.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.068 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.32 -84.57 0.84 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -171.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -138.3 -66.25 0.49 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptm -176.55 80.06 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.76 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.84 -52.28 4.65 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.723 2.282 . . . . 0.0 111.517 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -95.22 131.48 41.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.767 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.0 t -89.87 118.15 34.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -104.82 118.37 36.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.909 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 HG21 ' A' ' 39' ' ' VAL . 95.6 t -107.17 121.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.191 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -98.38 118.41 34.97 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.005 0.431 . . . . 0.0 109.862 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' SD ' ' A' ' 36' ' ' MET . 29.1 mt -114.47 142.94 25.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 67.2 m80 -124.12 125.36 44.35 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 13.2 m-30 -122.46 131.26 24.41 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 18.4 Cg_endo -60.13 121.52 9.93 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.813 2.342 . . . . 0.0 111.279 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.8 tp -51.42 -36.91 45.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.724 -173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HG3' ' OXT' ' A' ' 92' ' ' GLU . 57.3 mtmt -75.88 -38.86 57.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . 22.2 mtt180 -80.93 -29.86 35.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.2 -15.84 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.553 0.692 . . . . 0.0 109.528 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.77 24.02 7.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.087 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 144.18 44.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.4 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.27 -11.49 46.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.424 . . . . 0.0 110.542 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -99.93 32.6 7.08 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' HD22 ' A' ' 32' ' ' LEU . 52.6 p90 -63.56 -21.83 66.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.009 -0.595 . . . . 0.0 112.003 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.33 -17.59 64.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.017 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -97.67 -9.44 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.934 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 45.4 m-20 -81.36 103.32 11.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.705 0.764 . . . . 0.0 110.606 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.08 -38.94 71.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.031 -171.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 17.7 tp -61.75 -39.4 91.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.06 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.2 tp -68.81 -44.66 73.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.32 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.14 -48.22 68.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.959 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER -70.21 -32.02 69.72 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.363 -176.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -65.23 -43.33 91.78 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.223 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.5 ' SD ' HD13 ' A' ' 14' ' ' ILE . 81.7 mmm -83.87 4.11 30.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.656 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.34 -29.29 9.65 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 60.5 mtpt -68.2 -69.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.233 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.9 p -100.37 82.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.428 1.108 . . . . 0.0 110.424 -175.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -172.08 -26.82 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.842 -170.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -74.84 -36.04 62.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.894 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 p -135.87 67.96 64.33 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.366 0.603 . . . . 0.0 110.781 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -98.62 2.19 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.836 3.024 . . . . 0.0 113.168 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 73.61 -44.23 0.57 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.73 0.812 . . . . 0.0 111.922 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' CG ' HD21 ' A' ' 50' ' ' LEU . 42.7 tp10 -60.25 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.263 0.225 . . . . 0.0 111.241 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 76' ' ' ARG . 47.2 mt-10 -145.38 -102.01 0.1 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.614 0.245 . . . . 0.0 110.797 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 168.66 -106.74 0.26 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.375 176.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 tpt -49.71 -45.94 79.51 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 48' ' ' MET . 18.6 Cg_endo -58.44 -33.19 97.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.977 1.784 . . . . 0.0 111.914 174.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.73 HD23 ' HE1' ' A' ' 53' ' ' TRP . 82.1 mt -57.13 -48.1 79.49 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.184 0.516 . . . . 0.0 109.652 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -61.4 -46.4 90.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.608 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.17 70.62 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.6 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.73 ' HE1' HD23 ' A' ' 50' ' ' LEU . 7.4 p-90 -73.87 -37.82 64.62 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.46 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -69.64 -44.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.065 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.99 -39.79 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.626 0.251 . . . . 0.0 110.744 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -62.72 -48.85 77.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 48.4 t -65.04 -46.98 79.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.872 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.65 84.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -60.77 -46.73 89.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.858 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -63.18 -47.44 82.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.64 97.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.501 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -66.34 -46.0 78.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 -178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.54 -27.71 62.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 0.0 111.555 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -66.06 -34.32 77.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.573 . . . . 0.0 110.607 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -146.73 74.55 12.32 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.661 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.92 33.51 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.244 2.629 . . . . 0.0 113.721 -169.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.29 18.42 9.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -97.53 -179.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -145.23 -8.35 0.6 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -167.88 156.04 8.93 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 111.213 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG22 ' CG1' ' A' ' 87' ' ' VAL . 34.2 m -141.43 159.47 22.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.056 0.455 . . . . 0.0 110.648 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -108.28 120.09 41.38 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.8 0.809 . . . . 0.0 108.983 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.425 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 28.9 tp -123.0 141.1 52.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.565 -168.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 125.64 28.31 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 52.9 Cg_endo -74.33 173.61 13.92 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.819 1.679 . . . . 0.0 112.77 -175.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 57.1 mtp180 -65.72 -36.62 84.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.678 -162.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -68.93 93.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.658 0.742 . . . . 0.0 111.037 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.2 t -61.92 -32.17 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.783 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.24 -23.98 67.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 70.1 m-20 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.065 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p 57.06 -70.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.705 1.253 . . . . 0.0 112.864 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.436 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 8.1 m -90.89 57.84 3.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.259 0.552 . . . . 0.0 111.655 -172.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.21 130.46 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -139.53 138.39 36.26 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.133 0.492 . . . . 0.0 111.108 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -102.95 120.97 41.57 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.583 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -108.49 102.81 11.86 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 71' ' ' VAL . 8.7 p -97.81 124.05 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.568 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.447 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 77.8 mt -112.8 135.71 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.354 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.52 113.07 26.29 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.251 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.09 120.92 22.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -81.75 124.25 29.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 110.492 -173.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' OXT' ' HG3' ' A' ' 19' ' ' LYS . 8.8 pt-20 . . . . . 0 C--O 1.246 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.032 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -141.7 -51.82 0.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.0 110.697 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.98 99.59 2.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -98.01 -4.34 36.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.9 3.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.067 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.417 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 21.4 m80 -91.5 36.13 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.164 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mmt -92.83 106.36 18.6 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 25.8 Cg_exo -62.7 104.15 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.815 2.343 . . . . 0.0 113.076 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.39 108.97 18.71 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -93.1 127.77 44.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.896 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 4.5 p-10 -122.65 121.65 36.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.424 0.63 . . . . 0.0 110.066 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.2 121.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.477 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 50.0 mt-10 -93.95 111.97 23.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 110.855 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 ' SD ' ' A' ' 36' ' ' MET . 13.4 mt -102.33 142.81 15.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.529 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 62.8 m-70 -119.64 111.88 18.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.998 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-85 -110.46 117.29 51.4 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.154 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 32.5 Cg_exo -58.51 127.49 24.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.241 1.961 . . . . 0.0 110.954 174.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -49.44 -44.98 45.93 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.36 -173.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 92' ' ' GLU . 17.4 pttp -77.9 -19.78 54.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 20.4 mmm180 -91.24 -36.88 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -73.44 -14.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.304 0.574 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.65 -0.56 57.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.486 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.37 153.59 17.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.316 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.21 -23.34 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.161 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.87 18.73 52.32 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.661 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -22.88 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.959 0.504 . . . . 0.0 112.018 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.15 -13.61 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.118 0.485 . . . . 0.0 110.794 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -116.8 10.17 14.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.067 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.9 119.55 25.01 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.805 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.12 -33.37 73.27 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.931 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.63 -46.65 84.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.328 0.585 . . . . 0.0 109.977 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.42 -38.99 91.57 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.855 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.19 -41.82 80.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.012 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 96.0 m-20 -65.94 -49.37 68.19 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.054 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.55 -46.64 72.17 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.309 0.576 . . . . 0.0 110.265 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.778 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 11.1 tpt -67.45 -44.71 78.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.185 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.98 -34.13 57.68 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.634 0.584 . . . . 0.0 112.581 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 71.3 mmtt -60.92 -48.26 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.79 42.79 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.236 0.541 . . . . 0.0 111.611 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.778 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -117.64 -35.61 3.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.015 -171.128 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -81.9 -29.07 32.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.211 0.529 . . . . 0.0 110.537 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 p -127.82 65.45 68.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.226 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 82.3 Cg_endo -90.75 7.29 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.432 2.088 . . . . 0.0 111.533 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.12 -49.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.393 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.17 -80.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.13 -69.93 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 0.0 111.493 -172.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . 134.96 -95.01 0.25 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.762 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.464 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 6.8 ttp -64.91 -43.56 68.82 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 50' ' ' LEU . 5.3 Cg_exo -79.37 -26.79 4.72 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.526 2.151 . . . . 0.0 108.915 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.3 tm? -58.0 -45.53 86.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 112.524 -2.126 . . . . 0.0 109.235 172.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -62.97 -49.79 73.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.069 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.22 81.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.576 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.693 ' HE1' HD22 ' A' ' 50' ' ' LEU . 2.5 p-90 -72.16 -39.69 68.55 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.704 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.7 OUTLIER -69.22 -42.63 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.377 -174.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 65.2 mt -67.53 -41.95 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.058 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -61.31 -50.6 72.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.421 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.8 t -63.87 -40.85 97.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.67 87.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.793 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -57.51 -58.09 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.556 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 7.8 pt-20 -69.3 -32.84 72.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.698 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.74 94.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 62' ' ' LEU . 3.4 tm? -67.39 -48.0 68.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.05 -27.49 66.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -64.15 -43.59 94.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' LYS . 15.4 p30 -135.8 75.28 56.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.428 0.632 . . . . 0.0 110.113 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 38.51 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.104 2.536 . . . . 0.0 112.444 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 65' ' ' ASN . 34.7 mmtp -131.58 22.39 4.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.11 -174.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.358 0.599 . . . . 0.0 111.337 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -118.11 -49.78 2.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.235 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 9.2 pt-20 -163.56 163.19 24.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.425 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.71 149.93 32.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.855 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -110.37 118.58 36.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.513 0.673 . . . . 0.0 109.645 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.9 mt -108.02 144.4 35.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.655 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 12.8 tmtt? -121.45 120.04 29.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 28.8 Cg_endo -61.15 162.2 20.49 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.479 2.786 . . . . 0.0 113.634 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -66.3 -17.63 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.844 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.79 89.21 1.35 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.326 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.503 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.3 t -63.22 -21.92 29.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.846 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -56.93 -32.17 65.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.462 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -73.83 -38.66 64.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t 70.87 -63.74 0.4 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.761 0.663 . . . . 0.0 111.838 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.5 m -109.0 47.98 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.35 138.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.971 -0.456 . . . . 0.0 109.884 170.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 46.2 mt-30 -138.9 150.79 46.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.29 0.567 . . . . 0.0 110.714 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.69 117.82 35.11 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.4 t-160 -95.29 102.09 13.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.899 -173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 63.1 t -97.94 113.27 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.26 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 4.9 mp -101.9 139.8 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 70.9 m-85 -102.4 109.78 21.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.926 0.393 . . . . 0.0 110.172 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 16.7 m-20 -77.39 115.4 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.385 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.02 123.03 31.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' A' ' 17' ' ' PRO . 40.4 mt-10 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.561 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.406 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 37.9 p 51.01 57.61 6.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.599 0.76 . . . . 0.0 111.125 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.26 10.02 42.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.481 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.0 ttm -50.03 124.32 9.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.562 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.807 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -71.77 -43.46 65.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmt -126.97 113.83 22.0 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.901 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.5 -49.48 16.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.985 2.457 . . . . 0.0 111.865 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.7 142.74 51.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.7 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.02 118.05 55.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -105.38 118.74 37.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.191 0.52 . . . . 0.0 111.1 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 28.0 t -119.38 138.79 48.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -121.96 131.23 53.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.279 0.561 . . . . 0.0 111.941 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 ' SD ' ' A' ' 36' ' ' MET . 8.2 mt -106.98 136.09 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.693 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -109.01 127.84 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 22.7 m-85 -127.8 125.29 23.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.382 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.521 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 19.1 Cg_exo -66.8 120.79 7.91 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 121.934 1.756 . . . . 0.0 111.046 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 tp -42.18 -44.6 3.79 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.578 1.151 . . . . 0.0 113.645 -167.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -75.7 -40.59 55.48 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.548 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 14.3 ptp180 -90.75 -19.06 23.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.566 HG23 HD22 ' A' ' 62' ' ' LEU . 6.5 tp -72.26 -21.04 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.17 -14.44 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.552 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.61 151.76 34.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.575 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -78.46 -28.54 46.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.379 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.24 3.02 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -66.15 -38.64 88.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.641 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -1.37 21.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.92 -7.95 18.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.548 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 t70 -81.17 121.32 25.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.216 0.531 . . . . 0.0 110.966 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.18 -35.33 78.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.206 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 4.4 mt -65.44 -42.44 92.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.034 0.445 . . . . 0.0 110.005 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.3 -41.89 76.16 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.336 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.7 mt -66.37 -49.04 68.22 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.407 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 2.7 p30 -74.88 -28.66 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.811 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -69.65 -47.03 64.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.784 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 15.5 tpt -72.25 -42.6 65.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.67 -32.31 46.74 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.377 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.03 -53.38 39.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 39' ' ' VAL . 48.3 t -85.17 39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.132 0.968 . . . . 0.0 110.535 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.784 ' HB2' ' O ' ' A' ' 36' ' ' MET . 2.5 t-20 -133.44 -30.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.103 -0.998 . . . . 0.0 112.918 -170.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.511 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 26.2 t70 -80.04 -27.35 39.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -172.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.1 p -122.67 60.78 14.88 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 50' ' ' LEU . 26.8 Cg_endo -98.86 1.74 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.846 2.364 . . . . 0.0 113.711 -173.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 2' ' ' SER . 34.8 tt0 74.04 -46.83 0.63 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.554 0.742 . . . . 0.0 111.92 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' CB ' HD21 ' A' ' 50' ' ' LEU . 37.5 mt-10 -65.6 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 111.739 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -126.09 -77.95 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.266 0.555 . . . . 0.0 110.464 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.748 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 148.96 -96.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.834 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.73 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 1.5 tmt? -59.8 -40.68 80.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 O-C-N 122.121 -0.635 . . . . 0.0 112.34 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 48' ' ' MET . 38.2 Cg_exo -64.54 -29.78 61.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.706 1.604 . . . . 0.0 110.742 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -59.88 -47.77 84.39 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.581 178.43 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -67.46 -40.72 85.35 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.993 178.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.32 78.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.385 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.674 ' CH2' HD21 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -71.67 -46.13 59.83 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.984 -176.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG11 ' HE1' ' A' ' 36' ' ' MET . 1.4 p -70.68 -41.78 77.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.462 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 90.4 mt -64.64 -42.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.722 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.9 tttp -65.22 -46.6 79.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.141 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.6 -43.53 89.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.608 0.242 . . . . 0.0 110.904 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.7 95.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -60.09 -52.24 66.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.565 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.722 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 32.5 mm-40 -58.78 -44.18 90.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.254 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.83 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.747 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 21' ' ' ILE . 6.6 tp -67.31 -46.34 73.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.605 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.44 -25.92 65.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.342 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -63.96 -48.55 76.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -131.47 75.58 76.8 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.208 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.83 43.61 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.078 2.519 . . . . 0.0 112.675 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -128.46 10.38 6.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.846 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 pt -98.34 179.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.173 0.511 . . . . 0.0 110.989 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -128.36 -18.4 4.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.839 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.95 158.41 17.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.304 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.0 p -129.09 151.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -109.61 112.74 25.01 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 122.17 0.986 . . . . 0.0 109.36 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.674 HD21 ' CH2' ' A' ' 53' ' ' TRP . 8.8 tt -125.95 144.7 50.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.558 -163.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -126.95 132.32 24.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.236 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.657 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -33.82 140.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.141 3.894 . . . . 0.0 115.764 175.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -58.78 -38.93 79.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.007 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 74.31 4.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.409 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.18 -19.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.129 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.78 -23.77 65.27 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.63 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -63.24 -33.75 76.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.074 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m 69.84 -68.05 0.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.121 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 m -73.95 -19.5 60.65 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 75' ' ' PRO . 5.6 p -86.47 129.4 38.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.304 0.573 . . . . 0.0 110.669 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -130.69 137.53 49.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.041 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 19.9 m-85 -106.67 125.94 51.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.579 0.704 . . . . 0.0 110.652 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -105.14 104.92 14.74 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.401 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 48.1 t -92.4 112.09 25.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.66 137.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.33 109.67 21.37 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.676 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 115.52 16.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 0.0 110.231 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -84.89 134.05 34.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.074 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.605 -0.712 . . . . 0.0 110.318 -176.291 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -58.03 -41.23 82.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.43 122.04 28.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.9 tpp 74.06 -58.21 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.956 0.785 . . . . 0.0 112.275 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.75 -43.57 97.56 Favored Glycine 0 C--O 1.234 0.155 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.389 -174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -77.44 65.69 3.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.217 0.532 . . . . 0.0 110.248 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.45 ' HB3' ' CD ' ' A' ' 8' ' ' PRO . 50.8 ttp -164.24 -58.43 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.416 177.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' CD ' ' HB3' ' A' ' 7' ' ' MET . 43.9 Cg_endo -68.96 -37.94 10.38 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.616 1.544 . . . . 0.0 110.755 171.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.87 115.73 30.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.178 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.85 118.99 38.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.208 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -123.47 119.45 30.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.403 0.62 . . . . 0.0 109.595 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.568 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 96.3 t -120.95 125.48 74.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.065 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -105.54 112.92 26.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.459 0.647 . . . . 0.0 111.265 -174.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 4.1 mt -101.6 128.01 54.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.509 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 88.6 m-70 -104.13 109.6 21.46 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.288 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 18.6 m-30 -107.14 117.58 55.99 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.151 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' ILE . 31.6 Cg_exo -59.7 120.56 8.44 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.07 1.847 . . . . 0.0 110.982 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 62' ' ' LEU . 2.9 tt -50.57 -36.24 33.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.91 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 18.6 ptpt -72.2 -32.76 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.169 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 29' ' ' ASP . 3.0 mmp_? -92.76 -39.03 11.47 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -72.43 -21.99 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.278 0.561 . . . . 0.0 109.638 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.69 -26.96 64.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.846 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.07 155.59 25.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.855 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.18 -31.35 30.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.592 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.47 49.27 2.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.942 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' HB2' HD22 ' A' ' 32' ' ' LEU . 6.3 p90 -73.48 -18.34 61.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.614 0.245 . . . . 0.0 111.598 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.61 -13.39 62.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 -24.32 52.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.166 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 20' ' ' ARG . 7.7 m-20 -83.72 110.81 18.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.87 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.3 -25.11 67.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.797 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.2 pp -54.41 -41.63 69.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.196 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 31' ' ' LEU . 15.5 tp -73.18 -27.92 61.92 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.499 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.28 -45.82 65.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.901 172.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -61.07 -38.17 85.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.45 -46.68 82.06 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.994 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.67 ' HE1' HG11 ' A' ' 54' ' ' VAL . 83.9 mmm -94.46 17.6 12.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.702 0.763 . . . . 0.0 110.11 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.31 -24.44 7.15 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 164.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -82.81 -65.65 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.256 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' CG1' ' A' ' 12' ' ' VAL . 30.1 m -100.83 45.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.639 0.733 . . . . 0.0 111.072 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -139.79 -17.71 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.896 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.4 -38.2 68.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.866 0.365 . . . . 0.0 110.512 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 p -127.59 70.84 77.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.2 Cg_endo -92.65 13.28 1.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.949 2.433 . . . . 0.0 112.393 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 73.44 -40.45 0.47 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.203 1.001 . . . . 0.0 112.343 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 50' ' ' LEU . 37.7 mt-10 -74.53 -78.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 111.414 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 50' ' ' LEU . 44.4 mt-10 -138.63 -80.06 0.33 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 111.103 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.793 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 154.31 -92.79 0.13 Allowed Glycine 0 C--O 1.222 -0.624 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.697 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.474 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.5 tmt? -62.79 -43.93 84.51 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.931 -0.747 . . . . 0.0 112.692 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 48' ' ' MET . 41.4 Cg_endo -70.63 -24.44 25.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 120.913 1.075 . . . . 0.0 109.765 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -58.37 -45.86 87.43 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.115 172.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -61.51 -48.74 79.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.191 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.57 77.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.742 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 8.2 p-90 -73.52 -37.76 65.55 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.272 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.67 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.8 OUTLIER -69.3 -41.4 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.0 110.165 -174.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.58 -41.7 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.673 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.94 -50.11 73.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.207 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.6 t -62.36 -46.19 89.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.995 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 0.0 110.501 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -62.59 -50.5 71.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.129 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.02 -34.86 79.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.837 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.99 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' HG ' ' A' ' 18' ' ' LEU . 4.7 tt -71.23 -48.41 51.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.403 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.15 -25.7 67.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.693 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.81 -33.27 75.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 110.25 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.36 72.38 8.37 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.078 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.27 39.29 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.965 2.443 . . . . 0.0 113.924 -168.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 34.0 4.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.425 0.631 . . . . 0.0 109.532 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.8 pt -106.47 -175.45 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.577 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 16.9 mtm180 -117.52 -51.21 2.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.235 -177.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' HB2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -156.22 161.47 40.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.18 -177.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -132.46 158.4 43.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.435 0.636 . . . . 0.0 111.401 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.35 113.37 26.12 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.03 0.919 . . . . 0.0 109.428 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 ' CH2' ' A' ' 53' ' ' TRP . 6.1 tt -110.02 139.26 45.34 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.858 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.55 129.38 25.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.157 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.679 ' HG2' HG13 ' A' ' 83' ' ' VAL . 75.3 Cg_exo -46.11 151.03 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.809 3.006 . . . . 0.0 113.292 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -66.98 -37.69 84.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.565 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.6 75.78 2.61 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.737 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.15 -10.72 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.338 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -64.74 -37.1 86.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.184 0.516 . . . . 0.0 110.436 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.3 t 71.46 -67.15 0.27 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.744 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -82.27 6.35 17.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.8 p -108.39 131.83 57.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.034 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -139.21 144.36 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.186 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 81.0 m-85 -107.62 124.63 50.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.145 0.498 . . . . 0.0 109.789 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.1 t60 -103.0 106.0 16.43 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 91.8 t -93.22 116.83 35.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.393 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.416 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 4.4 mp -100.05 136.41 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 40.7 m-85 -103.08 106.68 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.94 0.4 . . . . 0.0 110.381 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 22.1 m-20 -79.69 114.86 18.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.013 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.95 39.89 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.145 -174.223 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -100.14 37.33 1.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.843 0.354 . . . . 0.0 111.263 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.61 75.88 4.15 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.745 0.307 . . . . 0.0 110.323 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.6 mtp 61.89 -96.02 0.06 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.413 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 9' ' ' ALA . . . -141.43 22.95 2.54 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 69.88 -59.99 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.864 0.866 . . . . 0.0 110.531 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.533 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 39.1 tpp -165.35 -55.23 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.552 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' H ' ' A' ' 7' ' ' MET . 58.7 Cg_endo -71.46 -29.13 16.98 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.894 1.729 . . . . 0.0 113.329 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . . . -96.12 145.69 25.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 39.8 t -107.23 134.74 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.054 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -136.11 134.93 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.37 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.23 138.66 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.243 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -106.82 121.22 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 85' ' ' PHE . 1.3 mt -115.91 122.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 79.6 m80 -99.73 132.01 45.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.182 0.515 . . . . 0.0 110.288 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CD1' HG13 ' A' ' 87' ' ' VAL . 3.3 m-85 -119.76 129.07 25.55 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.233 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 21.4 Cg_exo -65.25 110.92 1.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.005 1.804 . . . . 0.0 110.389 171.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.4 tm? -45.88 -42.51 12.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.953 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HG3' ' HD2' ' A' ' 20' ' ' ARG . 17.1 ptpt -78.1 -28.53 48.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 3.7 mpt_? -89.68 -35.27 15.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 112.049 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 6.4 tp -66.58 -25.74 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.463 . . . . 0.0 110.129 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.36 12.66 15.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.16 173.02 7.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.975 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.98 -26.86 20.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.229 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.79 46.72 3.48 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.604 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -79.09 -34.6 43.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.735 0.303 . . . . 0.0 111.277 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.04 59.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.303 0.573 . . . . 0.0 110.415 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -83.71 -9.41 58.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.3 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -85.15 110.54 19.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.244 0.545 . . . . 0.0 110.708 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.84 -34.81 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.764 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.8 mt -60.77 -46.69 89.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.87 -40.29 65.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.567 0.698 . . . . 0.0 109.794 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.15 -46.06 78.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.343 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 3.2 p30 -73.34 -30.78 63.57 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.395 -175.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.619 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 45.3 mt-30 -73.52 -44.84 56.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.346 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -75.09 -15.64 60.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.633 177.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 -21.2 41.29 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -76.2 -54.83 6.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 35' ' ' GLN . 14.7 m -85.71 59.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.739 0.78 . . . . 0.0 109.782 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 36' ' ' MET . 46.0 t30 -137.66 -39.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.398 -170.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -70.23 -41.14 73.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.849 -170.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 p -140.98 66.0 24.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.723 0.297 . . . . 0.0 111.51 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.2 Cg_endo -67.46 -62.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.252 1.968 . . . . 0.0 112.011 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 13.4 tp10 152.53 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -76.79 -85.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.587 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -135.7 -79.04 0.43 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.09 0.471 . . . . 0.0 109.988 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 151.17 -109.71 0.43 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.992 176.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.465 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -51.35 -48.21 86.59 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 36.2 Cg_exo -61.41 -40.43 48.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.032 1.821 . . . . 0.0 112.013 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.779 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -61.07 -43.68 98.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.958 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -67.63 -34.34 76.77 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.506 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.86 79.98 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.779 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.2 p-90 -72.44 -38.2 68.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.332 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.95 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.047 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.0 mt -57.86 -44.06 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.347 0.117 . . . . 0.0 110.752 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 53.3 tptt -63.85 -49.54 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.85 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.0 t -64.07 -43.86 94.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.051 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.85 92.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.0 109.977 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 1.1 t-80 -58.22 -58.93 6.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.544 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 11.8 pt-20 -66.98 -34.51 77.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.78 98.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 110.552 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -66.84 -45.96 76.59 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 51.6 mt-10 -63.31 -27.85 69.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.404 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.46 -39.54 85.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.458 . . . . 0.0 110.168 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -141.28 71.74 26.96 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.279 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.95 42.31 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.04 2.493 . . . . 0.0 113.065 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -128.79 11.6 6.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.008 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt -89.34 178.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.632 0.729 . . . . 0.0 112.268 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -110.37 -43.74 3.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.545 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.9 pt-20 -163.64 151.27 12.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.832 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.6 150.08 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.63 111.46 22.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.698 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.7 pp -109.85 133.23 53.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.464 0.65 . . . . 0.0 110.833 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -103.24 124.28 38.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 81.1 Cg_endo -80.03 175.97 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.201 1.934 . . . . 0.0 114.178 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.98 -13.88 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.551 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.49 74.99 3.23 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.52 -24.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.042 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -63.74 -27.47 69.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.563 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.42 -34.43 47.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.966 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.2 p 58.84 -72.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.709 1.256 . . . . 0.0 112.382 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m -84.07 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 8.5 p -134.32 130.65 54.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -136.92 139.0 41.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.154 0.502 . . . . 0.0 111.437 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 79.7 m-85 -101.92 128.1 48.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.688 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -96.74 107.95 20.51 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 16' ' ' PHE . 54.0 t -91.81 109.63 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.454 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 66.4 mt -102.42 135.04 41.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.76 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -102.62 110.25 22.13 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -99.36 122.95 43.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.804 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -84.58 113.77 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.123 178.229 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -101.4 104.79 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.911 0.386 . . . . 0.0 110.397 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.35 73.67 10.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.126 0.489 . . . . 0.0 110.218 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptp -82.24 -9.73 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.945 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 71.22 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.124 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -94.78 -0.9 53.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 0.0 110.479 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.4 tpt 70.64 110.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.83 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.66 141.43 90.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.46 120.78 27.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.946 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.96 118.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.22 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -127.35 133.58 50.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.967 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 85' ' ' PHE . 1.4 p -117.31 138.56 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.68 111.49 23.73 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.309 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 36' ' ' MET . 17.1 mt -102.79 123.69 56.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.184 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.87 127.11 46.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -120.84 126.96 26.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.17 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -59.97 117.03 3.73 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.147 1.898 . . . . 0.0 110.945 171.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.07 -36.89 66.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.931 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.49 -29.16 56.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.651 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HD3' ' HB2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -91.82 -31.38 15.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.862 -177.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.32 -19.1 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 109.983 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -89.12 -7.21 56.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.04 149.64 21.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.781 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.73 -21.03 41.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.63 34.92 4.57 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.401 ' HB2' HD22 ' A' ' 32' ' ' LEU . 53.2 p90 -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.402 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.54 -5.72 38.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 111.173 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.23 -2.94 35.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.855 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.49 117.16 28.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -63.91 -31.59 72.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.076 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.5 mm? -61.67 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.336 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 26' ' ' TYR . 34.2 tp -72.12 -37.59 69.47 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.595 0.712 . . . . 0.0 109.577 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.97 -45.64 63.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.349 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -73.44 -33.6 64.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.675 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.72 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -75.23 -46.72 32.0 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -176.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 9.7 tpt -95.06 3.62 54.63 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.22 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.27 -24.01 23.03 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 165.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.37 -68.75 0.42 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.879 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 m -87.73 65.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.87 0.843 . . . . 0.0 110.396 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 36' ' ' MET . 59.0 t30 -149.56 -27.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.78 -169.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 30.4 t70 -69.18 -44.97 71.1 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.665 0.745 . . . . 0.0 110.196 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -124.74 71.2 59.37 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.249 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 45' ' ' GLU . 73.5 Cg_endo -91.86 -2.12 4.27 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.774 2.316 . . . . 0.0 112.37 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 71.39 -42.58 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.56 0.744 . . . . 0.0 110.428 -173.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -50.67 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.026 175.219 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 49' ' ' PRO . 44.4 mt-10 -144.07 -73.77 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.595 0.712 . . . . 0.0 109.879 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 146.27 -105.81 0.35 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.528 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.421 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.7 tpt -57.3 -46.29 99.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 12.1 Cg_exo -68.7 -32.29 24.02 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.185 1.924 . . . . 0.0 110.742 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -57.76 -45.24 86.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.853 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.587 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 27.6 ttt180 -65.6 -45.91 81.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.013 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -48.32 81.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.716 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.8 p-90 -72.29 -39.18 68.5 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.019 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -41.15 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.716 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.8 -40.9 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.586 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -58.86 -50.44 74.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 111.009 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.453 ' SG ' HD21 ' A' ' 73' ' ' LEU . 44.6 t -61.97 -44.47 96.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.739 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.09 94.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.52 -51.11 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.83 -45.73 81.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.343 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.34 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 22' ' ' ALA . 3.0 tm? -66.47 -47.26 73.63 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.669 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.7 -36.76 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 110.324 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.74 75.07 12.2 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.828 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.21 39.99 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.214 2.609 . . . . 0.0 113.206 -170.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -136.3 26.15 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.5 -172.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.401 0.62 . . . . 0.0 111.835 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -123.99 -45.92 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.37 159.51 17.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.27 155.99 42.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.841 0.353 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.87 114.86 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.026 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.453 HD21 ' SG ' ' A' ' 57' ' ' CYS . 7.3 mt -108.12 140.14 41.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -101.86 122.5 47.15 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 91.1 Cg_endo -76.84 -171.19 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.121 1.881 . . . . 0.0 113.626 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -73.81 -47.03 41.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.24 76.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 111.063 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.96 -16.97 21.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.158 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -68.19 -25.31 65.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 110.293 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -64.46 -25.1 67.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 68.13 -81.49 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.6 173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -83.48 61.48 6.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.223 0.535 . . . . 0.0 111.53 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.13 135.32 37.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -140.22 137.68 34.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.887 0.375 . . . . 0.0 110.498 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 50' ' ' LEU . 20.9 m-85 -105.48 119.09 38.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.465 0.65 . . . . 0.0 109.407 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.71 102.87 13.08 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.698 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.1 t -92.8 113.44 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.47 135.61 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.03 106.86 17.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.171 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -79.4 142.43 35.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.64 106.4 13.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.777 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 126.163 1.785 . . . . 0.0 107.896 174.239 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 m -90.29 -35.55 15.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.918 0.39 . . . . 0.0 111.016 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.76 77.16 1.24 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -99.64 170.16 8.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.22 75.6 2.05 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.83 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -67.12 -30.79 70.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.892 0.377 . . . . 0.0 110.311 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 74.0 mtm -67.27 122.27 82.2 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.934 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.52 -37.92 76.97 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.683 2.255 . . . . 0.0 111.332 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.63 122.13 36.67 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.881 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.17 118.42 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -108.53 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.045 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 43.1 t -108.93 135.79 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -104.29 112.25 25.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.454 -175.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -108.3 129.14 63.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 68.8 m80 -113.91 127.76 56.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.13 0.49 . . . . 0.0 110.776 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 25.0 m-85 -125.51 121.87 24.83 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.223 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 27.9 Cg_exo -61.11 129.96 30.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.746 1.631 . . . . 0.0 110.84 175.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CD2' HD21 ' A' ' 62' ' ' LEU . 2.5 tm? -50.54 -38.66 46.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.043 -175.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.05 -29.68 60.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.34 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 21.3 mmm180 -90.35 -37.19 14.19 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.452 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 tp -73.17 -16.9 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 109.659 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -101.94 18.84 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.305 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.95 169.79 8.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.613 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.79 -38.47 18.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.03 42.38 2.28 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.314 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 27.1 p90 -73.77 -26.76 60.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.14 -4.02 36.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -114.69 4.7 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.752 0.787 . . . . 0.0 109.394 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 31' ' ' LEU . 19.2 t70 -87.18 119.6 27.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.511 -175.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.65 -36.71 67.35 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.71 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.471 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 3.9 mm? -63.9 -46.0 86.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.557 0.694 . . . . 0.0 110.665 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -35.84 75.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.358 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.1 -48.01 59.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.241 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.85 -35.67 64.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.728 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.53 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -71.66 -46.6 58.46 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.974 0.416 . . . . 0.0 110.723 -177.446 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.614 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -93.14 3.75 55.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.21 0.528 . . . . 0.0 110.467 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.62 -26.95 12.18 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 167.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -74.52 -58.86 3.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 35' ' ' GLN . 20.2 m -86.45 53.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.744 0.783 . . . . 0.0 110.338 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.5 t-20 -134.34 -35.25 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.85 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.6 -35.6 67.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 p -128.69 70.17 80.3 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.0 Cg_endo -92.63 5.54 3.31 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.878 2.385 . . . . 0.0 112.52 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 72.27 -43.14 0.55 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.786 0.834 . . . . 0.0 111.564 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 75' ' ' PRO . 10.8 tp10 -67.46 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.841 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -139.85 -88.97 0.19 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.51 0.195 . . . . 0.0 111.064 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 161.42 -92.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.725 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 1.7 tmt? -64.65 -45.22 75.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 31.9 Cg_exo -65.35 -31.1 53.13 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 121.526 1.484 . . . . 0.0 110.345 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.734 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.5 tm? -58.61 -47.1 85.47 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.045 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.4 ptm180 -69.72 -40.98 75.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.806 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.13 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.734 ' HE1' HD22 ' A' ' 50' ' ' LEU . 11.2 p-90 -73.63 -37.32 65.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.854 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.0 -42.27 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.422 0.153 . . . . 0.0 110.931 -175.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.518 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 93.0 mt -67.2 -39.53 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.6 mmmm -62.66 -50.18 72.2 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.707 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.29 -43.42 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.733 0.301 . . . . 0.0 110.747 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.22 98.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.541 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -63.44 -45.19 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.366 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 43.9 mm-40 -62.07 -47.18 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.38 83.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.155 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.1 tm? -65.17 -47.18 77.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.135 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.66 -27.05 62.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.789 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 3.0 ttmp? -71.5 -38.84 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.173 0.511 . . . . 0.0 110.125 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -135.81 74.98 56.76 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.25 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.45 29.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.455 2.77 . . . . 0.0 113.506 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -125.86 25.72 6.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.222 0.534 . . . . 0.0 110.232 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.71 179.39 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.809 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -118.97 -36.75 3.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.863 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -164.32 168.34 18.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.914 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 13.9 p -135.86 148.97 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.96 117.21 33.18 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 49.8 tp -130.71 132.29 45.28 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.54 -164.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -109.77 134.05 20.74 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.488 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 29.0 Cg_endo -61.23 158.78 33.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.639 2.226 . . . . 0.0 113.2 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -61.88 -42.86 99.57 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.399 -165.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.84 116.83 8.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.843 0.83 . . . . 0.0 110.946 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.86 -16.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.543 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -58.04 -40.59 81.29 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.149 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -75.09 -36.53 61.7 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.915 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.4 m 70.68 -63.55 0.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.425 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 p -111.18 58.85 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.37 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -135.43 142.13 45.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.952 0.406 . . . . 0.0 111.13 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 99.9 m-85 -105.16 124.29 49.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -97.31 103.89 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 75.2 t -91.42 110.76 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 89.8 mt -105.48 134.61 46.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.177 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 57.4 m-85 -103.02 106.26 16.75 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.181 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -86.07 126.47 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.18 126.07 42.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.694 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.586 176.947 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -91.06 114.25 26.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.833 0.349 . . . . 0.0 110.315 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.61 -61.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.952 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.3 mmm -91.45 78.37 5.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 110.764 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.65 -176.23 18.35 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -88.7 -47.09 8.5 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.9 tpp -132.91 81.77 57.07 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.701 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.19 -178.57 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.887 2.391 . . . . 0.0 112.285 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.51 139.75 53.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.38 121.08 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.935 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.25 118.55 36.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.285 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 21.4 t -121.07 121.78 65.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -112.04 132.59 54.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.919 -166.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.18 152.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.568 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -120.71 128.15 52.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.827 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 8.4 m-85 -127.75 105.63 20.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.835 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.768 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 26.3 Cg_exo -60.67 120.55 8.35 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 121.588 1.525 . . . . 0.0 110.888 172.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -54.6 -42.33 70.98 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.804 -169.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG3' HD23 ' A' ' 18' ' ' LEU . 54.8 mtmt -61.25 -32.0 71.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.251 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 5.0 mtt180 -95.55 -35.65 11.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 62' ' ' LEU . 4.8 tp -69.7 -27.13 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.069 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.46 59.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 110.967 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.63 -169.45 1.66 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -125.91 138.36 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.87 17.37 18.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -170.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 20' ' ' ARG . 7.9 t80 -67.03 -23.87 65.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.957 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.1 -9.36 38.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.661 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -103.41 1.66 32.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.708 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.57 112.66 6.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.57 -42.47 88.06 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.793 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.26 -42.21 90.64 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.517 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -64.52 -39.83 94.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.047 0.451 . . . . 0.0 110.046 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.24 -40.99 87.69 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.996 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -73.49 -41.63 62.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.137 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -70.13 -50.39 41.03 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.307 0.575 . . . . 0.0 111.899 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.625 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -80.68 -22.35 40.48 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.8 95.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.245 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -62.87 -56.72 14.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 39' ' ' VAL . 85.8 t -85.19 69.67 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.643 0.735 . . . . 0.0 110.242 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.625 ' HB2' ' O ' ' A' ' 36' ' ' MET . 1.8 t30 -154.08 -34.96 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.748 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.57 -36.8 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.205 -169.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -134.27 66.66 71.53 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.813 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -98.11 4.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.585 2.19 . . . . 0.0 112.948 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.85 -39.56 0.45 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.931 . . . . 0.0 112.417 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.6 OUTLIER -64.9 -79.25 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.363 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -143.95 -81.56 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.005 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 156.0 -110.93 0.46 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.194 177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.599 ' HA ' HD22 ' A' ' 40' ' ' ASN . 5.6 ttp -60.07 -41.35 84.29 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 48' ' ' MET . 43.3 Cg_exo -59.67 -44.47 31.37 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.84 1.693 . . . . 0.0 111.531 174.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -60.01 -37.68 80.43 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 48' ' ' MET . 22.1 ttt180 -55.51 -49.73 71.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.186 173.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.46 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.747 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.797 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.7 p-90 -72.1 -39.27 69.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.62 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -62.42 -51.04 77.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 96.0 mt -59.63 -36.91 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -48.52 67.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.987 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.432 ' HG ' ' HE3' ' A' ' 53' ' ' TRP . 95.1 m -70.58 -41.06 72.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.63 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.506 0.669 . . . . 0.0 109.626 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.661 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.3 t-160 -56.62 -54.03 50.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.954 175.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.41 -39.08 93.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.325 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.39 98.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 21' ' ' ILE . 13.2 tp -68.31 -46.65 69.69 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 39.4 mt-10 -65.31 -27.62 68.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.799 0.333 . . . . 0.0 110.986 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 12.3 tmtt? -65.33 -34.45 78.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 109.817 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.458 HD21 ' HD2' ' A' ' 64' ' ' LYS . 2.1 p30 -149.86 75.25 9.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.681 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 46.67 2.12 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.323 2.682 . . . . 0.0 113.285 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -143.38 34.87 1.32 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.304 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.3 pt -110.7 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.512 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -144.39 -19.85 0.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.467 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -166.34 149.91 7.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -139.05 157.84 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.379 . . . . 0.0 110.677 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -116.46 113.27 22.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.657 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.5 pp -109.28 136.31 48.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.566 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -109.87 129.16 24.24 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 90.5 Cg_endo -77.56 162.75 30.13 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.779 1.653 . . . . 0.0 114.097 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -65.31 -13.67 59.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.499 -172.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.4 88.08 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.224 0.535 . . . . 0.0 110.035 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.59 -33.06 57.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.607 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.8 -27.44 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.686 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . 5.0 m-20 -65.78 -38.9 90.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.627 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m 61.25 -77.43 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.344 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -83.53 33.74 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.686 ' CG2' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -112.01 130.45 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.85 139.57 51.17 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.763 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.526 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 69.8 m-85 -97.59 120.38 37.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.544 0.687 . . . . 0.0 109.252 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.76 100.61 13.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.547 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.7 t -98.37 112.2 29.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.195 0.521 . . . . 0.0 110.129 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.24 141.1 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.259 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 58.7 m-85 -101.32 106.46 17.64 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.768 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 m-20 -83.81 136.52 34.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.724 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HA ' HD21 ' A' ' 18' ' ' LEU . 6.1 pt-20 -109.28 125.52 52.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.572 -0.728 . . . . 0.0 109.839 -179.252 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.048 0.451 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.64 118.75 37.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 39' ' ' VAL . 38.2 t -111.83 119.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.417 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 30.0 mt-10 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.272 0.558 . . . . 0.0 110.687 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.758 HG21 ' SD ' ' A' ' 36' ' ' MET . 4.8 mt -98.08 152.48 4.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.378 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -122.33 126.07 47.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.922 0.391 . . . . 0.0 110.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE1' ' SD ' ' A' ' 36' ' ' MET . 8.0 m-30 -116.89 125.8 28.01 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.249 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 38.9 Cg_exo -59.4 108.5 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.036 1.824 . . . . 0.0 110.788 171.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.8 -36.07 35.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.743 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -38.55 75.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.637 0.256 . . . . 0.0 111.588 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.414 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.7 mpt_? -86.59 -35.56 19.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.379 -173.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.499 HG23 HD22 ' A' ' 62' ' ' LEU . 9.6 tp -66.12 -22.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 109.626 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.17 24.52 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.216 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.27 170.65 15.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.74 136.9 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.92 26.31 19.8 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -63.34 -29.17 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.579 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.88 -4.3 23.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.487 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.23 -8.41 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.898 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -80.43 115.69 20.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.345 0.593 . . . . 0.0 109.897 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.29 -33.46 75.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.325 -168.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -43.31 75.8 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.841 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -64.45 -40.07 95.03 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.719 0.771 . . . . 0.0 109.02 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.77 -44.76 66.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -74.19 -26.8 60.49 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.559 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.9 50.49 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.388 0.613 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.758 ' SD ' HG21 ' A' ' 14' ' ' ILE . 94.8 mmm -72.69 -29.37 63.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.445 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.47 -27.84 70.64 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.88 -41.57 91.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 110.17 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 12' ' ' VAL . 3.6 p -108.65 77.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.161 0.981 . . . . 0.0 110.202 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -150.6 -25.47 0.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.401 -174.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.18 -32.56 16.57 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.103 -174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 t -143.45 63.77 12.91 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.407 0.622 . . . . 0.0 110.695 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 17.5 Cg_endo -93.58 14.86 1.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.96 2.44 . . . . 0.0 113.332 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HG3' HD21 ' A' ' 80' ' ' ASN . 21.2 tp10 75.36 -39.32 0.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.444 0.698 . . . . 0.0 112.117 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 27.4 tt0 -84.42 -104.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.937 -0.477 . . . . 0.0 110.632 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -102.05 -90.5 0.35 Allowed 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.028 0.442 . . . . 0.0 110.735 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 162.97 -111.71 0.48 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.45 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.5 tmt? -57.95 -44.86 99.7 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 51.8 Cg_exo -58.2 -41.85 62.78 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.971 1.78 . . . . 0.0 111.976 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.91 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.83 -40.59 93.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.317 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.517 ' HB2' HD21 ' A' ' 40' ' ' ASN . 5.1 ttp85 -54.95 -46.21 74.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.602 0.239 . . . . 0.0 110.583 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -58.76 -48.53 80.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.675 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.91 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.0 p-90 -72.73 -40.05 66.42 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.235 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 t -61.2 -51.04 77.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.576 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 36' ' ' MET . 50.5 mt -57.75 -43.25 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.249 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 52' ' ' ALA . 62.4 mttp -63.23 -50.23 71.03 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.26 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.8 m -61.39 -45.85 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.21 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.31 . . . . 0.0 110.859 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -57.97 -52.49 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.934 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 46.8 mt-10 -69.09 -39.73 78.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.28 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.83 88.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 21' ' ' ILE . 6.4 tp -70.71 -45.55 64.74 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.95 -32.87 74.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 28.4 mmmt -80.03 -22.71 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.349 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.42 HD21 HD13 ' A' ' 68' ' ' ILE . 1.6 p-10 -140.94 69.56 29.16 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.475 0.655 . . . . 0.0 109.707 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.47 50.34 3.35 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.406 2.737 . . . . 0.0 113.182 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -142.18 28.33 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.374 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.42 HD13 HD21 ' A' ' 65' ' ' ASN . 33.1 pt -110.07 -172.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.35 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -131.57 -39.86 1.12 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.143 -173.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -164.3 156.75 16.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.797 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.11 122.55 48.17 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.442 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 7.9 mt -106.56 136.71 45.87 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.125 -173.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.99 117.62 61.06 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.448 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.728 ' HG2' HG13 ' A' ' 83' ' ' VAL . 43.1 Cg_exo -40.05 135.5 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.58 2.853 . . . . 0.0 113.347 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -62.65 -25.67 68.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.355 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -82.87 68.3 9.3 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 t -57.35 -23.19 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.363 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.514 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 3.5 mptp? -61.56 -24.05 66.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.626 ' ND2' HG11 ' A' ' 83' ' ' VAL . 51.5 t30 -65.9 -17.94 65.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.34 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.1 p 62.17 -96.57 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 168.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -78.11 53.69 1.24 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.33 0.586 . . . . 0.0 112.555 -167.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.1 p -142.11 134.53 27.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.928 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -139.37 145.4 38.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.693 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.0 117.29 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.713 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 13.2 t-160 -98.01 102.64 14.44 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.7 t -91.77 112.92 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.101 0.477 . . . . 0.0 109.985 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.2 mt -104.3 139.03 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.051 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -102.71 106.91 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.49 135.91 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.77 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 9.3 p-10 -101.43 119.2 38.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.578 0.704 . . . . 0.0 109.771 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -95.3 139.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.791 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -92.25 130.95 37.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.381 0.61 . . . . 0.0 110.337 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.516 HD13 ' SD ' ' A' ' 36' ' ' MET . 25.5 mt -128.59 133.19 67.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 61.1 m80 -120.26 126.29 50.23 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 110.795 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.2 m-85 -127.57 115.01 21.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 37.3 Cg_exo -61.27 121.95 10.4 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.292 1.994 . . . . 0.0 111.861 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -43.35 -44.01 5.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 113.851 -1.522 . . . . 0.0 113.901 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -77.41 -38.31 49.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HD2' ' HG2' ' A' ' 17' ' ' PRO . 17.7 ptp180 -89.34 -25.14 21.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.741 -172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HD22 ' A' ' 62' ' ' LEU . 7.2 tp -71.65 -22.57 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.08 -11.89 58.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 142.3 44.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.198 0.523 . . . . 0.0 110.845 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.44 -19.43 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.75 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.54 55.36 0.83 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -67.85 -40.46 83.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.489 0.185 . . . . 0.0 111.211 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 61.92 1.51 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.696 0.76 . . . . 0.0 110.032 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.21 -34.9 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.247 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 29.2 t70 -75.1 119.97 19.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.813 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 29.5 tt0 -64.57 -35.24 80.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.36 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.36 -43.06 92.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.252 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -65.59 -41.9 92.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.73 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -70.3 -45.09 66.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.092 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 90.4 m-20 -61.8 -37.6 84.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.379 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 43.6 mt-30 -73.76 -41.93 61.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.609 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 70.8 mmm -86.84 12.24 11.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.9 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.19 -27.14 6.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 164.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.77 -62.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.076 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.09 71.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 122.07 0.938 . . . . 0.0 109.771 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.7 t-20 -147.5 -44.65 0.17 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -165.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.27 -39.56 54.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.838 0.352 . . . . 0.0 111.034 -171.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -128.55 69.77 79.48 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.694 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HB2' HD12 ' A' ' 50' ' ' LEU . 53.2 Cg_endo -98.96 25.52 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.312 2.674 . . . . 0.0 112.816 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.456 ' HG3' HD21 ' A' ' 80' ' ' ASN . 5.1 tp10 73.38 -39.39 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.552 0.741 . . . . 0.0 112.114 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.562 ' CB ' HD21 ' A' ' 50' ' ' LEU . 32.5 mt-10 -85.56 -88.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.266 0.555 . . . . 0.0 111.441 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.01 -86.61 0.44 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.054 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.672 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 158.49 -78.45 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.972 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.48 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -63.0 -47.62 86.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 17.3 Cg_exo -69.02 -24.32 33.19 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.857 1.705 . . . . 0.0 110.326 175.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -59.77 -48.2 82.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.649 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 36.3 ptt180 -75.11 -38.86 60.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.584 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.29 81.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.209 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.0 p-90 -72.45 -43.83 63.21 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.91 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -40.99 78.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.383 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.492 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 83.1 mt -66.54 -45.59 88.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.522 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 38.6 ttmt -63.96 -47.7 79.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.5 m -65.26 -42.61 93.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.193 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.73 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.395 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.21 -52.63 64.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.575 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 19.2 mm-40 -61.53 -42.47 98.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.863 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.03 93.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 HG23 ' A' ' 21' ' ' ILE . 8.4 tp -63.65 -46.97 83.21 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.511 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.1 -26.89 63.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.18 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.77 -40.03 91.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 110.082 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.419 HD21 HD13 ' A' ' 68' ' ' ILE . 2.1 p-10 -135.86 73.78 59.25 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.322 177.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 55.84 4.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.037 2.492 . . . . 0.0 112.322 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -132.16 -6.58 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.631 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.419 HD13 HD21 ' A' ' 65' ' ' ASN . 31.6 pt -93.52 -175.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.177 -170.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.82 -9.51 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.418 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -166.37 152.72 8.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.973 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.89 156.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.353 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -111.17 115.66 29.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.325 0.583 . . . . 0.0 109.898 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.123 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -118.93 131.84 24.17 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.43 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.641 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -26.9 137.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 1 C-N-CA 125.709 4.272 . . . . 0.0 115.905 173.317 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -55.47 -45.1 76.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.578 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.68 83.25 2.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.59 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.38 -21.37 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.394 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -65.07 -24.09 67.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.606 ' ND2' HG11 ' A' ' 83' ' ' VAL . 48.4 t30 -64.75 -22.76 67.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m 68.54 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 m -79.24 49.45 0.97 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -167.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 75' ' ' PRO . 6.7 p -142.85 136.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -146.79 154.59 41.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.539 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.07 135.06 54.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.126 0.489 . . . . 0.0 110.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -106.11 103.47 12.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.608 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.0 111.95 24.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.71 137.76 35.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.172 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 71.4 m-85 -102.46 108.53 19.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.391 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 15' ' ' HIS . 10.5 m-20 -76.38 120.39 21.56 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 121.573 0.701 . . . . 0.0 110.914 -174.135 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 3.3 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.123 0.487 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.42 118.62 37.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.233 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.72 117.78 43.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 31.7 mt-10 -103.93 112.04 24.85 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.202 0.525 . . . . 0.0 110.449 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 2.3 mt -108.5 124.42 64.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 79.6 m80 -101.83 112.37 24.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -99.94 128.93 29.64 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.526 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 40.5 Cg_endo -68.13 111.43 2.46 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.048 1.832 . . . . 0.0 111.133 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HG22 ' A' ' 21' ' ' ILE . 10.4 tt -51.09 -37.87 48.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.223 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -70.34 -34.95 73.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -93.49 -30.79 14.85 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.304 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 18' ' ' LEU . 7.3 tp -66.08 -24.85 34.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 121.076 0.465 . . . . 0.0 109.901 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.03 68.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.26 148.53 41.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.521 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.86 -22.01 29.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.327 0.584 . . . . 0.0 109.77 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.57 3.24 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 173.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -71.87 -13.93 61.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.807 0.337 . . . . 0.0 111.627 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.13 -12.08 61.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.304 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.14 -5.42 56.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.48 107.05 18.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.253 0.549 . . . . 0.0 110.876 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.58 -32.15 72.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.5 mt -58.5 -45.78 88.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.001 0.429 . . . . 0.0 110.507 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.17 -40.8 67.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.46 0.648 . . . . 0.0 110.001 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' LEU . 12.4 tp -70.76 -44.08 67.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.621 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 2.5 p30 -71.94 -34.24 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.792 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -69.87 -38.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.807 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.24 5.68 29.25 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.762 175.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.88 -28.68 8.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 32.3 mmtp -77.02 -70.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.38 34.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.975 0.893 . . . . 0.0 110.596 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 36' ' ' MET . 26.8 t-20 -138.63 -8.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.812 -173.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.14 -32.27 63.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.453 0.644 . . . . 0.0 109.866 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -138.45 67.75 45.47 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.462 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -88.9 7.96 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 112.636 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 72.64 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.711 0.804 . . . . 0.0 111.873 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 10.2 tt0 -64.1 -70.05 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.828 0.346 . . . . 0.0 111.05 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.63 -129.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.675 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -154.61 -94.88 0.11 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 167.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 11.1 ttp -53.16 -42.89 93.3 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.675 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 14.4 Cg_exo -70.5 -28.36 21.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.912 1.742 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.8 tm? -57.69 -45.69 85.32 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -60.19 -49.22 78.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.46 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.72 76.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 -175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.5 p-90 -73.41 -37.38 65.93 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.523 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.96 -51.34 67.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.61 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.707 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 4.8 tppp? -64.1 -50.37 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.863 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 73' ' ' LEU . 50.0 t -61.7 -46.46 89.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.342 . . . . 0.0 110.724 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.43 89.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.461 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -62.37 -45.35 93.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.114 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 56' ' ' LYS . 58.6 mt-10 -62.45 -47.21 85.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.2 96.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.199 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 62' ' ' LEU . 3.2 tm? -74.37 -37.88 63.33 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.436 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.27 -26.07 36.05 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.449 -0.782 . . . . 0.0 112.024 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.7 tmtp? -82.72 -37.12 25.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.639 ' ND2' HG23 ' A' ' 68' ' ' ILE . 4.0 t30 -131.4 90.43 37.88 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.864 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -88.14 31.68 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.611 2.207 . . . . 0.0 111.365 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -118.34 11.29 13.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.639 HG23 ' ND2' ' A' ' 65' ' ' ASN . 7.3 pt -95.49 166.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.243 173.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -129.4 -3.58 4.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.92 157.35 9.82 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.984 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.38 156.94 39.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.981 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -110.39 117.45 33.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.384 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.5 mt -111.1 140.76 45.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.627 0.727 . . . . 0.0 112.383 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.472 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 23.6 tptm -117.58 123.93 29.38 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.425 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HG2' HG13 ' A' ' 83' ' ' VAL . 68.7 Cg_exo -38.97 144.44 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.247 3.298 . . . . 0.0 113.799 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -65.79 -30.96 71.68 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -79.11 76.62 5.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.844 169.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.73 -25.14 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -57.09 -24.0 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.683 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HB3' HG12 ' A' ' 83' ' ' VAL . 8.7 m-20 -62.93 -36.57 83.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.107 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m 65.67 -76.38 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -86.68 36.33 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.4 p -140.79 130.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -127.9 151.15 49.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.208 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.412 ' CE2' HD21 ' A' ' 50' ' ' LEU . 74.4 m-85 -112.19 123.65 50.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.239 0.542 . . . . 0.0 110.2 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 12.1 t-160 -112.14 102.25 10.46 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 90.1 t -95.52 113.68 30.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.135 0.493 . . . . 0.0 110.206 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 88.0 mt -101.82 140.78 19.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -103.13 107.62 18.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.676 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 33.8 m-20 -94.72 116.69 29.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 121.574 0.702 . . . . 0.0 111.083 -176.139 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.08 121.53 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.549 0.69 . . . . 0.0 110.27 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 39' ' ' VAL . 87.3 t -92.28 139.58 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.719 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.62 112.8 26.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.0 110.519 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.0 mt -103.07 152.21 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 56.3 m80 -130.43 142.84 50.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.488 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -141.96 132.53 12.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.075 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 21' ' ' ILE . 19.4 Cg_endo -58.3 115.26 2.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.503 2.135 . . . . 0.0 111.706 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 62' ' ' LEU . 1.5 tm? -43.07 -50.82 6.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.584 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.55 -18.82 58.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 9.5 ttt180 -100.77 -35.3 9.5 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.881 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -69.4 -25.72 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.223 0.535 . . . . 0.0 109.81 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.85 -12.13 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.92 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.6 171.31 12.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.002 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.24 -52.3 17.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 109.783 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.06 71.32 3.03 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.103 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.552 ' O ' HD22 ' A' ' 32' ' ' LEU . 16.7 p90 -65.24 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.909 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.04 4.97 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.0 111.251 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 20' ' ' ARG . 36.3 t70 -75.39 113.96 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.51 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -63.03 -34.8 78.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.466 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 32.1 tp -61.5 -40.33 94.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.522 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -55.84 -42.73 76.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 109.58 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD13 ' NH2' ' A' ' 51' ' ' ARG . 3.5 mm? -65.08 -47.7 76.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.407 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.53 -41.83 88.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.83 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.544 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 14.5 mt-30 -66.42 -44.09 83.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.343 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.5 mmm -87.68 -1.09 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.3 -26.68 15.12 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 165.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' GLN . 60.6 tttp -64.81 -66.58 0.52 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.274 -0.963 . . . . 0.0 110.829 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 12' ' ' VAL . 7.5 p -108.61 97.59 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.748 0.785 . . . . 0.0 110.229 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -176.59 -26.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.55 -44.56 96.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.043 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -145.1 73.98 14.44 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.745 0.783 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -91.44 21.03 0.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.838 2.359 . . . . 0.0 112.45 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 71.59 -37.76 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 112.366 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 75' ' ' PRO . 23.6 tp10 -82.4 -94.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.332 -0.23 . . . . 0.0 111.169 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.668 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 32.7 mt-10 -114.82 -109.16 0.36 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.737 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 167.67 -106.27 0.25 Allowed Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.658 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.689 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 10.8 tpt -49.77 -48.39 77.34 Favored Pre-proline 0 C--O 1.247 0.954 0 CA-C-O 120.958 0.409 . . . . 0.0 111.317 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HG2' ' HB3' ' A' ' 46' ' ' GLU . 31.4 Cg_endo -60.58 -34.15 92.81 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.043 1.162 . . . . 0.0 110.366 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.711 ' O ' ' HE3' ' A' ' 53' ' ' TRP . 4.0 mt -60.28 -44.41 95.38 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.2 ptm180 -62.83 -39.21 93.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.211 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.36 94.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.722 0.772 . . . . 0.0 110.047 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.711 ' HE3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -51.15 69.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.95 1.3 . . . . 0.0 112.881 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -73.35 -43.71 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -58.52 -38.98 73.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.628 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 12.5 mmmm -69.62 -49.1 57.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.698 174.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.697 ' SG ' HD11 ' A' ' 73' ' ' LEU . 49.7 t -59.18 -44.45 92.17 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.777 0.322 . . . . 0.0 110.942 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -65.38 -42.18 92.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.301 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -61.35 -48.14 82.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.424 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 33.3 mm-40 -64.54 -44.0 92.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.514 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.45 95.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.439 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 18' ' ' LEU . 10.1 tt -68.63 -48.19 64.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.149 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -63.64 -25.51 68.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.702 0.287 . . . . 0.0 111.337 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -71.76 -33.58 68.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.219 0.533 . . . . 0.0 110.279 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -149.36 73.4 9.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.717 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.29 33.73 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.323 2.682 . . . . 0.0 113.026 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.04 18.87 10.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.525 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.0 pt -96.1 -173.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.923 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.72 -27.38 2.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.529 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -165.06 168.86 16.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 176.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.17 153.51 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -110.96 132.55 54.11 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.644 0.735 . . . . 0.0 111.303 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.697 HD11 ' SG ' ' A' ' 57' ' ' CYS . 1.8 mm? -107.87 143.9 35.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.492 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -130.83 122.62 19.6 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.696 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -32.74 140.46 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 125.273 3.982 . . . . 0.0 115.906 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 42.4 mtp180 -57.75 -37.59 73.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.989 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.96 84.6 7.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.511 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.68 -12.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.379 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -59.07 -32.14 69.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.608 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 45' ' ' GLU . 4.9 t-20 -63.13 -37.72 88.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.503 -172.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m 69.24 -59.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -77.63 -34.2 53.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -167.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.665 HG13 ' HG2' ' A' ' 75' ' ' PRO . 8.8 p -89.88 132.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 112.255 -171.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -130.6 161.66 31.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.721 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.93 136.23 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.442 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -111.92 111.12 21.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' ALA . 86.8 t -92.04 110.36 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' HIS . 82.3 mt -101.2 136.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.162 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.31 111.51 23.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.239 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -77.19 113.92 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 N--CA 1.439 -1.008 0 CA-C-O 121.725 0.774 . . . . 0.0 110.341 179.726 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.675 0.274 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.58 118.42 31.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 39' ' ' VAL . 39.2 t -106.24 119.98 56.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 23.6 mt-10 -100.27 118.98 37.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.085 0.469 . . . . 0.0 111.173 -168.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.53 HD13 ' SD ' ' A' ' 36' ' ' MET . 24.4 mt -101.32 132.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.084 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.5 m80 -112.39 112.09 23.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 110.896 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -106.21 153.51 40.28 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.0 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 21' ' ' ILE . 87.5 Cg_endo -81.69 113.89 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.281 1.988 . . . . 0.0 111.673 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -43.3 -49.1 6.86 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.95 -32.07 61.64 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 29' ' ' ASP . 2.6 ttm180 -96.86 -21.46 17.49 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.85 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.625 HG23 HD22 ' A' ' 62' ' ' LEU . 6.7 tp -72.28 -27.34 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.02 -9.11 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.13 155.27 19.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.125 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.9 pt-20 -84.01 -14.35 50.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.833 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.08 43.71 1.65 Allowed Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -60.03 -27.76 67.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 111.624 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -14.34 62.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.639 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.99 -18.47 43.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 25.5 t70 -84.7 109.0 17.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 111.57 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -29.61 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.25 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . 2.9 tm? -63.86 -40.2 95.98 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.3 -43.84 98.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.297 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.97 -44.57 92.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -58.4 -43.32 88.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.257 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 2.4 mp0 -68.44 -45.21 73.16 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 14' ' ' ILE . 66.2 mmm -90.15 13.43 15.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.172 0.51 . . . . 0.0 110.825 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.88 -38.29 3.67 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -63.4 -66.11 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.121 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 12' ' ' VAL . 7.0 p -91.36 68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 122.338 1.066 . . . . 0.0 110.267 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.11 9.8 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.145 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.34 -36.95 3.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.987 0.423 . . . . 0.0 110.055 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.1 p -141.94 59.3 9.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.989 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 42' ' ' THR . 67.1 Cg_endo -94.68 30.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.047 2.498 . . . . 0.0 113.098 -174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 73.79 -47.9 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.31 0.644 . . . . 0.0 111.048 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -77.81 -92.64 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.95 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -130.06 -91.3 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.605 0.241 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 165.96 -102.6 0.19 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.597 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 9.1 ttp -53.55 -45.97 98.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 48' ' ' MET . 19.2 Cg_endo -60.9 -30.2 89.56 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.879 1.719 . . . . 0.0 111.05 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.81 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -59.06 -45.96 89.47 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.292 176.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.518 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 18.0 ttm180 -59.98 -48.94 79.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.2 78.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.376 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.81 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.3 p-90 -72.38 -41.93 65.8 Favored 'General case' 0 CA--C 1.522 -0.096 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.852 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.5 OUTLIER -69.48 -43.18 80.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.689 -174.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.78 -46.23 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.316 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.53 -41.81 88.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.586 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.415 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 71.7 m -66.28 -44.85 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.819 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.33 83.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.833 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -59.35 -49.35 78.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.967 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -64.56 -41.83 96.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.043 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.9 96.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.283 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.625 HD22 HG23 ' A' ' 21' ' ' ILE . 15.6 tp -69.48 -47.36 64.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.135 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.66 -26.44 67.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -42.17 98.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.494 0.664 . . . . 0.0 109.961 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.417 HD21 HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -139.4 75.09 33.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.75 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.15 47.77 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.073 2.515 . . . . 0.0 112.709 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -139.26 2.83 2.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.69 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 65' ' ' ASN . 31.2 pt -85.64 -179.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.574 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.19 -19.75 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.878 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -165.51 155.47 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.0 t -127.28 152.36 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.681 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -110.1 116.22 31.16 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.43 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 29.8 tp -127.7 141.89 51.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.338 -167.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -126.38 126.86 24.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 18.1 Cg_endo -63.16 171.22 6.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.107 2.538 . . . . 0.0 114.733 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 3.8 mtp180 -66.41 -61.01 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.66 -168.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.99 118.01 4.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.49 -9.75 13.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.156 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -58.81 -39.57 81.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' OD1' HG12 ' A' ' 83' ' ' VAL . 1.6 p30 -73.46 -27.06 61.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.495 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m 74.49 -66.51 0.29 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 m -125.85 27.07 6.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 80' ' ' ASN . 9.9 p -90.16 134.98 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -134.86 152.25 51.59 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.996 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -108.51 118.86 37.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.632 0.73 . . . . 0.0 109.623 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.4 t-160 -94.05 102.04 14.09 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.32 112.22 25.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -113.54 139.11 40.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.528 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.57 106.65 17.12 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.201 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -86.9 127.32 35.05 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.248 179.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.21 118.39 28.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.014 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.05 119.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -98.77 112.22 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 0.0 110.26 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.2 mt -111.95 123.34 67.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -99.66 112.82 25.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.237 0.542 . . . . 0.0 110.914 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-30 -111.42 116.04 51.23 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.589 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 33.6 Cg_exo -61.79 119.74 7.01 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.008 . . . . 0.0 111.789 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 62' ' ' LEU . 1.7 tm? -42.38 -45.2 4.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.765 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -71.98 -43.54 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.785 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 11.5 ptp180 -83.13 -28.66 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.277 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 17' ' ' PRO . 7.8 tp -75.24 -17.69 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.0 109.891 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.88 -13.72 55.6 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.25 0.548 . . . . 0.0 110.395 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.35 156.94 20.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.369 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.9 -14.37 51.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.351 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.16 60.61 1.1 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -82.16 -41.53 20.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 111.158 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.37 -4.75 43.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.2 9.38 30.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.515 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 18.0 t70 -95.57 119.5 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.882 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.62 -31.56 71.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.607 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 6.4 mt -69.03 -43.21 75.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.26 0.552 . . . . 0.0 110.465 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.0 -36.56 75.24 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.394 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.34 -47.9 58.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.28 -178.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.3 p30 -71.45 -35.16 70.81 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.864 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -66.47 -45.21 80.47 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.999 0.428 . . . . 0.0 110.64 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 7.3 tpt -93.34 16.81 12.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.133 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.09 -32.98 3.85 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 163.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.53 -62.98 1.43 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.63 -0.785 . . . . 0.0 110.576 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 39' ' ' VAL . 11.4 p -94.6 52.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.705 1.24 . . . . 0.0 110.165 -176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' MET . 4.2 t-20 -133.16 -29.37 1.43 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.583 -171.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 80.3 m-20 -79.48 -31.38 42.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.67 -169.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 p -126.1 62.38 44.92 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.906 0.384 . . . . 0.0 111.225 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 83' ' ' VAL . 11.3 Cg_endo -97.21 6.6 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.936 2.424 . . . . 0.0 113.456 -174.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 71.19 -42.03 0.52 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.698 0.799 . . . . 0.0 112.205 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 50' ' ' LEU . 3.9 tp10 -66.72 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.345 0.117 . . . . 0.0 110.983 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 31.5 mt-10 -136.28 -86.44 0.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.328 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 160.9 -110.26 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.099 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.6 tpt -52.72 -49.53 85.91 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.9 Cg_endo -67.82 -35.73 20.47 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.208 1.272 . . . . 0.0 111.566 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.731 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.38 -43.2 96.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.415 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 48' ' ' MET . 35.6 ptt180 -69.51 -29.87 67.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.997 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -49.31 77.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.668 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 12.2 p-90 -73.09 -36.84 66.87 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.148 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -49.1 82.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 79.6 mt -65.55 -38.64 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.427 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.2 tptt -63.65 -48.86 75.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.727 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.7 t -62.68 -46.95 85.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.69 83.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.667 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -62.4 -52.23 64.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.547 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 56.7 mm-40 -65.04 -38.35 90.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.661 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.71 -44.12 90.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.487 HD11 HD22 ' A' ' 18' ' ' LEU . 8.2 tt -72.94 -47.23 47.39 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.782 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.55 -26.08 63.18 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.805 -0.559 . . . . 0.0 112.09 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -84.05 -44.96 13.57 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.615 ' ND2' HG23 ' A' ' 68' ' ' ILE . 3.2 t30 -139.45 100.14 7.69 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.866 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -96.79 25.66 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.695 2.263 . . . . 0.0 112.012 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.04 8.22 32.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.615 HG23 ' ND2' ' A' ' 65' ' ' ASN . 4.7 pt -77.51 166.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.733 0.777 . . . . 0.0 111.474 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HE ' ' HB2' ' A' ' 69' ' ' ARG . 2.0 mtm180 -106.89 -51.39 2.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.325 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.658 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.9 150.37 27.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.139 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 87' ' ' VAL . 9.1 p -119.55 156.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.772 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -111.16 115.1 28.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 57' ' ' CYS . 11.2 mt -111.69 136.68 50.6 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.636 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -113.93 119.16 41.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.674 ' HG2' HG13 ' A' ' 83' ' ' VAL . 88.2 Cg_exo -37.23 147.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 125.034 3.823 . . . . 0.0 114.301 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -61.32 -40.33 93.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.957 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.76 85.8 3.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.984 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.51 -22.67 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.075 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -57.58 -29.27 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.216 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.23 -38.56 91.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.724 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m 65.6 -56.64 0.33 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 123.945 0.778 . . . . 0.0 113.02 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 m -76.87 -37.37 55.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.674 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.8 p -87.68 140.23 16.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -146.47 153.3 40.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.69 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.15 126.43 52.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.447 0.641 . . . . 0.0 111.053 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -109.31 102.84 11.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 71' ' ' VAL . 76.0 t -91.87 114.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 77.2 mt -104.17 133.15 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.85 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 87.6 m-85 -102.65 109.91 21.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 17.5 t70 -99.58 131.91 45.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 C--N 1.32 -0.698 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.892 -179.004 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.16 119.61 26.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.688 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.1 t -118.54 130.3 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.4 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.14 127.07 53.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 110.552 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mt -116.16 129.45 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -102.22 140.12 36.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -132.46 126.87 20.42 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 22.4 Cg_endo -63.59 111.25 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.941 1.76 . . . . 0.0 110.242 172.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.31 -35.44 18.2 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.894 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 3.5 mptp? -68.23 -40.58 82.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.682 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -83.19 -36.69 24.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.832 0.348 . . . . 0.0 110.508 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.546 HG23 HD22 ' A' ' 62' ' ' LEU . 10.8 tp -74.69 -3.49 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.248 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.59 -6.36 22.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.13 168.81 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.066 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.41 -44.48 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.13 49.97 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.178 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.01 -34.9 77.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.39 32.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -95.62 2.1 53.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.19 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -89.56 123.06 33.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.094 0.473 . . . . 0.0 109.996 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.68 -32.59 74.12 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.809 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.765 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 22.4 tp -70.71 -42.36 70.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -43.04 86.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.308 0.575 . . . . 0.0 109.831 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.4 tp -70.6 -49.87 43.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.935 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 4.5 p30 -74.8 -27.58 60.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.728 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.765 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.2 tt0 -66.63 -45.45 79.03 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.407 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -92.17 7.03 44.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.059 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.04 -27.15 8.42 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.74 -66.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.449 . . . . 0.0 111.171 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 39' ' ' VAL . 9.8 p -85.49 41.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.924 1.345 . . . . 0.0 109.719 -172.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -145.84 -3.94 0.67 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.119 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.88 -30.83 65.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.506 0.669 . . . . 0.0 109.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.8 67.89 79.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 89.4 Cg_endo -95.37 25.48 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.257 2.638 . . . . 0.0 113.263 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.49 -55.58 0.62 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.456 0.702 . . . . 0.0 111.773 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.13 -108.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -93.88 -124.79 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.565 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.668 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -153.1 -89.17 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.562 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -58.38 -39.6 76.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 32.8 Cg_endo -77.63 -23.97 9.28 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 120.82 1.329 . . . . 0.0 110.591 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.604 HD22 ' NE1' ' A' ' 53' ' ' TRP . 3.1 tm? -58.87 -46.01 88.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.725 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 48' ' ' MET . 13.0 ptt180 -67.36 -38.6 85.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.42 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.69 80.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.891 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.604 ' NE1' HD22 ' A' ' 50' ' ' LEU . 7.6 p-90 -72.93 -37.28 67.24 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.885 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.47 -51.11 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.43 -41.15 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.734 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -62.45 -49.5 75.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.768 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.44 -45.24 94.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.99 92.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -57.79 -58.23 9.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.299 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -64.08 -41.95 97.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.72 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -76.84 -47.79 20.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.035 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.68 -27.35 65.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 2.7 mmmp? -69.36 -29.15 66.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -149.01 73.62 10.19 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.12 41.39 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.076 2.517 . . . . 0.0 113.171 -170.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -133.44 26.22 4.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.38 -172.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.3 0.571 . . . . 0.0 111.67 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -127.04 -44.01 1.64 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.555 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.46 152.87 12.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -122.73 156.96 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.985 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.47 116.88 32.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.71 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 73' ' ' LEU . 7.3 mt -106.08 144.28 33.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.3 0.571 . . . . 0.0 111.198 -174.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 13.4 tmtt? -123.83 115.38 27.96 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.887 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.598 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 90.0 Cg_exo -46.32 138.51 13.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.867 3.045 . . . . 0.0 113.521 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -56.91 -29.51 63.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.031 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.67 96.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.054 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.4 -29.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.269 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -61.69 -28.54 69.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.829 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -73.54 -39.77 64.49 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.076 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 m 64.4 -71.97 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.436 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 m -91.92 59.6 3.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.3 p -140.95 136.22 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.978 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.38 160.16 40.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.229 0.538 . . . . 0.0 111.399 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.598 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 62.0 m-85 -120.79 123.62 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.709 171.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -91.9 101.65 14.22 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.77 112.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.2 138.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.661 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -103.61 110.35 22.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 7.5 m-20 -99.34 132.36 44.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.721 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 1.1 pm0 . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 0.0 110.811 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.7 t . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 120.583 0.23 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.39 117.78 35.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -106.06 140.24 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -103.09 112.26 25.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.421 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.401 HD13 ' SD ' ' A' ' 36' ' ' MET . 40.2 mt -111.63 142.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 64.7 m80 -125.61 119.52 28.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.632 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 21.8 m-85 -118.11 106.96 44.43 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.157 174.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_exo -59.07 123.33 13.25 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.931 1.754 . . . . 0.0 111.586 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -48.86 19.74 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -68.74 -29.11 67.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 12.4 ptp180 -94.58 -28.66 15.28 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.605 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 6.1 tp -72.91 -25.06 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.184 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -82.17 -11.22 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 110.686 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.57 177.11 6.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.438 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.58 151.93 24.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 21.61 51.15 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -170.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -61.84 -30.51 70.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.544 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.24 59.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.214 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -76.64 -27.29 55.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.425 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 102.55 0.79 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.039 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 35.8 tt0 -62.46 -31.13 71.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.008 -171.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 36.8 tp -60.65 -42.51 97.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.46 -42.14 83.51 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.618 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.432 HD11 ' NH2' ' A' ' 51' ' ' ARG . 7.3 tp -67.16 -46.3 74.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.779 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 93.5 m-20 -59.74 -42.95 94.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 43.3 mt-30 -64.86 -43.49 92.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 72.2 mmm -87.69 9.02 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.78 -29.26 5.04 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 166.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -73.19 -61.62 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.587 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -92.77 30.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.428 1.109 . . . . 0.0 110.188 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.616 HD21 ' HB2' ' A' ' 50' ' ' LEU . 26.0 t-20 -141.6 0.78 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.778 -170.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.77 -47.07 76.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.294 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.37 72.04 82.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 50' ' ' LEU . 75.6 Cg_endo -92.69 23.09 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.095 2.53 . . . . 0.0 113.577 -172.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 71.3 -57.33 0.61 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.257 0.623 . . . . 0.0 112.004 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.876 ' HB3' HD11 ' A' ' 50' ' ' LEU . 5.5 tp10 -67.0 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.895 0.478 . . . . 0.0 111.231 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -127.93 -91.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 170.63 -114.42 0.54 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.897 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -56.91 -40.14 82.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.58 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.21 -37.38 69.98 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.921 1.747 . . . . 0.0 112.11 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 45' ' ' GLU . 2.9 mt -60.08 -45.56 92.5 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 36' ' ' MET . 1.8 ttt180 -56.55 -41.83 77.5 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.106 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.76 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.1 -40.32 68.27 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.767 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -43.08 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 71.2 mt -64.06 -44.89 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 176.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.63 -48.4 77.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.603 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.0 m -67.59 -39.38 84.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.089 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.64 89.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.44 -54.56 39.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.578 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.02 -36.74 82.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.3 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 65' ' ' ASN . . . -65.83 -33.37 75.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.191 0.52 . . . . 0.0 110.932 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' C ' HD13 ' A' ' 62' ' ' LEU . 2.9 tm? -83.62 -41.43 17.82 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.717 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -79.64 -29.13 40.87 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.107 -0.37 . . . . 0.0 111.321 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -89.64 -14.78 34.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.822 0.82 . . . . 0.0 109.315 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.507 HD21 HG23 ' A' ' 68' ' ' ILE . 11.6 t30 -144.45 68.9 15.34 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.373 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.24 37.93 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.767 2.312 . . . . 0.0 112.766 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -17.97 13.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.498 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.507 HG23 HD21 ' A' ' 65' ' ' ASN . 2.5 pp -80.77 -173.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.426 0.632 . . . . 0.0 112.184 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -140.94 -16.42 0.87 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.643 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.25 163.06 20.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.199 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p -134.59 153.25 34.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.075 0.464 . . . . 0.0 110.422 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -109.52 113.58 26.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -121.8 143.82 49.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.544 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -116.89 131.78 23.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.33 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 83' ' ' VAL . 86.8 Cg_exo -51.41 151.62 13.22 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.382 2.721 . . . . 0.0 112.848 172.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -63.12 -33.19 74.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.733 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -65.87 112.81 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.751 0.786 . . . . 0.0 111.131 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.4 -33.54 59.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.771 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -65.02 -26.13 68.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.743 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 87.7 m-20 -64.55 -29.36 70.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.783 0.325 . . . . 0.0 110.909 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.9 t 66.67 -82.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.666 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 t -108.8 37.99 2.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 80' ' ' ASN . 13.1 p -101.03 130.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -130.36 136.31 48.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 12' ' ' VAL . 10.9 m-30 -105.61 124.2 49.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.742 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.27 102.47 12.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 40.4 t -94.43 111.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.92 140.43 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.425 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 78.9 m-85 -101.33 108.22 19.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 6.5 t70 -83.94 135.78 34.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.265 -169.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--N 1.321 -0.661 0 CA-C-O 121.351 0.596 . . . . 0.0 109.981 176.631 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.81 119.01 33.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.23 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.28 130.19 55.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.271 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -108.41 117.17 33.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.507 0.67 . . . . 0.0 110.406 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.438 HD13 ' SD ' ' A' ' 36' ' ' MET . 33.4 mt -115.75 133.06 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.06 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -120.84 107.72 13.07 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.589 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.3 132.23 24.75 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.847 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 10.2 Cg_exo -66.56 120.73 7.88 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.672 1.581 . . . . 0.0 109.547 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -53.92 -42.23 68.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.814 -167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -79.56 -24.11 42.34 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.492 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 17' ' ' PRO . 7.8 mpt_? -81.28 -38.03 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.53 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tp -70.75 -26.31 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.287 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.23 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.99 157.85 34.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.55 -21.72 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.335 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.52 38.94 3.14 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' HD22 ' A' ' 32' ' ' LEU . 32.1 p90 -66.36 -35.94 81.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.503 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.0 -9.68 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.224 0.535 . . . . 0.0 111.29 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.38 -3.2 50.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 20' ' ' ARG . 24.3 t70 -82.2 124.78 30.21 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.738 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.29 -28.98 70.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -170.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 3.1 tm? -76.51 -36.82 57.53 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.69 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -66.23 -40.33 90.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.829 177.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.31 -49.6 63.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.966 -176.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.9 p30 -73.45 -34.06 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.91 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 32' ' ' LEU . 3.5 pt20 -67.99 -41.48 82.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.926 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.459 ' HG3' HD11 ' A' ' 55' ' ' ILE . 86.7 mmm -90.32 5.82 45.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.11 -28.19 11.19 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 164.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 68.1 mttm -77.11 -73.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.344 -0.428 . . . . 0.0 111.986 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.59 50.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.722 0.772 . . . . 0.0 110.564 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -142.49 -23.9 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.404 -170.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p-10 -87.18 -18.23 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.173 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 p -133.27 57.43 27.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.25 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 42' ' ' THR . 26.5 Cg_endo -101.52 24.01 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.321 2.681 . . . . 0.0 113.814 -174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 10.9 tp10 70.54 -58.04 0.56 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.053 0.541 . . . . 0.0 112.239 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.584 ' HB3' HD11 ' A' ' 50' ' ' LEU . 37.8 tt0 -73.09 -86.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.601 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 51.3 mt-10 -127.32 -95.7 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.171 -0.331 . . . . 0.0 110.569 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 162.18 -83.05 0.12 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.84 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.477 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 12.6 tpt -54.36 -49.89 88.08 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 48' ' ' MET . 47.9 Cg_endo -68.56 -27.78 32.46 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.402 1.401 . . . . 0.0 110.02 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 2.3 mt -57.83 -46.31 84.92 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -64.28 -47.0 81.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.61 -49.87 75.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.841 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.595 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 6.2 p-90 -74.06 -41.29 61.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.888 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.7 t -61.45 -51.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 36' ' ' MET . 80.1 mt -60.28 -41.37 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.7 tmtt? -63.2 -50.43 70.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.578 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -64.14 -41.45 97.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.832 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.72 97.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.369 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.99 -49.58 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.29 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 10.4 mm-40 -61.77 -45.8 92.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.51 93.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.415 ' C ' HD13 ' A' ' 62' ' ' LEU . 3.4 tm? -60.95 -46.03 92.35 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.452 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.4 -27.46 52.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -63.72 -50.3 69.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.995 0.426 . . . . 0.0 109.854 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.411 HD21 HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -130.58 76.04 78.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 121.44 0.638 . . . . 0.0 109.936 177.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 42.02 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.483 2.789 . . . . 0.0 113.237 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -124.89 -1.21 7.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.407 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 65' ' ' ASN . 47.0 pt -83.0 -174.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -143.04 -18.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.697 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -165.63 157.73 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.108 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 87' ' ' VAL . 20.1 m -135.24 155.49 37.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -111.56 116.83 31.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.217 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.479 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 15.5 mt -108.44 140.22 42.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.77 0.795 . . . . 0.0 112.611 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 24.3 tptm -120.97 116.68 31.24 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.689 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 83' ' ' VAL . 96.0 Cg_exo -33.29 143.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.766 3.644 . . . . 0.0 114.605 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -62.87 -32.24 73.44 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.305 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.11 69.9 7.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.037 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.5 -22.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.945 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -57.74 -23.77 53.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.97 -36.1 80.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m 71.51 -57.1 0.62 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.299 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -96.63 54.57 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -140.68 134.4 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.208 173.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.74 143.98 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -117.17 123.98 48.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.176 0.513 . . . . 0.0 109.957 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -101.68 103.61 14.4 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.017 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 71' ' ' VAL . 74.7 t -95.85 112.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.1 mt -113.26 142.36 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -101.81 110.49 22.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.303 0.573 . . . . 0.0 110.131 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.49 133.03 38.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.238 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 1.4 pm0 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.516 0.674 . . . . 0.0 110.026 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.0 118.69 23.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.17 139.12 49.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -107.43 128.35 54.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.266 0.555 . . . . 0.0 110.235 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' SD ' ' A' ' 36' ' ' MET . 44.2 mt -117.13 149.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -125.96 123.14 37.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.977 0.418 . . . . 0.0 111.099 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 22.1 m-85 -126.09 108.29 24.69 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.814 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 36.7 Cg_exo -57.55 124.16 15.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.02 1.813 . . . . 0.0 111.546 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -49.83 9.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -170.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -77.04 -29.17 55.1 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.232 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -79.92 -34.33 39.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.82 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 5.4 tp -73.63 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.975 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.4 -7.78 54.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.19 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 26' ' ' TYR . . . -83.58 149.13 26.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.941 0.401 . . . . 0.0 110.689 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.66 -40.07 29.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.278 0.561 . . . . 0.0 109.826 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.21 44.8 2.63 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.639 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.544 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 26.2 p90 -70.1 -10.6 59.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.381 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.75 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.539 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -80.53 -16.96 52.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.894 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 31.1 m-20 -81.72 94.55 7.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.636 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -60.4 -31.29 70.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.74 -173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.618 HD13 ' NE2' ' A' ' 35' ' ' GLN . 1.3 tm? -57.08 -42.94 81.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 26' ' ' TYR . 6.9 tp -64.2 -43.65 94.38 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.617 -178.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.31 -46.14 79.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.748 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' A' ' 31' ' ' LEU . 6.3 mt-30 -64.74 -44.56 89.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.58 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 82.3 mmm -91.78 18.0 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.735 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.73 -31.5 3.16 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 163.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -70.54 -63.78 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -0.634 . . . . 0.0 111.086 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 35' ' ' GLN . 26.8 m -90.84 41.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.846 0.831 . . . . 0.0 110.088 -175.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 51' ' ' ARG . 28.3 t-20 -137.25 -21.99 1.17 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.584 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.57 -43.72 96.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.5 t -135.26 79.2 50.12 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.856 0.836 . . . . 0.0 110.192 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 72.6 Cg_endo -91.33 14.44 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.077 2.518 . . . . 0.0 112.609 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 72.74 -47.45 0.67 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.684 0.794 . . . . 0.0 111.297 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.505 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 54.9 mm-40 -56.32 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.204 0.525 . . . . 0.0 111.066 174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -146.04 -98.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.582 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.577 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . 174.1 -83.23 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 168.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.23 -45.73 99.1 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 11.7 Cg_exo -72.84 -28.24 13.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.081 1.854 . . . . 0.0 110.715 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.7 tm? -57.34 -44.77 84.55 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.58 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 34.4 ttp180 -67.06 -49.32 65.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.159 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.49 80.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.75 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.695 ' HE1' HD22 ' A' ' 50' ' ' LEU . 5.6 p-90 -72.75 -39.07 67.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.022 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.17 -43.1 79.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.743 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.73 -41.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 110.518 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -65.33 -44.99 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.113 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 t -63.76 -44.87 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.458 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.412 . . . . 0.0 110.394 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -60.05 -50.95 71.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.299 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.23 -34.89 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.211 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.02 -42.44 76.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.97 0.414 . . . . 0.0 111.185 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 62' ' ' LEU . 2.9 tm? -72.14 -47.32 51.89 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.486 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.99 -28.8 63.64 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 111.841 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -86.26 -12.64 49.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.91 0.862 . . . . 0.0 109.173 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.66 HD21 HG23 ' A' ' 68' ' ' ILE . 8.7 t30 -154.64 73.43 5.95 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.041 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -85.86 34.34 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.605 2.203 . . . . 0.0 112.629 -170.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.41 -2.78 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.75 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.66 HG23 HD21 ' A' ' 65' ' ' ASN . 6.1 pt -84.96 166.9 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.371 0.605 . . . . 0.0 111.388 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 89' ' ' PHE . 35.4 ptt180 -138.46 -4.16 1.66 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.509 176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -167.75 149.47 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.479 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.2 m -136.83 156.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 122.706 0.402 . . . . 0.0 110.015 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.84 117.74 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.879 0.371 . . . . 0.0 110.052 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.33 141.09 45.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 112.361 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -108.78 122.18 40.87 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 59.3 Cg_endo -70.3 -179.97 3.55 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.878 2.385 . . . . 0.0 114.542 -171.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 76' ' ' ARG . 47.3 mtp180 -65.12 -54.74 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.73 -167.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . . . -58.96 107.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 0.0 111.828 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.82 -37.93 79.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.672 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -70.68 -25.05 62.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.151 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.491 ' ND2' HG11 ' A' ' 83' ' ' VAL . 59.8 t30 -65.14 -36.48 84.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t 67.24 -89.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 163.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.7 m -80.46 63.91 5.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.604 0.716 . . . . 0.0 111.592 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG11 ' ND2' ' A' ' 80' ' ' ASN . 4.9 p -139.92 129.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.511 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -128.39 137.12 51.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.229 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -115.3 122.49 46.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.314 0.578 . . . . 0.0 110.28 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -95.81 108.64 20.99 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.226 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -92.12 108.88 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.597 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 72.2 m-85 -100.77 111.61 23.87 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 13.4 t70 -74.94 142.88 43.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.2 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.488 0.661 . . . . 0.0 109.33 -167.51 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.5 t . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -120.16 132.95 55.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.175 0.512 . . . . 0.0 110.028 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.01 119.71 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.4 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 7.1 pt-20 -102.21 113.77 27.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.341 0.591 . . . . 0.0 110.846 -174.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.481 HD13 ' SD ' ' A' ' 36' ' ' MET . 5.9 mt -105.66 142.73 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.104 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 73.1 m80 -113.07 112.67 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.076 0.465 . . . . 0.0 110.579 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 14.7 m-30 -104.08 120.62 50.43 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.533 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' HE ' ' A' ' 20' ' ' ARG . 32.3 Cg_exo -58.96 116.37 3.21 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.048 1.832 . . . . 0.0 111.081 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.2 tm? -46.68 -43.28 17.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.55 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.136 -172.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HE ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -88.63 -29.47 19.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.253 -173.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.476 HG23 HD22 ' A' ' 62' ' ' LEU . 6.1 tp -74.47 -25.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.29 11.95 9.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.642 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.95 173.94 7.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.813 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -116.13 144.35 44.27 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.1 22.83 16.25 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -168.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -59.84 -18.66 45.81 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.909 -0.646 . . . . 0.0 111.688 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.9 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.74 1.36 57.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.967 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 35.6 t70 -85.6 104.02 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.21 -28.12 69.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.2 mt -62.07 -42.94 99.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.123 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.578 HD22 ' NH1' ' A' ' 20' ' ' ARG . 51.9 tp -70.94 -41.58 70.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.23 -46.52 73.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.086 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.3 p30 -72.58 -32.39 65.97 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.039 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.746 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.97 -45.33 82.06 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.373 0.606 . . . . 0.0 110.085 177.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.481 ' SD ' HD13 ' A' ' 14' ' ' ILE . 83.0 mmm -91.24 12.3 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.363 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.7 -33.24 6.5 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 162.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 43.8 mmtm -72.28 -75.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.263 -0.469 . . . . 0.0 111.557 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -84.84 60.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 122.138 0.97 . . . . 0.0 110.178 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -161.82 -23.42 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.396 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.63 -39.41 67.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 0.0 110.592 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -134.81 63.98 60.79 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.976 0.893 . . . . 0.0 110.528 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 46.3 Cg_endo -97.3 23.54 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.364 2.709 . . . . 0.0 113.466 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 71.97 -56.13 0.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.768 0.668 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.731 ' HB3' HD11 ' A' ' 50' ' ' LEU . 3.7 tp10 -65.86 -77.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.405 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 41.8 mt-10 -143.7 -91.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 160.59 -90.72 0.11 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.837 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 6.8 ttp -57.24 -47.35 99.2 Favored Pre-proline 0 C--N 1.314 -0.969 0 O-C-N 122.172 -0.605 . . . . 0.0 112.156 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 48' ' ' MET . 54.4 Cg_endo -69.69 -24.02 30.44 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.34 1.36 . . . . 0.0 110.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 45' ' ' GLU . 3.0 mt -59.1 -47.63 84.54 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.204 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' MET . 32.0 ptt180 -73.73 -33.62 64.43 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.68 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.7 73.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.254 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.544 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 7.0 p-90 -73.75 -42.06 61.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.247 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.1 t -60.0 -51.03 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.611 0.243 . . . . 0.0 111.132 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' A' ' 36' ' ' MET . 97.1 mt -63.79 -41.49 92.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.971 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 46.5 tttm -69.91 -41.47 74.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.927 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.1 m -67.46 -41.46 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.465 0.174 . . . . 0.0 110.803 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.09 85.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 109.914 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 5.1 t-160 -61.46 -53.69 53.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.84 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 17.0 mm-40 -59.0 -47.19 86.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.155 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.8 99.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.333 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 21' ' ' ILE . 6.7 tp -68.88 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.483 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.3 -32.15 73.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -78.96 -20.1 50.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.172 -176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.401 HD21 HD13 ' A' ' 68' ' ' ILE . 1.9 p-10 -145.68 70.13 13.72 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.371 0.605 . . . . 0.0 109.697 173.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.09 45.78 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.18 2.587 . . . . 0.0 112.787 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -127.01 -1.19 6.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.522 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.401 HD13 HD21 ' A' ' 65' ' ' ASN . 36.5 pt -86.66 -172.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.739 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 69' ' ' ARG . 4.8 ptp180 -153.19 -0.55 0.24 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.17 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -166.43 157.18 12.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.524 0.202 . . . . 0.0 110.593 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.44 156.73 42.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.989 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -110.35 113.39 26.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.088 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.544 HD22 ' HZ3' ' A' ' 53' ' ' TRP . 12.1 mt -112.27 134.65 53.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -115.03 127.93 26.39 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.252 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 56.0 Cg_endo -69.03 -173.0 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.316 2.011 . . . . 0.0 112.649 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -80.64 -38.87 28.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.684 -174.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' OE1' ' A' ' 45' ' ' GLU . . . -76.28 78.6 3.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.562 0.696 . . . . 0.0 110.365 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.68 -17.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.421 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -57.35 -24.94 58.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -63.14 -27.95 69.73 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 109.898 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.3 m 67.22 -77.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.834 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 m -103.38 29.86 5.34 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -101.23 136.68 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.38 160.16 38.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.9 120.13 29.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.7 t-160 -110.05 102.64 11.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.051 -176.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.88 113.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.846 0.355 . . . . 0.0 110.33 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.5 141.69 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 66.0 m-85 -103.23 114.53 28.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.54 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 15.7 m-20 -76.08 115.34 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.319 -176.459 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.251 0.548 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.35 138.81 50.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.799 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -114.46 140.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.78 117.98 35.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.171 0.51 . . . . 0.0 110.499 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.607 HD13 ' SD ' ' A' ' 36' ' ' MET . 22.1 mt -115.24 123.3 70.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.559 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 48.4 m80 -110.74 112.0 23.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.518 0.675 . . . . 0.0 111.11 -177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 17.1 m-85 -106.52 116.97 58.17 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.461 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 35.9 Cg_exo -58.75 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.214 1.942 . . . . 0.0 110.543 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.5 tp -52.61 -39.28 61.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.897 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -79.19 -28.57 42.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 9.1 mmm180 -81.5 -38.79 25.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.406 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.11 -28.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.859 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.91 59.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 110.83 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.26 -179.97 6.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.709 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -115.79 18.5 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.939 0.876 . . . . 0.0 109.844 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.5 25.36 10.45 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' HD22 ' A' ' 32' ' ' LEU . 45.0 p90 -71.14 -35.31 71.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.67 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -17.32 60.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 0.0 110.414 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -91.53 -2.06 57.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.608 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 22.3 t70 -90.71 116.08 28.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.032 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.61 -28.89 64.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.448 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.598 ' HG ' HE22 ' A' ' 35' ' ' GLN . 9.6 tp -70.23 -43.79 69.89 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.7 tp -63.9 -39.5 94.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.623 0.725 . . . . 0.0 109.423 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -41.72 92.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.397 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 m-20 -60.22 -49.24 78.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.612 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.598 HE22 ' HG ' ' A' ' 31' ' ' LEU . 1.4 mp0 -64.99 -45.1 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.607 ' SD ' HD13 ' A' ' 14' ' ' ILE . 88.7 mmm -97.53 21.26 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.511 . . . . 0.0 111.038 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.98 -34.07 4.13 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 31.9 mmtp -67.95 -68.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.03 76.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 48' ' ' MET . 20.3 t-20 -173.54 -41.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.842 -171.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -40.4 75.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 p -142.14 67.2 21.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.199 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 80.8 Cg_endo -89.69 28.21 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.831 2.354 . . . . 0.0 112.352 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 72.58 -50.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.641 0.776 . . . . 0.0 111.414 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.56 -82.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -176.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.22 -86.63 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.477 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 161.98 -101.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.122 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.443 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 12.5 tpt -56.22 -44.82 99.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 39.5 Cg_exo -60.77 -33.78 92.51 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.374 2.049 . . . . 0.0 111.414 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.93 -45.4 86.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.515 176.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 22.7 ttt180 -63.38 -47.72 80.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.004 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.53 -47.72 84.42 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.456 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.707 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.34 -44.57 62.42 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.886 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -40.88 78.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.206 -174.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 69.5 mt -64.45 -45.82 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.834 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 61.0 tttp -64.76 -47.87 76.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.14 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 88.9 m -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.491 0.186 . . . . 0.0 111.163 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.14 92.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.652 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -61.08 -50.85 71.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.158 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 34.7 mm-40 -61.34 -44.34 97.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.136 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 tp -71.06 -45.34 63.99 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.77 -25.56 67.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.47 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -97.84 -2.2 41.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.517 0.675 . . . . 0.0 109.725 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.74 55.0 1.88 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.91 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.83 48.52 2.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.485 2.124 . . . . 0.0 112.438 -168.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -125.83 -11.64 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.807 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 pp -92.73 -172.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -143.61 -11.91 0.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.986 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -165.95 150.35 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.143 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 87' ' ' VAL . 18.8 m -131.54 155.66 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.948 0.404 . . . . 0.0 110.298 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -111.48 117.28 32.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.335 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -121.59 144.19 48.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.28 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.547 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -118.05 120.83 32.07 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.95 174.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.613 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 26.5 Cg_endo -61.41 160.41 27.58 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.978 2.452 . . . . 0.0 112.964 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 76' ' ' ARG . 11.7 mtp180 -58.26 -28.62 65.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.151 -172.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.92 86.63 0.71 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.5 0.667 . . . . 0.0 110.708 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.547 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 12.0 p -64.77 -28.09 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.815 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -63.58 -24.69 67.91 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.883 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -64.33 -31.74 73.06 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m 65.98 -74.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -98.15 54.05 1.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.136 0.493 . . . . 0.0 112.113 -170.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 10' ' ' VAL . 14.3 p -134.58 130.53 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -132.87 137.76 46.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.2 m-85 -102.36 124.33 47.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.264 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -104.1 103.43 13.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 71' ' ' VAL . 97.3 t -91.97 110.38 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -109.72 139.34 33.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.217 -173.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 83.3 m-85 -102.65 108.95 20.39 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.924 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 7.0 m-20 -75.76 116.89 16.93 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.406 0.622 . . . . 0.0 109.843 -176.508 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -104.82 118.37 36.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.909 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 HG21 ' A' ' 39' ' ' VAL . 95.6 t -107.17 121.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.191 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -98.38 118.41 34.97 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.005 0.431 . . . . 0.0 109.862 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' SD ' ' A' ' 36' ' ' MET . 29.1 mt -114.47 142.94 25.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 67.2 m80 -124.12 125.36 44.35 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 13.2 m-30 -122.46 131.26 24.41 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 18.4 Cg_endo -60.13 121.52 9.93 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.813 2.342 . . . . 0.0 111.279 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.8 tp -51.42 -36.91 45.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.724 -173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -75.88 -38.86 57.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . 22.2 mtt180 -80.93 -29.86 35.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.2 -15.84 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.553 0.692 . . . . 0.0 109.528 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.77 24.02 7.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.087 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 144.18 44.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.4 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.27 -11.49 46.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.424 . . . . 0.0 110.542 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -99.93 32.6 7.08 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' HD22 ' A' ' 32' ' ' LEU . 52.6 p90 -63.56 -21.83 66.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.009 -0.595 . . . . 0.0 112.003 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.33 -17.59 64.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.017 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -97.67 -9.44 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.934 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 45.4 m-20 -81.36 103.32 11.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.705 0.764 . . . . 0.0 110.606 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.08 -38.94 71.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.031 -171.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HG ' HE22 ' A' ' 35' ' ' GLN . 17.7 tp -61.75 -39.4 91.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.06 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.2 tp -68.81 -44.66 73.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.32 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.14 -48.22 68.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.959 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 p30 -70.21 -32.02 69.72 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.363 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.617 HE22 ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -65.23 -43.33 91.78 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.223 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.5 ' SD ' HD13 ' A' ' 14' ' ' ILE . 81.7 mmm -83.87 4.11 30.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.656 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.34 -29.29 9.65 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 60.5 mtpt -68.2 -69.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.233 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.9 p -100.37 82.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.428 1.108 . . . . 0.0 110.424 -175.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -172.08 -26.82 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.842 -170.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -74.84 -36.04 62.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.894 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 p -135.87 67.96 64.33 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.366 0.603 . . . . 0.0 110.781 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -98.62 2.19 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.836 3.024 . . . . 0.0 113.168 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 73.61 -44.23 0.57 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.73 0.812 . . . . 0.0 111.922 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' CG ' HD21 ' A' ' 50' ' ' LEU . 42.7 tp10 -60.25 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.263 0.225 . . . . 0.0 111.241 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 76' ' ' ARG . 47.2 mt-10 -145.38 -102.01 0.1 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.614 0.245 . . . . 0.0 110.797 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 168.66 -106.74 0.26 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.375 176.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 tpt -49.71 -45.94 79.51 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 48' ' ' MET . 18.6 Cg_endo -58.44 -33.19 97.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.977 1.784 . . . . 0.0 111.914 174.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.73 HD23 ' HE1' ' A' ' 53' ' ' TRP . 82.1 mt -57.13 -48.1 79.49 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.184 0.516 . . . . 0.0 109.652 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -61.4 -46.4 90.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.608 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.17 70.62 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.6 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.73 ' HE1' HD23 ' A' ' 50' ' ' LEU . 7.4 p-90 -73.87 -37.82 64.62 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.46 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -69.64 -44.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.99 -39.79 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.626 0.251 . . . . 0.0 110.744 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -62.72 -48.85 77.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 48.4 t -65.04 -46.98 79.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.872 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.65 84.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -60.77 -46.73 89.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.858 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -63.18 -47.44 82.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.64 97.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.501 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 62' ' ' LEU . 3.4 tm? -66.34 -46.0 78.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 -178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.54 -27.71 62.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 0.0 111.555 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -66.06 -34.32 77.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.573 . . . . 0.0 110.607 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.417 HD21 HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -146.73 74.55 12.32 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.661 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.92 33.51 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.244 2.629 . . . . 0.0 113.721 -169.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.29 18.42 9.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 65' ' ' ASN . 31.2 pt -97.53 -179.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -145.23 -8.35 0.6 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -167.88 156.04 8.93 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 111.213 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG22 ' CG1' ' A' ' 87' ' ' VAL . 34.2 m -141.43 159.47 22.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.056 0.455 . . . . 0.0 110.648 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -108.28 120.09 41.38 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.8 0.809 . . . . 0.0 108.983 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.425 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 28.9 tp -123.0 141.1 52.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.565 -168.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 125.64 28.31 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 52.9 Cg_endo -74.33 173.61 13.92 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.819 1.679 . . . . 0.0 112.77 -175.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 57.1 mtp180 -65.72 -36.62 84.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.678 -162.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -68.93 93.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.658 0.742 . . . . 0.0 111.037 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.2 t -61.92 -32.17 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.783 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.24 -23.98 67.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 70.1 m-20 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.065 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p 57.06 -70.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.705 1.253 . . . . 0.0 112.864 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 m -90.89 57.84 3.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.259 0.552 . . . . 0.0 111.655 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.21 130.46 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.53 138.39 36.26 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.133 0.492 . . . . 0.0 111.108 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -102.95 120.97 41.57 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.583 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -108.49 102.81 11.86 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 71' ' ' VAL . 8.7 p -97.81 124.05 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.568 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.447 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 77.8 mt -112.8 135.71 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.354 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.52 113.07 26.29 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.251 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.09 120.92 22.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 110.492 -173.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 4.5 p-10 -122.65 121.65 36.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.424 0.63 . . . . 0.0 110.066 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.2 121.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.477 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 50.0 mt-10 -93.95 111.97 23.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 110.855 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 ' SD ' ' A' ' 36' ' ' MET . 13.4 mt -102.33 142.81 15.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.529 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 33.6 m80 -119.64 111.88 18.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.998 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-85 -110.46 117.29 51.4 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.154 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -58.51 127.49 24.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.241 1.961 . . . . 0.0 110.954 174.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -49.44 -44.98 45.93 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.36 -173.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -77.9 -19.78 54.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 20.4 mmm180 -91.24 -36.88 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -73.44 -14.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.304 0.574 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.65 -0.56 57.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.486 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.37 153.59 17.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.316 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.21 -23.34 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.161 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.87 18.73 52.32 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.661 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -22.88 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.959 0.504 . . . . 0.0 112.018 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.15 -13.61 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.118 0.485 . . . . 0.0 110.794 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -116.8 10.17 14.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.067 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.9 119.55 25.01 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.805 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.12 -33.37 73.27 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.931 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.63 -46.65 84.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.328 0.585 . . . . 0.0 109.977 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.42 -38.99 91.57 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.855 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.19 -41.82 80.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.012 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 96.0 m-20 -65.94 -49.37 68.19 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.054 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.55 -46.64 72.17 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.309 0.576 . . . . 0.0 110.265 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.778 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 11.1 tpt -67.45 -44.71 78.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.185 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.98 -34.13 57.68 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.634 0.584 . . . . 0.0 112.581 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 71.3 mmtt -60.92 -48.26 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.79 42.79 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.236 0.541 . . . . 0.0 111.611 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.778 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -117.64 -35.61 3.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.015 -171.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -81.9 -29.07 32.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.211 0.529 . . . . 0.0 110.537 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 p -127.82 65.45 68.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.226 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 82.3 Cg_endo -90.75 7.29 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.432 2.088 . . . . 0.0 111.533 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.12 -49.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.393 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.17 -80.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.13 -69.93 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 0.0 111.493 -172.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . 134.96 -95.01 0.25 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.762 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.464 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 6.8 ttp -64.91 -43.56 68.82 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 50' ' ' LEU . 5.3 Cg_exo -79.37 -26.79 4.72 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.526 2.151 . . . . 0.0 108.915 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.3 tm? -58.0 -45.53 86.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 112.524 -2.126 . . . . 0.0 109.235 172.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -62.97 -49.79 73.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.069 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.22 81.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.576 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.693 ' HE1' HD22 ' A' ' 50' ' ' LEU . 2.5 p-90 -72.16 -39.69 68.55 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.704 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.7 OUTLIER -69.22 -42.63 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.377 -174.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 65.2 mt -67.53 -41.95 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.058 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -61.31 -50.6 72.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.421 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.8 t -63.87 -40.85 97.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.67 87.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.793 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -57.51 -58.09 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.556 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 7.8 pt-20 -69.3 -32.84 72.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.698 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.74 94.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.426 ' C ' HD13 ' A' ' 62' ' ' LEU . 3.4 tm? -67.39 -48.0 68.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.05 -27.49 66.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -64.15 -43.59 94.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -135.8 75.28 56.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.428 0.632 . . . . 0.0 110.113 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 38.51 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.104 2.536 . . . . 0.0 112.444 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 65' ' ' ASN . 34.7 mmtp -131.58 22.39 4.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.11 -174.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.358 0.599 . . . . 0.0 111.337 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -118.11 -49.78 2.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.235 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 9.2 pt-20 -163.56 163.19 24.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.425 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.71 149.93 32.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.855 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -110.37 118.58 36.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.513 0.673 . . . . 0.0 109.645 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.9 mt -108.02 144.4 35.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.655 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 12.8 tmtt? -121.45 120.04 29.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 28.8 Cg_endo -61.15 162.2 20.49 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.479 2.786 . . . . 0.0 113.634 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -66.3 -17.63 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.844 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.79 89.21 1.35 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.326 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.503 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.3 t -63.22 -21.92 29.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.846 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -56.93 -32.17 65.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.462 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.406 HD22 HG11 ' A' ' 83' ' ' VAL . 37.0 m-20 -73.83 -38.66 64.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t 70.87 -63.74 0.4 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.761 0.663 . . . . 0.0 111.838 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.5 m -109.0 47.98 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.406 HG11 HD22 ' A' ' 80' ' ' ASN . 8.5 p -125.35 138.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.971 -0.456 . . . . 0.0 109.884 170.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 46.2 mt-30 -138.9 150.79 46.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.29 0.567 . . . . 0.0 110.714 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.69 117.82 35.11 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.4 t-160 -95.29 102.09 13.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.899 -173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 63.1 t -97.94 113.27 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.26 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 4.9 mp -101.9 139.8 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 70.9 m-85 -102.4 109.78 21.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.926 0.393 . . . . 0.0 110.172 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 16.7 m-20 -77.39 115.4 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.385 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.56 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -105.38 118.74 37.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.191 0.52 . . . . 0.0 111.1 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 28.0 t -119.38 138.79 48.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -121.96 131.23 53.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.279 0.561 . . . . 0.0 111.941 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 ' SD ' ' A' ' 36' ' ' MET . 8.2 mt -106.98 136.09 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.693 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.404 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 48.9 m80 -109.01 127.84 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 22.7 m-85 -127.8 125.29 23.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.382 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.521 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 19.1 Cg_exo -66.8 120.79 7.91 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 121.934 1.756 . . . . 0.0 111.046 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 tp -42.18 -44.6 3.79 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.578 1.151 . . . . 0.0 113.645 -167.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -75.7 -40.59 55.48 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.548 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 14.3 ptp180 -90.75 -19.06 23.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.566 HG23 HD22 ' A' ' 62' ' ' LEU . 6.5 tp -72.26 -21.04 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.17 -14.44 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.552 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.61 151.76 34.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.575 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -78.46 -28.54 46.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.379 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.24 3.02 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -66.15 -38.64 88.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.641 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -1.37 21.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.92 -7.95 18.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.548 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 t70 -81.17 121.32 25.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.216 0.531 . . . . 0.0 110.966 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.18 -35.33 78.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.206 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 4.4 mt -65.44 -42.44 92.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.034 0.445 . . . . 0.0 110.005 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.3 -41.89 76.16 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.336 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.7 mt -66.37 -49.04 68.22 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.407 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 2.7 p30 -74.88 -28.66 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.811 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -69.65 -47.03 64.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.784 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 15.5 tpt -72.25 -42.6 65.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.67 -32.31 46.74 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.377 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.03 -53.38 39.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 39' ' ' VAL . 48.3 t -85.17 39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.132 0.968 . . . . 0.0 110.535 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.784 ' HB2' ' O ' ' A' ' 36' ' ' MET . 2.5 t-20 -133.44 -30.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.103 -0.998 . . . . 0.0 112.918 -170.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.511 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 26.2 t70 -80.04 -27.35 39.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -172.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.1 p -122.67 60.78 14.88 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 50' ' ' LEU . 26.8 Cg_endo -98.86 1.74 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.846 2.364 . . . . 0.0 113.711 -173.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 74.04 -46.83 0.63 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.554 0.742 . . . . 0.0 111.92 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' CB ' HD21 ' A' ' 50' ' ' LEU . 37.5 mt-10 -65.6 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 111.739 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -126.09 -77.95 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.266 0.555 . . . . 0.0 110.464 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.748 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 148.96 -96.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.834 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.73 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 1.5 tmt? -59.8 -40.68 80.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 O-C-N 122.121 -0.635 . . . . 0.0 112.34 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 48' ' ' MET . 38.2 Cg_exo -64.54 -29.78 61.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.706 1.604 . . . . 0.0 110.742 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -59.88 -47.77 84.39 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.581 178.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -67.46 -40.72 85.35 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.993 178.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.32 78.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.385 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.674 ' CH2' HD21 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -71.67 -46.13 59.83 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.984 -176.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG11 ' HE1' ' A' ' 36' ' ' MET . 1.4 p -70.68 -41.78 77.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.462 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 90.4 mt -64.64 -42.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.722 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.9 tttp -65.22 -46.6 79.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.141 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.6 -43.53 89.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.608 0.242 . . . . 0.0 110.904 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.7 95.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -60.09 -52.24 66.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.565 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.722 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 32.5 mm-40 -58.78 -44.18 90.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.254 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.83 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.747 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 21' ' ' ILE . 6.6 tp -67.31 -46.34 73.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.605 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.44 -25.92 65.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.342 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -63.96 -48.55 76.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -131.47 75.58 76.8 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.208 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.83 43.61 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.078 2.519 . . . . 0.0 112.675 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -128.46 10.38 6.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.846 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 pt -98.34 179.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.173 0.511 . . . . 0.0 110.989 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -128.36 -18.4 4.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.839 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.95 158.41 17.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.304 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.0 p -129.09 151.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -109.61 112.74 25.01 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 122.17 0.986 . . . . 0.0 109.36 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.674 HD21 ' CH2' ' A' ' 53' ' ' TRP . 8.8 tt -125.95 144.7 50.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.558 -163.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -126.95 132.32 24.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.236 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.657 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -33.82 140.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.141 3.894 . . . . 0.0 115.764 175.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -58.78 -38.93 79.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.007 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 74.31 4.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.409 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.18 -19.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.129 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.78 -23.77 65.27 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.63 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -63.24 -33.75 76.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.074 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m 69.84 -68.05 0.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.121 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 m -73.95 -19.5 60.65 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 75' ' ' PRO . 5.6 p -86.47 129.4 38.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.304 0.573 . . . . 0.0 110.669 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -130.69 137.53 49.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.041 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 19.9 m-85 -106.67 125.94 51.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.579 0.704 . . . . 0.0 110.652 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -105.14 104.92 14.74 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.401 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 48.1 t -92.4 112.09 25.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.404 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 73.9 mt -105.66 137.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.33 109.67 21.37 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.676 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 115.52 16.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 0.0 110.231 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.074 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 120.806 0.336 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -123.47 119.45 30.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.403 0.62 . . . . 0.0 109.595 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.568 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 96.3 t -120.95 125.48 74.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.065 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -105.54 112.92 26.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.459 0.647 . . . . 0.0 111.265 -174.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 4.1 mt -101.6 128.01 54.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.509 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 79.8 m80 -104.13 109.6 21.46 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.288 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 18.6 m-30 -107.14 117.58 55.99 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.151 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' ILE . 31.6 Cg_exo -59.7 120.56 8.44 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.07 1.847 . . . . 0.0 110.982 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 62' ' ' LEU . 2.9 tt -50.57 -36.24 33.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.91 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 18.6 ptpt -72.2 -32.76 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.169 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 29' ' ' ASP . 3.0 mmp_? -92.76 -39.03 11.47 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -72.43 -21.99 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.278 0.561 . . . . 0.0 109.638 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.69 -26.96 64.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.846 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.07 155.59 25.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.855 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.18 -31.35 30.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.592 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.47 49.27 2.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.942 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' HB2' HD22 ' A' ' 32' ' ' LEU . 6.3 p90 -73.48 -18.34 61.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.614 0.245 . . . . 0.0 111.598 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.61 -13.39 62.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 -24.32 52.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.166 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 20' ' ' ARG . 7.7 m-20 -83.72 110.81 18.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.87 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.3 -25.11 67.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.797 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.2 pp -54.41 -41.63 69.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.196 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 31' ' ' LEU . 15.5 tp -73.18 -27.92 61.92 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.499 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.28 -45.82 65.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.901 172.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -61.07 -38.17 85.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.45 -46.68 82.06 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.994 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.67 ' HE1' HG11 ' A' ' 54' ' ' VAL . 83.9 mmm -94.46 17.6 12.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.702 0.763 . . . . 0.0 110.11 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.31 -24.44 7.15 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 164.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -82.81 -65.65 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.256 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' CG1' ' A' ' 12' ' ' VAL . 30.1 m -100.83 45.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.639 0.733 . . . . 0.0 111.072 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -139.79 -17.71 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.896 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.4 -38.2 68.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.866 0.365 . . . . 0.0 110.512 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 p -127.59 70.84 77.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.2 Cg_endo -92.65 13.28 1.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.949 2.433 . . . . 0.0 112.393 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 73.44 -40.45 0.47 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.203 1.001 . . . . 0.0 112.343 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 50' ' ' LEU . 37.7 mt-10 -74.53 -78.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 111.414 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 50' ' ' LEU . 44.4 mt-10 -138.63 -80.06 0.33 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 111.103 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.793 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 154.31 -92.79 0.13 Allowed Glycine 0 C--O 1.222 -0.624 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.697 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.474 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.5 tmt? -62.79 -43.93 84.51 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.931 -0.747 . . . . 0.0 112.692 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 48' ' ' MET . 41.4 Cg_endo -70.63 -24.44 25.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 120.913 1.075 . . . . 0.0 109.765 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -58.37 -45.86 87.43 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.115 172.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -61.51 -48.74 79.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.191 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.57 77.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.742 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 8.2 p-90 -73.52 -37.76 65.55 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.272 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.67 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.8 OUTLIER -69.3 -41.4 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.0 110.165 -174.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.58 -41.7 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.673 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.94 -50.11 73.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.207 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.6 t -62.36 -46.19 89.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.995 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 0.0 110.501 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -62.59 -50.5 71.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.129 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.02 -34.86 79.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.837 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.99 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' HG ' ' A' ' 18' ' ' LEU . 4.7 tt -71.23 -48.41 51.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.403 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.15 -25.7 67.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.693 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.81 -33.27 75.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 110.25 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -151.36 72.38 8.37 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.078 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.27 39.29 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.965 2.443 . . . . 0.0 113.924 -168.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 34.0 4.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.425 0.631 . . . . 0.0 109.532 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.8 pt -106.47 -175.45 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.577 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 16.9 mtm180 -117.52 -51.21 2.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.235 -177.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' HB2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -156.22 161.47 40.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.18 -177.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -132.46 158.4 43.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.435 0.636 . . . . 0.0 111.401 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.35 113.37 26.12 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.03 0.919 . . . . 0.0 109.428 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 ' CH2' ' A' ' 53' ' ' TRP . 6.1 tt -110.02 139.26 45.34 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.858 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.55 129.38 25.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.157 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.679 ' HG2' HG13 ' A' ' 83' ' ' VAL . 75.3 Cg_exo -46.11 151.03 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.809 3.006 . . . . 0.0 113.292 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -66.98 -37.69 84.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.565 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.6 75.78 2.61 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.737 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.15 -10.72 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.338 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -64.74 -37.1 86.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.184 0.516 . . . . 0.0 110.436 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.3 t 71.46 -67.15 0.27 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.744 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -82.27 6.35 17.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.8 p -108.39 131.83 57.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.034 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -139.21 144.36 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.186 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 81.0 m-85 -107.62 124.63 50.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.145 0.498 . . . . 0.0 109.789 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.1 t60 -103.0 106.0 16.43 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 91.8 t -93.22 116.83 35.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.393 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.427 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.4 mp -100.05 136.41 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 40.7 m-85 -103.08 106.68 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.94 0.4 . . . . 0.0 110.381 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 22.1 m-20 -79.69 114.86 18.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.013 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 39.8 t . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -136.11 134.93 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.37 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.23 138.66 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.243 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -106.82 121.22 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 85' ' ' PHE . 1.3 mt -115.91 122.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.619 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 79.6 m80 -99.73 132.01 45.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.182 0.515 . . . . 0.0 110.288 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CD1' HG13 ' A' ' 87' ' ' VAL . 3.3 m-85 -119.76 129.07 25.55 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.233 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 21.4 Cg_exo -65.25 110.92 1.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.005 1.804 . . . . 0.0 110.389 171.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.4 tm? -45.88 -42.51 12.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.953 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HG3' ' HD2' ' A' ' 20' ' ' ARG . 17.1 ptpt -78.1 -28.53 48.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 3.7 mpt_? -89.68 -35.27 15.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 112.049 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 6.4 tp -66.58 -25.74 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.463 . . . . 0.0 110.129 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.36 12.66 15.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.16 173.02 7.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.975 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.98 -26.86 20.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.229 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.79 46.72 3.48 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.604 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -79.09 -34.6 43.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.735 0.303 . . . . 0.0 111.277 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.04 59.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.303 0.573 . . . . 0.0 110.415 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -83.71 -9.41 58.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.3 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -85.15 110.54 19.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.244 0.545 . . . . 0.0 110.708 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.84 -34.81 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.764 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.8 mt -60.77 -46.69 89.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.87 -40.29 65.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.567 0.698 . . . . 0.0 109.794 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.15 -46.06 78.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.343 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 3.2 p30 -73.34 -30.78 63.57 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.395 -175.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.619 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 45.3 mt-30 -73.52 -44.84 56.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.346 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -75.09 -15.64 60.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.633 177.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 -21.2 41.29 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -76.2 -54.83 6.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 35' ' ' GLN . 14.7 m -85.71 59.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.739 0.78 . . . . 0.0 109.782 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.1 t-20 -137.66 -39.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.398 -170.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -70.23 -41.14 73.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.849 -170.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 p -140.98 66.0 24.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.723 0.297 . . . . 0.0 111.51 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.2 Cg_endo -67.46 -62.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.252 1.968 . . . . 0.0 112.011 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 13.4 tp10 152.53 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -76.79 -85.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.587 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -135.7 -79.04 0.43 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.09 0.471 . . . . 0.0 109.988 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 151.17 -109.71 0.43 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.992 176.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.465 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -51.35 -48.21 86.59 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 36.2 Cg_exo -61.41 -40.43 48.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.032 1.821 . . . . 0.0 112.013 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.779 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -61.07 -43.68 98.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.958 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -67.63 -34.34 76.77 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.506 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.86 79.98 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.779 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.2 p-90 -72.44 -38.2 68.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.332 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.95 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.047 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.0 mt -57.86 -44.06 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.347 0.117 . . . . 0.0 110.752 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 53.3 tptt -63.85 -49.54 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.85 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.0 t -64.07 -43.86 94.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.051 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.85 92.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.0 109.977 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 6.4 t-160 -58.22 -58.93 6.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.544 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 11.8 pt-20 -66.98 -34.51 77.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.78 98.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 110.552 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -66.84 -45.96 76.59 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 51.6 mt-10 -63.31 -27.85 69.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.404 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.46 -39.54 85.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.458 . . . . 0.0 110.168 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.454 HD22 HG23 ' A' ' 68' ' ' ILE . 2.3 p-10 -141.28 71.74 26.96 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.279 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.95 42.31 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.04 2.493 . . . . 0.0 113.065 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -128.79 11.6 6.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.008 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.454 HG23 HD22 ' A' ' 65' ' ' ASN . 11.2 pt -89.34 178.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.632 0.729 . . . . 0.0 112.268 -176.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -110.37 -43.74 3.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.545 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.9 pt-20 -163.64 151.27 12.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.832 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.6 150.08 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.63 111.46 22.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.698 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.7 pp -109.85 133.23 53.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.464 0.65 . . . . 0.0 110.833 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -103.24 124.28 38.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 81.1 Cg_endo -80.03 175.97 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.201 1.934 . . . . 0.0 114.178 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.98 -13.88 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.551 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.49 74.99 3.23 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.52 -24.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.042 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -63.74 -27.47 69.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.563 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.42 -34.43 47.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.966 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.2 p 58.84 -72.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.709 1.256 . . . . 0.0 112.382 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m -84.07 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 8.5 p -134.32 130.65 54.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -136.92 139.0 41.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.154 0.502 . . . . 0.0 111.437 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 79.7 m-85 -101.92 128.1 48.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.688 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -96.74 107.95 20.51 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 16' ' ' PHE . 54.0 t -91.81 109.63 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.454 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 66.4 mt -102.42 135.04 41.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.76 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -102.62 110.25 22.13 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -99.36 122.95 43.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.804 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 . . . . . 0 C--N 1.328 -0.344 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.843 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -127.35 133.58 50.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.967 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 85' ' ' PHE . 1.4 p -117.31 138.56 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.68 111.49 23.73 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.309 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 36' ' ' MET . 17.1 mt -102.79 123.69 56.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.184 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.87 127.11 46.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -120.84 126.96 26.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.17 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -59.97 117.03 3.73 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.147 1.898 . . . . 0.0 110.945 171.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.07 -36.89 66.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.931 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.49 -29.16 56.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.651 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HD3' ' HB2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -91.82 -31.38 15.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.862 -177.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.32 -19.1 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 109.983 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -89.12 -7.21 56.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.04 149.64 21.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.781 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.73 -21.03 41.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.63 34.92 4.57 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.401 ' HB2' HD22 ' A' ' 32' ' ' LEU . 53.2 p90 -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.402 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.54 -5.72 38.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 111.173 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.23 -2.94 35.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.855 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.49 117.16 28.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -63.91 -31.59 72.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.076 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.5 mm? -61.67 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.336 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 26' ' ' TYR . 34.2 tp -72.12 -37.59 69.47 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.595 0.712 . . . . 0.0 109.577 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.97 -45.64 63.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.349 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -73.44 -33.6 64.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.675 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.72 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.23 -46.72 32.0 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -176.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 9.7 tpt -95.06 3.62 54.63 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.22 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.27 -24.01 23.03 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 165.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.37 -68.75 0.42 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.879 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 m -87.73 65.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.87 0.843 . . . . 0.0 110.396 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.476 HD22 HD12 ' A' ' 50' ' ' LEU . 4.5 t-20 -149.56 -27.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.78 -169.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 30.4 t70 -69.18 -44.97 71.1 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.665 0.745 . . . . 0.0 110.196 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -124.74 71.2 59.37 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.249 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 45' ' ' GLU . 73.5 Cg_endo -91.86 -2.12 4.27 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.774 2.316 . . . . 0.0 112.37 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 71.39 -42.58 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.56 0.744 . . . . 0.0 110.428 -173.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -50.67 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.026 175.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 49' ' ' PRO . 44.4 mt-10 -144.07 -73.77 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.595 0.712 . . . . 0.0 109.879 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 146.27 -105.81 0.35 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.528 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.421 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.7 tpt -57.3 -46.29 99.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 12.1 Cg_exo -68.7 -32.29 24.02 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.185 1.924 . . . . 0.0 110.742 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -57.76 -45.24 86.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.853 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.587 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 27.6 ttt180 -65.6 -45.91 81.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.013 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -48.32 81.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.716 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.8 p-90 -72.29 -39.18 68.5 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.019 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -41.15 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.716 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.8 -40.9 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.586 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -58.86 -50.44 74.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 111.009 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.453 ' SG ' HD21 ' A' ' 73' ' ' LEU . 44.6 t -61.97 -44.47 96.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.739 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.09 94.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.52 -51.11 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.83 -45.73 81.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.343 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.34 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 22' ' ' ALA . 3.0 tm? -66.47 -47.26 73.63 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.669 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.7 -36.76 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 110.324 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.74 75.07 12.2 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.828 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.21 39.99 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.214 2.609 . . . . 0.0 113.206 -170.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -136.3 26.15 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.5 -172.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.401 0.62 . . . . 0.0 111.835 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -123.99 -45.92 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.37 159.51 17.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.27 155.99 42.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.841 0.353 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.87 114.86 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.026 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.453 HD21 ' SG ' ' A' ' 57' ' ' CYS . 7.3 mt -108.12 140.14 41.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -101.86 122.5 47.15 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 91.1 Cg_endo -76.84 -171.19 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.121 1.881 . . . . 0.0 113.626 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -73.81 -47.03 41.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.24 76.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 111.063 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.96 -16.97 21.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.158 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -68.19 -25.31 65.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 110.293 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 83' ' ' VAL . 66.2 t30 -64.46 -25.1 67.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 68.13 -81.49 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.6 173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -83.48 61.48 6.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.223 0.535 . . . . 0.0 111.53 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.474 ' HB ' ' ND2' ' A' ' 80' ' ' ASN . 10.0 p -140.13 135.32 37.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -140.22 137.68 34.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.887 0.375 . . . . 0.0 110.498 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 50' ' ' LEU . 20.9 m-85 -105.48 119.09 38.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.465 0.65 . . . . 0.0 109.407 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.71 102.87 13.08 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.698 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.1 t -92.8 113.44 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.47 135.61 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.03 106.86 17.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.171 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -79.4 142.43 35.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.777 -177.369 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -108.53 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.045 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 43.1 t -108.93 135.79 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -104.29 112.25 25.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.454 -175.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -108.3 129.14 63.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 68.8 m80 -113.91 127.76 56.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.13 0.49 . . . . 0.0 110.776 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 25.0 m-85 -125.51 121.87 24.83 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.223 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 27.9 Cg_exo -61.11 129.96 30.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.746 1.631 . . . . 0.0 110.84 175.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CD2' HD21 ' A' ' 62' ' ' LEU . 2.5 tm? -50.54 -38.66 46.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.043 -175.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.05 -29.68 60.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.34 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 21.3 mmm180 -90.35 -37.19 14.19 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.452 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 tp -73.17 -16.9 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 109.659 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -101.94 18.84 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.305 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.95 169.79 8.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.613 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.79 -38.47 18.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.03 42.38 2.28 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.314 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 27.1 p90 -73.77 -26.76 60.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.14 -4.02 36.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -114.69 4.7 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.752 0.787 . . . . 0.0 109.394 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 31' ' ' LEU . 19.2 t70 -87.18 119.6 27.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.511 -175.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.65 -36.71 67.35 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.71 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.471 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 3.9 mm? -63.9 -46.0 86.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.557 0.694 . . . . 0.0 110.665 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -35.84 75.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.358 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.1 -48.01 59.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.241 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.85 -35.67 64.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.728 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.53 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -71.66 -46.6 58.46 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.974 0.416 . . . . 0.0 110.723 -177.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.614 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -93.14 3.75 55.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.21 0.528 . . . . 0.0 110.467 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.62 -26.95 12.18 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 167.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -74.52 -58.86 3.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 35' ' ' GLN . 20.2 m -86.45 53.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.744 0.783 . . . . 0.0 110.338 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.5 t-20 -134.34 -35.25 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.85 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.6 -35.6 67.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 p -128.69 70.17 80.3 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.0 Cg_endo -92.63 5.54 3.31 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.878 2.385 . . . . 0.0 112.52 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 72.27 -43.14 0.55 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.786 0.834 . . . . 0.0 111.564 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 75' ' ' PRO . 10.8 tp10 -67.46 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.841 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -139.85 -88.97 0.19 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.51 0.195 . . . . 0.0 111.064 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 161.42 -92.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.725 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 1.7 tmt? -64.65 -45.22 75.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 31.9 Cg_exo -65.35 -31.1 53.13 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 121.526 1.484 . . . . 0.0 110.345 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.734 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.5 tm? -58.61 -47.1 85.47 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.045 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.4 ptm180 -69.72 -40.98 75.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.806 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.13 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.734 ' HE1' HD22 ' A' ' 50' ' ' LEU . 11.2 p-90 -73.63 -37.32 65.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.854 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.0 -42.27 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.422 0.153 . . . . 0.0 110.931 -175.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.518 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 93.0 mt -67.2 -39.53 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.6 mmmm -62.66 -50.18 72.2 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.707 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.29 -43.42 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.733 0.301 . . . . 0.0 110.747 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.22 98.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.541 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -63.44 -45.19 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.366 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 43.9 mm-40 -62.07 -47.18 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.38 83.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.155 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.1 tm? -65.17 -47.18 77.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.135 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.66 -27.05 62.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.789 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 3.0 ttmp? -71.5 -38.84 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.173 0.511 . . . . 0.0 110.125 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -135.81 74.98 56.76 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.25 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.45 29.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.455 2.77 . . . . 0.0 113.506 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -125.86 25.72 6.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.222 0.534 . . . . 0.0 110.232 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.71 179.39 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.809 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -118.97 -36.75 3.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.863 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -164.32 168.34 18.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.914 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 13.9 p -135.86 148.97 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.96 117.21 33.18 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.442 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 49.8 tp -130.71 132.29 45.28 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.54 -164.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -109.77 134.05 20.74 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.488 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 29.0 Cg_endo -61.23 158.78 33.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.639 2.226 . . . . 0.0 113.2 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -61.88 -42.86 99.57 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.399 -165.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.84 116.83 8.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.843 0.83 . . . . 0.0 110.946 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.86 -16.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.543 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -58.04 -40.59 81.29 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.149 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -75.09 -36.53 61.7 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.915 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.4 m 70.68 -63.55 0.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.425 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 p -111.18 58.85 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.37 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -135.43 142.13 45.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.952 0.406 . . . . 0.0 111.13 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 99.9 m-85 -105.16 124.29 49.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -97.31 103.89 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 75.2 t -91.42 110.76 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 89.8 mt -105.48 134.61 46.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.177 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 57.4 m-85 -103.02 106.26 16.75 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.181 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -86.07 126.47 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.694 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.25 118.55 36.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.285 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 21.4 t -121.07 121.78 65.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -112.04 132.59 54.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.919 -166.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.18 152.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.568 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.415 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 64.7 m80 -120.71 128.15 52.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.827 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 8.4 m-85 -127.75 105.63 20.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.835 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.768 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 26.3 Cg_exo -60.67 120.55 8.35 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 121.588 1.525 . . . . 0.0 110.888 172.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -54.6 -42.33 70.98 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.804 -169.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG3' HD23 ' A' ' 18' ' ' LEU . 54.8 mtmt -61.25 -32.0 71.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.251 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 5.0 mtt180 -95.55 -35.65 11.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 62' ' ' LEU . 4.8 tp -69.7 -27.13 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.069 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.46 59.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 110.967 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.63 -169.45 1.66 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -125.91 138.36 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.87 17.37 18.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -170.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 20' ' ' ARG . 7.9 t80 -67.03 -23.87 65.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.957 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.1 -9.36 38.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.661 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -103.41 1.66 32.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.708 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.57 112.66 6.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.57 -42.47 88.06 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.793 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.26 -42.21 90.64 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.517 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -64.52 -39.83 94.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.047 0.451 . . . . 0.0 110.046 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.24 -40.99 87.69 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.996 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -73.49 -41.63 62.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.137 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' A' ' 32' ' ' LEU . 15.3 mt-30 -70.13 -50.39 41.03 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.307 0.575 . . . . 0.0 111.899 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.625 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -80.68 -22.35 40.48 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.8 95.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.245 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -62.87 -56.72 14.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 39' ' ' VAL . 85.8 t -85.19 69.67 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.643 0.735 . . . . 0.0 110.242 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.625 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -154.08 -34.96 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.748 -175.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.57 -36.8 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.205 -169.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -134.27 66.66 71.53 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.813 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -98.11 4.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.585 2.19 . . . . 0.0 112.948 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.85 -39.56 0.45 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.931 . . . . 0.0 112.417 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.6 OUTLIER -64.9 -79.25 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.363 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -143.95 -81.56 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.005 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 156.0 -110.93 0.46 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.194 177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.452 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 5.6 ttp -60.07 -41.35 84.29 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 48' ' ' MET . 43.3 Cg_exo -59.67 -44.47 31.37 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.84 1.693 . . . . 0.0 111.531 174.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -60.01 -37.68 80.43 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.606 ' HB2' HD21 ' A' ' 40' ' ' ASN . 22.1 ttt180 -55.51 -49.73 71.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.186 173.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.46 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.747 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.797 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.7 p-90 -72.1 -39.27 69.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.62 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -62.42 -51.04 77.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 96.0 mt -59.63 -36.91 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -48.52 67.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.987 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.432 ' HG ' ' HE3' ' A' ' 53' ' ' TRP . 95.1 m -70.58 -41.06 72.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.63 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.506 0.669 . . . . 0.0 109.626 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.661 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.3 t-160 -56.62 -54.03 50.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.954 175.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.41 -39.08 93.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.325 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.39 98.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 21' ' ' ILE . 13.2 tp -68.31 -46.65 69.69 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 39.4 mt-10 -65.31 -27.62 68.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.799 0.333 . . . . 0.0 110.986 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 12.3 tmtt? -65.33 -34.45 78.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 109.817 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -149.86 75.25 9.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.681 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 46.67 2.12 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.323 2.682 . . . . 0.0 113.285 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -143.38 34.87 1.32 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.304 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.411 HD13 ' ND2' ' A' ' 65' ' ' ASN . 23.3 pt -110.7 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.512 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -144.39 -19.85 0.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.467 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -166.34 149.91 7.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -139.05 157.84 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.379 . . . . 0.0 110.677 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -116.46 113.27 22.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.657 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.5 pp -109.28 136.31 48.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.566 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -109.87 129.16 24.24 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 90.5 Cg_endo -77.56 162.75 30.13 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.779 1.653 . . . . 0.0 114.097 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -65.31 -13.67 59.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.499 -172.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.4 88.08 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.224 0.535 . . . . 0.0 110.035 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.59 -33.06 57.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.607 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.8 -27.44 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.686 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . 5.0 m-20 -65.78 -38.9 90.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.627 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m 61.25 -77.43 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.344 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -83.53 33.74 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.686 ' CG2' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -112.01 130.45 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.85 139.57 51.17 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.763 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.526 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 69.8 m-85 -97.59 120.38 37.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.544 0.687 . . . . 0.0 109.252 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.76 100.61 13.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.547 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.7 t -98.37 112.2 29.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.195 0.521 . . . . 0.0 110.129 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.415 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.0 mp -99.24 141.1 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.259 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 58.7 m-85 -101.32 106.46 17.64 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.768 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 m-20 -83.81 136.52 34.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.724 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HA ' HD21 ' A' ' 18' ' ' LEU . 6.1 pt-20 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -83.98 50.31 1.81 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.143 0.497 . . . . 0.0 111.392 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.0 76.06 1.36 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.831 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.3 mtp -83.06 60.27 5.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.091 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.51 -85.29 0.41 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.179 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -147.96 137.88 22.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 55.7 ttp -103.31 104.8 43.2 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.59 -9.09 23.57 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.938 2.425 . . . . 0.0 113.438 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.75 108.86 17.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.13 0.49 . . . . 0.0 110.015 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -103.16 119.27 51.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.877 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.64 118.75 37.38 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 39' ' ' VAL . 38.2 t -111.83 119.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 30.0 mt-10 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.272 0.558 . . . . 0.0 110.687 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.758 HG21 ' SD ' ' A' ' 36' ' ' MET . 4.8 mt -98.08 152.48 4.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.378 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -122.33 126.07 47.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.922 0.391 . . . . 0.0 110.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HE1' ' SD ' ' A' ' 36' ' ' MET . 8.0 m-30 -116.89 125.8 28.01 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.249 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 38.9 Cg_exo -59.4 108.5 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.036 1.824 . . . . 0.0 110.788 171.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 tt -50.8 -36.07 35.3 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.743 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -38.55 75.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.637 0.256 . . . . 0.0 111.588 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.414 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.7 mpt_? -86.59 -35.56 19.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.379 -173.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.499 HG23 HD22 ' A' ' 62' ' ' LEU . 9.6 tp -66.12 -22.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 109.626 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.17 24.52 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.216 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.27 170.65 15.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.74 136.9 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.92 26.31 19.8 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -63.34 -29.17 70.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.579 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.88 -4.3 23.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.487 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -92.23 -8.41 45.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.898 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -80.43 115.69 20.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.345 0.593 . . . . 0.0 109.897 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.29 -33.46 75.87 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.325 -168.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -43.31 75.8 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.841 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -64.45 -40.07 95.03 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.719 0.771 . . . . 0.0 109.02 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.77 -44.76 66.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -74.19 -26.8 60.49 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.559 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.9 50.49 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.388 0.613 . . . . 0.0 110.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.758 ' SD ' HG21 ' A' ' 14' ' ' ILE . 94.8 mmm -72.69 -29.37 63.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.445 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.47 -27.84 70.64 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -65.88 -41.57 91.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 110.17 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 HG11 ' A' ' 12' ' ' VAL . 3.6 p -108.65 77.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.161 0.981 . . . . 0.0 110.202 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -150.6 -25.47 0.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.401 -174.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.18 -32.56 16.57 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.103 -174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 t -143.45 63.77 12.91 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.407 0.622 . . . . 0.0 110.695 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 17.5 Cg_endo -93.58 14.86 1.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.96 2.44 . . . . 0.0 113.332 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HG3' HD21 ' A' ' 80' ' ' ASN . 21.2 tp10 75.36 -39.32 0.39 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.444 0.698 . . . . 0.0 112.117 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 27.4 tt0 -84.42 -104.34 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.937 -0.477 . . . . 0.0 110.632 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -102.05 -90.5 0.35 Allowed 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.028 0.442 . . . . 0.0 110.735 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 162.97 -111.71 0.48 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.45 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.5 tmt? -57.95 -44.86 99.7 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 51.8 Cg_exo -58.2 -41.85 62.78 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.971 1.78 . . . . 0.0 111.976 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.91 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.83 -40.59 93.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.317 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.517 ' HB2' HD21 ' A' ' 40' ' ' ASN . 5.1 ttp85 -54.95 -46.21 74.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.602 0.239 . . . . 0.0 110.583 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 56' ' ' LYS . . . -58.76 -48.53 80.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.675 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.91 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.0 p-90 -72.73 -40.05 66.42 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.235 -177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 t -61.2 -51.04 77.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.576 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' HG3' ' A' ' 36' ' ' MET . 50.5 mt -57.75 -43.25 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.249 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 52' ' ' ALA . 62.4 mttp -63.23 -50.23 71.03 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.26 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.8 m -61.39 -45.85 92.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.141 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.21 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.75 0.31 . . . . 0.0 110.859 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -57.97 -52.49 65.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.934 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 46.8 mt-10 -69.09 -39.73 78.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.28 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.83 88.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 21' ' ' ILE . 6.4 tp -70.71 -45.55 64.74 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.95 -32.87 74.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 28.4 mmmt -80.03 -22.71 42.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.349 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.42 HD21 HD13 ' A' ' 68' ' ' ILE . 1.6 p-10 -140.94 69.56 29.16 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.475 0.655 . . . . 0.0 109.707 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.47 50.34 3.35 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.406 2.737 . . . . 0.0 113.182 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -142.18 28.33 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.374 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.42 HD13 HD21 ' A' ' 65' ' ' ASN . 33.1 pt -110.07 -172.11 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.35 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -131.57 -39.86 1.12 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.143 -173.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -164.3 156.75 16.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.797 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.11 122.55 48.17 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 7.9 mt -106.56 136.71 45.87 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.125 -173.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.99 117.62 61.06 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.448 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.728 ' HG2' HG13 ' A' ' 83' ' ' VAL . 43.1 Cg_exo -40.05 135.5 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.58 2.853 . . . . 0.0 113.347 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -62.65 -25.67 68.25 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.355 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -82.87 68.3 9.3 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 t -57.35 -23.19 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.363 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.514 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 3.5 mptp? -61.56 -24.05 66.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.626 ' ND2' HG11 ' A' ' 83' ' ' VAL . 51.5 t30 -65.9 -17.94 65.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.34 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.1 p 62.17 -96.57 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 168.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -78.11 53.69 1.24 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.33 0.586 . . . . 0.0 112.555 -167.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.728 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.1 p -142.11 134.53 27.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.928 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -139.37 145.4 38.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.693 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.0 117.29 33.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.713 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 13.2 t-160 -98.01 102.64 14.44 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.7 t -91.77 112.92 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.101 0.477 . . . . 0.0 109.985 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.2 mt -104.3 139.03 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.051 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -102.71 106.91 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.154 0.502 . . . . 0.0 110.867 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.49 135.91 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.77 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -90.13 112.99 24.66 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.697 -175.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 73.55 -51.52 0.7 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.2 55.63 7.35 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.405 0.621 . . . . 0.0 110.631 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -127.18 146.83 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.803 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.16 124.37 8.98 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.409 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.475 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 m170 -77.93 62.77 2.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.231 0.539 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.3 mtp -109.68 90.56 9.11 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.417 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 36.7 Cg_exo -60.05 132.97 47.4 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.241 2.627 . . . . 0.0 112.615 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.17 108.77 17.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.4 t -96.55 119.04 44.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.1 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 9.3 p-10 -101.43 119.2 38.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.578 0.704 . . . . 0.0 109.771 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.5 t -95.3 139.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.791 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -92.25 130.95 37.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.381 0.61 . . . . 0.0 110.337 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.516 HD13 ' SD ' ' A' ' 36' ' ' MET . 25.5 mt -128.59 133.19 67.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 61.1 m80 -120.26 126.29 50.23 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 110.795 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.2 m-85 -127.57 115.01 21.09 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.856 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 37.3 Cg_exo -61.27 121.95 10.4 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.292 1.994 . . . . 0.0 111.861 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -43.35 -44.01 5.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 113.851 -1.522 . . . . 0.0 113.901 -168.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -77.41 -38.31 49.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HD2' ' HG2' ' A' ' 17' ' ' PRO . 17.7 ptp180 -89.34 -25.14 21.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.741 -172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HD22 ' A' ' 62' ' ' LEU . 7.2 tp -71.65 -22.57 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.08 -11.89 58.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 142.3 44.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.198 0.523 . . . . 0.0 110.845 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.44 -19.43 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.75 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.54 55.36 0.83 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 172.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -67.85 -40.46 83.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.489 0.185 . . . . 0.0 111.211 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 61.92 1.51 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.696 0.76 . . . . 0.0 110.032 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.21 -34.9 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.247 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 29.2 t70 -75.1 119.97 19.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.813 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 29.5 tt0 -64.57 -35.24 80.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.36 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mt -59.36 -43.06 92.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.252 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -65.59 -41.9 92.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.73 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -70.3 -45.09 66.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.092 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 90.4 m-20 -61.8 -37.6 84.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.379 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 43.6 mt-30 -73.76 -41.93 61.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.609 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 70.8 mmm -86.84 12.24 11.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.9 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.19 -27.14 6.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 164.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -62.77 -62.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.076 172.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -95.09 71.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 122.07 0.938 . . . . 0.0 109.771 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.7 t-20 -147.5 -44.65 0.17 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.068 -165.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.27 -39.56 54.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.838 0.352 . . . . 0.0 111.034 -171.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -128.55 69.77 79.48 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.694 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HB2' HD12 ' A' ' 50' ' ' LEU . 53.2 Cg_endo -98.96 25.52 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.312 2.674 . . . . 0.0 112.816 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' HG3' HD21 ' A' ' 80' ' ' ASN . 5.1 tp10 73.38 -39.39 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.552 0.741 . . . . 0.0 112.114 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.562 ' CB ' HD21 ' A' ' 50' ' ' LEU . 32.5 mt-10 -85.56 -88.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.266 0.555 . . . . 0.0 111.441 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.01 -86.61 0.44 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.054 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.672 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 158.49 -78.45 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.972 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.48 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -63.0 -47.62 86.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 17.3 Cg_exo -69.02 -24.32 33.19 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.857 1.705 . . . . 0.0 110.326 175.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -59.77 -48.2 82.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.649 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 36.3 ptt180 -75.11 -38.86 60.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.584 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.69 -48.29 81.61 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.209 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.0 p-90 -72.45 -43.83 63.21 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.91 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -40.99 78.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.383 -174.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.492 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 83.1 mt -66.54 -45.59 88.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.522 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 38.6 ttmt -63.96 -47.7 79.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.5 m -65.26 -42.61 93.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.193 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.73 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.395 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.21 -52.63 64.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.575 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 19.2 mm-40 -61.53 -42.47 98.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.863 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.03 93.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 HG23 ' A' ' 21' ' ' ILE . 8.4 tp -63.65 -46.97 83.21 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.511 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.1 -26.89 63.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.18 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -65.77 -40.03 91.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 110.082 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.419 HD21 HD13 ' A' ' 68' ' ' ILE . 2.1 p-10 -135.86 73.78 59.25 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.322 177.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.24 55.84 4.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.037 2.492 . . . . 0.0 112.322 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -132.16 -6.58 3.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.631 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.419 HD13 HD21 ' A' ' 65' ' ' ASN . 31.6 pt -93.52 -175.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.177 -170.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.82 -9.51 0.8 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.418 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -166.37 152.72 8.95 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.973 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.89 156.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 110.353 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -111.17 115.66 29.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.325 0.583 . . . . 0.0 109.898 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.123 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -118.93 131.84 24.17 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.43 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.641 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -26.9 137.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 1 C-N-CA 125.709 4.272 . . . . 0.0 115.905 173.317 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -55.47 -45.1 76.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.578 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.68 83.25 2.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.59 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.38 -21.37 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.394 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -65.07 -24.09 67.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.018 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.606 ' ND2' HG11 ' A' ' 83' ' ' VAL . 48.4 t30 -64.75 -22.76 67.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m 68.54 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.9 m -79.24 49.45 0.97 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -167.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 75' ' ' PRO . 6.7 p -142.85 136.77 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -146.79 154.59 41.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.539 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.07 135.06 54.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.126 0.489 . . . . 0.0 110.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -106.11 103.47 12.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.608 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.0 111.95 24.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.1 mt -106.71 137.76 35.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.172 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 71.4 m-85 -102.46 108.53 19.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.391 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 15' ' ' HIS . 10.5 m-20 -76.38 120.39 21.56 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.39 115.55 21.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.573 0.701 . . . . 0.0 110.914 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 C--O 1.244 0.769 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.421 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m 71.27 -55.16 0.66 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.405 0.682 . . . . 0.0 112.332 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.21 59.68 2.63 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.451 0.643 . . . . 0.0 110.451 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -89.59 -22.3 22.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.38 -119.68 3.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.402 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 56.05 52.3 10.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 110.53 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 75.3 mtp -71.25 120.91 82.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.145 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.37 152.57 59.9 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.462 2.108 . . . . 0.0 111.479 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 82' ' ' SER . . . -83.76 114.33 21.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.232 0.539 . . . . 0.0 110.239 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 3.3 m -94.29 140.44 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.466 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -107.42 118.62 37.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.233 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.72 117.78 43.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 31.7 mt-10 -103.93 112.04 24.85 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.202 0.525 . . . . 0.0 110.449 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 2.3 mt -108.5 124.42 64.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 79.6 m80 -101.83 112.37 24.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -99.94 128.93 29.64 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.526 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 40.5 Cg_endo -68.13 111.43 2.46 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.048 1.832 . . . . 0.0 111.133 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HG22 ' A' ' 21' ' ' ILE . 10.4 tt -51.09 -37.87 48.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.223 -171.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -70.34 -34.95 73.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -93.49 -30.79 14.85 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.304 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 18' ' ' LEU . 7.3 tp -66.08 -24.85 34.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.118 0 CA-C-O 121.076 0.465 . . . . 0.0 109.901 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.03 68.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.26 148.53 41.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.521 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.86 -22.01 29.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.327 0.584 . . . . 0.0 109.77 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.24 46.57 3.24 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 173.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -71.87 -13.93 61.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.807 0.337 . . . . 0.0 111.627 -174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.13 -12.08 61.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.304 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.14 -5.42 56.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.48 107.05 18.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.253 0.549 . . . . 0.0 110.876 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.58 -32.15 72.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.5 mt -58.5 -45.78 88.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.001 0.429 . . . . 0.0 110.507 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.17 -40.8 67.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.46 0.648 . . . . 0.0 110.001 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 33' ' ' LEU . 12.4 tp -70.76 -44.08 67.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.621 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 2.5 p30 -71.94 -34.24 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.792 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -69.87 -38.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.807 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.24 5.68 29.25 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.762 175.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.88 -28.68 8.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 32.3 mmtp -77.02 -70.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.38 34.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.975 0.893 . . . . 0.0 110.596 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 36' ' ' MET . 26.8 t-20 -138.63 -8.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.812 -173.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.14 -32.27 63.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.453 0.644 . . . . 0.0 109.866 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -138.45 67.75 45.47 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.462 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -88.9 7.96 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.956 2.437 . . . . 0.0 112.636 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 72.64 -51.33 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.711 0.804 . . . . 0.0 111.873 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 77' ' ' ALA . 10.2 tt0 -64.1 -70.05 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.828 0.346 . . . . 0.0 111.05 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.63 -129.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.675 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -154.61 -94.88 0.11 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 167.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 11.1 ttp -53.16 -42.89 93.3 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.675 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 14.4 Cg_exo -70.5 -28.36 21.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.912 1.742 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 2.8 tm? -57.69 -45.69 85.32 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -60.19 -49.22 78.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.46 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.86 -49.72 76.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 -175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 4.5 p-90 -73.41 -37.38 65.93 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.523 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.96 -51.34 67.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.61 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.707 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 4.8 tppp? -64.1 -50.37 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.863 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 73' ' ' LEU . 50.0 t -61.7 -46.46 89.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.342 . . . . 0.0 110.724 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.43 89.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.461 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -62.37 -45.35 93.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.114 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 56' ' ' LYS . 58.6 mt-10 -62.45 -47.21 85.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.7 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.2 96.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.199 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 62' ' ' LEU . 3.2 tm? -74.37 -37.88 63.33 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.436 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -81.27 -26.07 36.05 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.449 -0.782 . . . . 0.0 112.024 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.7 tmtp? -82.72 -37.12 25.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.639 ' ND2' HG23 ' A' ' 68' ' ' ILE . 4.0 t30 -131.4 90.43 37.88 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.864 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -88.14 31.68 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.611 2.207 . . . . 0.0 111.365 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -118.34 11.29 13.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.925 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.639 HG23 ' ND2' ' A' ' 65' ' ' ASN . 7.3 pt -95.49 166.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.243 173.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -129.4 -3.58 4.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.92 157.35 9.82 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.984 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.38 156.94 39.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.981 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -110.39 117.45 33.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.384 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.5 mt -111.1 140.76 45.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.627 0.727 . . . . 0.0 112.383 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.472 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 23.6 tptm -117.58 123.93 29.38 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.425 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HG2' HG13 ' A' ' 83' ' ' VAL . 68.7 Cg_exo -38.97 144.44 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.247 3.298 . . . . 0.0 113.799 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -65.79 -30.96 71.68 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . . . -79.11 76.62 5.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.844 169.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -56.73 -25.14 20.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -57.09 -24.0 50.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.683 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HB3' HG12 ' A' ' 83' ' ' VAL . 8.7 m-20 -62.93 -36.57 83.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.107 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m 65.67 -76.38 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 16.0 m -86.68 36.33 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -167.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.4 p -140.79 130.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -127.9 151.15 49.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.208 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.412 ' CE2' HD21 ' A' ' 50' ' ' LEU . 74.4 m-85 -112.19 123.65 50.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.239 0.542 . . . . 0.0 110.2 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 12.1 t-160 -112.14 102.25 10.46 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 90.1 t -95.52 113.68 30.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.135 0.493 . . . . 0.0 110.206 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 88.0 mt -101.82 140.78 19.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -103.13 107.62 18.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.676 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 33.8 m-20 -94.72 116.69 29.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.96 114.21 25.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.574 0.702 . . . . 0.0 111.083 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 C--O 1.246 0.908 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.224 178.443 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.924 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 m -82.15 69.12 8.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 111.199 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.31 -49.56 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.485 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.0 mtt -105.81 6.25 31.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 171.29 40.27 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.155 -174.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -145.83 -31.67 0.38 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.1 mmm -130.91 71.1 82.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.735 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.64 78.03 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.044 2.496 . . . . 0.0 111.787 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.59 109.53 18.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.101 0.477 . . . . 0.0 110.448 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.66 119.06 48.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.879 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.08 121.53 44.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.549 0.69 . . . . 0.0 110.27 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 39' ' ' VAL . 87.3 t -92.28 139.58 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.719 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.62 112.8 26.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.0 110.519 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.0 mt -103.07 152.21 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 56.3 m80 -130.43 142.84 50.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.488 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -141.96 132.53 12.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.075 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 21' ' ' ILE . 19.4 Cg_endo -58.3 115.26 2.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.503 2.135 . . . . 0.0 111.706 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 62' ' ' LEU . 1.5 tm? -43.07 -50.82 6.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.584 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -76.55 -18.82 58.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 9.5 ttt180 -100.77 -35.3 9.5 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.881 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -69.4 -25.72 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.223 0.535 . . . . 0.0 109.81 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.85 -12.13 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.92 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.6 171.31 12.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.002 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.24 -52.3 17.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 109.783 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.06 71.32 3.03 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.103 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' O ' HD22 ' A' ' 32' ' ' LEU . 16.7 p90 -65.24 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.764 0.316 . . . . 0.0 110.909 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.04 4.97 8.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.0 111.251 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 20' ' ' ARG . 36.3 t70 -75.39 113.96 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.51 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -63.03 -34.8 78.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.466 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 32.1 tp -61.5 -40.33 94.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.522 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -55.84 -42.73 76.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.528 0.68 . . . . 0.0 109.58 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD13 ' NH2' ' A' ' 51' ' ' ARG . 3.5 mm? -65.08 -47.7 76.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.407 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.53 -41.83 88.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.83 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.544 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 14.5 mt-30 -66.42 -44.09 83.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.343 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.5 mmm -87.68 -1.09 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.3 -26.68 15.12 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 165.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' GLN . 60.6 tttp -64.81 -66.58 0.52 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.274 -0.963 . . . . 0.0 110.829 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 12' ' ' VAL . 7.5 p -108.61 97.59 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.748 0.785 . . . . 0.0 110.229 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -176.59 -26.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.55 -44.56 96.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.043 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -145.1 73.98 14.44 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.745 0.783 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -91.44 21.03 0.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.838 2.359 . . . . 0.0 112.45 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 71.59 -37.76 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.93 0.892 . . . . 0.0 112.366 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.696 ' CD ' ' HB3' ' A' ' 75' ' ' PRO . 23.6 tp10 -82.4 -94.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.332 -0.23 . . . . 0.0 111.169 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.668 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 32.7 mt-10 -114.82 -109.16 0.36 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.737 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 167.67 -106.27 0.25 Allowed Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.658 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.689 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 10.8 tpt -49.77 -48.39 77.34 Favored Pre-proline 0 C--O 1.247 0.954 0 CA-C-O 120.958 0.409 . . . . 0.0 111.317 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HG2' ' HB3' ' A' ' 46' ' ' GLU . 31.4 Cg_endo -60.58 -34.15 92.81 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.043 1.162 . . . . 0.0 110.366 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.711 ' O ' ' HE3' ' A' ' 53' ' ' TRP . 4.0 mt -60.28 -44.41 95.38 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.2 ptm180 -62.83 -39.21 93.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.211 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.36 94.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.722 0.772 . . . . 0.0 110.047 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.711 ' HE3' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -62.12 -51.15 69.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.95 1.3 . . . . 0.0 112.881 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -73.35 -43.71 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -58.52 -38.98 73.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.628 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 12.5 mmmm -69.62 -49.1 57.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.698 174.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.697 ' SG ' HD11 ' A' ' 73' ' ' LEU . 49.7 t -59.18 -44.45 92.17 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.777 0.322 . . . . 0.0 110.942 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -65.38 -42.18 92.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.301 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -61.35 -48.14 82.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.424 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 33.3 mm-40 -64.54 -44.0 92.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.514 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.45 95.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.439 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.619 HD11 HD22 ' A' ' 18' ' ' LEU . 10.1 tt -68.63 -48.19 64.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.149 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -63.64 -25.51 68.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.702 0.287 . . . . 0.0 111.337 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -71.76 -33.58 68.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.219 0.533 . . . . 0.0 110.279 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -149.36 73.4 9.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.717 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.29 33.73 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.323 2.682 . . . . 0.0 113.026 -168.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.04 18.87 10.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.525 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.0 pt -96.1 -173.9 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.923 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -130.72 -27.38 2.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.529 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -165.06 168.86 16.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 176.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.17 153.51 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -110.96 132.55 54.11 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.644 0.735 . . . . 0.0 111.303 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.697 HD11 ' SG ' ' A' ' 57' ' ' CYS . 1.8 mm? -107.87 143.9 35.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.492 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -130.83 122.62 19.6 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.696 ' HB3' ' CD ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -32.74 140.46 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 125.273 3.982 . . . . 0.0 115.906 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 42.4 mtp180 -57.75 -37.59 73.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.989 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.96 84.6 7.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.511 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.68 -12.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.379 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -59.07 -32.14 69.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.608 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 45' ' ' GLU . 4.9 t-20 -63.13 -37.72 88.32 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.503 -172.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m 69.24 -59.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -77.63 -34.2 53.33 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -167.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.665 HG13 ' HG2' ' A' ' 75' ' ' PRO . 8.8 p -89.88 132.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 112.255 -171.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -130.6 161.66 31.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.721 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.93 136.23 51.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.442 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -111.92 111.12 21.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' ALA . 86.8 t -92.04 110.36 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' HIS . 82.3 mt -101.2 136.78 31.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.162 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.31 111.51 23.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.239 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -77.19 113.92 15.46 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -89.66 110.64 21.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.725 0.774 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.301 170.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.633 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -80.53 -67.29 0.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.701 0.286 . . . . 0.0 111.425 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.86 -74.18 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.4 mmt 58.37 67.54 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.679 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 37.03 51.0 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.285 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -141.93 114.14 8.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.931 0.396 . . . . 0.0 110.605 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.5 ptm -154.44 156.26 31.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.616 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.25 43.08 0.95 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.769 2.312 . . . . 0.0 113.077 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 82' ' ' SER . . . -108.86 115.93 31.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.719 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.1 t -114.52 119.35 61.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.923 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.58 118.42 31.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 39' ' ' VAL . 39.2 t -106.24 119.98 56.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 86' ' ' HIS . 23.6 mt-10 -100.27 118.98 37.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.085 0.469 . . . . 0.0 111.173 -168.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.53 HD13 ' SD ' ' A' ' 36' ' ' MET . 24.4 mt -101.32 132.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.084 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 60.5 m80 -112.39 112.09 23.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 110.896 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -106.21 153.51 40.28 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.0 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.519 ' O ' HG22 ' A' ' 21' ' ' ILE . 87.5 Cg_endo -81.69 113.89 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.281 1.988 . . . . 0.0 111.673 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -43.3 -49.1 6.86 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' OE2' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -74.95 -32.07 61.64 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 29' ' ' ASP . 2.6 ttm180 -96.86 -21.46 17.49 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.85 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.625 HG23 HD22 ' A' ' 62' ' ' LEU . 6.7 tp -72.28 -27.34 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 172.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.02 -9.11 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.257 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.13 155.27 19.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.125 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.9 pt-20 -84.01 -14.35 50.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.833 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.08 43.71 1.65 Allowed Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -60.03 -27.76 67.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 111.624 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -14.34 62.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.639 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.99 -18.47 43.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.564 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 25.5 t70 -84.7 109.0 17.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 111.57 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -29.61 70.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.25 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . 2.9 tm? -63.86 -40.2 95.98 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.3 -43.84 98.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.297 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.97 -44.57 92.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -58.4 -43.32 88.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.257 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 15' ' ' HIS . 2.4 mp0 -68.44 -45.21 73.16 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 14' ' ' ILE . 66.2 mmm -90.15 13.43 15.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.172 0.51 . . . . 0.0 110.825 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.88 -38.29 3.67 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -63.4 -66.11 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.158 -0.521 . . . . 0.0 111.121 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 12' ' ' VAL . 7.0 p -91.36 68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 122.338 1.066 . . . . 0.0 110.267 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.11 9.8 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.145 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.34 -36.95 3.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.987 0.423 . . . . 0.0 110.055 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.1 p -141.94 59.3 9.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.989 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 42' ' ' THR . 67.1 Cg_endo -94.68 30.43 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.047 2.498 . . . . 0.0 113.098 -174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 73.79 -47.9 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.31 0.644 . . . . 0.0 111.048 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HB2' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -77.81 -92.64 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.95 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -130.06 -91.3 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.605 0.241 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 165.96 -102.6 0.19 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.597 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 9.1 ttp -53.55 -45.97 98.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 48' ' ' MET . 19.2 Cg_endo -60.9 -30.2 89.56 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.879 1.719 . . . . 0.0 111.05 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.81 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -59.06 -45.96 89.47 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.292 176.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.518 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 18.0 ttm180 -59.98 -48.94 79.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.2 78.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.376 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.81 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 2.3 p-90 -72.38 -41.93 65.8 Favored 'General case' 0 CA--C 1.522 -0.096 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.852 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.5 OUTLIER -69.48 -43.18 80.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.689 -174.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.78 -46.23 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.316 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.53 -41.81 88.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.586 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.415 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 71.7 m -66.28 -44.85 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.819 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.33 83.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.833 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -59.35 -49.35 78.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.967 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -64.56 -41.83 96.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.043 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.9 96.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.283 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.625 HD22 HG23 ' A' ' 21' ' ' ILE . 15.6 tp -69.48 -47.36 64.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.135 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.66 -26.44 67.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -42.17 98.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.494 0.664 . . . . 0.0 109.961 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.417 HD21 HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -139.4 75.09 33.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.75 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.15 47.77 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.073 2.515 . . . . 0.0 112.709 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -139.26 2.83 2.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.69 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 65' ' ' ASN . 31.2 pt -85.64 -179.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.574 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.19 -19.75 1.94 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.878 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -165.51 155.47 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.0 t -127.28 152.36 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.681 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -110.1 116.22 31.16 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.43 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 29.8 tp -127.7 141.89 51.48 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.338 -167.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -126.38 126.86 24.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 18.1 Cg_endo -63.16 171.22 6.6 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.107 2.538 . . . . 0.0 114.733 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 3.8 mtp180 -66.41 -61.01 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.66 -168.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.99 118.01 4.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.49 -9.75 13.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.156 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -58.81 -39.57 81.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' OD1' HG12 ' A' ' 83' ' ' VAL . 1.6 p30 -73.46 -27.06 61.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.495 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m 74.49 -66.51 0.29 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 26.8 m -125.85 27.07 6.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 80' ' ' ASN . 9.9 p -90.16 134.98 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 168.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -134.86 152.25 51.59 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.996 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -108.51 118.86 37.88 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.632 0.73 . . . . 0.0 109.623 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.4 t-160 -94.05 102.04 14.09 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.32 112.22 25.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -113.54 139.11 40.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.528 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.57 106.65 17.12 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.201 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -86.9 127.32 35.05 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.29 114.85 21.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.462 ' OE2' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.664 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -78.47 124.96 28.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.911 0.386 . . . . 0.0 111.089 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.13 -42.48 2.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.555 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 ttp 54.94 71.49 0.53 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.89 -175.21 46.67 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.448 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -139.85 149.22 43.17 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.8 mtm -64.25 117.65 38.92 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 82' ' ' SER . 36.1 Cg_endo -64.94 95.94 0.25 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.89 2.393 . . . . 0.0 113.072 -172.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.22 113.55 21.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.489 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -98.99 119.71 47.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.21 118.39 28.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.014 175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.05 119.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -98.77 112.22 24.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 0.0 110.26 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.2 mt -111.95 123.34 67.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -99.66 112.82 25.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.237 0.542 . . . . 0.0 110.914 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-30 -111.42 116.04 51.23 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.589 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 33.6 Cg_exo -61.79 119.74 7.01 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.008 . . . . 0.0 111.789 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.487 HD22 HD11 ' A' ' 62' ' ' LEU . 1.7 tm? -42.38 -45.2 4.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.765 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -71.98 -43.54 64.97 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.785 -171.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 11.5 ptp180 -83.13 -28.66 29.25 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.277 -171.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 17' ' ' PRO . 7.8 tp -75.24 -17.69 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.0 109.891 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.88 -13.72 55.6 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.25 0.548 . . . . 0.0 110.395 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.35 156.94 20.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.369 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.9 -14.37 51.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.351 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.16 60.61 1.1 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -82.16 -41.53 20.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.854 0.359 . . . . 0.0 111.158 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.37 -4.75 43.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 111.503 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.2 9.38 30.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.515 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 18.0 t70 -95.57 119.5 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 110.882 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -61.62 -31.56 71.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.607 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 6.4 mt -69.03 -43.21 75.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.26 0.552 . . . . 0.0 110.465 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.0 -36.56 75.24 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.394 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -70.34 -47.9 58.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.28 -178.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.3 p30 -71.45 -35.16 70.81 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.864 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -66.47 -45.21 80.47 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.999 0.428 . . . . 0.0 110.64 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 7.3 tpt -93.34 16.81 12.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.133 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.09 -32.98 3.85 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 163.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.53 -62.98 1.43 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.63 -0.785 . . . . 0.0 110.576 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 39' ' ' VAL . 11.4 p -94.6 52.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.705 1.24 . . . . 0.0 110.165 -176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' MET . 4.2 t-20 -133.16 -29.37 1.43 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.583 -171.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 80.3 m-20 -79.48 -31.38 42.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.67 -169.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.8 p -126.1 62.38 44.92 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 120.906 0.384 . . . . 0.0 111.225 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 83' ' ' VAL . 11.3 Cg_endo -97.21 6.6 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.936 2.424 . . . . 0.0 113.456 -174.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 71.19 -42.03 0.52 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.698 0.799 . . . . 0.0 112.205 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 50' ' ' LEU . 3.9 tp10 -66.72 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.345 0.117 . . . . 0.0 110.983 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 31.5 mt-10 -136.28 -86.44 0.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.328 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 160.9 -110.26 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.099 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.6 tpt -52.72 -49.53 85.91 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 48' ' ' MET . 34.9 Cg_endo -67.82 -35.73 20.47 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.208 1.272 . . . . 0.0 111.566 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.731 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -60.38 -43.2 96.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.415 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 48' ' ' MET . 35.6 ptt180 -69.51 -29.87 67.58 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.997 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -49.31 77.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.668 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 12.2 p-90 -73.09 -36.84 66.87 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.148 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.27 -49.1 82.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 79.6 mt -65.55 -38.64 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.427 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.2 tptt -63.65 -48.86 75.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.727 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.7 t -62.68 -46.95 85.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.69 83.88 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 110.667 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -62.4 -52.23 64.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.547 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 56.7 mm-40 -65.04 -38.35 90.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.661 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.71 -44.12 90.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.487 HD11 HD22 ' A' ' 18' ' ' LEU . 8.2 tt -72.94 -47.23 47.39 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.782 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.55 -26.08 63.18 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.805 -0.559 . . . . 0.0 112.09 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -84.05 -44.96 13.57 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.615 ' ND2' HG23 ' A' ' 68' ' ' ILE . 3.2 t30 -139.45 100.14 7.69 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.866 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -96.79 25.66 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.695 2.263 . . . . 0.0 112.012 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.04 8.22 32.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.615 HG23 ' ND2' ' A' ' 65' ' ' ASN . 4.7 pt -77.51 166.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.733 0.777 . . . . 0.0 111.474 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HE ' ' HB2' ' A' ' 69' ' ' ARG . 2.0 mtm180 -106.89 -51.39 2.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.325 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.658 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -154.9 150.37 27.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.139 175.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 87' ' ' VAL . 9.1 p -119.55 156.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.772 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -111.16 115.1 28.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.283 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 57' ' ' CYS . 11.2 mt -111.69 136.68 50.6 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.636 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -113.93 119.16 41.49 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.674 ' HG2' HG13 ' A' ' 83' ' ' VAL . 88.2 Cg_exo -37.23 147.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 125.034 3.823 . . . . 0.0 114.301 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -61.32 -40.33 93.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.957 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.76 85.8 3.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.984 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.51 -22.67 18.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.075 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -57.58 -29.27 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.216 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.23 -38.56 91.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.724 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m 65.6 -56.64 0.33 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 123.945 0.778 . . . . 0.0 113.02 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 8' ' ' PRO . 5.7 m -76.87 -37.37 55.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.674 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.8 p -87.68 140.23 16.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.047 0.451 . . . . 0.0 111.426 -172.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -146.47 153.3 40.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.69 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.15 126.43 52.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.447 0.641 . . . . 0.0 111.053 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -109.31 102.84 11.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 71' ' ' VAL . 76.0 t -91.87 114.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 77.2 mt -104.17 133.15 49.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.85 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 87.6 m-85 -102.65 109.91 21.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 17.5 t70 -99.58 131.91 45.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -86.68 108.32 18.6 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.892 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.245 0.847 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.885 172.324 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -138.44 143.83 39.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.689 0.244 . . . . 0.0 110.467 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.89 39.02 20.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.476 0.655 . . . . 0.0 110.596 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.75 116.02 26.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.115 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.83 70.18 2.93 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.197 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 26.3 p80 -83.22 26.54 0.63 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.924 0.392 . . . . 0.0 111.272 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.62 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 26.4 ttt -108.88 -54.48 0.06 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.737 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 7' ' ' MET . 29.9 Cg_endo -64.85 -34.18 50.15 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.355 1.37 . . . . 0.0 111.177 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' HIS . . . -124.81 108.54 12.05 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.49 119.39 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.16 119.61 26.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.688 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.1 t -118.54 130.3 73.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.4 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -108.14 127.07 53.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.476 0.655 . . . . 0.0 110.552 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mt -116.16 129.45 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -102.22 140.12 36.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -132.46 126.87 20.42 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 22.4 Cg_endo -63.59 111.25 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.941 1.76 . . . . 0.0 110.242 172.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.31 -35.44 18.2 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.894 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 3.5 mptp? -68.23 -40.58 82.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.682 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -83.19 -36.69 24.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.832 0.348 . . . . 0.0 110.508 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.546 HG23 HD22 ' A' ' 62' ' ' LEU . 10.8 tp -74.69 -3.49 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.248 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.59 -6.36 22.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.13 168.81 10.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.066 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.41 -44.48 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.13 49.97 3.32 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.178 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.01 -34.9 77.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.39 32.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -95.62 2.1 53.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.19 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -89.56 123.06 33.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.094 0.473 . . . . 0.0 109.996 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.68 -32.59 74.12 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.809 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.765 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 22.4 tp -70.71 -42.36 70.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.93 -43.04 86.05 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.308 0.575 . . . . 0.0 109.831 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.4 tp -70.6 -49.87 43.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.935 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 4.5 p30 -74.8 -27.58 60.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.728 -176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.765 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.2 tt0 -66.63 -45.45 79.03 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.407 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -92.17 7.03 44.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.059 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.04 -27.15 8.42 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.74 -66.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.449 . . . . 0.0 111.171 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 39' ' ' VAL . 9.8 p -85.49 41.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.924 1.345 . . . . 0.0 109.719 -172.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -145.84 -3.94 0.67 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.119 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.88 -30.83 65.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.506 0.669 . . . . 0.0 109.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.8 67.89 79.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 89.4 Cg_endo -95.37 25.48 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.257 2.638 . . . . 0.0 113.263 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.49 -55.58 0.62 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.456 0.702 . . . . 0.0 111.773 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.13 -108.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.257 0.551 . . . . 0.0 111.126 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -93.88 -124.79 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.565 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.668 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . -153.1 -89.17 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.562 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -58.38 -39.6 76.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.668 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 32.8 Cg_endo -77.63 -23.97 9.28 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 120.82 1.329 . . . . 0.0 110.591 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.604 HD22 ' NE1' ' A' ' 53' ' ' TRP . 3.1 tm? -58.87 -46.01 88.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.725 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 48' ' ' MET . 13.0 ptt180 -67.36 -38.6 85.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.42 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.69 80.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.891 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.604 ' NE1' HD22 ' A' ' 50' ' ' LEU . 7.6 p-90 -72.93 -37.28 67.24 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.885 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.47 -51.11 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.43 -41.15 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.734 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -62.45 -49.5 75.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.768 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.44 -45.24 94.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.99 92.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -57.79 -58.23 9.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.299 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 51.0 mt-10 -64.08 -41.95 97.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.856 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.72 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -76.84 -47.79 20.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.035 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.68 -27.35 65.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 2.7 mmmp? -69.36 -29.15 66.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -149.01 73.62 10.19 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.921 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.12 41.39 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.076 2.517 . . . . 0.0 113.171 -170.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -133.44 26.22 4.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 pt -104.38 -172.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.3 0.571 . . . . 0.0 111.67 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -127.04 -44.01 1.64 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.555 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -164.46 152.87 12.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -122.73 156.96 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.985 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -110.47 116.88 32.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.71 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 73' ' ' LEU . 7.3 mt -106.08 144.28 33.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.3 0.571 . . . . 0.0 111.198 -174.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 13.4 tmtt? -123.83 115.38 27.96 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.887 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.598 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 90.0 Cg_exo -46.32 138.51 13.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.867 3.045 . . . . 0.0 113.521 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -56.91 -29.51 63.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.031 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.67 96.94 0.07 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.054 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.4 -29.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.269 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -61.69 -28.54 69.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.829 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -73.54 -39.77 64.49 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.076 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 m 64.4 -71.97 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.436 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 m -91.92 59.6 3.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 ' HG2' ' A' ' 75' ' ' PRO . 7.3 p -140.95 136.22 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.978 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.38 160.16 40.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.229 0.538 . . . . 0.0 111.399 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.598 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 62.0 m-85 -120.79 123.62 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.709 171.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -91.9 101.65 14.22 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.77 112.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -111.2 138.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.661 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -103.61 110.35 22.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.906 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 7.5 m-20 -99.34 132.36 44.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.721 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 1.1 pm0 -94.59 120.9 35.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.252 0.549 . . . . 0.0 110.811 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.139 175.476 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 m -70.94 -33.29 70.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.92 83.0 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.417 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -58.56 -46.15 87.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.279 0.561 . . . . 0.0 109.708 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.81 179.27 41.24 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.253 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 41.7 m80 -78.95 91.32 4.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.548 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 21.8 mmt -64.22 -53.73 44.78 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.9 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 64.0 Cg_endo -92.63 37.3 0.23 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.009 1.806 . . . . 0.0 112.452 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 6' ' ' HIS . . . -107.52 135.99 48.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.629 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.98 118.6 44.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.503 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -108.39 117.78 35.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -106.06 140.24 24.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -103.09 112.26 25.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.421 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.401 HD13 ' SD ' ' A' ' 36' ' ' MET . 40.2 mt -111.63 142.65 23.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 64.7 m80 -125.61 119.52 28.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.632 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 21.8 m-85 -118.11 106.96 44.43 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.157 174.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_exo -59.07 123.33 13.25 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 121.931 1.754 . . . . 0.0 111.586 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -48.86 19.74 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -68.74 -29.11 67.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.431 HH21 ' CD ' ' A' ' 92' ' ' GLU . 12.4 ptp180 -94.58 -28.66 15.28 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.605 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 6.1 tp -72.91 -25.06 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.184 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -82.17 -11.22 58.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.052 0.453 . . . . 0.0 110.686 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.57 177.11 6.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.438 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.58 151.93 24.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 21.61 51.15 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -170.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -61.84 -30.51 70.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.544 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.24 59.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.214 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -76.64 -27.29 55.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.425 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.89 102.55 0.79 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.039 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 35.8 tt0 -62.46 -31.13 71.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.008 -171.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' HG ' ' NE2' ' A' ' 35' ' ' GLN . 36.8 tp -60.65 -42.51 97.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.46 -42.14 83.51 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.618 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.432 HD11 ' NH2' ' A' ' 51' ' ' ARG . 7.3 tp -67.16 -46.3 74.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.779 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 93.5 m-20 -59.74 -42.95 94.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' HG ' ' A' ' 31' ' ' LEU . 43.3 mt-30 -64.86 -43.49 92.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 72.2 mmm -87.69 9.02 22.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.78 -29.26 5.04 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 166.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -73.19 -61.62 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.587 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -92.77 30.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.428 1.109 . . . . 0.0 110.188 -171.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.616 HD21 ' HB2' ' A' ' 50' ' ' LEU . 26.0 t-20 -141.6 0.78 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.778 -170.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.77 -47.07 76.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.294 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.37 72.04 82.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 50' ' ' LEU . 75.6 Cg_endo -92.69 23.09 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.095 2.53 . . . . 0.0 113.577 -172.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 71.3 -57.33 0.61 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.257 0.623 . . . . 0.0 112.004 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.876 ' HB3' HD11 ' A' ' 50' ' ' LEU . 5.5 tp10 -67.0 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.895 0.478 . . . . 0.0 111.231 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -127.93 -91.95 0.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 170.63 -114.42 0.54 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.897 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -56.91 -40.14 82.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.58 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.21 -37.38 69.98 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.921 1.747 . . . . 0.0 112.11 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 45' ' ' GLU . 2.9 mt -60.08 -45.56 92.5 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 36' ' ' MET . 1.8 ttt180 -56.55 -41.83 77.5 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.106 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.76 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.1 -40.32 68.27 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.767 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -43.08 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 71.2 mt -64.06 -44.89 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 176.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.63 -48.4 77.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.603 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.0 m -67.59 -39.38 84.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.089 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.64 89.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.819 0.342 . . . . 0.0 110.26 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.44 -54.56 39.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.578 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.02 -36.74 82.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.3 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 65' ' ' ASN . . . -65.83 -33.37 75.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.191 0.52 . . . . 0.0 110.932 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' C ' HD13 ' A' ' 62' ' ' LEU . 2.9 tm? -83.62 -41.43 17.82 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.717 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -79.64 -29.13 40.87 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.107 -0.37 . . . . 0.0 111.321 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -89.64 -14.78 34.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.822 0.82 . . . . 0.0 109.315 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.507 HD21 HG23 ' A' ' 68' ' ' ILE . 11.6 t30 -144.45 68.9 15.34 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.373 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.24 37.93 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.767 2.312 . . . . 0.0 112.766 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.41 -17.97 13.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.498 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.507 HG23 HD21 ' A' ' 65' ' ' ASN . 2.5 pp -80.77 -173.46 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.426 0.632 . . . . 0.0 112.184 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -140.94 -16.42 0.87 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.643 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.25 163.06 20.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.199 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.3 p -134.59 153.25 34.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.075 0.464 . . . . 0.0 110.422 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -109.52 113.58 26.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -121.8 143.82 49.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.544 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -116.89 131.78 23.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.33 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' A' ' 83' ' ' VAL . 86.8 Cg_exo -51.41 151.62 13.22 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.382 2.721 . . . . 0.0 112.848 172.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -63.12 -33.19 74.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.733 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -65.87 112.81 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.751 0.786 . . . . 0.0 111.131 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.4 -33.54 59.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.771 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -65.02 -26.13 68.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.743 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 87.7 m-20 -64.55 -29.36 70.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.783 0.325 . . . . 0.0 110.909 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.9 t 66.67 -82.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.666 173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 t -108.8 37.99 2.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -168.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 80' ' ' ASN . 13.1 p -101.03 130.04 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -130.36 136.31 48.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 12' ' ' VAL . 10.9 m-30 -105.61 124.2 49.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.742 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.27 102.47 12.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 40.4 t -94.43 111.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.92 140.43 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.425 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 78.9 m-85 -101.33 108.22 19.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 6.5 t70 -83.94 135.78 34.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.265 -169.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.83 113.84 26.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.351 0.596 . . . . 0.0 109.981 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' HG3' ' HB3' ' A' ' 17' ' ' PRO . 1.7 pp20? . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.845 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 m -75.04 -30.29 61.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.796 0.331 . . . . 0.0 111.195 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 4' ' ' MET . . . -86.65 63.6 8.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 26.8 ptm 51.12 -171.72 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.544 1.137 . . . . 0.0 112.46 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.43 124.68 5.48 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.817 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -118.3 96.3 5.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.9 ttt -101.82 111.36 63.97 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.33 70.13 7.65 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.835 2.357 . . . . 0.0 111.628 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -84.67 119.4 25.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.512 -173.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.1 t -91.72 119.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.101 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.81 119.01 33.58 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.23 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.28 130.19 55.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.271 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -108.41 117.17 33.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.507 0.67 . . . . 0.0 110.406 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.438 HD13 ' SD ' ' A' ' 36' ' ' MET . 33.4 mt -115.75 133.06 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.06 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -120.84 107.72 13.07 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.589 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.3 132.23 24.75 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.847 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 10.2 Cg_exo -66.56 120.73 7.88 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.672 1.581 . . . . 0.0 109.547 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -53.92 -42.23 68.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.814 -167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 7.7 mtmp? -79.56 -24.11 42.34 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.492 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 17' ' ' PRO . 7.8 mpt_? -81.28 -38.03 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.53 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tp -70.75 -26.31 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.287 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.23 65.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.99 157.85 34.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.55 -21.72 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.335 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.52 38.94 3.14 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' O ' HD22 ' A' ' 32' ' ' LEU . 32.1 p90 -66.36 -35.94 81.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.503 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.0 -9.68 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.224 0.535 . . . . 0.0 111.29 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.38 -3.2 50.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 20' ' ' ARG . 24.3 t70 -82.2 124.78 30.21 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.302 0.572 . . . . 0.0 110.738 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.29 -28.98 70.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -170.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 3.1 tm? -76.51 -36.82 57.53 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.69 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -66.23 -40.33 90.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.829 177.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.31 -49.6 63.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.966 -176.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 5.9 p30 -73.45 -34.06 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.91 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 32' ' ' LEU . 3.5 pt20 -67.99 -41.48 82.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.926 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.459 ' HG3' HD11 ' A' ' 55' ' ' ILE . 86.7 mmm -90.32 5.82 45.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.11 -28.19 11.19 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 164.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 68.1 mttm -77.11 -73.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.344 -0.428 . . . . 0.0 111.986 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.59 50.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.722 0.772 . . . . 0.0 110.564 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -142.49 -23.9 0.66 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.404 -170.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 1.6 p-10 -87.18 -18.23 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.173 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 p -133.27 57.43 27.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.25 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 42' ' ' THR . 26.5 Cg_endo -101.52 24.01 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.321 2.681 . . . . 0.0 113.814 -174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 43' ' ' PRO . 10.9 tp10 70.54 -58.04 0.56 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.053 0.541 . . . . 0.0 112.239 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.584 ' HB3' HD11 ' A' ' 50' ' ' LEU . 37.8 tt0 -73.09 -86.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.601 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 51.3 mt-10 -127.32 -95.7 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.171 -0.331 . . . . 0.0 110.569 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 162.18 -83.05 0.12 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.84 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.477 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 12.6 tpt -54.36 -49.89 88.08 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 48' ' ' MET . 47.9 Cg_endo -68.56 -27.78 32.46 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.402 1.401 . . . . 0.0 110.02 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 2.3 mt -57.83 -46.31 84.92 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.803 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -64.28 -47.0 81.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 56' ' ' LYS . . . -60.61 -49.87 75.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.841 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.595 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 6.2 p-90 -74.06 -41.29 61.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.888 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.7 t -61.45 -51.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.573 0.225 . . . . 0.0 110.636 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 36' ' ' MET . 80.1 mt -60.28 -41.37 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 5.7 tmtt? -63.2 -50.43 70.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.578 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -64.14 -41.45 97.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.832 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.72 97.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.369 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.99 -49.58 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.29 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 10.4 mm-40 -61.77 -45.8 92.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.51 93.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.415 ' C ' HD13 ' A' ' 62' ' ' LEU . 3.4 tm? -60.95 -46.03 92.35 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.452 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.4 -27.46 52.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -63.72 -50.3 69.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.995 0.426 . . . . 0.0 109.854 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.411 HD21 HD13 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -130.58 76.04 78.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 121.44 0.638 . . . . 0.0 109.936 177.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 42.02 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.483 2.789 . . . . 0.0 113.237 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -124.89 -1.21 7.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.407 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.411 HD13 HD21 ' A' ' 65' ' ' ASN . 47.0 pt -83.0 -174.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.38 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -143.04 -18.25 0.66 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.697 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -165.63 157.73 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.108 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 87' ' ' VAL . 20.1 m -135.24 155.49 37.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -111.56 116.83 31.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.217 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.479 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 15.5 mt -108.44 140.22 42.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.77 0.795 . . . . 0.0 112.611 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD2' ' HD2' ' A' ' 75' ' ' PRO . 24.3 tptm -120.97 116.68 31.24 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.689 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 83' ' ' VAL . 96.0 Cg_exo -33.29 143.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.766 3.644 . . . . 0.0 114.605 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -62.87 -32.24 73.44 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.305 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.11 69.9 7.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.037 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.5 -22.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.945 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -57.74 -23.77 53.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.494 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -61.97 -36.1 80.46 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m 71.51 -57.1 0.62 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.299 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 17.8 m -96.63 54.57 1.35 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -172.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HB ' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -140.68 134.4 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.208 173.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.42 HE22 ' HB1' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -135.74 143.98 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -117.17 123.98 48.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.176 0.513 . . . . 0.0 109.957 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -101.68 103.61 14.4 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.017 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.43 ' HB ' HG23 ' A' ' 71' ' ' VAL . 74.7 t -95.85 112.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.1 mt -113.26 142.36 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -101.81 110.49 22.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.303 0.573 . . . . 0.0 110.131 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.49 133.03 38.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.238 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 1.4 pm0 -83.01 116.38 22.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.516 0.674 . . . . 0.0 110.026 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.504 ' CD ' ' HB2' ' A' ' 19' ' ' LYS . 5.6 pt-20 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.066 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 p -111.69 155.85 22.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.814 0.34 . . . . 0.0 110.542 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.83 143.97 49.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.09 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.36 60.26 4.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.149 0.499 . . . . 0.0 110.793 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.5 25.52 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.332 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 40.1 m80 -139.78 56.31 1.64 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 109.77 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.89 88.29 11.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.894 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 7.9 Cg_exo -72.72 138.37 28.96 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.939 2.426 . . . . 0.0 112.0 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.29 113.02 18.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.056 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.6 118.86 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.831 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.0 118.69 23.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.17 139.12 49.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -107.43 128.35 54.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.266 0.555 . . . . 0.0 110.235 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.511 HD13 ' SD ' ' A' ' 36' ' ' MET . 44.2 mt -117.13 149.81 19.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -125.96 123.14 37.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.977 0.418 . . . . 0.0 111.099 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 22.1 m-85 -126.09 108.29 24.69 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.814 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 36.7 Cg_exo -57.55 124.16 15.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.02 1.813 . . . . 0.0 111.546 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -49.83 9.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -170.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -77.04 -29.17 55.1 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.232 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -79.92 -34.33 39.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.82 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 5.4 tp -73.63 -14.59 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.975 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.4 -7.78 54.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.19 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 26' ' ' TYR . . . -83.58 149.13 26.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.941 0.401 . . . . 0.0 110.689 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.66 -40.07 29.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.278 0.561 . . . . 0.0 109.826 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.21 44.8 2.63 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.639 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.544 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 26.2 p90 -70.1 -10.6 59.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.381 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.75 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.539 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -80.53 -16.96 52.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.894 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 31.1 m-20 -81.72 94.55 7.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.636 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -60.4 -31.29 70.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.74 -173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.618 HD13 ' NE2' ' A' ' 35' ' ' GLN . 1.3 tm? -57.08 -42.94 81.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 26' ' ' TYR . 6.9 tp -64.2 -43.65 94.38 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -67.5 -44.99 77.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.617 -178.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -56.31 -46.14 79.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.748 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.618 ' NE2' HD13 ' A' ' 31' ' ' LEU . 6.3 mt-30 -64.74 -44.56 89.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.563 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.58 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 82.3 mmm -91.78 18.0 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.735 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.73 -31.5 3.16 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 163.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -70.54 -63.78 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -0.634 . . . . 0.0 111.086 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 35' ' ' GLN . 26.8 m -90.84 41.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.846 0.831 . . . . 0.0 110.088 -175.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 51' ' ' ARG . 28.3 t-20 -137.25 -21.99 1.17 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.584 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.57 -43.72 96.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.5 t -135.26 79.2 50.12 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.856 0.836 . . . . 0.0 110.192 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 72.6 Cg_endo -91.33 14.44 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.077 2.518 . . . . 0.0 112.609 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 72.74 -47.45 0.67 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.684 0.794 . . . . 0.0 111.297 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 54.9 mm-40 -56.32 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.204 0.525 . . . . 0.0 111.066 174.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -146.04 -98.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.582 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.577 ' H ' ' HD2' ' A' ' 49' ' ' PRO . . . 174.1 -83.23 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 168.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -54.23 -45.73 99.1 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 47' ' ' GLY . 11.7 Cg_exo -72.84 -28.24 13.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.081 1.854 . . . . 0.0 110.715 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.7 tm? -57.34 -44.77 84.55 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.58 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 34.4 ttp180 -67.06 -49.32 65.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.159 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.49 80.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.75 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.695 ' HE1' HD22 ' A' ' 50' ' ' LEU . 5.6 p-90 -72.75 -39.07 67.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.022 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.17 -43.1 79.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.743 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.73 -41.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 110.518 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -65.33 -44.99 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.113 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 t -63.76 -44.87 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.458 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.966 0.412 . . . . 0.0 110.394 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -60.05 -50.95 71.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.299 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.23 -34.89 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.211 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.02 -42.44 76.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.97 0.414 . . . . 0.0 111.185 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 62' ' ' LEU . 2.9 tm? -72.14 -47.32 51.89 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.486 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.99 -28.8 63.64 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 111.841 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -86.26 -12.64 49.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.91 0.862 . . . . 0.0 109.173 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.66 HD21 HG23 ' A' ' 68' ' ' ILE . 8.7 t30 -154.64 73.43 5.95 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.041 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -85.86 34.34 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.605 2.203 . . . . 0.0 112.629 -170.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.41 -2.78 13.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.75 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.66 HG23 HD21 ' A' ' 65' ' ' ASN . 6.1 pt -84.96 166.9 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 121.371 0.605 . . . . 0.0 111.388 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 89' ' ' PHE . 35.4 ptt180 -138.46 -4.16 1.66 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.509 176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -167.75 149.47 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.479 171.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.2 m -136.83 156.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 122.706 0.402 . . . . 0.0 110.015 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.84 117.74 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.879 0.371 . . . . 0.0 110.052 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.33 141.09 45.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.301 0.572 . . . . 0.0 112.361 -174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -108.78 122.18 40.87 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 59.3 Cg_endo -70.3 -179.97 3.55 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.878 2.385 . . . . 0.0 114.542 -171.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 76' ' ' ARG . 47.3 mtp180 -65.12 -54.74 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.73 -167.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 45' ' ' GLU . . . -58.96 107.2 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 0.0 111.828 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.82 -37.93 79.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.672 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -70.68 -25.05 62.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.151 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' ND2' HG11 ' A' ' 83' ' ' VAL . 59.8 t30 -65.14 -36.48 84.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.008 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t 67.24 -89.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 163.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.7 m -80.46 63.91 5.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.604 0.716 . . . . 0.0 111.592 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG11 ' ND2' ' A' ' 80' ' ' ASN . 4.9 p -139.92 129.59 28.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.511 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -128.39 137.12 51.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.229 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -115.3 122.49 46.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.314 0.578 . . . . 0.0 110.28 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -95.81 108.64 20.99 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.226 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -92.12 108.88 20.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.79 141.34 17.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.597 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 72.2 m-85 -100.77 111.61 23.87 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 13.4 t70 -74.94 142.88 43.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.2 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.16 112.74 16.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.488 0.661 . . . . 0.0 109.33 -167.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--O 1.247 0.93 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.288 -172.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 m -67.12 -59.04 3.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.739 0.304 . . . . 0.0 110.43 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -161.77 129.96 4.21 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -72.8 126.48 30.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.593 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.15 -35.8 4.26 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.079 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.424 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 37.8 m80 -142.95 80.91 1.7 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.509 0.195 . . . . 0.0 110.846 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.488 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 22.5 mmt -65.04 -47.92 72.11 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.802 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 16.3 Cg_exo -69.1 131.68 22.7 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.844 1.696 . . . . 0.0 111.831 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -86.11 122.84 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.5 t -125.95 125.46 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -120.16 132.95 55.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.175 0.512 . . . . 0.0 110.028 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.01 119.71 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.4 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 7.1 pt-20 -102.21 113.77 27.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.341 0.591 . . . . 0.0 110.846 -174.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.481 HD13 ' SD ' ' A' ' 36' ' ' MET . 5.9 mt -105.66 142.73 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.104 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 73.1 m80 -113.07 112.67 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.076 0.465 . . . . 0.0 110.579 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 14.7 m-30 -104.08 120.62 50.43 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.533 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HD2' ' HE ' ' A' ' 20' ' ' ARG . 32.3 Cg_exo -58.96 116.37 3.21 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.048 1.832 . . . . 0.0 111.081 174.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.2 tm? -46.68 -43.28 17.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.55 -173.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' A' ' 92' ' ' GLU . 21.4 mtpp -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.136 -172.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HE ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -88.63 -29.47 19.93 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.253 -173.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.476 HG23 HD22 ' A' ' 62' ' ' LEU . 6.1 tp -74.47 -25.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.29 11.95 9.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.642 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.95 173.94 7.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.813 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -116.13 144.35 44.27 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.1 22.83 16.25 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -168.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -59.84 -18.66 45.81 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.909 -0.646 . . . . 0.0 111.688 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.9 66.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.74 1.36 57.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.967 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 35.6 t70 -85.6 104.02 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -64.21 -28.12 69.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.2 mt -62.07 -42.94 99.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.123 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.578 HD22 ' NH1' ' A' ' 20' ' ' ARG . 51.9 tp -70.94 -41.58 70.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.23 -46.52 73.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.086 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 4.3 p30 -72.58 -32.39 65.97 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.039 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.746 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.97 -45.33 82.06 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.373 0.606 . . . . 0.0 110.085 177.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.481 ' SD ' HD13 ' A' ' 14' ' ' ILE . 83.0 mmm -91.24 12.3 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.363 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.7 -33.24 6.5 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 162.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 43.8 mmtm -72.28 -75.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.263 -0.469 . . . . 0.0 111.557 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -84.84 60.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 122.138 0.97 . . . . 0.0 110.178 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -161.82 -23.42 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.396 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.63 -39.41 67.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 0.0 110.592 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -134.81 63.98 60.79 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.976 0.893 . . . . 0.0 110.528 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 46.3 Cg_endo -97.3 23.54 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.364 2.709 . . . . 0.0 113.466 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 71.97 -56.13 0.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.768 0.668 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.731 ' HB3' HD11 ' A' ' 50' ' ' LEU . 3.7 tp10 -65.86 -77.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.405 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' H ' ' CD1' ' A' ' 50' ' ' LEU . 41.8 mt-10 -143.7 -91.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.833 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 160.59 -90.72 0.11 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.837 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 6.8 ttp -57.24 -47.35 99.2 Favored Pre-proline 0 C--N 1.314 -0.969 0 O-C-N 122.172 -0.605 . . . . 0.0 112.156 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 48' ' ' MET . 54.4 Cg_endo -69.69 -24.02 30.44 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.34 1.36 . . . . 0.0 110.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 45' ' ' GLU . 3.0 mt -59.1 -47.63 84.54 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.204 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' MET . 32.0 ptt180 -73.73 -33.62 64.43 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.68 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.7 73.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.254 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.544 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 7.0 p-90 -73.75 -42.06 61.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.247 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.1 t -60.0 -51.03 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.611 0.243 . . . . 0.0 111.132 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' HG3' ' A' ' 36' ' ' MET . 97.1 mt -63.79 -41.49 92.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.971 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 46.5 tttm -69.91 -41.47 74.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.927 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.1 m -67.46 -41.46 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.465 0.174 . . . . 0.0 110.803 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.09 85.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 109.914 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 5.1 t-160 -61.46 -53.69 53.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.84 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 17.0 mm-40 -59.0 -47.19 86.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.155 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.8 99.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.333 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 21' ' ' ILE . 6.7 tp -68.88 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.483 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.3 -32.15 73.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -78.96 -20.1 50.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.172 -176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.401 HD21 HD13 ' A' ' 68' ' ' ILE . 1.9 p-10 -145.68 70.13 13.72 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 121.371 0.605 . . . . 0.0 109.697 173.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.09 45.78 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.18 2.587 . . . . 0.0 112.787 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -127.01 -1.19 6.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.522 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.401 HD13 HD21 ' A' ' 65' ' ' ASN . 36.5 pt -86.66 -172.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.739 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 69' ' ' ARG . 4.8 ptp180 -153.19 -0.55 0.24 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.17 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -166.43 157.18 12.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.524 0.202 . . . . 0.0 110.593 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.44 156.73 42.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.989 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -110.35 113.39 26.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.088 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.544 HD22 ' HZ3' ' A' ' 53' ' ' TRP . 12.1 mt -112.27 134.65 53.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -115.03 127.93 26.39 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.252 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 56.0 Cg_endo -69.03 -173.0 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.316 2.011 . . . . 0.0 112.649 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -80.64 -38.87 28.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.684 -174.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' HB3' ' OE1' ' A' ' 45' ' ' GLU . . . -76.28 78.6 3.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.562 0.696 . . . . 0.0 110.365 177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.68 -17.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.421 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -57.35 -24.94 58.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -63.14 -27.95 69.73 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.0 109.898 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.3 m 67.22 -77.12 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.834 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 47.9 m -103.38 29.86 5.34 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -101.23 136.68 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -133.38 160.16 38.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.865 0.364 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.9 120.13 29.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.7 t-160 -110.05 102.64 11.34 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.051 -176.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.88 113.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.846 0.355 . . . . 0.0 110.33 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.5 141.69 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 66.0 m-85 -103.23 114.53 28.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.667 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.54 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 15.7 m-20 -76.08 115.34 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.43 115.76 28.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.319 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 19.3 mm-40 . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.106 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -134.44 15.81 3.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.01 -176.33 0.19 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.233 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 68.8 5.29 4.88 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.353 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.7 120.5 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.376 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -76.67 -43.11 39.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -117.13 141.69 28.86 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.376 174.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' MET . 2.9 Cg_exo -73.57 73.08 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.656 2.237 . . . . 0.0 111.619 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -89.64 131.99 35.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.832 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 83' ' ' VAL . 6.7 m -101.16 137.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.835 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.35 138.81 50.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.799 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -114.46 140.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.78 117.98 35.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.171 0.51 . . . . 0.0 110.499 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.607 HD13 ' SD ' ' A' ' 36' ' ' MET . 22.1 mt -115.24 123.3 70.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.559 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 48.4 m80 -110.74 112.0 23.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.518 0.675 . . . . 0.0 111.11 -177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 17.1 m-85 -106.52 116.97 58.17 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.461 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 35.9 Cg_exo -58.75 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.214 1.942 . . . . 0.0 110.543 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.5 tp -52.61 -39.28 61.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.897 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HE3' ' CB ' ' A' ' 92' ' ' GLU . 15.2 pttp -79.19 -28.57 42.67 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 9.1 mmm180 -81.5 -38.79 25.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.406 -177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.11 -28.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.859 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.62 -21.91 59.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 110.83 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.26 -179.97 6.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.709 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -115.79 18.5 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.939 0.876 . . . . 0.0 109.844 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.5 25.36 10.45 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 170.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.505 ' HB2' HD22 ' A' ' 32' ' ' LEU . 45.0 p90 -71.14 -35.31 71.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.67 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -17.32 60.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 0.0 110.414 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -91.53 -2.06 57.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.608 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 31' ' ' LEU . 22.3 t70 -90.71 116.08 28.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.032 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -57.61 -28.89 64.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.448 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.598 ' HG ' HE22 ' A' ' 35' ' ' GLN . 9.6 tp -70.23 -43.79 69.89 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.7 tp -63.9 -39.5 94.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.623 0.725 . . . . 0.0 109.423 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -41.72 92.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.397 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 92.7 m-20 -60.22 -49.24 78.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.612 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.598 HE22 ' HG ' ' A' ' 31' ' ' LEU . 1.4 mp0 -64.99 -45.1 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.607 ' SD ' HD13 ' A' ' 14' ' ' ILE . 88.7 mmm -97.53 21.26 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.511 . . . . 0.0 111.038 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.98 -34.07 4.13 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 31.9 mmtp -67.95 -68.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.03 76.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 48' ' ' MET . 20.3 t-20 -173.54 -41.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.842 -171.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -40.4 75.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.6 p -142.14 67.2 21.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.199 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 80.8 Cg_endo -89.69 28.21 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.831 2.354 . . . . 0.0 112.352 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 72.58 -50.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.641 0.776 . . . . 0.0 111.414 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.56 -82.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -176.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.22 -86.63 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 110.477 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 161.98 -101.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.122 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.443 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 12.5 tpt -56.22 -44.82 99.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 39.5 Cg_exo -60.77 -33.78 92.51 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.374 2.049 . . . . 0.0 111.414 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -57.93 -45.4 86.61 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.515 176.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 22.7 ttt180 -63.38 -47.72 80.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.004 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.53 -47.72 84.42 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.456 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.707 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.3 p-90 -72.34 -44.57 62.42 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.886 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -40.88 78.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.206 -174.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 69.5 mt -64.45 -45.82 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.834 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 61.0 tttp -64.76 -47.87 76.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.14 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 53' ' ' TRP . 88.9 m -61.14 -43.52 98.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.491 0.186 . . . . 0.0 111.163 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.14 92.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.652 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -61.08 -50.85 71.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.158 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 34.7 mm-40 -61.34 -44.34 97.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.781 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.136 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 tp -71.06 -45.34 63.99 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.77 -25.56 67.97 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.47 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -97.84 -2.2 41.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.517 0.675 . . . . 0.0 109.725 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.74 55.0 1.88 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.91 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.83 48.52 2.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.485 2.124 . . . . 0.0 112.438 -168.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -125.83 -11.64 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.807 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 pp -92.73 -172.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -143.61 -11.91 0.69 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.986 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -165.95 150.35 8.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.143 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 87' ' ' VAL . 18.8 m -131.54 155.66 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.948 0.404 . . . . 0.0 110.298 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -111.48 117.28 32.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.335 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -121.59 144.19 48.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.28 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.547 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -118.05 120.83 32.07 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.95 174.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.613 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 26.5 Cg_endo -61.41 160.41 27.58 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.978 2.452 . . . . 0.0 112.964 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 76' ' ' ARG . 11.7 mtp180 -58.26 -28.62 65.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.151 -172.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.92 86.63 0.71 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.5 0.667 . . . . 0.0 110.708 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.547 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 12.0 p -64.77 -28.09 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.815 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -63.58 -24.69 67.91 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.883 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -64.33 -31.74 73.06 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 110.71 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m 65.98 -74.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 15.7 m -98.15 54.05 1.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.136 0.493 . . . . 0.0 112.113 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.471 HG23 HG23 ' A' ' 10' ' ' VAL . 14.3 p -134.58 130.53 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -132.87 137.76 46.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.141 0.496 . . . . 0.0 111.011 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.2 m-85 -102.36 124.33 47.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.264 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -104.1 103.43 13.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 71' ' ' VAL . 97.3 t -91.97 110.38 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -109.72 139.34 33.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.217 -173.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 83.3 m-85 -102.65 108.95 20.39 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.924 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 7.0 m-20 -75.76 116.89 16.93 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.5 115.29 21.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.406 0.622 . . . . 0.0 109.843 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 39.9 mt-10 . . . . . 0 C--O 1.247 0.921 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.45 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -89.8 28.13 1.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.23 6.02 7.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -76.03 141.6 42.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.068 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.32 -84.57 0.84 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -171.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -138.3 -66.25 0.49 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptm -176.55 80.06 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.76 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.84 -52.28 4.65 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.723 2.282 . . . . 0.0 111.517 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 82' ' ' SER . . . -95.22 131.48 41.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.767 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.0 t -89.87 118.15 34.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -104.82 118.37 36.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.909 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 HG21 ' A' ' 39' ' ' VAL . 95.6 t -107.17 121.19 59.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.191 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -98.38 118.41 34.97 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.005 0.431 . . . . 0.0 109.862 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.5 HD13 ' SD ' ' A' ' 36' ' ' MET . 29.1 mt -114.47 142.94 25.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 67.2 m80 -124.12 125.36 44.35 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 13.2 m-30 -122.46 131.26 24.41 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.602 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 18.4 Cg_endo -60.13 121.52 9.93 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.813 2.342 . . . . 0.0 111.279 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.8 tp -51.42 -36.91 45.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.724 -173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HG3' ' OXT' ' A' ' 92' ' ' GLU . 57.3 mtmt -75.88 -38.86 57.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . 22.2 mtt180 -80.93 -29.86 35.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.2 -15.84 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.553 0.692 . . . . 0.0 109.528 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.77 24.02 7.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.087 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 144.18 44.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.4 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.27 -11.49 46.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.424 . . . . 0.0 110.542 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -99.93 32.6 7.08 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' HB2' HD22 ' A' ' 32' ' ' LEU . 52.6 p90 -63.56 -21.83 66.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.009 -0.595 . . . . 0.0 112.003 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.33 -17.59 64.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 111.017 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -97.67 -9.44 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.934 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' A' ' 26' ' ' TYR . 45.4 m-20 -81.36 103.32 11.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.705 0.764 . . . . 0.0 110.606 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.08 -38.94 71.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.031 -171.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HG ' HE22 ' A' ' 35' ' ' GLN . 17.7 tp -61.75 -39.4 91.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.06 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 26' ' ' TYR . 1.2 tp -68.81 -44.66 73.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.32 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.14 -48.22 68.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.959 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.65 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 p30 -70.21 -32.02 69.72 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.363 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.617 HE22 ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -65.23 -43.33 91.78 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.223 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.5 ' SD ' HD13 ' A' ' 14' ' ' ILE . 81.7 mmm -83.87 4.11 30.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.656 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.34 -29.29 9.65 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 165.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 60.5 mtpt -68.2 -69.89 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.233 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.9 p -100.37 82.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 122.428 1.108 . . . . 0.0 110.424 -175.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -172.08 -26.82 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.842 -170.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -74.84 -36.04 62.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.894 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 p -135.87 67.96 64.33 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 121.366 0.603 . . . . 0.0 110.781 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -98.62 2.19 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.836 3.024 . . . . 0.0 113.168 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 73.61 -44.23 0.57 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.73 0.812 . . . . 0.0 111.922 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' CG ' HD21 ' A' ' 50' ' ' LEU . 42.7 tp10 -60.25 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.263 0.225 . . . . 0.0 111.241 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 76' ' ' ARG . 47.2 mt-10 -145.38 -102.01 0.1 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.614 0.245 . . . . 0.0 110.797 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 168.66 -106.74 0.26 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.375 176.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.592 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 tpt -49.71 -45.94 79.51 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 48' ' ' MET . 18.6 Cg_endo -58.44 -33.19 97.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.977 1.784 . . . . 0.0 111.914 174.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.73 HD23 ' HE1' ' A' ' 53' ' ' TRP . 82.1 mt -57.13 -48.1 79.49 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.184 0.516 . . . . 0.0 109.652 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -61.4 -46.4 90.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.608 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.17 70.62 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.6 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.73 ' HE1' HD23 ' A' ' 50' ' ' LEU . 7.4 p-90 -73.87 -37.82 64.62 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.46 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -69.64 -44.09 79.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.99 -39.79 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.626 0.251 . . . . 0.0 110.744 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -62.72 -48.85 77.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 48.4 t -65.04 -46.98 79.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.872 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.65 84.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.981 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -60.77 -46.73 89.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.858 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -63.18 -47.44 82.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.64 97.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.501 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 62' ' ' LEU . 3.4 tm? -66.34 -46.0 78.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 -178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.54 -27.71 62.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 0.0 111.555 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -66.06 -34.32 77.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.573 . . . . 0.0 110.607 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.417 HD21 HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -146.73 74.55 12.32 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.661 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.92 33.51 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.244 2.629 . . . . 0.0 113.721 -169.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.29 18.42 9.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 65' ' ' ASN . 31.2 pt -97.53 -179.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.692 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -145.23 -8.35 0.6 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -167.88 156.04 8.93 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 111.213 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG22 ' CG1' ' A' ' 87' ' ' VAL . 34.2 m -141.43 159.47 22.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.056 0.455 . . . . 0.0 110.648 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -108.28 120.09 41.38 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 121.8 0.809 . . . . 0.0 108.983 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.425 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 28.9 tp -123.0 141.1 52.33 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.244 -1.343 . . . . 0.0 110.565 -168.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 125.64 28.31 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HB2' ' CD ' ' A' ' 45' ' ' GLU . 52.9 Cg_endo -74.33 173.61 13.92 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.819 1.679 . . . . 0.0 112.77 -175.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 46' ' ' GLU . 57.1 mtp180 -65.72 -36.62 84.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.678 -162.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -68.93 93.53 0.57 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.658 0.742 . . . . 0.0 111.037 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.2 t -61.92 -32.17 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.783 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.24 -23.98 67.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 70.1 m-20 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.065 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p 57.06 -70.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.705 1.253 . . . . 0.0 112.864 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.436 ' HB3' ' HA ' ' A' ' 9' ' ' ALA . 8.1 m -90.89 57.84 3.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.259 0.552 . . . . 0.0 111.655 -172.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.21 130.46 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.53 138.39 36.26 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.133 0.492 . . . . 0.0 111.108 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -102.95 120.97 41.57 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.583 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -108.49 102.81 11.86 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' A' ' 71' ' ' VAL . 8.7 p -97.81 124.05 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.568 -176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.447 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 77.8 mt -112.8 135.71 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.354 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.52 113.07 26.29 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.251 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -77.09 120.92 22.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -81.75 124.25 29.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.506 0.67 . . . . 0.0 110.492 -173.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' OXT' ' HG3' ' A' ' 19' ' ' LYS . 8.8 pt-20 . . . . . 0 C--O 1.246 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.032 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -141.7 -51.82 0.42 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.0 110.697 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.98 99.59 2.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -98.01 -4.34 36.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.09 43.9 3.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.067 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.417 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 21.4 m80 -91.5 36.13 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.164 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mmt -92.83 106.36 18.6 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 6' ' ' HIS . 25.8 Cg_exo -62.7 104.15 0.36 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.815 2.343 . . . . 0.0 113.076 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.39 108.97 18.71 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -93.1 127.77 44.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.896 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 4.5 p-10 -122.65 121.65 36.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.424 0.63 . . . . 0.0 110.066 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.2 121.58 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.477 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 50.0 mt-10 -93.95 111.97 23.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 110.855 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 ' SD ' ' A' ' 36' ' ' MET . 13.4 mt -102.33 142.81 15.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.529 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 33.6 m80 -119.64 111.88 18.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.998 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 19.3 m-85 -110.46 117.29 51.4 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.154 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 32.5 Cg_exo -58.51 127.49 24.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.241 1.961 . . . . 0.0 110.954 174.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -49.44 -44.98 45.93 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.36 -173.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 92' ' ' GLU . 17.4 pttp -77.9 -19.78 54.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 20.4 mmm180 -91.24 -36.88 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 7.2 tp -73.44 -14.72 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.304 0.574 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.65 -0.56 57.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.486 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.37 153.59 17.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.316 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.21 -23.34 24.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.161 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.87 18.73 52.32 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.661 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -22.88 65.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.959 0.504 . . . . 0.0 112.018 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.15 -13.61 62.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.118 0.485 . . . . 0.0 110.794 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -116.8 10.17 14.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.067 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.9 119.55 25.01 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.805 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.12 -33.37 73.27 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.931 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.63 -46.65 84.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.328 0.585 . . . . 0.0 109.977 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.42 -38.99 91.57 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.855 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.19 -41.82 80.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.012 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 96.0 m-20 -65.94 -49.37 68.19 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.054 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.55 -46.64 72.17 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.309 0.576 . . . . 0.0 110.265 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.778 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 11.1 tpt -67.45 -44.71 78.01 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.185 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.98 -34.13 57.68 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.634 0.584 . . . . 0.0 112.581 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 71.3 mmtt -60.92 -48.26 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.79 42.79 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.236 0.541 . . . . 0.0 111.611 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.778 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -117.64 -35.61 3.9 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.015 -171.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -81.9 -29.07 32.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.211 0.529 . . . . 0.0 110.537 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 p -127.82 65.45 68.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.226 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 82.3 Cg_endo -90.75 7.29 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.432 2.088 . . . . 0.0 111.533 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 74.12 -49.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.393 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.17 -80.68 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.13 -69.93 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 0.0 111.493 -172.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . 134.96 -95.01 0.25 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.762 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.464 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 6.8 ttp -64.91 -43.56 68.82 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 50' ' ' LEU . 5.3 Cg_exo -79.37 -26.79 4.72 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.526 2.151 . . . . 0.0 108.915 -175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.3 tm? -58.0 -45.53 86.69 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 112.524 -2.126 . . . . 0.0 109.235 172.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -62.97 -49.79 73.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.069 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.22 81.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.576 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.693 ' HE1' HD22 ' A' ' 50' ' ' LEU . 2.5 p-90 -72.16 -39.69 68.55 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.704 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.7 OUTLIER -69.22 -42.63 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.377 -174.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 65.2 mt -67.53 -41.95 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.058 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -61.31 -50.6 72.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.933 0.397 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.421 ' SG ' HD21 ' A' ' 73' ' ' LEU . 47.8 t -63.87 -40.85 97.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.67 87.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.793 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -57.51 -58.09 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.556 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 7.8 pt-20 -69.3 -32.84 72.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.698 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.74 94.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.426 ' C ' HD13 ' A' ' 62' ' ' LEU . 3.4 tm? -67.39 -48.0 68.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.05 -27.49 66.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -64.15 -43.59 94.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.115 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -135.8 75.28 56.15 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.428 0.632 . . . . 0.0 110.113 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 38.51 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.104 2.536 . . . . 0.0 112.444 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 65' ' ' ASN . 34.7 mmtp -131.58 22.39 4.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.11 -174.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.358 0.599 . . . . 0.0 111.337 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -118.11 -49.78 2.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.235 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 88' ' ' ILE . 9.2 pt-20 -163.56 163.19 24.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.425 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.71 149.93 32.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.855 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -110.37 118.58 36.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.513 0.673 . . . . 0.0 109.645 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.9 mt -108.02 144.4 35.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.655 -174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 78' ' ' VAL . 12.8 tmtt? -121.45 120.04 29.08 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 28.8 Cg_endo -61.15 162.2 20.49 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.479 2.786 . . . . 0.0 113.634 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -66.3 -17.63 64.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.844 -175.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.79 89.21 1.35 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.326 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.503 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.3 t -63.22 -21.92 29.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.846 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -56.93 -32.17 65.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.462 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.406 HD22 HG11 ' A' ' 83' ' ' VAL . 37.0 m-20 -73.83 -38.66 64.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -170.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t 70.87 -63.74 0.4 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.761 0.663 . . . . 0.0 111.838 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.5 m -109.0 47.98 0.89 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.406 HG11 HD22 ' A' ' 80' ' ' ASN . 8.5 p -125.35 138.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.971 -0.456 . . . . 0.0 109.884 170.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 46.2 mt-30 -138.9 150.79 46.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.29 0.567 . . . . 0.0 110.714 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.69 117.82 35.11 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 22.4 t-160 -95.29 102.09 13.87 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.899 -173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 63.1 t -97.94 113.27 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.26 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 4.9 mp -101.9 139.8 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 70.9 m-85 -102.4 109.78 21.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.926 0.393 . . . . 0.0 110.172 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 16.7 m-20 -77.39 115.4 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.385 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -87.02 123.03 31.67 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' A' ' 17' ' ' PRO . 40.4 mt-10 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.561 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.406 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 37.9 p 51.01 57.61 6.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.599 0.76 . . . . 0.0 111.125 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.26 10.02 42.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.481 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.0 ttm -50.03 124.32 9.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.562 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.807 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -71.77 -43.46 65.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 mmt -126.97 113.83 22.0 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.901 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.5 -49.48 16.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.985 2.457 . . . . 0.0 111.865 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.7 142.74 51.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.7 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.02 118.05 55.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -105.38 118.74 37.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.191 0.52 . . . . 0.0 111.1 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 28.0 t -119.38 138.79 48.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -121.96 131.23 53.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.279 0.561 . . . . 0.0 111.941 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 ' SD ' ' A' ' 36' ' ' MET . 8.2 mt -106.98 136.09 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.693 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.404 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 48.9 m80 -109.01 127.84 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.483 ' CZ ' HG12 ' A' ' 55' ' ' ILE . 22.7 m-85 -127.8 125.29 23.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.382 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.521 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 19.1 Cg_exo -66.8 120.79 7.91 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 121.934 1.756 . . . . 0.0 111.046 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 29.6 tp -42.18 -44.6 3.79 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.578 1.151 . . . . 0.0 113.645 -167.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -75.7 -40.59 55.48 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.548 ' HD3' ' CG ' ' A' ' 29' ' ' ASP . 14.3 ptp180 -90.75 -19.06 23.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.566 HG23 HD22 ' A' ' 62' ' ' LEU . 6.5 tp -72.26 -21.04 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.17 -14.44 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.552 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.61 151.76 34.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.575 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -78.46 -28.54 46.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.379 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.24 3.02 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -66.15 -38.64 88.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.412 -0.394 . . . . 0.0 111.641 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -1.37 21.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -104.92 -7.95 18.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.548 ' CG ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 t70 -81.17 121.32 25.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.216 0.531 . . . . 0.0 110.966 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.18 -35.33 78.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.206 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 4.4 mt -65.44 -42.44 92.39 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.034 0.445 . . . . 0.0 110.005 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.3 -41.89 76.16 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.336 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.7 mt -66.37 -49.04 68.22 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.407 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 2.7 p30 -74.88 -28.66 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.811 -175.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -69.65 -47.03 64.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.784 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 15.5 tpt -72.25 -42.6 65.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.692 176.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.67 -32.31 46.74 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.446 -0.407 . . . . 0.0 112.377 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.03 -53.38 39.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 39' ' ' VAL . 48.3 t -85.17 39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.132 0.968 . . . . 0.0 110.535 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.784 ' HB2' ' O ' ' A' ' 36' ' ' MET . 2.5 t-20 -133.44 -30.92 1.26 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.103 -0.998 . . . . 0.0 112.918 -170.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.511 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 26.2 t70 -80.04 -27.35 39.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -172.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.1 p -122.67 60.78 14.88 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 50' ' ' LEU . 26.8 Cg_endo -98.86 1.74 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.846 2.364 . . . . 0.0 113.711 -173.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 2' ' ' SER . 34.8 tt0 74.04 -46.83 0.63 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.554 0.742 . . . . 0.0 111.92 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' CB ' HD21 ' A' ' 50' ' ' LEU . 37.5 mt-10 -65.6 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 111.739 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -126.09 -77.95 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.266 0.555 . . . . 0.0 110.464 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.748 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 148.96 -96.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.834 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.73 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 1.5 tmt? -59.8 -40.68 80.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 O-C-N 122.121 -0.635 . . . . 0.0 112.34 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 48' ' ' MET . 38.2 Cg_exo -64.54 -29.78 61.37 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.706 1.604 . . . . 0.0 110.742 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -59.88 -47.77 84.39 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.581 178.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -67.46 -40.72 85.35 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.993 178.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.4 -49.32 78.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.385 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.674 ' CH2' HD21 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -71.67 -46.13 59.83 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.984 -176.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG11 ' HE1' ' A' ' 36' ' ' MET . 1.4 p -70.68 -41.78 77.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.462 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.483 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 90.4 mt -64.64 -42.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.722 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 59.9 tttp -65.22 -46.6 79.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.141 176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.6 -43.53 89.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.608 0.242 . . . . 0.0 110.904 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.7 95.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.385 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -60.09 -52.24 66.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.565 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.722 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 32.5 mm-40 -58.78 -44.18 90.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.254 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.83 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.747 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 21' ' ' ILE . 6.6 tp -67.31 -46.34 73.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.605 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -68.44 -25.92 65.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.342 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -63.96 -48.55 76.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -131.47 75.58 76.8 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.208 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.83 43.61 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.078 2.519 . . . . 0.0 112.675 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -128.46 10.38 6.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.846 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 pt -98.34 179.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.173 0.511 . . . . 0.0 110.989 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -128.36 -18.4 4.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.839 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.95 158.41 17.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.304 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 11.0 p -129.09 151.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -109.61 112.74 25.01 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 122.17 0.986 . . . . 0.0 109.36 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.674 HD21 ' CH2' ' A' ' 53' ' ' TRP . 8.8 tt -125.95 144.7 50.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.558 -163.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -126.95 132.32 24.27 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.236 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.657 ' HG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -33.82 140.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.141 3.894 . . . . 0.0 115.764 175.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -58.78 -38.93 79.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.007 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 74.31 4.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.409 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.18 -19.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.129 -176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.78 -23.77 65.27 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.63 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -63.24 -33.75 76.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.074 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m 69.84 -68.05 0.21 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.121 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.9 m -73.95 -19.5 60.65 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 75' ' ' PRO . 5.6 p -86.47 129.4 38.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.304 0.573 . . . . 0.0 110.669 -174.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -130.69 137.53 49.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.041 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 19.9 m-85 -106.67 125.94 51.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.579 0.704 . . . . 0.0 110.652 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -105.14 104.92 14.74 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.401 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 48.1 t -92.4 112.09 25.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.404 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 73.9 mt -105.66 137.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.006 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 67.6 m-85 -103.33 109.67 21.37 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.676 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 115.52 16.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 0.0 110.231 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -84.89 134.05 34.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.074 -179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.605 -0.712 . . . . 0.0 110.318 -176.291 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -58.03 -41.23 82.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.43 122.04 28.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.9 tpp 74.06 -58.21 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.956 0.785 . . . . 0.0 112.275 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.75 -43.57 97.56 Favored Glycine 0 C--O 1.234 0.155 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.389 -174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -77.44 65.69 3.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.217 0.532 . . . . 0.0 110.248 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.45 ' HB3' ' CD ' ' A' ' 8' ' ' PRO . 50.8 ttp -164.24 -58.43 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.416 177.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' CD ' ' HB3' ' A' ' 7' ' ' MET . 43.9 Cg_endo -68.96 -37.94 10.38 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.616 1.544 . . . . 0.0 110.755 171.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.87 115.73 30.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.178 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.85 118.99 38.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.208 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -123.47 119.45 30.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.403 0.62 . . . . 0.0 109.595 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.568 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 96.3 t -120.95 125.48 74.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.065 -177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -105.54 112.92 26.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.459 0.647 . . . . 0.0 111.265 -174.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 4.1 mt -101.6 128.01 54.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.509 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 79.8 m80 -104.13 109.6 21.46 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.288 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 18.6 m-30 -107.14 117.58 55.99 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.151 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' HG22 ' A' ' 21' ' ' ILE . 31.6 Cg_exo -59.7 120.56 8.44 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.07 1.847 . . . . 0.0 110.982 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 62' ' ' LEU . 2.9 tt -50.57 -36.24 33.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.91 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 18.6 ptpt -72.2 -32.76 67.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.169 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 29' ' ' ASP . 3.0 mmp_? -92.76 -39.03 11.47 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 17' ' ' PRO . 6.8 tp -72.43 -21.99 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.278 0.561 . . . . 0.0 109.638 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.69 -26.96 64.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.846 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.07 155.59 25.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.855 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.18 -31.35 30.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.592 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.47 49.27 2.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.942 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' HB2' HD22 ' A' ' 32' ' ' LEU . 6.3 p90 -73.48 -18.34 61.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.614 0.245 . . . . 0.0 111.598 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.61 -13.39 62.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 -24.32 52.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.166 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 20' ' ' ARG . 7.7 m-20 -83.72 110.81 18.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.87 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.3 -25.11 67.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.797 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.2 pp -54.41 -41.63 69.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.879 0.847 . . . . 0.0 110.196 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 31' ' ' LEU . 15.5 tp -73.18 -27.92 61.92 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.499 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.28 -45.82 65.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.901 172.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -61.07 -38.17 85.29 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.45 -46.68 82.06 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.994 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.67 ' HE1' HG11 ' A' ' 54' ' ' VAL . 83.9 mmm -94.46 17.6 12.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.702 0.763 . . . . 0.0 110.11 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.31 -24.44 7.15 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 164.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -82.81 -65.65 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.256 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' CG1' ' A' ' 12' ' ' VAL . 30.1 m -100.83 45.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.639 0.733 . . . . 0.0 111.072 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -139.79 -17.71 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.896 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.4 -38.2 68.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.866 0.365 . . . . 0.0 110.512 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 p -127.59 70.84 77.08 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.2 Cg_endo -92.65 13.28 1.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.949 2.433 . . . . 0.0 112.393 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 73.44 -40.45 0.47 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.203 1.001 . . . . 0.0 112.343 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 50' ' ' LEU . 37.7 mt-10 -74.53 -78.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 111.414 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 50' ' ' LEU . 44.4 mt-10 -138.63 -80.06 0.33 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 111.103 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.793 ' O ' ' HB2' ' A' ' 50' ' ' LEU . . . 154.31 -92.79 0.13 Allowed Glycine 0 C--O 1.222 -0.624 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.697 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.474 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 1.5 tmt? -62.79 -43.93 84.51 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.931 -0.747 . . . . 0.0 112.692 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 48' ' ' MET . 41.4 Cg_endo -70.63 -24.44 25.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 120.913 1.075 . . . . 0.0 109.765 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -58.37 -45.86 87.43 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.115 172.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -61.51 -48.74 79.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.191 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.5 -49.57 77.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.806 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.742 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 8.2 p-90 -73.52 -37.76 65.55 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.272 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.67 HG11 ' HE1' ' A' ' 36' ' ' MET . 0.8 OUTLIER -69.3 -41.4 81.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.0 110.165 -174.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.58 -41.7 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.673 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -61.94 -50.11 73.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.207 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.6 t -62.36 -46.19 89.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.995 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.17 79.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 0.0 110.501 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -62.59 -50.5 71.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.129 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.02 -34.86 79.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.837 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.99 88.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' HG ' ' A' ' 18' ' ' LEU . 4.7 tt -71.23 -48.41 51.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.403 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -65.15 -25.7 67.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.693 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.81 -33.27 75.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 110.25 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -151.36 72.38 8.37 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.078 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.27 39.29 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.965 2.443 . . . . 0.0 113.924 -168.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.12 34.0 4.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.425 0.631 . . . . 0.0 109.532 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.8 pt -106.47 -175.45 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.577 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 16.9 mtm180 -117.52 -51.21 2.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.235 -177.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' HB2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -156.22 161.47 40.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.18 -177.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -132.46 158.4 43.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.435 0.636 . . . . 0.0 111.401 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -109.35 113.37 26.12 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.03 0.919 . . . . 0.0 109.428 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 ' CH2' ' A' ' 53' ' ' TRP . 6.1 tt -110.02 139.26 45.34 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.858 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.55 129.38 25.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.157 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.679 ' HG2' HG13 ' A' ' 83' ' ' VAL . 75.3 Cg_exo -46.11 151.03 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.809 3.006 . . . . 0.0 113.292 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -66.98 -37.69 84.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.565 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.6 75.78 2.61 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.737 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.15 -10.72 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.338 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -64.74 -37.1 86.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.184 0.516 . . . . 0.0 110.436 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.3 t 71.46 -67.15 0.27 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.744 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -82.27 6.35 17.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 75' ' ' PRO . 4.8 p -108.39 131.83 57.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.938 0.399 . . . . 0.0 111.034 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -139.21 144.36 38.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.186 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 75' ' ' PRO . 81.0 m-85 -107.62 124.63 50.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.145 0.498 . . . . 0.0 109.789 176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.1 t60 -103.0 106.0 16.43 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 91.8 t -93.22 116.83 35.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.393 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.427 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.4 mp -100.05 136.41 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 40.7 m-85 -103.08 106.68 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.94 0.4 . . . . 0.0 110.381 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 15' ' ' HIS . 22.1 m-20 -79.69 114.86 18.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.013 -176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.95 39.89 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.145 -174.223 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -100.14 37.33 1.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.843 0.354 . . . . 0.0 111.263 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.61 75.88 4.15 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.745 0.307 . . . . 0.0 110.323 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.6 mtp 61.89 -96.02 0.06 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.413 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 9' ' ' ALA . . . -141.43 22.95 2.54 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 69.88 -59.99 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.864 0.866 . . . . 0.0 110.531 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.533 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 39.1 tpp -165.35 -55.23 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.552 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' H ' ' A' ' 7' ' ' MET . 58.7 Cg_endo -71.46 -29.13 16.98 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.894 1.729 . . . . 0.0 113.329 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . . . -96.12 145.69 25.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 39.8 t -107.23 134.74 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.054 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -136.11 134.93 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.37 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.23 138.66 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.243 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -106.82 121.22 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 85' ' ' PHE . 1.3 mt -115.91 122.66 70.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.619 ' HB2' ' OE1' ' A' ' 35' ' ' GLN . 79.6 m80 -99.73 132.01 45.35 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.182 0.515 . . . . 0.0 110.288 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CD1' HG13 ' A' ' 87' ' ' VAL . 3.3 m-85 -119.76 129.07 25.55 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.233 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HG2' ' OD2' ' A' ' 29' ' ' ASP . 21.4 Cg_exo -65.25 110.92 1.65 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.005 1.804 . . . . 0.0 110.389 171.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.4 tm? -45.88 -42.51 12.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.953 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HG3' ' HD2' ' A' ' 20' ' ' ARG . 17.1 ptpt -78.1 -28.53 48.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 3.7 mpt_? -89.68 -35.27 15.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 112.049 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 6.4 tp -66.58 -25.74 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.463 . . . . 0.0 110.129 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.36 12.66 15.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.16 173.02 7.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.975 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.98 -26.86 20.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.229 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.79 46.72 3.48 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.604 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -79.09 -34.6 43.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.735 0.303 . . . . 0.0 111.277 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.04 59.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.303 0.573 . . . . 0.0 110.415 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -83.71 -9.41 58.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.3 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 17' ' ' PRO . 28.7 t70 -85.15 110.54 19.07 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.244 0.545 . . . . 0.0 110.708 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.84 -34.81 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.764 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 5.8 mt -60.77 -46.69 89.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.87 -40.29 65.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.567 0.698 . . . . 0.0 109.794 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.15 -46.06 78.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.343 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 31' ' ' LEU . 3.2 p30 -73.34 -30.78 63.57 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.395 -175.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.619 ' OE1' ' HB2' ' A' ' 15' ' ' HIS . 45.3 mt-30 -73.52 -44.84 56.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.346 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -75.09 -15.64 60.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.633 177.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 -21.2 41.29 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -76.2 -54.83 6.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 35' ' ' GLN . 14.7 m -85.71 59.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.739 0.78 . . . . 0.0 109.782 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.1 t-20 -137.66 -39.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.398 -170.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -70.23 -41.14 73.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.849 -170.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 p -140.98 66.0 24.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.723 0.297 . . . . 0.0 111.51 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.2 Cg_endo -67.46 -62.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.252 1.968 . . . . 0.0 112.011 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 13.4 tp10 152.53 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -76.79 -85.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.587 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -135.7 -79.04 0.43 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.09 0.471 . . . . 0.0 109.988 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 151.17 -109.71 0.43 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.992 176.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.465 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.3 tpt -51.35 -48.21 86.59 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 36.2 Cg_exo -61.41 -40.43 48.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.032 1.821 . . . . 0.0 112.013 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.779 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -61.07 -43.68 98.52 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.958 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -67.63 -34.34 76.77 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.506 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.86 79.98 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.779 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.2 p-90 -72.44 -38.2 68.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.332 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.95 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.047 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.0 mt -57.86 -44.06 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.347 0.117 . . . . 0.0 110.752 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 53.3 tptt -63.85 -49.54 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.85 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.0 t -64.07 -43.86 94.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.051 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.85 92.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.0 109.977 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 6.4 t-160 -58.22 -58.93 6.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.544 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 11.8 pt-20 -66.98 -34.51 77.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -177.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.78 98.81 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 110.552 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 21' ' ' ILE . 7.8 tp -66.84 -45.96 76.59 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 51.6 mt-10 -63.31 -27.85 69.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.404 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -67.46 -39.54 85.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.063 0.458 . . . . 0.0 110.168 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.454 HD22 HG23 ' A' ' 68' ' ' ILE . 2.3 p-10 -141.28 71.74 26.96 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.279 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.95 42.31 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.04 2.493 . . . . 0.0 113.065 -170.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -128.79 11.6 6.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.008 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.454 HG23 HD22 ' A' ' 65' ' ' ASN . 11.2 pt -89.34 178.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.632 0.729 . . . . 0.0 112.268 -176.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -110.37 -43.74 3.85 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.545 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 9.9 pt-20 -163.64 151.27 12.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.832 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.6 150.08 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.63 111.46 22.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.698 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.7 pp -109.85 133.23 53.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.464 0.65 . . . . 0.0 110.833 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -103.24 124.28 38.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 81.1 Cg_endo -80.03 175.97 9.84 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.201 1.934 . . . . 0.0 114.178 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.98 -13.88 62.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.551 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.49 74.99 3.23 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.52 -24.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.042 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -63.74 -27.47 69.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.563 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -78.42 -34.43 47.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.966 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.2 p 58.84 -72.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.709 1.256 . . . . 0.0 112.382 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m -84.07 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 8.5 p -134.32 130.65 54.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -136.92 139.0 41.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.154 0.502 . . . . 0.0 111.437 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.503 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 79.7 m-85 -101.92 128.1 48.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.688 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -96.74 107.95 20.51 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 16' ' ' PHE . 54.0 t -91.81 109.63 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.454 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 66.4 mt -102.42 135.04 41.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.76 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -102.62 110.25 22.13 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -99.36 122.95 43.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.804 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -84.58 113.77 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.123 178.229 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -101.4 104.79 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.911 0.386 . . . . 0.0 110.397 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.35 73.67 10.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.126 0.489 . . . . 0.0 110.218 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptp -82.24 -9.73 59.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.945 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 71.22 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.124 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -94.78 -0.9 53.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 0.0 110.479 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.4 tpt 70.64 110.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.83 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.66 141.43 90.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.46 120.78 27.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.946 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.96 118.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.22 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -127.35 133.58 50.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.967 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 85' ' ' PHE . 1.4 p -117.31 138.56 47.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.68 111.49 23.73 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.309 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.487 HD13 ' SD ' ' A' ' 36' ' ' MET . 17.1 mt -102.79 123.69 56.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.184 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.87 127.11 46.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -120.84 126.96 26.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.17 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 32.5 Cg_exo -59.97 117.03 3.73 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.147 1.898 . . . . 0.0 110.945 171.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.07 -36.89 66.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.931 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.49 -29.16 56.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.651 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HD3' ' HB2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -91.82 -31.38 15.75 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.862 -177.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.32 -19.1 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 109.983 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -89.12 -7.21 56.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.04 149.64 21.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.781 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.73 -21.03 41.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.144 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.63 34.92 4.57 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.401 ' HB2' HD22 ' A' ' 32' ' ' LEU . 53.2 p90 -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.402 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.54 -5.72 38.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 111.173 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.23 -2.94 35.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.855 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.49 117.16 28.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.005 0.431 . . . . 0.0 110.788 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -63.91 -31.59 72.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.076 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 1.5 mm? -61.67 -43.25 99.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.336 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 26' ' ' TYR . 34.2 tp -72.12 -37.59 69.47 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.595 0.712 . . . . 0.0 109.577 -177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.97 -45.64 63.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.349 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -73.44 -33.6 64.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.675 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.72 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.23 -46.72 32.0 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -176.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 51' ' ' ARG . 9.7 tpt -95.06 3.62 54.63 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.22 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.27 -24.01 23.03 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 165.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.37 -68.75 0.42 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.879 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 m -87.73 65.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.87 0.843 . . . . 0.0 110.396 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.476 HD22 HD12 ' A' ' 50' ' ' LEU . 4.5 t-20 -149.56 -27.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.78 -169.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 30.4 t70 -69.18 -44.97 71.1 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.665 0.745 . . . . 0.0 110.196 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -124.74 71.2 59.37 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.249 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 45' ' ' GLU . 73.5 Cg_endo -91.86 -2.12 4.27 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.774 2.316 . . . . 0.0 112.37 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 71.39 -42.58 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.56 0.744 . . . . 0.0 110.428 -173.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -50.67 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.026 175.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 49' ' ' PRO . 44.4 mt-10 -144.07 -73.77 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.595 0.712 . . . . 0.0 109.879 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 146.27 -105.81 0.35 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.528 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.421 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 11.7 tpt -57.3 -46.29 99.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.492 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 12.1 Cg_exo -68.7 -32.29 24.02 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.185 1.924 . . . . 0.0 110.742 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -57.76 -45.24 86.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.853 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.587 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 27.6 ttt180 -65.6 -45.91 81.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.013 175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -48.32 81.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.716 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 3.8 p-90 -72.29 -39.18 68.5 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.019 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -41.15 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.716 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.8 -40.9 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.586 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -58.86 -50.44 74.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.35 . . . . 0.0 111.009 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.453 ' SG ' HD21 ' A' ' 73' ' ' LEU . 44.6 t -61.97 -44.47 96.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.739 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.56 -40.09 94.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.719 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.52 -51.11 71.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.83 -45.73 81.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.343 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.15 99.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.34 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 22' ' ' ALA . 3.0 tm? -66.47 -47.26 73.63 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.33 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.1 -29.5 68.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.669 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.7 -36.76 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 110.324 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.74 75.07 12.2 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.828 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.21 39.99 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.214 2.609 . . . . 0.0 113.206 -170.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -136.3 26.15 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.74 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.5 -172.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.401 0.62 . . . . 0.0 111.835 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -123.99 -45.92 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.37 159.51 17.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.27 155.99 42.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.841 0.353 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.87 114.86 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.026 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.453 HD21 ' SG ' ' A' ' 57' ' ' CYS . 7.3 mt -108.12 140.14 41.75 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -101.86 122.5 47.15 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 91.1 Cg_endo -76.84 -171.19 1.07 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.121 1.881 . . . . 0.0 113.626 -172.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -73.81 -47.03 41.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.024 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.24 76.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 111.063 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 m -68.96 -16.97 21.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.158 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -68.19 -25.31 65.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 110.293 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 83' ' ' VAL . 66.2 t30 -64.46 -25.1 67.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 68.13 -81.49 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.6 173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -83.48 61.48 6.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.223 0.535 . . . . 0.0 111.53 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.474 ' HB ' ' ND2' ' A' ' 80' ' ' ASN . 10.0 p -140.13 135.32 37.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -140.22 137.68 34.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.887 0.375 . . . . 0.0 110.498 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.63 ' CE2' HD21 ' A' ' 50' ' ' LEU . 20.9 m-85 -105.48 119.09 38.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.465 0.65 . . . . 0.0 109.407 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.71 102.87 13.08 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.698 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.1 t -92.8 113.44 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.6 mt -107.47 135.61 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.03 106.86 17.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.171 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -79.4 142.43 35.97 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.419 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -81.64 106.4 13.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.777 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 126.163 1.785 . . . . 0.0 107.896 174.239 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 m -90.29 -35.55 15.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.918 0.39 . . . . 0.0 111.016 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.76 77.16 1.24 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -99.64 170.16 8.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.22 75.6 2.05 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.83 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -67.12 -30.79 70.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.892 0.377 . . . . 0.0 110.311 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 74.0 mtm -67.27 122.27 82.2 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.934 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.52 -37.92 76.97 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.683 2.255 . . . . 0.0 111.332 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.63 122.13 36.67 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.881 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.17 118.42 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -108.53 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.045 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 43.1 t -108.93 135.79 46.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -104.29 112.25 25.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.454 -175.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -108.3 129.14 63.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 68.8 m80 -113.91 127.76 56.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.13 0.49 . . . . 0.0 110.776 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 25.0 m-85 -125.51 121.87 24.83 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.223 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HB2' ' HG2' ' A' ' 20' ' ' ARG . 27.9 Cg_exo -61.11 129.96 30.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.746 1.631 . . . . 0.0 110.84 175.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CD2' HD21 ' A' ' 62' ' ' LEU . 2.5 tm? -50.54 -38.66 46.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.043 -175.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.05 -29.68 60.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.34 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 17' ' ' PRO . 21.3 mmm180 -90.35 -37.19 14.19 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.452 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 tp -73.17 -16.9 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 109.659 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -101.94 18.84 19.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.305 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.95 169.79 8.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.613 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.79 -38.47 18.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.03 42.38 2.28 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.314 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 20' ' ' ARG . 27.1 p90 -73.77 -26.76 60.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.706 0.289 . . . . 0.0 111.36 -176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.14 -4.02 36.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.12 0.486 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -114.69 4.7 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.752 0.787 . . . . 0.0 109.394 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 31' ' ' LEU . 19.2 t70 -87.18 119.6 27.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.511 -175.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.65 -36.71 67.35 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.71 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.471 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 3.9 mm? -63.9 -46.0 86.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.557 0.694 . . . . 0.0 110.665 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -35.84 75.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.358 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.1 -48.01 59.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.241 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.85 -35.67 64.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.728 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.53 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -71.66 -46.6 58.46 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.974 0.416 . . . . 0.0 110.723 -177.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.614 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -93.14 3.75 55.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.21 0.528 . . . . 0.0 110.467 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.62 -26.95 12.18 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 167.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -74.52 -58.86 3.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.286 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 35' ' ' GLN . 20.2 m -86.45 53.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.744 0.783 . . . . 0.0 110.338 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 36' ' ' MET . 3.5 t-20 -134.34 -35.25 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.85 -169.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.6 -35.6 67.92 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 p -128.69 70.17 80.3 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 74.0 Cg_endo -92.63 5.54 3.31 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.878 2.385 . . . . 0.0 112.52 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 72.27 -43.14 0.55 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.786 0.834 . . . . 0.0 111.564 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.663 ' OE1' ' HB2' ' A' ' 75' ' ' PRO . 10.8 tp10 -67.46 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.841 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -139.85 -88.97 0.19 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.51 0.195 . . . . 0.0 111.064 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' LEU . . . 161.42 -92.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.725 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 1.7 tmt? -64.65 -45.22 75.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 48' ' ' MET . 31.9 Cg_exo -65.35 -31.1 53.13 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 121.526 1.484 . . . . 0.0 110.345 174.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.734 HD22 ' HE1' ' A' ' 53' ' ' TRP . 2.5 tm? -58.61 -47.1 85.47 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.045 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 48' ' ' MET . 14.4 ptm180 -69.72 -40.98 75.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.806 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.13 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.734 ' HE1' HD22 ' A' ' 50' ' ' LEU . 11.2 p-90 -73.63 -37.32 65.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.854 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -70.0 -42.27 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.422 0.153 . . . . 0.0 110.931 -175.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.518 HG12 ' CZ ' ' A' ' 16' ' ' PHE . 93.0 mt -67.2 -39.53 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.6 mmmm -62.66 -50.18 72.2 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.707 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.29 -43.42 92.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.733 0.301 . . . . 0.0 110.747 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.22 98.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.541 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -63.44 -45.19 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.366 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 56' ' ' LYS . 43.9 mm-40 -62.07 -47.18 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.38 83.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.155 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.1 tm? -65.17 -47.18 77.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.135 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.66 -27.05 62.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.789 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 3.0 ttmp? -71.5 -38.84 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.173 0.511 . . . . 0.0 110.125 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -135.81 74.98 56.76 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.25 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.45 29.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.455 2.77 . . . . 0.0 113.506 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -125.86 25.72 6.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.222 0.534 . . . . 0.0 110.232 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.71 179.39 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.809 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -118.97 -36.75 3.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.863 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -164.32 168.34 18.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.914 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 87' ' ' VAL . 13.9 p -135.86 148.97 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.96 117.21 33.18 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 49.8 tp -130.71 132.29 45.28 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.54 -164.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -109.77 134.05 20.74 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.488 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 29.0 Cg_endo -61.23 158.78 33.53 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.639 2.226 . . . . 0.0 113.2 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -61.88 -42.86 99.57 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.399 -165.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.84 116.83 8.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.843 0.83 . . . . 0.0 110.946 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.86 -16.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.543 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -58.04 -40.59 81.29 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.149 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -75.09 -36.53 61.7 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.915 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.4 m 70.68 -63.55 0.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.425 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 p -111.18 58.85 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.37 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -135.43 142.13 45.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.952 0.406 . . . . 0.0 111.13 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 99.9 m-85 -105.16 124.29 49.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -97.31 103.89 15.86 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 75.2 t -91.42 110.76 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 89.8 mt -105.48 134.61 46.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.177 -176.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 57.4 m-85 -103.02 106.26 16.75 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.181 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -86.07 126.47 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.18 126.07 42.12 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.694 175.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.586 176.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -91.06 114.25 26.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.833 0.349 . . . . 0.0 110.315 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.61 -61.05 0.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.952 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.3 mmm -91.45 78.37 5.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.17 0.509 . . . . 0.0 110.764 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.65 -176.23 18.35 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -88.7 -47.09 8.5 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.9 tpp -132.91 81.77 57.07 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.701 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.19 -178.57 1.55 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.887 2.391 . . . . 0.0 112.285 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.51 139.75 53.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.38 121.08 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.935 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.25 118.55 36.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.285 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 21.4 t -121.07 121.78 65.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -112.04 132.59 54.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.919 -166.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.18 152.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.568 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.415 ' CD2' ' HB ' ' A' ' 88' ' ' ILE . 64.7 m80 -120.71 128.15 52.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.827 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 8.4 m-85 -127.75 105.63 20.78 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.835 -176.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.768 ' HA ' ' O ' ' A' ' 90' ' ' ASP . 26.3 Cg_exo -60.67 120.55 8.35 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 121.588 1.525 . . . . 0.0 110.888 172.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -54.6 -42.33 70.98 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.804 -169.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG3' HD23 ' A' ' 18' ' ' LEU . 54.8 mtmt -61.25 -32.0 71.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.251 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 5.0 mtt180 -95.55 -35.65 11.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 62' ' ' LEU . 4.8 tp -69.7 -27.13 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.069 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.46 59.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 110.967 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.63 -169.45 1.66 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -125.91 138.36 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.87 17.37 18.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -170.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 20' ' ' ARG . 7.9 t80 -67.03 -23.87 65.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.957 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.1 -9.36 38.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.661 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -103.41 1.66 32.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.708 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.57 112.66 6.99 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -58.57 -42.47 88.06 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.793 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.26 -42.21 90.64 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.517 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -64.52 -39.83 94.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.047 0.451 . . . . 0.0 110.046 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.24 -40.99 87.69 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.996 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -73.49 -41.63 62.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.137 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' A' ' 32' ' ' LEU . 15.3 mt-30 -70.13 -50.39 41.03 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.307 0.575 . . . . 0.0 111.899 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.625 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.0 tpt -80.68 -22.35 40.48 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.8 95.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.245 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -62.87 -56.72 14.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.02 0.438 . . . . 0.0 109.941 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 39' ' ' VAL . 85.8 t -85.19 69.67 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.643 0.735 . . . . 0.0 110.242 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.625 ' HB2' ' O ' ' A' ' 36' ' ' MET . 0.2 OUTLIER -154.08 -34.96 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.748 -175.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.57 -36.8 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.205 -169.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 m -134.27 66.66 71.53 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.813 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -98.11 4.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.585 2.19 . . . . 0.0 112.948 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.85 -39.56 0.45 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.931 . . . . 0.0 112.417 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 0.6 OUTLIER -64.9 -79.25 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.892 0.377 . . . . 0.0 110.363 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -143.95 -81.56 0.18 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.005 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . 156.0 -110.93 0.46 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.194 177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.452 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 5.6 ttp -60.07 -41.35 84.29 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 48' ' ' MET . 43.3 Cg_exo -59.67 -44.47 31.37 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.84 1.693 . . . . 0.0 111.531 174.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HA ' ' CD1' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -60.01 -37.68 80.43 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.606 ' HB2' HD21 ' A' ' 40' ' ' ASN . 22.1 ttt180 -55.51 -49.73 71.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.186 173.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.46 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.747 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.797 ' CD1' ' HA ' ' A' ' 50' ' ' LEU . 1.7 p-90 -72.1 -39.27 69.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.62 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -62.42 -51.04 77.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 96.0 mt -59.63 -36.91 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -48.52 67.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.987 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.432 ' HG ' ' HE3' ' A' ' 53' ' ' TRP . 95.1 m -70.58 -41.06 72.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.589 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.26 89.63 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.506 0.669 . . . . 0.0 109.626 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.661 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 3.3 t-160 -56.62 -54.03 50.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.954 175.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.41 -39.08 93.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.325 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.39 98.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 21' ' ' ILE . 13.2 tp -68.31 -46.65 69.69 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' HIS . 39.4 mt-10 -65.31 -27.62 68.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.799 0.333 . . . . 0.0 110.986 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 12.3 tmtt? -65.33 -34.45 78.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 109.817 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -149.86 75.25 9.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.681 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.91 46.67 2.12 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.323 2.682 . . . . 0.0 113.285 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -143.38 34.87 1.32 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.304 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.411 HD13 ' ND2' ' A' ' 65' ' ' ASN . 23.3 pt -110.7 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.512 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -144.39 -19.85 0.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.467 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -166.34 149.91 7.37 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -139.05 157.84 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.379 . . . . 0.0 110.677 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -116.46 113.27 22.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.657 HD13 ' CH2' ' A' ' 53' ' ' TRP . 3.5 pp -109.28 136.31 48.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.566 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -109.87 129.16 24.24 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 90.5 Cg_endo -77.56 162.75 30.13 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.779 1.653 . . . . 0.0 114.097 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -65.31 -13.67 59.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.499 -172.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.4 88.08 0.64 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.224 0.535 . . . . 0.0 110.035 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.59 -33.06 57.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.607 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.8 -27.44 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.686 ' HB3' ' CG2' ' A' ' 83' ' ' VAL . 5.0 m-20 -65.78 -38.9 90.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.627 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.8 m 61.25 -77.43 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.344 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -83.53 33.74 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.686 ' CG2' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -112.01 130.45 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.85 139.57 51.17 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.763 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.526 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 69.8 m-85 -97.59 120.38 37.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.544 0.687 . . . . 0.0 109.252 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.76 100.61 13.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.547 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.7 t -98.37 112.2 29.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.195 0.521 . . . . 0.0 110.129 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.415 ' HB ' ' CD2' ' A' ' 15' ' ' HIS . 4.0 mp -99.24 141.1 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.259 177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.602 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 58.7 m-85 -101.32 106.46 17.64 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.768 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 m-20 -83.81 136.52 34.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.724 -175.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HA ' HD21 ' A' ' 18' ' ' LEU . 6.1 pt-20 -109.28 125.52 52.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.572 -0.728 . . . . 0.0 109.839 -179.252 . . . . . . . . 0 0 . 1 stop_ save_